id,name,CDEs,Frequency..0.1.normalized.,UMLS.Semantic.Types
1,adjustment-disorders,malignant neoplasms,0.16183,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
1,adjustment-disorders,pharmacotherapy,0.13278,therapeutic or preventive procedure
1,adjustment-disorders,contraceptive methods,0.12863,therapeutic or preventive procedure
1,adjustment-disorders,active brand of pseudoephedrine-triprolidine,0.09959,organic chemical - pharmacologic substance
1,adjustment-disorders,bilirubin,0.09959,biologically active substance - laboratory or test result - organic chemical
1,adjustment-disorders,gravidity,0.09544,finding
1,adjustment-disorders,pregnancy tests,0.08714,diagnostic procedure
1,adjustment-disorders,intravenous infusion procedures,0.08299,therapeutic or preventive procedure
1,adjustment-disorders,creatinine clearance,0.07884,finding
1,adjustment-disorders,pregnancy test negative,0.07469,finding - laboratory or test result
1,adjustment-disorders,positive finding,0.07054,finding
1,adjustment-disorders,life expectancy,0.07054,group attribute
1,adjustment-disorders,skeletal bone,0.05809,body location or region - body part, organ, or organ component - body substance - disease or syndrome
1,adjustment-disorders,congestive heart failure,0.05809,congenital abnormality - disease or syndrome
1,adjustment-disorders,arteries,0.05809,body part, organ, or organ component
1,adjustment-disorders,alanine transaminase,0.05809,congenital abnormality - disease or syndrome - enzyme
1,adjustment-disorders,neoplasm metastasis,0.05809,neoplastic process
1,adjustment-disorders,allergy severity - severe,0.05394,finding
1,adjustment-disorders,body mass index,0.04979,clinical attribute - diagnostic procedure
1,adjustment-disorders,aspartate transaminase,0.04979,enzyme
1,adjustment-disorders,treatment protocols,0.04564,therapeutic or preventive procedure
1,adjustment-disorders,myocardial infarction,0.04564,disease or syndrome - finding
1,adjustment-disorders,operative surgical procedures,0.04564,diagnostic procedure - therapeutic or preventive procedure
1,adjustment-disorders,lung,0.04564,body part, organ, or organ component - disease or syndrome
1,adjustment-disorders,pharmacologic substance,0.04149,pharmacologic substance - therapeutic or preventive procedure
1,adjustment-disorders,heart ventricle,0.04149,body part, organ, or organ component
1,adjustment-disorders,kidney,0.04149,body part, organ, or organ component
1,adjustment-disorders,pathology processes,0.03734,pathologic function
1,adjustment-disorders,hepatic,0.03734,body location or region
1,adjustment-disorders,heart diseases,0.03734,disease or syndrome
1,adjustment-disorders,hypertensive disease,0.03734,biologically active substance - disease or syndrome - finding
1,adjustment-disorders,aggressive behavior,0.03734,mental or behavioral dysfunction
1,adjustment-disorders,pharmaceutical preparations,0.0332,pharmacologic substance
1,adjustment-disorders,insulin,0.0332,pharmacologic substance
1,adjustment-disorders,mass of body structure,0.0332,finding
1,adjustment-disorders,multiple endocrine neoplasia,0.0332,antibiotic - neoplastic process - organic chemical
1,adjustment-disorders,electrocardiogram,0.02905,diagnostic procedure - finding - organic chemical - pharmacologic substance
1,adjustment-disorders,cardiac arrhythmia,0.02905,finding - pathologic function
1,adjustment-disorders,angina pectoris,0.02905,sign or symptom
1,adjustment-disorders,relate - vinyl resin,0.0249,organic chemical
1,adjustment-disorders,congenital abnormality,0.0249,congenital abnormality - disease or syndrome
1,adjustment-disorders,follow-up status,0.0249,finding
1,adjustment-disorders,cerebrovascular accident,0.0249,disease or syndrome - therapeutic or preventive procedure
1,adjustment-disorders,liver function,0.02075,organ or tissue function
1,adjustment-disorders,unstable status,0.02075,finding
1,adjustment-disorders,transaminases,0.02075,enzyme
1,adjustment-disorders,angina unstable,0.02075,disease or syndrome
1,adjustment-disorders,physical assessment findings,0.02075,finding
1,adjustment-disorders,diastolic blood pressure,0.0166,clinical attribute - diagnostic procedure - finding
1,adjustment-disorders,chronic obstructive airway disease,0.0166,disease or syndrome
1,adjustment-disorders,disease of diaphragm,0.0166,body part, organ, or organ component - disease or syndrome
1,adjustment-disorders,moderate adverse event,0.0166,finding
1,adjustment-disorders,spermatocidal agents,0.0166,pharmacologic substance
1,adjustment-disorders,observation of attack,0.0166,finding
1,adjustment-disorders,hypersensitivity,0.0166,clinical attribute - finding - pathologic function
1,adjustment-disorders,diastole,0.0166,clinical attribute
1,adjustment-disorders,brain injuries,0.0166,injury or poisoning
1,adjustment-disorders,epilepsy,0.01245,disease or syndrome
1,adjustment-disorders,nervousness,0.01245,sign or symptom
1,adjustment-disorders,schizophrenia,0.01245,mental or behavioral dysfunction
1,adjustment-disorders,mercury,0.01245,hazardous or poisonous substance
1,adjustment-disorders,injury wounds,0.01245,body substance - injury or poisoning
1,adjustment-disorders,blood pressure finding,0.01245,finding
1,adjustment-disorders,psychiatric problem,0.01245,mental or behavioral dysfunction
1,adjustment-disorders,neurological observations,0.01245,finding
1,adjustment-disorders,depressed mood,0.01245,finding - mental or behavioral dysfunction
1,adjustment-disorders,cardiovascular diseases,0.0083,disease or syndrome
1,adjustment-disorders,systolic pressure,0.0083,clinical attribute - diagnostic procedure
1,adjustment-disorders,investigational new drugs,0.0083,pharmacologic substance - therapeutic or preventive procedure
1,adjustment-disorders,mental disorders,0.0083,mental or behavioral dysfunction
1,adjustment-disorders,chronic disease,0.0083,disease or syndrome
1,adjustment-disorders,ethanol,0.00415,organic chemical - pharmacologic substance
1,adjustment-disorders,liver diseases,0.00415,disease or syndrome
1,adjustment-disorders,medical contraindication,0.00415,finding
2,affective-disorders-psychotic,depressed mood,0.3821,finding - mental or behavioral dysfunction
2,affective-disorders-psychotic,intravenous infusion procedures,0.361,therapeutic or preventive procedure
2,affective-disorders-psychotic,major depressive disorder,0.26702,mental or behavioral dysfunction
2,affective-disorders-psychotic,antidepressive agents,0.13168,pharmacologic substance
2,affective-disorders-psychotic,depressive episode unspecified,0.12352,mental or behavioral dysfunction
2,affective-disorders-psychotic,contraceptive methods,0.11958,therapeutic or preventive procedure
2,affective-disorders-psychotic,bipolar disorder,0.11733,mental or behavioral dysfunction
2,affective-disorders-psychotic,unipolar depression,0.11564,mental or behavioral dysfunction
2,affective-disorders-psychotic,mental disorders,0.08441,mental or behavioral dysfunction
2,affective-disorders-psychotic,tropical spastic paraparesis,0.07259,disease or syndrome - therapeutic or preventive procedure
2,affective-disorders-psychotic,manic,0.06415,finding - mental or behavioral dysfunction
2,affective-disorders-psychotic,physical assessment findings,0.06162,finding
2,affective-disorders-psychotic,anxiety disorders,0.05824,finding - mental or behavioral dysfunction
2,affective-disorders-psychotic,negative finding,0.05656,finding
2,affective-disorders-psychotic,severe combined immunodeficiency,0.05543,diagnostic procedure - disease or syndrome
2,affective-disorders-psychotic,pharmacologic substance,0.0529,pharmacologic substance - therapeutic or preventive procedure
2,affective-disorders-psychotic,multiple endocrine neoplasia,0.05205,antibiotic - neoplastic process - organic chemical
2,affective-disorders-psychotic,moderate adverse event,0.05177,finding
2,affective-disorders-psychotic,depressive symptoms,0.04952,sign or symptom
2,affective-disorders-psychotic,antipsychotic agents,0.04671,pharmacologic substance
2,affective-disorders-psychotic,schizophrenia,0.04474,mental or behavioral dysfunction
2,affective-disorders-psychotic,pregnancy tests,0.04361,diagnostic procedure
2,affective-disorders-psychotic,gravidity,0.04305,finding
2,affective-disorders-psychotic,mood disorders,0.04192,mental or behavioral dysfunction
2,affective-disorders-psychotic,unmarried,0.03967,finding
2,affective-disorders-psychotic,body mass index,0.03883,clinical attribute - diagnostic procedure
2,affective-disorders-psychotic,allergy severity - severe,0.03883,finding
2,affective-disorders-psychotic,dysthymic disorder,0.03686,mental or behavioral dysfunction
2,affective-disorders-psychotic,active brand of pseudoephedrine-triprolidine,0.03545,organic chemical - pharmacologic substance
2,affective-disorders-psychotic,nitric oxide synthase,0.03123,enzyme
2,affective-disorders-psychotic,psychotropic drugs,0.03095,pharmacologic substance
2,affective-disorders-psychotic,operative surgical procedures,0.03039,diagnostic procedure - therapeutic or preventive procedure
2,affective-disorders-psychotic,medical history,0.03039,finding
2,affective-disorders-psychotic,lithium,0.03039,congenital abnormality - disease or syndrome - pharmacologic substance
2,affective-disorders-psychotic,stabilizer - function,0.02983,organ or tissue function
2,affective-disorders-psychotic,ethanol,0.02983,organic chemical - pharmacologic substance
2,affective-disorders-psychotic,mild adverse event,0.02926,finding
2,affective-disorders-psychotic,malignant neoplasms,0.02898,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
2,affective-disorders-psychotic,surgical revision,0.0287,therapeutic or preventive procedure
2,affective-disorders-psychotic,personality inventories,0.0287,diagnostic procedure
2,affective-disorders-psychotic,selective serotonin re-uptake inhibitor,0.02757,pharmacologic substance
2,affective-disorders-psychotic,mass of body structure,0.02701,finding
2,affective-disorders-psychotic,serum,0.02673,biologically active substance - body substance - pharmacologic substance
2,affective-disorders-psychotic,schizoaffective disorder,0.02617,mental or behavioral dysfunction
2,affective-disorders-psychotic,psychotic disorders,0.02392,mental or behavioral dysfunction
2,affective-disorders-psychotic,treatment protocols,0.02392,therapeutic or preventive procedure
2,affective-disorders-psychotic,electrocardiogram,0.02307,diagnostic procedure - finding - organic chemical - pharmacologic substance
2,affective-disorders-psychotic,screening for cancer,0.02307,diagnostic procedure
2,affective-disorders-psychotic,cancer remission,0.02167,finding - neoplastic process
2,affective-disorders-psychotic,relate - vinyl resin,0.01941,organic chemical
2,affective-disorders-psychotic,post-traumatic stress disorder,0.01941,mental or behavioral dysfunction
2,affective-disorders-psychotic,pharmacotherapy,0.01913,therapeutic or preventive procedure
2,affective-disorders-psychotic,psychotherapy,0.01885,therapeutic or preventive procedure
2,affective-disorders-psychotic,pharmaceutical preparations,0.01801,pharmacologic substance
2,affective-disorders-psychotic,positive finding,0.01745,finding
2,affective-disorders-psychotic,suicidal,0.01716,finding
2,affective-disorders-psychotic,fluoxetine,0.01688,organic chemical - pharmacologic substance
2,affective-disorders-psychotic,mini-mental status exam,0.0166,diagnostic procedure
2,affective-disorders-psychotic,generalized anxiety disorder,0.01632,mental or behavioral dysfunction
2,affective-disorders-psychotic,benign rolandic epilepsy,0.01604,disease or syndrome - therapeutic or preventive procedure
2,affective-disorders-psychotic,therapeutic brand of coal tar,0.01548,organic chemical - pharmacologic substance - therapeutic or preventive procedure
2,affective-disorders-psychotic,substance abuse problem,0.01491,mental or behavioral dysfunction
2,affective-disorders-psychotic,anxiety generalized,0.01379,mental or behavioral dysfunction
2,affective-disorders-psychotic,blood pressure finding,0.01379,finding
2,affective-disorders-psychotic,contraceptives oral,0.01379,pharmacologic substance - therapeutic or preventive procedure
2,affective-disorders-psychotic,infantile neuroaxonal dystrophy,0.01322,disease or syndrome
2,affective-disorders-psychotic,benzodiazepines,0.01238,organic chemical - pharmacologic substance
2,affective-disorders-psychotic,neoplasm metastasis,0.01182,neoplastic process
2,affective-disorders-psychotic,magnetic resonance imaging,0.01125,diagnostic procedure
2,affective-disorders-psychotic,panic disorder,0.01041,disease or syndrome - mental or behavioral dysfunction
2,affective-disorders-psychotic,alcoholic intoxication chronic,0.01041,mental or behavioral dysfunction
2,affective-disorders-psychotic,congenital abnormality,0.01013,congenital abnormality - disease or syndrome
2,affective-disorders-psychotic,impaired cognition,0.00985,finding - mental or behavioral dysfunction
2,affective-disorders-psychotic,suicide attempt,0.009,finding - mental or behavioral dysfunction
2,affective-disorders-psychotic,hypertensive disease,0.00844,biologically active substance - disease or syndrome - finding
2,affective-disorders-psychotic,psychotic symptoms,0.00844,sign or symptom
2,affective-disorders-psychotic,hiv,0.00816,disease or syndrome - pharmacologic substance - virus
2,affective-disorders-psychotic,obsessive-compulsive disorder,0.00788,disease or syndrome - mental or behavioral dysfunction
2,affective-disorders-psychotic,anticonvulsants,0.0076,pharmacologic substance
2,affective-disorders-psychotic,borderline personality disorder,0.00732,disease or syndrome - mental or behavioral dysfunction
2,affective-disorders-psychotic,injury wounds,0.00732,body substance - injury or poisoning
2,affective-disorders-psychotic,stress disorders traumatic,0.00703,mental or behavioral dysfunction
2,affective-disorders-psychotic,personality disorders,0.00675,mental or behavioral dysfunction
2,affective-disorders-psychotic,diabetes mellitus,0.00619,disease or syndrome - pharmacologic substance
2,affective-disorders-psychotic,unstable status,0.00619,finding
2,affective-disorders-psychotic,cerebrovascular accident,0.00619,disease or syndrome - therapeutic or preventive procedure
2,affective-disorders-psychotic,cardiovascular diseases,0.00506,disease or syndrome
2,affective-disorders-psychotic,heart diseases,0.00506,disease or syndrome
2,affective-disorders-psychotic,nervous system disorder,0.00506,disease or syndrome
2,affective-disorders-psychotic,stimulation procedure,0.00506,therapeutic or preventive procedure
2,affective-disorders-psychotic,hepatic,0.00478,body location or region
2,affective-disorders-psychotic,compulsive disorder,0.0045,finding
2,affective-disorders-psychotic,breast,0.00394,body part, organ, or organ component
2,affective-disorders-psychotic,thyroid gland,0.00394,body part, organ, or organ component - disease or syndrome - pharmacologic substance
2,affective-disorders-psychotic,illicit drugs,0.00394,hazardous or poisonous substance - pharmacologic substance
2,affective-disorders-psychotic,multiple sclerosis,0.00394,body part, organ, or organ component - disease or syndrome - finding
2,affective-disorders-psychotic,suicidality,0.00366,clinical attribute
2,affective-disorders-psychotic,mental retardation,0.00366,mental or behavioral dysfunction
2,affective-disorders-psychotic,monoamine oxidase inhibitors,0.00366,organic chemical - pharmacologic substance
2,affective-disorders-psychotic,substance dependence,0.00338,mental or behavioral dysfunction
2,affective-disorders-psychotic,developmental disabilities,0.00338,mental or behavioral dysfunction
2,affective-disorders-psychotic,hypothyroidism,0.0031,disease or syndrome
2,affective-disorders-psychotic,substance use disorders,0.0031,mental or behavioral dysfunction
2,affective-disorders-psychotic,medical contraindication,0.0031,finding
2,affective-disorders-psychotic,craniocerebral trauma,0.00281,injury or poisoning
2,affective-disorders-psychotic,alcohol abuse,0.00281,mental or behavioral dysfunction
2,affective-disorders-psychotic,kidney diseases,0.00253,disease or syndrome
2,affective-disorders-psychotic,pervasive development disorder,0.00253,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
2,affective-disorders-psychotic,eating disorders,0.00253,mental or behavioral dysfunction
2,affective-disorders-psychotic,hypersensitivity,0.00253,clinical attribute - finding - pathologic function
2,affective-disorders-psychotic,myocardial infarction,0.00225,disease or syndrome - finding
2,affective-disorders-psychotic,nervousness,0.00169,sign or symptom
2,affective-disorders-psychotic,nicotine,0.00169,hazardous or poisonous substance - organic chemical - pharmacologic substance
2,affective-disorders-psychotic,lung,0.00169,body part, organ, or organ component - disease or syndrome
2,affective-disorders-psychotic,investigational new drugs,0.00141,pharmacologic substance - therapeutic or preventive procedure
2,affective-disorders-psychotic,caffeine,0.00113,organic chemical - pharmacologic substance - therapeutic or preventive procedure
2,affective-disorders-psychotic,suicide risk,0.00028,finding
3,affective-symptoms,intravenous infusion procedures,0.4825,therapeutic or preventive procedure
3,affective-symptoms,depressed mood,0.4425,finding - mental or behavioral dysfunction
3,affective-symptoms,bipolar disorder,0.4025,mental or behavioral dysfunction
3,affective-symptoms,depressive episode unspecified,0.22,mental or behavioral dysfunction
3,affective-symptoms,contraceptive methods,0.16,therapeutic or preventive procedure
3,affective-symptoms,manic,0.1575,finding - mental or behavioral dysfunction
3,affective-symptoms,major depressive disorder,0.15,mental or behavioral dysfunction
3,affective-symptoms,antidepressive agents,0.13,pharmacologic substance
3,affective-symptoms,mental disorders,0.13,mental or behavioral dysfunction
3,affective-symptoms,unipolar depression,0.1175,mental or behavioral dysfunction
3,affective-symptoms,schizophrenia,0.11,mental or behavioral dysfunction
3,affective-symptoms,antipsychotic agents,0.1075,pharmacologic substance
3,affective-symptoms,stabilizer - function,0.1,organ or tissue function
3,affective-symptoms,lithium,0.095,congenital abnormality - disease or syndrome - pharmacologic substance
3,affective-symptoms,severe combined immunodeficiency,0.0875,diagnostic procedure - disease or syndrome
3,affective-symptoms,pharmacologic substance,0.08,pharmacologic substance - therapeutic or preventive procedure
3,affective-symptoms,schizoaffective disorder,0.08,mental or behavioral dysfunction
3,affective-symptoms,tropical spastic paraparesis,0.08,disease or syndrome - therapeutic or preventive procedure
3,affective-symptoms,nitric oxide synthase,0.0775,enzyme
3,affective-symptoms,mood disorders,0.0775,mental or behavioral dysfunction
3,affective-symptoms,physical assessment findings,0.0625,finding
3,affective-symptoms,psychotropic drugs,0.0625,pharmacologic substance
3,affective-symptoms,negative finding,0.06,finding
3,affective-symptoms,psychotic disorders,0.0575,mental or behavioral dysfunction
3,affective-symptoms,multiple endocrine neoplasia,0.055,antibiotic - neoplastic process - organic chemical
3,affective-symptoms,allergy severity - severe,0.05,finding
3,affective-symptoms,depressive symptoms,0.0475,sign or symptom
3,affective-symptoms,moderate adverse event,0.0425,finding
3,affective-symptoms,atypia morphology,0.0375,finding
3,affective-symptoms,anxiety disorders,0.035,finding - mental or behavioral dysfunction
3,affective-symptoms,gravidity,0.035,finding
3,affective-symptoms,therapeutic brand of coal tar,0.035,organic chemical - pharmacologic substance - therapeutic or preventive procedure
3,affective-symptoms,bleomycin-cisplatin protocol,0.0325,therapeutic or preventive procedure
3,affective-symptoms,pregnancy tests,0.0325,diagnostic procedure
3,affective-symptoms,pharmaceutical preparations,0.03,pharmacologic substance
3,affective-symptoms,active brand of pseudoephedrine-triprolidine,0.03,organic chemical - pharmacologic substance
3,affective-symptoms,benign rolandic epilepsy,0.03,disease or syndrome - therapeutic or preventive procedure
3,affective-symptoms,serum,0.0275,biologically active substance - body substance - pharmacologic substance
3,affective-symptoms,cancer remission,0.0275,finding - neoplastic process
3,affective-symptoms,benzodiazepines,0.025,organic chemical - pharmacologic substance
3,affective-symptoms,valproic acid,0.025,body part, organ, or organ component - organic chemical - pharmacologic substance
3,affective-symptoms,medical history,0.025,finding
3,affective-symptoms,contraceptives oral,0.025,pharmacologic substance - therapeutic or preventive procedure
3,affective-symptoms,psychotic symptoms,0.025,sign or symptom
3,affective-symptoms,pharmacotherapy,0.0225,therapeutic or preventive procedure
3,affective-symptoms,anticonvulsants,0.0225,pharmacologic substance
3,affective-symptoms,post-traumatic stress disorder,0.0225,mental or behavioral dysfunction
3,affective-symptoms,suicidal,0.02,finding
3,affective-symptoms,ethanol,0.02,organic chemical - pharmacologic substance
3,affective-symptoms,operative surgical procedures,0.02,diagnostic procedure - therapeutic or preventive procedure
3,affective-symptoms,screening for cancer,0.02,diagnostic procedure
3,affective-symptoms,substance abuse problem,0.0175,mental or behavioral dysfunction
3,affective-symptoms,body mass index,0.0175,clinical attribute - diagnostic procedure
3,affective-symptoms,magnetic resonance imaging,0.0175,diagnostic procedure
3,affective-symptoms,selective serotonin re-uptake inhibitor,0.0175,pharmacologic substance
3,affective-symptoms,family history,0.0175,congenital abnormality - disease or syndrome - enzyme - finding
3,affective-symptoms,borderline personality disorder,0.0175,disease or syndrome - mental or behavioral dysfunction
3,affective-symptoms,attention deficit hyperactivity disorder,0.0175,disease or syndrome - mental or behavioral dysfunction
3,affective-symptoms,diabetes mellitus,0.015,disease or syndrome - pharmacologic substance
3,affective-symptoms,relate - vinyl resin,0.015,organic chemical
3,affective-symptoms,congenital abnormality,0.015,congenital abnormality - disease or syndrome
3,affective-symptoms,impaired cognition,0.015,finding - mental or behavioral dysfunction
3,affective-symptoms,fluoxetine,0.015,organic chemical - pharmacologic substance
3,affective-symptoms,sexually active,0.015,finding
3,affective-symptoms,personality disorders,0.0125,mental or behavioral dysfunction
3,affective-symptoms,neoplasm metastasis,0.0125,neoplastic process
3,affective-symptoms,alcoholic intoxication chronic,0.0125,mental or behavioral dysfunction
3,affective-symptoms,mental retardation,0.0125,mental or behavioral dysfunction
3,affective-symptoms,electrocardiogram,0.0125,diagnostic procedure - finding - organic chemical - pharmacologic substance
3,affective-symptoms,obsessive-compulsive disorder,0.0125,disease or syndrome - mental or behavioral dysfunction
3,affective-symptoms,psychotherapy,0.0125,therapeutic or preventive procedure
3,affective-symptoms,positive finding,0.01,finding
3,affective-symptoms,blood pressure finding,0.01,finding
3,affective-symptoms,stress disorders traumatic,0.01,mental or behavioral dysfunction
3,affective-symptoms,nervous system disorder,0.01,disease or syndrome
3,affective-symptoms,suicide attempt,0.01,finding - mental or behavioral dysfunction
3,affective-symptoms,developmental disabilities,0.01,mental or behavioral dysfunction
3,affective-symptoms,pervasive development disorder,0.0075,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
3,affective-symptoms,hypertensive disease,0.0075,biologically active substance - disease or syndrome - finding
3,affective-symptoms,cardiovascular diseases,0.0075,disease or syndrome
3,affective-symptoms,infantile neuroaxonal dystrophy,0.0075,disease or syndrome
3,affective-symptoms,substance use disorders,0.0075,mental or behavioral dysfunction
3,affective-symptoms,monoamine oxidase inhibitors,0.0075,organic chemical - pharmacologic substance
3,affective-symptoms,injury wounds,0.0075,body substance - injury or poisoning
3,affective-symptoms,implantation procedure,0.0075,therapeutic or preventive procedure
3,affective-symptoms,breast,0.005,body part, organ, or organ component
3,affective-symptoms,multiple sclerosis,0.005,body part, organ, or organ component - disease or syndrome - finding
3,affective-symptoms,craniocerebral trauma,0.005,injury or poisoning
3,affective-symptoms,unstable status,0.005,finding
3,affective-symptoms,compulsive disorder,0.005,finding
3,affective-symptoms,kidney,0.005,body part, organ, or organ component
3,affective-symptoms,cerebrovascular accident,0.005,disease or syndrome - therapeutic or preventive procedure
3,affective-symptoms,substance dependence,0.0025,mental or behavioral dysfunction
3,affective-symptoms,consciousness related finding,0.0025,finding
3,affective-symptoms,nicotine dependence,0.0025,mental or behavioral dysfunction
3,affective-symptoms,hepatic,0.0025,body location or region
3,affective-symptoms,hypothyroidism,0.0025,disease or syndrome
3,affective-symptoms,caffeine,0.0025,organic chemical - pharmacologic substance - therapeutic or preventive procedure
3,affective-symptoms,suicidality,0.0025,clinical attribute
3,affective-symptoms,unconscious state,0.0025,disease or syndrome - finding
3,affective-symptoms,cocaine,0.0025,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
3,affective-symptoms,brain injuries,0.0025,injury or poisoning
3,affective-symptoms,medical contraindication,0.0025,finding
3,affective-symptoms,drug abuse,0.0025,mental or behavioral dysfunction
4,aggression,aggressive behavior,0.40957,mental or behavioral dysfunction
4,aggression,pharmacotherapy,0.28457,therapeutic or preventive procedure
4,aggression,contraceptive methods,0.2633,therapeutic or preventive procedure
4,aggression,bilirubin,0.21543,biologically active substance - laboratory or test result - organic chemical
4,aggression,malignant neoplasms,0.19947,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
4,aggression,gravidity,0.17021,finding
4,aggression,active brand of pseudoephedrine-triprolidine,0.16755,organic chemical - pharmacologic substance
4,aggression,intravenous infusion procedures,0.16755,therapeutic or preventive procedure
4,aggression,alanine transaminase,0.16489,congenital abnormality - disease or syndrome - enzyme
4,aggression,pregnancy tests,0.16489,diagnostic procedure
4,aggression,skeletal bone,0.15691,body location or region - body part, organ, or organ component - body substance - disease or syndrome
4,aggression,life expectancy,0.15691,group attribute
4,aggression,aspartate transaminase,0.1383,enzyme
4,aggression,pregnancy test negative,0.13298,finding - laboratory or test result
4,aggression,kidney,0.13298,body part, organ, or organ component
4,aggression,positive finding,0.13032,finding
4,aggression,creatinine clearance,0.10372,finding
4,aggression,hepatic,0.10106,body location or region
4,aggression,treatment protocols,0.09309,therapeutic or preventive procedure
4,aggression,cognitive therapy,0.08777,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
4,aggression,operative surgical procedures,0.08245,diagnostic procedure - therapeutic or preventive procedure
4,aggression,allergy severity - severe,0.08245,finding
4,aggression,neoplasm metastasis,0.06915,neoplastic process
4,aggression,pharmaceutical preparations,0.06649,pharmacologic substance
4,aggression,physical assessment findings,0.06649,finding
4,aggression,mental disorders,0.06649,mental or behavioral dysfunction
4,aggression,hypersensitivity,0.06383,clinical attribute - finding - pathologic function
4,aggression,pharmacologic substance,0.06117,pharmacologic substance - therapeutic or preventive procedure
4,aggression,relate - vinyl resin,0.06117,organic chemical
4,aggression,multiple endocrine neoplasia,0.05851,antibiotic - neoplastic process - organic chemical
4,aggression,heart ventricle,0.05585,body part, organ, or organ component
4,aggression,angina pectoris,0.05585,sign or symptom
4,aggression,congestive heart failure,0.05319,congenital abnormality - disease or syndrome
4,aggression,magnetic resonance imaging,0.05319,diagnostic procedure
4,aggression,myocardial infarction,0.05319,disease or syndrome - finding
4,aggression,transaminases,0.05319,enzyme
4,aggression,electrocardiogram,0.05053,diagnostic procedure - finding - organic chemical - pharmacologic substance
4,aggression,cardiac arrhythmia,0.05053,finding - pathologic function
4,aggression,arteries,0.04521,body part, organ, or organ component
4,aggression,unstable status,0.04521,finding
4,aggression,therapeutic brand of coal tar,0.04255,organic chemical - pharmacologic substance - therapeutic or preventive procedure
4,aggression,heart diseases,0.03989,disease or syndrome
4,aggression,hypertensive disease,0.03989,biologically active substance - disease or syndrome - finding
4,aggression,unmarried,0.03723,finding
4,aggression,positron-emission tomography,0.03723,diagnostic procedure
4,aggression,adrenal cortex hormones,0.03723,pharmacologic substance
4,aggression,angina unstable,0.03457,disease or syndrome
4,aggression,follow-up status,0.03457,finding
4,aggression,cancer remission,0.03457,finding - neoplastic process
4,aggression,contraception barrier,0.03191,therapeutic or preventive procedure
4,aggression,schizophrenia,0.02926,mental or behavioral dysfunction
4,aggression,agitation,0.02926,finding - sign or symptom
4,aggression,investigational new drugs,0.02926,pharmacologic substance - therapeutic or preventive procedure
4,aggression,liver function,0.0266,organ or tissue function
4,aggression,congenital abnormality,0.0266,congenital abnormality - disease or syndrome
4,aggression,blood vessel,0.0266,body part, organ, or organ component - finding
4,aggression,nervousness,0.02394,sign or symptom
4,aggression,antipsychotic agents,0.02394,pharmacologic substance
4,aggression,valproic acid,0.02394,body part, organ, or organ component - organic chemical - pharmacologic substance
4,aggression,neurological observations,0.02394,finding
4,aggression,psychotropic drugs,0.02128,pharmacologic substance
4,aggression,moderate adverse event,0.02128,finding
4,aggression,cerebrovascular accident,0.02128,disease or syndrome - therapeutic or preventive procedure
4,aggression,mass of body structure,0.02128,finding
4,aggression,pathology processes,0.01862,pathologic function
4,aggression,sexually active,0.01862,finding
4,aggression,psychotic disorders,0.01596,mental or behavioral dysfunction
4,aggression,human chorionic gonadotropin,0.01596,disease or syndrome - pharmacologic substance
4,aggression,cardiovascular diseases,0.01596,disease or syndrome
4,aggression,injury wounds,0.01596,body substance - injury or poisoning
4,aggression,dementia,0.01596,mental or behavioral dysfunction
4,aggression,pervasive development disorder,0.0133,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
4,aggression,breast,0.0133,body part, organ, or organ component
4,aggression,ethanol,0.0133,organic chemical - pharmacologic substance
4,aggression,insulin,0.0133,pharmacologic substance
4,aggression,medical contraindication,0.0133,finding
4,aggression,epilepsy,0.01064,disease or syndrome
4,aggression,substance abuse problem,0.00798,mental or behavioral dysfunction
4,aggression,developmental disabilities,0.00798,mental or behavioral dysfunction
4,aggression,diabetes mellitus,0.00798,disease or syndrome - pharmacologic substance
4,aggression,blood pressure finding,0.00798,finding
4,aggression,depressed mood,0.00798,finding - mental or behavioral dysfunction
4,aggression,liver diseases,0.00532,disease or syndrome
5,alcohol-drinking,ethanol,0.55821,organic chemical - pharmacologic substance
5,alcohol-drinking,alcohol consumption,0.27164,individual behavior
5,alcohol-drinking,multiple endocrine neoplasia,0.1791,antibiotic - neoplastic process - organic chemical
5,alcohol-drinking,intravenous infusion procedures,0.17612,therapeutic or preventive procedure
5,alcohol-drinking,alcoholic intoxication chronic,0.15522,mental or behavioral dysfunction
5,alcohol-drinking,consumption-archaic term for tb,0.10448,disease or syndrome
5,alcohol-drinking,contraceptive methods,0.09552,therapeutic or preventive procedure
5,alcohol-drinking,alcohol abuse,0.08358,mental or behavioral dysfunction
5,alcohol-drinking,physical assessment findings,0.07164,finding
5,alcohol-drinking,electrocardiogram,0.05672,diagnostic procedure - finding - organic chemical - pharmacologic substance
5,alcohol-drinking,negative finding,0.05373,finding
5,alcohol-drinking,follow-up status,0.05075,finding
5,alcohol-drinking,body mass index,0.05075,clinical attribute - diagnostic procedure
5,alcohol-drinking,active brand of pseudoephedrine-triprolidine,0.04776,organic chemical - pharmacologic substance
5,alcohol-drinking,positive finding,0.04776,finding
5,alcohol-drinking,pregnancy tests,0.04478,diagnostic procedure
5,alcohol-drinking,relate - vinyl resin,0.04179,organic chemical
5,alcohol-drinking,pharmacologic substance,0.04179,pharmacologic substance - therapeutic or preventive procedure
5,alcohol-drinking,smoker,0.04179,finding
5,alcohol-drinking,moderate adverse event,0.03881,finding
5,alcohol-drinking,hiv,0.03881,disease or syndrome - pharmacologic substance - virus
5,alcohol-drinking,mass of body structure,0.03881,finding
5,alcohol-drinking,post-traumatic stress disorder,0.03582,mental or behavioral dysfunction
5,alcohol-drinking,gravidity,0.03284,finding
5,alcohol-drinking,anxiety disorders,0.03284,finding - mental or behavioral dysfunction
5,alcohol-drinking,operative surgical procedures,0.03284,diagnostic procedure - therapeutic or preventive procedure
5,alcohol-drinking,mental disorders,0.03284,mental or behavioral dysfunction
5,alcohol-drinking,impaired cognition,0.02985,finding - mental or behavioral dysfunction
5,alcohol-drinking,screening for cancer,0.02985,diagnostic procedure
5,alcohol-drinking,medical history,0.02687,finding
5,alcohol-drinking,contraceptives oral,0.02687,pharmacologic substance - therapeutic or preventive procedure
5,alcohol-drinking,detoxification procedure,0.02388,therapeutic or preventive procedure
5,alcohol-drinking,smoking,0.02388,hazardous or poisonous substance - individual behavior
5,alcohol-drinking,substance abuse problem,0.02388,mental or behavioral dysfunction
5,alcohol-drinking,substance use disorders,0.01791,mental or behavioral dysfunction
5,alcohol-drinking,pharmaceutical preparations,0.01791,pharmacologic substance
5,alcohol-drinking,depressed mood,0.01791,finding - mental or behavioral dysfunction
5,alcohol-drinking,marihuana,0.01791,mental or behavioral dysfunction - organic chemical - pharmacologic substance
5,alcohol-drinking,unipolar depression,0.01194,mental or behavioral dysfunction
5,alcohol-drinking,infantile neuroaxonal dystrophy,0.01194,disease or syndrome
5,alcohol-drinking,injury wounds,0.01194,body substance - injury or poisoning
5,alcohol-drinking,allergy severity - severe,0.01194,finding
5,alcohol-drinking,opioids,0.01194,hazardous or poisonous substance - organic chemical - pharmacologic substance
5,alcohol-drinking,malignant neoplasms,0.01194,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
5,alcohol-drinking,schizophrenia,0.00896,mental or behavioral dysfunction
5,alcohol-drinking,bipolar disorder,0.00896,mental or behavioral dysfunction
5,alcohol-drinking,opiates,0.00896,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
5,alcohol-drinking,major depressive disorder,0.00896,mental or behavioral dysfunction
5,alcohol-drinking,antipsychotic agents,0.00597,pharmacologic substance
5,alcohol-drinking,liver diseases,0.00597,disease or syndrome
5,alcohol-drinking,drug dependence,0.00597,mental or behavioral dysfunction
5,alcohol-drinking,manic,0.00597,finding - mental or behavioral dysfunction
5,alcohol-drinking,psychotropic drugs,0.00597,pharmacologic substance
5,alcohol-drinking,caffeine,0.00299,organic chemical - pharmacologic substance - therapeutic or preventive procedure
5,alcohol-drinking,psychotic disorders,0.00299,mental or behavioral dysfunction
5,alcohol-drinking,panic disorder,0.00299,disease or syndrome - mental or behavioral dysfunction
5,alcohol-drinking,antidepressive agents,0.00299,pharmacologic substance
5,alcohol-drinking,substance dependence,0.00299,mental or behavioral dysfunction
5,alcohol-drinking,personality disorders,0.00299,mental or behavioral dysfunction
5,alcohol-drinking,benzodiazepines,0.00299,organic chemical - pharmacologic substance
5,alcohol-drinking,hypersensitivity,0.00299,clinical attribute - finding - pathologic function
5,alcohol-drinking,alanine transaminase,0.00299,congenital abnormality - disease or syndrome - enzyme
5,alcohol-drinking,nicotine dependence,0.00299,mental or behavioral dysfunction
5,alcohol-drinking,eating disorders,0.00299,mental or behavioral dysfunction
5,alcohol-drinking,hepatic,0.00299,body location or region
6,alcohol-related-disorders,ethanol,0.67857,organic chemical - pharmacologic substance
6,alcohol-related-disorders,alcoholic intoxication chronic,0.38286,mental or behavioral dysfunction
6,alcohol-related-disorders,intravenous infusion procedures,0.31143,therapeutic or preventive procedure
6,alcohol-related-disorders,alcohol consumption,0.21857,individual behavior
6,alcohol-related-disorders,multiple endocrine neoplasia,0.14571,antibiotic - neoplastic process - organic chemical
6,alcohol-related-disorders,contraceptive methods,0.13571,therapeutic or preventive procedure
6,alcohol-related-disorders,negative finding,0.09571,finding
6,alcohol-related-disorders,pharmacologic substance,0.09429,pharmacologic substance - therapeutic or preventive procedure
6,alcohol-related-disorders,consumption-archaic term for tb,0.09286,disease or syndrome
6,alcohol-related-disorders,alcohol abuse,0.07286,mental or behavioral dysfunction
6,alcohol-related-disorders,physical assessment findings,0.07286,finding
6,alcohol-related-disorders,follow-up status,0.06714,finding
6,alcohol-related-disorders,pregnancy tests,0.05714,diagnostic procedure
6,alcohol-related-disorders,detoxification procedure,0.05571,therapeutic or preventive procedure
6,alcohol-related-disorders,severe combined immunodeficiency,0.05143,diagnostic procedure - disease or syndrome
6,alcohol-related-disorders,mental disorders,0.05,mental or behavioral dysfunction
6,alcohol-related-disorders,positive finding,0.04857,finding
6,alcohol-related-disorders,electrocardiogram,0.04857,diagnostic procedure - finding - organic chemical - pharmacologic substance
6,alcohol-related-disorders,active brand of pseudoephedrine-triprolidine,0.04571,organic chemical - pharmacologic substance
6,alcohol-related-disorders,post-traumatic stress disorder,0.04,mental or behavioral dysfunction
6,alcohol-related-disorders,screening for cancer,0.04,diagnostic procedure
6,alcohol-related-disorders,substance abuse problem,0.03857,mental or behavioral dysfunction
6,alcohol-related-disorders,gravidity,0.03857,finding
6,alcohol-related-disorders,operative surgical procedures,0.03714,diagnostic procedure - therapeutic or preventive procedure
6,alcohol-related-disorders,anxiety disorders,0.03286,finding - mental or behavioral dysfunction
6,alcohol-related-disorders,marihuana,0.03286,mental or behavioral dysfunction - organic chemical - pharmacologic substance
6,alcohol-related-disorders,body mass index,0.03,clinical attribute - diagnostic procedure
6,alcohol-related-disorders,pharmaceutical preparations,0.03,pharmacologic substance
6,alcohol-related-disorders,medical history,0.03,finding
6,alcohol-related-disorders,smoking,0.03,hazardous or poisonous substance - individual behavior
6,alcohol-related-disorders,valproic acid,0.02857,body part, organ, or organ component - organic chemical - pharmacologic substance
6,alcohol-related-disorders,smoker,0.02714,finding
6,alcohol-related-disorders,relate - vinyl resin,0.02571,organic chemical
6,alcohol-related-disorders,substance use disorders,0.02571,mental or behavioral dysfunction
6,alcohol-related-disorders,depressed mood,0.02571,finding - mental or behavioral dysfunction
6,alcohol-related-disorders,household composition,0.02429,finding
6,alcohol-related-disorders,schizophrenia,0.02429,mental or behavioral dysfunction
6,alcohol-related-disorders,sterility,0.02286,pathologic function
6,alcohol-related-disorders,cocaine,0.02286,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
6,alcohol-related-disorders,schizoaffective disorder,0.02143,mental or behavioral dysfunction
6,alcohol-related-disorders,tobacco,0.02143,hazardous or poisonous substance - organic chemical - pharmacologic substance
6,alcohol-related-disorders,allergy severity - severe,0.02143,finding
6,alcohol-related-disorders,contraceptives oral,0.02143,pharmacologic substance - therapeutic or preventive procedure
6,alcohol-related-disorders,treatment protocols,0.02,therapeutic or preventive procedure
6,alcohol-related-disorders,alanine transaminase,0.02,congenital abnormality - disease or syndrome - enzyme
6,alcohol-related-disorders,nicotine dependence,0.02,mental or behavioral dysfunction
6,alcohol-related-disorders,pregnancy test negative,0.02,finding - laboratory or test result
6,alcohol-related-disorders,opiates,0.02,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
6,alcohol-related-disorders,aspartate transaminase,0.02,enzyme
6,alcohol-related-disorders,liver diseases,0.02,disease or syndrome
6,alcohol-related-disorders,antipsychotic agents,0.01857,pharmacologic substance
6,alcohol-related-disorders,moderate adverse event,0.01857,finding
6,alcohol-related-disorders,impaired cognition,0.01857,finding - mental or behavioral dysfunction
6,alcohol-related-disorders,hiv,0.01714,disease or syndrome - pharmacologic substance - virus
6,alcohol-related-disorders,disease of diaphragm,0.01714,body part, organ, or organ component - disease or syndrome
6,alcohol-related-disorders,serum,0.01714,biologically active substance - body substance - pharmacologic substance
6,alcohol-related-disorders,psychotropic drugs,0.01571,pharmacologic substance
6,alcohol-related-disorders,contraception barrier,0.01571,therapeutic or preventive procedure
6,alcohol-related-disorders,opioids,0.01571,hazardous or poisonous substance - organic chemical - pharmacologic substance
6,alcohol-related-disorders,human chorionic gonadotropin,0.01429,disease or syndrome - pharmacologic substance
6,alcohol-related-disorders,hepatic,0.01429,body location or region
6,alcohol-related-disorders,illicit drugs,0.01429,hazardous or poisonous substance - pharmacologic substance
6,alcohol-related-disorders,substance dependence,0.01429,mental or behavioral dysfunction
6,alcohol-related-disorders,unipolar depression,0.01429,mental or behavioral dysfunction
6,alcohol-related-disorders,bipolar disorder,0.01286,mental or behavioral dysfunction
6,alcohol-related-disorders,major depressive disorder,0.01286,mental or behavioral dysfunction
6,alcohol-related-disorders,benzodiazepines,0.01143,organic chemical - pharmacologic substance
6,alcohol-related-disorders,infantile neuroaxonal dystrophy,0.01143,disease or syndrome
6,alcohol-related-disorders,injury wounds,0.01143,body substance - injury or poisoning
6,alcohol-related-disorders,pharmacotherapy,0.01,therapeutic or preventive procedure
6,alcohol-related-disorders,drug dependence,0.01,mental or behavioral dysfunction
6,alcohol-related-disorders,bilirubin,0.01,biologically active substance - laboratory or test result - organic chemical
6,alcohol-related-disorders,sexually active,0.01,finding
6,alcohol-related-disorders,psychotic disorders,0.00857,mental or behavioral dysfunction
6,alcohol-related-disorders,psychiatric problem,0.00857,mental or behavioral dysfunction
6,alcohol-related-disorders,transaminases,0.00857,enzyme
6,alcohol-related-disorders,drug abuse,0.00857,mental or behavioral dysfunction
6,alcohol-related-disorders,claustrophobia,0.00714,mental or behavioral dysfunction
6,alcohol-related-disorders,antidepressive agents,0.00714,pharmacologic substance
6,alcohol-related-disorders,panic disorder,0.00571,disease or syndrome - mental or behavioral dysfunction
6,alcohol-related-disorders,manic,0.00571,finding - mental or behavioral dysfunction
6,alcohol-related-disorders,magnetic resonance imaging,0.00571,diagnostic procedure
6,alcohol-related-disorders,opiate addiction,0.00571,mental or behavioral dysfunction
6,alcohol-related-disorders,malignant neoplasms,0.00571,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
6,alcohol-related-disorders,blood pressure finding,0.00429,finding
6,alcohol-related-disorders,unstable status,0.00429,finding
6,alcohol-related-disorders,hypersensitivity,0.00429,clinical attribute - finding - pathologic function
6,alcohol-related-disorders,liver function,0.00429,organ or tissue function
6,alcohol-related-disorders,hypertensive disease,0.00429,biologically active substance - disease or syndrome - finding
6,alcohol-related-disorders,suicidal,0.00286,finding
6,alcohol-related-disorders,epilepsy,0.00286,disease or syndrome
6,alcohol-related-disorders,pathology processes,0.00286,pathologic function
6,alcohol-related-disorders,suicidality,0.00286,clinical attribute
6,alcohol-related-disorders,congenital abnormality,0.00286,congenital abnormality - disease or syndrome
6,alcohol-related-disorders,mood disorders,0.00286,mental or behavioral dysfunction
6,alcohol-related-disorders,suicide attempt,0.00286,finding - mental or behavioral dysfunction
6,alcohol-related-disorders,diabetes,0.00286,disease or syndrome
6,alcohol-related-disorders,kidney diseases,0.00143,disease or syndrome
6,alcohol-related-disorders,caffeine,0.00143,organic chemical - pharmacologic substance - therapeutic or preventive procedure
6,alcohol-related-disorders,personality disorders,0.00143,mental or behavioral dysfunction
6,alcohol-related-disorders,myocardial infarction,0.00143,disease or syndrome - finding
6,alcohol-related-disorders,anticonvulsants,0.00143,pharmacologic substance
6,alcohol-related-disorders,mental retardation,0.00143,mental or behavioral dysfunction
6,alcohol-related-disorders,heart diseases,0.00143,disease or syndrome
6,alcohol-related-disorders,craniocerebral trauma,0.00143,injury or poisoning
6,alcohol-related-disorders,investigational new drugs,0.00143,pharmacologic substance - therapeutic or preventive procedure
6,alcohol-related-disorders,current therapy,0.00143,therapeutic or preventive procedure
6,alcohol-related-disorders,breast,0.00143,body part, organ, or organ component
7,alcoholism,ethanol,0.74669,organic chemical - pharmacologic substance
7,alcoholism,alcoholic intoxication chronic,0.50851,mental or behavioral dysfunction
7,alcoholism,intravenous infusion procedures,0.37996,therapeutic or preventive procedure
7,alcoholism,alcohol consumption,0.23819,individual behavior
7,alcoholism,contraceptive methods,0.17202,therapeutic or preventive procedure
7,alcoholism,multiple endocrine neoplasia,0.15312,antibiotic - neoplastic process - organic chemical
7,alcoholism,negative finding,0.12098,finding
7,alcoholism,pharmacologic substance,0.09452,pharmacologic substance - therapeutic or preventive procedure
7,alcoholism,consumption-archaic term for tb,0.09263,disease or syndrome
7,alcoholism,physical assessment findings,0.08507,finding
7,alcoholism,alcohol abuse,0.08318,mental or behavioral dysfunction
7,alcoholism,pregnancy tests,0.0775,diagnostic procedure
7,alcoholism,detoxification procedure,0.07561,therapeutic or preventive procedure
7,alcoholism,follow-up status,0.07561,finding
7,alcoholism,severe combined immunodeficiency,0.06994,diagnostic procedure - disease or syndrome
7,alcoholism,electrocardiogram,0.06616,diagnostic procedure - finding - organic chemical - pharmacologic substance
7,alcoholism,mental disorders,0.06238,mental or behavioral dysfunction
7,alcoholism,operative surgical procedures,0.04726,diagnostic procedure - therapeutic or preventive procedure
7,alcoholism,positive finding,0.04159,finding
7,alcoholism,active brand of pseudoephedrine-triprolidine,0.04159,organic chemical - pharmacologic substance
7,alcoholism,post-traumatic stress disorder,0.04159,mental or behavioral dysfunction
7,alcoholism,anxiety disorders,0.0397,finding - mental or behavioral dysfunction
7,alcoholism,body mass index,0.0397,clinical attribute - diagnostic procedure
7,alcoholism,screening for cancer,0.0397,diagnostic procedure
7,alcoholism,substance abuse problem,0.03592,mental or behavioral dysfunction
7,alcoholism,medical history,0.03592,finding
7,alcoholism,gravidity,0.03592,finding
7,alcoholism,smoker,0.03403,finding
7,alcoholism,household composition,0.03214,finding
7,alcoholism,personal satisfaction,0.03214,finding
7,alcoholism,smoking,0.03214,hazardous or poisonous substance - individual behavior
7,alcoholism,depressed mood,0.03214,finding - mental or behavioral dysfunction
7,alcoholism,sterility,0.03025,pathologic function
7,alcoholism,schizophrenia,0.03025,mental or behavioral dysfunction
7,alcoholism,valproic acid,0.03025,body part, organ, or organ component - organic chemical - pharmacologic substance
7,alcoholism,relate - vinyl resin,0.02836,organic chemical
7,alcoholism,pharmaceutical preparations,0.02836,pharmacologic substance
7,alcoholism,contraceptives oral,0.02836,pharmacologic substance - therapeutic or preventive procedure
7,alcoholism,schizoaffective disorder,0.02647,mental or behavioral dysfunction
7,alcoholism,pregnancy test negative,0.02647,finding - laboratory or test result
7,alcoholism,nicotine dependence,0.02457,mental or behavioral dysfunction
7,alcoholism,antipsychotic agents,0.02457,pharmacologic substance
7,alcoholism,impaired cognition,0.02457,finding - mental or behavioral dysfunction
7,alcoholism,treatment protocols,0.02268,therapeutic or preventive procedure
7,alcoholism,substance use disorders,0.02268,mental or behavioral dysfunction
7,alcoholism,cocaine,0.02268,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
7,alcoholism,tobacco,0.02079,hazardous or poisonous substance - organic chemical - pharmacologic substance
7,alcoholism,bipolar disorder,0.02079,mental or behavioral dysfunction
7,alcoholism,opiates,0.02079,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
7,alcoholism,contraception barrier,0.02079,therapeutic or preventive procedure
7,alcoholism,spermatocidal agents,0.0189,pharmacologic substance
7,alcoholism,disease of diaphragm,0.0189,body part, organ, or organ component - disease or syndrome
7,alcoholism,smoke,0.0189,hazardous or poisonous substance - individual behavior
7,alcoholism,unipolar depression,0.0189,mental or behavioral dysfunction
7,alcoholism,mass of body structure,0.0189,finding
7,alcoholism,hiv,0.01701,disease or syndrome - pharmacologic substance - virus
7,alcoholism,human chorionic gonadotropin,0.01701,disease or syndrome - pharmacologic substance
7,alcoholism,psychotropic drugs,0.01701,pharmacologic substance
7,alcoholism,allergy severity - severe,0.01701,finding
7,alcoholism,marihuana,0.01701,mental or behavioral dysfunction - organic chemical - pharmacologic substance
7,alcoholism,dactinomycin,0.01701,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
7,alcoholism,moderate adverse event,0.01512,finding
7,alcoholism,opioids,0.01512,hazardous or poisonous substance - organic chemical - pharmacologic substance
7,alcoholism,major depressive disorder,0.01512,mental or behavioral dysfunction
7,alcoholism,pharmacotherapy,0.01323,therapeutic or preventive procedure
7,alcoholism,illicit drugs,0.01323,hazardous or poisonous substance - pharmacologic substance
7,alcoholism,serum,0.01323,biologically active substance - body substance - pharmacologic substance
7,alcoholism,substance dependence,0.01134,mental or behavioral dysfunction
7,alcoholism,psychotic disorders,0.01134,mental or behavioral dysfunction
7,alcoholism,stabilizer - function,0.01134,organ or tissue function
7,alcoholism,benzodiazepines,0.01134,organic chemical - pharmacologic substance
7,alcoholism,drug dependence,0.01134,mental or behavioral dysfunction
7,alcoholism,injury wounds,0.01134,body substance - injury or poisoning
7,alcoholism,psychiatric problem,0.00945,mental or behavioral dysfunction
7,alcoholism,alanine transaminase,0.00945,congenital abnormality - disease or syndrome - enzyme
7,alcoholism,claustrophobia,0.00945,mental or behavioral dysfunction
7,alcoholism,antidepressive agents,0.00945,pharmacologic substance
7,alcoholism,aspartate transaminase,0.00945,enzyme
7,alcoholism,sexually active,0.00945,finding
7,alcoholism,panic disorder,0.00756,disease or syndrome - mental or behavioral dysfunction
7,alcoholism,manic,0.00756,finding - mental or behavioral dysfunction
7,alcoholism,hepatic,0.00756,body location or region
7,alcoholism,infantile neuroaxonal dystrophy,0.00756,disease or syndrome
7,alcoholism,implantation procedure,0.00756,therapeutic or preventive procedure
7,alcoholism,drug abuse,0.00756,mental or behavioral dysfunction
7,alcoholism,magnetic resonance imaging,0.00567,diagnostic procedure
7,alcoholism,opiate addiction,0.00567,mental or behavioral dysfunction
7,alcoholism,unstable status,0.00567,finding
7,alcoholism,stress disorders traumatic,0.00567,mental or behavioral dysfunction
7,alcoholism,stimulant,0.00567,pharmacologic substance
7,alcoholism,suicidal,0.00378,finding
7,alcoholism,epilepsy,0.00378,disease or syndrome
7,alcoholism,suicidality,0.00378,clinical attribute
7,alcoholism,liver diseases,0.00378,disease or syndrome
7,alcoholism,anticonvulsants,0.00378,pharmacologic substance
7,alcoholism,obsessive-compulsive disorder,0.00378,disease or syndrome - mental or behavioral dysfunction
7,alcoholism,mood disorders,0.00378,mental or behavioral dysfunction
7,alcoholism,transaminases,0.00378,enzyme
7,alcoholism,suicide attempt,0.00378,finding - mental or behavioral dysfunction
7,alcoholism,current therapy,0.00378,therapeutic or preventive procedure
7,alcoholism,malignant neoplasms,0.00378,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
7,alcoholism,kidney diseases,0.00189,disease or syndrome
7,alcoholism,personality disorders,0.00189,mental or behavioral dysfunction
7,alcoholism,myocardial infarction,0.00189,disease or syndrome - finding
7,alcoholism,caffeine,0.00189,organic chemical - pharmacologic substance - therapeutic or preventive procedure
7,alcoholism,unconscious state,0.00189,disease or syndrome - finding
7,alcoholism,heart diseases,0.00189,disease or syndrome
7,alcoholism,blood pressure finding,0.00189,finding
7,alcoholism,craniocerebral trauma,0.00189,injury or poisoning
7,alcoholism,lung,0.00189,body part, organ, or organ component - disease or syndrome
7,alcoholism,liver function,0.00189,organ or tissue function
7,alcoholism,hypertensive disease,0.00189,biologically active substance - disease or syndrome - finding
7,alcoholism,investigational new drugs,0.00189,pharmacologic substance - therapeutic or preventive procedure
7,alcoholism,hypersensitivity,0.00189,clinical attribute - finding - pathologic function
7,alcoholism,diabetes,0.00189,disease or syndrome
8,alzheimer-disease,mini-mental status exam,0.44513,diagnostic procedure
8,alzheimer-disease,dactinomycin,0.32046,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
8,alzheimer-disease,mild adverse event,0.24671,finding
8,alzheimer-disease,intravenous infusion procedures,0.15891,therapeutic or preventive procedure
8,alzheimer-disease,magnetic resonance imaging,0.15364,diagnostic procedure
8,alzheimer-disease,relate - vinyl resin,0.1396,organic chemical
8,alzheimer-disease,impaired cognition,0.13257,finding - mental or behavioral dysfunction
8,alzheimer-disease,memory observations,0.12906,finding
8,alzheimer-disease,physical assessment findings,0.10272,finding
8,alzheimer-disease,cholinesterase inhibitors,0.09833,organic chemical - pharmacologic substance
8,alzheimer-disease,operative surgical procedures,0.08428,diagnostic procedure - therapeutic or preventive procedure
8,alzheimer-disease,memantine,0.08428,organic chemical - pharmacologic substance
8,alzheimer-disease,depressed mood,0.08341,finding - mental or behavioral dysfunction
8,alzheimer-disease,multiple endocrine neoplasia,0.07726,antibiotic - neoplastic process - organic chemical
8,alzheimer-disease,moderate adverse event,0.07463,finding
8,alzheimer-disease,body mass index,0.07287,clinical attribute - diagnostic procedure
8,alzheimer-disease,cognitive therapy,0.06936,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
8,alzheimer-disease,medical history,0.06848,finding
8,alzheimer-disease,contraceptive methods,0.0676,therapeutic or preventive procedure
8,alzheimer-disease,mental disorders,0.0676,mental or behavioral dysfunction
8,alzheimer-disease,electrocardiogram,0.06321,diagnostic procedure - finding - organic chemical - pharmacologic substance
8,alzheimer-disease,mass of body structure,0.06146,finding
8,alzheimer-disease,sterility,0.0597,pathologic function
8,alzheimer-disease,neuropsychological tests,0.0518,diagnostic procedure
8,alzheimer-disease,cerebrovascular accident,0.04917,disease or syndrome - therapeutic or preventive procedure
8,alzheimer-disease,pharmacologic substance,0.04653,pharmacologic substance - therapeutic or preventive procedure
8,alzheimer-disease,negative finding,0.04565,finding
8,alzheimer-disease,hearing examination finding,0.04478,finding
8,alzheimer-disease,blood vessel,0.04039,body part, organ, or organ component - finding
8,alzheimer-disease,pregnancy tests,0.03863,diagnostic procedure
8,alzheimer-disease,positron-emission tomography,0.036,diagnostic procedure
8,alzheimer-disease,vital signs,0.03424,clinical attribute
8,alzheimer-disease,personal satisfaction,0.03248,finding
8,alzheimer-disease,allergy severity - severe,0.03248,finding
8,alzheimer-disease,weighing patient,0.03161,diagnostic procedure - finding
8,alzheimer-disease,congenital abnormality,0.03073,congenital abnormality - disease or syndrome
8,alzheimer-disease,positive finding,0.02809,finding
8,alzheimer-disease,nervous system disorder,0.02809,disease or syndrome
8,alzheimer-disease,agitation,0.02546,finding - sign or symptom
8,alzheimer-disease,personality inventories,0.02371,diagnostic procedure
8,alzheimer-disease,hypertensive disease,0.02283,biologically active substance - disease or syndrome - finding
8,alzheimer-disease,pharmaceutical preparations,0.02195,pharmacologic substance
8,alzheimer-disease,follow-up status,0.02195,finding
8,alzheimer-disease,antipsychotic agents,0.02019,pharmacologic substance
8,alzheimer-disease,mental retardation,0.02019,mental or behavioral dysfunction
8,alzheimer-disease,antidepressive agents,0.02019,pharmacologic substance
8,alzheimer-disease,household composition,0.01932,finding
8,alzheimer-disease,gravidity,0.01932,finding
8,alzheimer-disease,psychotropic drugs,0.01756,pharmacologic substance
8,alzheimer-disease,blood pressure finding,0.0158,finding
8,alzheimer-disease,pathology processes,0.01493,pathologic function
8,alzheimer-disease,injury wounds,0.01493,body substance - injury or poisoning
8,alzheimer-disease,unipolar depression,0.01405,mental or behavioral dysfunction
8,alzheimer-disease,frontotemporal dementia,0.01317,disease or syndrome
8,alzheimer-disease,ethanol,0.01054,organic chemical - pharmacologic substance
8,alzheimer-disease,alanine transaminase,0.01054,congenital abnormality - disease or syndrome - enzyme
8,alzheimer-disease,active brand of pseudoephedrine-triprolidine,0.01054,organic chemical - pharmacologic substance
8,alzheimer-disease,serum,0.01054,biologically active substance - body substance - pharmacologic substance
8,alzheimer-disease,epilepsy,0.00966,disease or syndrome
8,alzheimer-disease,hepatic,0.00966,body location or region
8,alzheimer-disease,schizophrenia,0.00966,mental or behavioral dysfunction
8,alzheimer-disease,family history,0.00966,congenital abnormality - disease or syndrome - enzyme - finding
8,alzheimer-disease,thyroid gland,0.00966,body part, organ, or organ component - disease or syndrome - pharmacologic substance
8,alzheimer-disease,screening for cancer,0.00966,diagnostic procedure
8,alzheimer-disease,aspartate transaminase,0.00966,enzyme
8,alzheimer-disease,craniocerebral trauma,0.00878,injury or poisoning
8,alzheimer-disease,nervousness,0.00878,sign or symptom
8,alzheimer-disease,neurological observations,0.00878,finding
8,alzheimer-disease,psychotic disorders,0.0079,mental or behavioral dysfunction
8,alzheimer-disease,cardiovascular diseases,0.00702,disease or syndrome
8,alzheimer-disease,diastole,0.00702,clinical attribute
8,alzheimer-disease,unstable status,0.00702,finding
8,alzheimer-disease,malignant neoplasms,0.00702,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
8,alzheimer-disease,anti-anxiety agents,0.00615,pharmacologic substance
8,alzheimer-disease,mood disorders,0.00615,mental or behavioral dysfunction
8,alzheimer-disease,multiple sclerosis,0.00527,body part, organ, or organ component - disease or syndrome - finding
8,alzheimer-disease,traumatic brain injury,0.00527,disease or syndrome - injury or poisoning
8,alzheimer-disease,unconscious state,0.00527,disease or syndrome - finding
8,alzheimer-disease,insulin,0.00527,pharmacologic substance
8,alzheimer-disease,consciousness related finding,0.00527,finding
8,alzheimer-disease,blind vision,0.00527,disease or syndrome
8,alzheimer-disease,bilirubin,0.00527,biologically active substance - laboratory or test result - organic chemical
8,alzheimer-disease,hypersensitivity,0.00527,clinical attribute - finding - pathologic function
8,alzheimer-disease,medical contraindication,0.00527,finding
8,alzheimer-disease,congestive heart failure,0.00439,congenital abnormality - disease or syndrome
8,alzheimer-disease,diastolic blood pressure,0.00439,clinical attribute - diagnostic procedure - finding
8,alzheimer-disease,delirium,0.00439,mental or behavioral dysfunction
8,alzheimer-disease,substance abuse problem,0.00439,mental or behavioral dysfunction
8,alzheimer-disease,pharmacotherapy,0.00439,therapeutic or preventive procedure
8,alzheimer-disease,cardiac arrhythmia,0.00439,finding - pathologic function
8,alzheimer-disease,angina pectoris,0.00439,sign or symptom
8,alzheimer-disease,investigational new drugs,0.00439,pharmacologic substance - therapeutic or preventive procedure
8,alzheimer-disease,brain injuries,0.00439,injury or poisoning
8,alzheimer-disease,benzodiazepines,0.00439,organic chemical - pharmacologic substance
8,alzheimer-disease,kidney diseases,0.00351,disease or syndrome
8,alzheimer-disease,hypothyroidism,0.00351,disease or syndrome
8,alzheimer-disease,alcohol abuse,0.00351,mental or behavioral dysfunction
8,alzheimer-disease,neoplasm metastasis,0.00351,neoplastic process
8,alzheimer-disease,alcoholic intoxication chronic,0.00351,mental or behavioral dysfunction
8,alzheimer-disease,systolic pressure,0.00351,clinical attribute - diagnostic procedure
8,alzheimer-disease,observation of attack,0.00351,finding
8,alzheimer-disease,bipolar disorder,0.00263,mental or behavioral dysfunction
8,alzheimer-disease,myocardial infarction,0.00263,disease or syndrome - finding
8,alzheimer-disease,heart diseases,0.00263,disease or syndrome
8,alzheimer-disease,diabetes mellitus,0.00176,disease or syndrome - pharmacologic substance
8,alzheimer-disease,liver diseases,0.00176,disease or syndrome
8,alzheimer-disease,angina unstable,0.00176,disease or syndrome
8,alzheimer-disease,major depressive disorder,0.00176,mental or behavioral dysfunction
8,alzheimer-disease,drug abuse,0.00176,mental or behavioral dysfunction
8,alzheimer-disease,claustrophobia,0.00088,mental or behavioral dysfunction
9,amnesia,mini-mental status exam,0.27941,diagnostic procedure
9,amnesia,mild adverse event,0.26471,finding
9,amnesia,memory observations,0.26471,finding
9,amnesia,impaired cognition,0.14706,finding - mental or behavioral dysfunction
9,amnesia,dactinomycin,0.13235,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
9,amnesia,contraceptive methods,0.08824,therapeutic or preventive procedure
9,amnesia,cognitive therapy,0.08824,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
9,amnesia,magnetic resonance imaging,0.08824,diagnostic procedure
9,amnesia,moderate adverse event,0.07353,finding
9,amnesia,gravidity,0.07353,finding
9,amnesia,treatment protocols,0.07353,therapeutic or preventive procedure
9,amnesia,depressed mood,0.07353,finding - mental or behavioral dysfunction
9,amnesia,operative surgical procedures,0.07353,diagnostic procedure - therapeutic or preventive procedure
9,amnesia,relate - vinyl resin,0.05882,organic chemical
9,amnesia,cholinesterase inhibitors,0.05882,organic chemical - pharmacologic substance
9,amnesia,intravenous infusion procedures,0.05882,therapeutic or preventive procedure
9,amnesia,neuropsychological tests,0.05882,diagnostic procedure
9,amnesia,serum,0.04412,biologically active substance - body substance - pharmacologic substance
9,amnesia,physical assessment findings,0.04412,finding
9,amnesia,pregnancy tests,0.04412,diagnostic procedure
9,amnesia,active brand of pseudoephedrine-triprolidine,0.04412,organic chemical - pharmacologic substance
9,amnesia,blood vessel,0.02941,body part, organ, or organ component - finding
9,amnesia,allergy severity - severe,0.02941,finding
9,amnesia,arteries,0.02941,body part, organ, or organ component
9,amnesia,positron-emission tomography,0.02941,diagnostic procedure
9,amnesia,household composition,0.02941,finding
9,amnesia,hypertensive disease,0.02941,biologically active substance - disease or syndrome - finding
9,amnesia,memantine,0.02941,organic chemical - pharmacologic substance
9,amnesia,congenital abnormality,0.01471,congenital abnormality - disease or syndrome
9,amnesia,unstable status,0.01471,finding
9,amnesia,unipolar depression,0.01471,mental or behavioral dysfunction
9,amnesia,schizophrenia,0.01471,mental or behavioral dysfunction
9,amnesia,psychotic disorders,0.01471,mental or behavioral dysfunction
9,amnesia,brain injuries,0.01471,injury or poisoning
9,amnesia,neoplasm metastasis,0.01471,neoplastic process
9,amnesia,frontotemporal dementia,0.01471,disease or syndrome
9,amnesia,adrenal cortex hormones,0.01471,pharmacologic substance
9,amnesia,bipolar disorder,0.01471,mental or behavioral dysfunction
9,amnesia,antipsychotic agents,0.01471,pharmacologic substance
9,amnesia,life expectancy,0.01471,group attribute
9,amnesia,pharmaceutical preparations,0.01471,pharmacologic substance
9,amnesia,hiv,0.01471,disease or syndrome - pharmacologic substance - virus
9,amnesia,follow-up status,0.01471,finding
9,amnesia,pharmacotherapy,0.01471,therapeutic or preventive procedure
9,amnesia,pharmacologic substance,0.01471,pharmacologic substance - therapeutic or preventive procedure
9,amnesia,ethanol,0.01471,organic chemical - pharmacologic substance
9,amnesia,medical contraindication,0.01471,finding
9,amnesia,malignant neoplasms,0.01471,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
9,amnesia,mass of body structure,0.01471,finding
9,amnesia,mental disorders,0.01471,mental or behavioral dysfunction
10,amphetamine-related-disorders,intravenous infusion procedures,0.38,therapeutic or preventive procedure
10,amphetamine-related-disorders,contraceptive methods,0.26,therapeutic or preventive procedure
10,amphetamine-related-disorders,positive finding,0.22,finding
10,amphetamine-related-disorders,pregnancy tests,0.2,diagnostic procedure
10,amphetamine-related-disorders,ethanol,0.2,organic chemical - pharmacologic substance
10,amphetamine-related-disorders,body mass index,0.2,clinical attribute - diagnostic procedure
10,amphetamine-related-disorders,mass of body structure,0.2,finding
10,amphetamine-related-disorders,negative finding,0.18,finding
10,amphetamine-related-disorders,physical assessment findings,0.18,finding
10,amphetamine-related-disorders,pharmacologic substance,0.18,pharmacologic substance - therapeutic or preventive procedure
10,amphetamine-related-disorders,multiple endocrine neoplasia,0.14,antibiotic - neoplastic process - organic chemical
10,amphetamine-related-disorders,medical history,0.12,finding
10,amphetamine-related-disorders,gravidity,0.12,finding
10,amphetamine-related-disorders,pregnancy test negative,0.12,finding - laboratory or test result
10,amphetamine-related-disorders,personal satisfaction,0.08,finding
10,amphetamine-related-disorders,contraception barrier,0.06,therapeutic or preventive procedure
10,amphetamine-related-disorders,congenital abnormality,0.04,congenital abnormality - disease or syndrome
10,amphetamine-related-disorders,substance abuse problem,0.04,mental or behavioral dysfunction
10,amphetamine-related-disorders,severe combined immunodeficiency,0.04,diagnostic procedure - disease or syndrome
10,amphetamine-related-disorders,infantile neuroaxonal dystrophy,0.04,disease or syndrome
10,amphetamine-related-disorders,kidney,0.04,body part, organ, or organ component
10,amphetamine-related-disorders,mercury,0.04,hazardous or poisonous substance
10,amphetamine-related-disorders,hypersensitivity,0.04,clinical attribute - finding - pathologic function
10,amphetamine-related-disorders,sterility,0.04,pathologic function
10,amphetamine-related-disorders,stimulant,0.04,pharmacologic substance
10,amphetamine-related-disorders,diastole,0.04,clinical attribute
10,amphetamine-related-disorders,cardiac arrhythmia,0.04,finding - pathologic function
10,amphetamine-related-disorders,nicotine dependence,0.04,mental or behavioral dysfunction
10,amphetamine-related-disorders,opioids,0.04,hazardous or poisonous substance - organic chemical - pharmacologic substance
10,amphetamine-related-disorders,smoker,0.04,finding
10,amphetamine-related-disorders,operative surgical procedures,0.04,diagnostic procedure - therapeutic or preventive procedure
10,amphetamine-related-disorders,magnetic resonance imaging,0.04,diagnostic procedure
10,amphetamine-related-disorders,mental disorders,0.04,mental or behavioral dysfunction
10,amphetamine-related-disorders,schizophrenia,0.02,mental or behavioral dysfunction
10,amphetamine-related-disorders,benzodiazepines,0.02,organic chemical - pharmacologic substance
10,amphetamine-related-disorders,aspartate transaminase,0.02,enzyme
10,amphetamine-related-disorders,thyroid gland,0.02,body part, organ, or organ component - disease or syndrome - pharmacologic substance
10,amphetamine-related-disorders,diastolic blood pressure,0.02,clinical attribute - diagnostic procedure - finding
10,amphetamine-related-disorders,opiates,0.02,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
10,amphetamine-related-disorders,marihuana,0.02,mental or behavioral dysfunction - organic chemical - pharmacologic substance
10,amphetamine-related-disorders,major depressive disorder,0.02,mental or behavioral dysfunction
10,amphetamine-related-disorders,alanine transaminase,0.02,congenital abnormality - disease or syndrome - enzyme
10,amphetamine-related-disorders,psychotropic drugs,0.02,pharmacologic substance
10,amphetamine-related-disorders,screening for cancer,0.02,diagnostic procedure
10,amphetamine-related-disorders,depressed mood,0.02,finding - mental or behavioral dysfunction
10,amphetamine-related-disorders,systolic pressure,0.02,clinical attribute - diagnostic procedure
10,amphetamine-related-disorders,drug abuse,0.02,mental or behavioral dysfunction
11,anorexia-nervosa,intravenous infusion procedures,0.43878,therapeutic or preventive procedure
11,anorexia-nervosa,body mass index,0.29592,clinical attribute - diagnostic procedure
11,anorexia-nervosa,eating disorders,0.20408,mental or behavioral dysfunction
11,anorexia-nervosa,weighing patient,0.17347,diagnostic procedure - finding
11,anorexia-nervosa,mental disorders,0.10204,mental or behavioral dysfunction
11,anorexia-nervosa,mass of body structure,0.09184,finding
11,anorexia-nervosa,psychotropic drugs,0.08163,pharmacologic substance
11,anorexia-nervosa,contraceptive methods,0.06122,therapeutic or preventive procedure
11,anorexia-nervosa,skeletal bone,0.04082,body location or region - body part, organ, or organ component - body substance - disease or syndrome
11,anorexia-nervosa,active brand of pseudoephedrine-triprolidine,0.04082,organic chemical - pharmacologic substance
11,anorexia-nervosa,physical assessment findings,0.03061,finding
11,anorexia-nervosa,psychotherapy,0.03061,therapeutic or preventive procedure
11,anorexia-nervosa,allergy severity - severe,0.03061,finding
11,anorexia-nervosa,pathology processes,0.02041,pathologic function
11,anorexia-nervosa,gravidity,0.02041,finding
11,anorexia-nervosa,relate - vinyl resin,0.02041,organic chemical
11,anorexia-nervosa,treatment protocols,0.02041,therapeutic or preventive procedure
11,anorexia-nervosa,antidepressive agents,0.02041,pharmacologic substance
11,anorexia-nervosa,antipsychotic agents,0.02041,pharmacologic substance
11,anorexia-nervosa,pregnancy tests,0.02041,diagnostic procedure
11,anorexia-nervosa,anxiety disorders,0.02041,finding - mental or behavioral dysfunction
11,anorexia-nervosa,fluoxetine,0.02041,organic chemical - pharmacologic substance
11,anorexia-nervosa,psychiatric problem,0.02041,mental or behavioral dysfunction
11,anorexia-nervosa,epilepsy,0.0102,disease or syndrome
11,anorexia-nervosa,schizophrenia,0.0102,mental or behavioral dysfunction
11,anorexia-nervosa,psychotic disorders,0.0102,mental or behavioral dysfunction
11,anorexia-nervosa,oral contraception,0.0102,pharmacologic substance - therapeutic or preventive procedure
11,anorexia-nervosa,substance abuse problem,0.0102,mental or behavioral dysfunction
11,anorexia-nervosa,disability,0.0102,finding
11,anorexia-nervosa,stabilizer - function,0.0102,organ or tissue function
11,anorexia-nervosa,pharmaceutical preparations,0.0102,pharmacologic substance
11,anorexia-nervosa,suicidality,0.0102,clinical attribute
11,anorexia-nervosa,unipolar depression,0.0102,mental or behavioral dysfunction
11,anorexia-nervosa,pharmacologic substance,0.0102,pharmacologic substance - therapeutic or preventive procedure
11,anorexia-nervosa,alcohol abuse,0.0102,mental or behavioral dysfunction
11,anorexia-nervosa,ethanol,0.0102,organic chemical - pharmacologic substance
11,anorexia-nervosa,depressed mood,0.0102,finding - mental or behavioral dysfunction
11,anorexia-nervosa,magnetic resonance imaging,0.0102,diagnostic procedure
11,anorexia-nervosa,mental retardation,0.0102,mental or behavioral dysfunction
11,anorexia-nervosa,tic disorder,0.0102,mental or behavioral dysfunction
11,anorexia-nervosa,suicide risk,0.0102,finding
11,anorexia-nervosa,selective serotonin re-uptake inhibitor,0.0102,pharmacologic substance
11,anorexia-nervosa,positive finding,0.0102,finding
12,anxiety-disorders,intravenous infusion procedures,0.26592,therapeutic or preventive procedure
12,anxiety-disorders,post-traumatic stress disorder,0.24842,mental or behavioral dysfunction
12,anxiety-disorders,anxiety disorders,0.23238,finding - mental or behavioral dysfunction
12,anxiety-disorders,generalized anxiety disorder,0.11473,mental or behavioral dysfunction
12,anxiety-disorders,depressed mood,0.10015,finding - mental or behavioral dysfunction
12,anxiety-disorders,anxiety generalized,0.08313,mental or behavioral dysfunction
12,anxiety-disorders,contraceptive methods,0.07924,therapeutic or preventive procedure
12,anxiety-disorders,physical assessment findings,0.07098,finding
12,anxiety-disorders,phobia social,0.06709,mental or behavioral dysfunction
12,anxiety-disorders,osteochondritis dissecans,0.06417,disease or syndrome - mental or behavioral dysfunction
12,anxiety-disorders,negative finding,0.05688,finding
12,anxiety-disorders,phobic anxiety disorder,0.05639,mental or behavioral dysfunction
12,anxiety-disorders,mental disorders,0.0525,mental or behavioral dysfunction
12,anxiety-disorders,panic disorder,0.05153,disease or syndrome - mental or behavioral dysfunction
12,anxiety-disorders,injury wounds,0.05007,body substance - injury or poisoning
12,anxiety-disorders,stress disorders traumatic,0.04959,mental or behavioral dysfunction
12,anxiety-disorders,psychotropic drugs,0.04618,pharmacologic substance
12,anxiety-disorders,malignant neoplasms,0.0457,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
12,anxiety-disorders,pharmacologic substance,0.04327,pharmacologic substance - therapeutic or preventive procedure
12,anxiety-disorders,active brand of pseudoephedrine-triprolidine,0.04278,organic chemical - pharmacologic substance
12,anxiety-disorders,moderate adverse event,0.04181,finding
12,anxiety-disorders,pregnancy tests,0.04181,diagnostic procedure
12,anxiety-disorders,ethanol,0.03986,organic chemical - pharmacologic substance
12,anxiety-disorders,obsessive-compulsive disorder,0.03889,disease or syndrome - mental or behavioral dysfunction
12,anxiety-disorders,relate - vinyl resin,0.03743,organic chemical
12,anxiety-disorders,allergy severity - severe,0.03549,finding
12,anxiety-disorders,multiple endocrine neoplasia,0.03209,antibiotic - neoplastic process - organic chemical
12,anxiety-disorders,major depressive disorder,0.03014,mental or behavioral dysfunction
12,anxiety-disorders,tropical spastic paraparesis,0.02965,disease or syndrome - therapeutic or preventive procedure
12,anxiety-disorders,severe combined immunodeficiency,0.02868,diagnostic procedure - disease or syndrome
12,anxiety-disorders,selective serotonin re-uptake inhibitor,0.0282,pharmacologic substance
12,anxiety-disorders,pharmacotherapy,0.02771,therapeutic or preventive procedure
12,anxiety-disorders,gravidity,0.02674,finding
12,anxiety-disorders,operative surgical procedures,0.02625,diagnostic procedure - therapeutic or preventive procedure
12,anxiety-disorders,antidepressive agents,0.02577,pharmacologic substance
12,anxiety-disorders,positive finding,0.02236,finding
12,anxiety-disorders,treatment protocols,0.02188,therapeutic or preventive procedure
12,anxiety-disorders,unipolar depression,0.02139,mental or behavioral dysfunction
12,anxiety-disorders,electrocardiogram,0.02042,diagnostic procedure - finding - organic chemical - pharmacologic substance
12,anxiety-disorders,medical history,0.01993,finding
12,anxiety-disorders,compulsive disorder,0.01945,finding
12,anxiety-disorders,fluoxetine,0.01847,organic chemical - pharmacologic substance
12,anxiety-disorders,pharmaceutical preparations,0.01847,pharmacologic substance
12,anxiety-disorders,traumatic brain injury,0.01847,disease or syndrome - injury or poisoning
12,anxiety-disorders,screening for cancer,0.01847,diagnostic procedure
12,anxiety-disorders,psychotherapy,0.01799,therapeutic or preventive procedure
12,anxiety-disorders,antipsychotic agents,0.01653,pharmacologic substance
12,anxiety-disorders,benzodiazepines,0.01604,organic chemical - pharmacologic substance
12,anxiety-disorders,alcoholic intoxication chronic,0.01556,mental or behavioral dysfunction
12,anxiety-disorders,mood disorders,0.01556,mental or behavioral dysfunction
12,anxiety-disorders,body mass index,0.01507,clinical attribute - diagnostic procedure
12,anxiety-disorders,cognitive therapy,0.01507,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
12,anxiety-disorders,psychotic disorders,0.01361,mental or behavioral dysfunction
12,anxiety-disorders,psychiatric problem,0.01361,mental or behavioral dysfunction
12,anxiety-disorders,neoplasm metastasis,0.01313,neoplastic process
12,anxiety-disorders,substance abuse problem,0.01167,mental or behavioral dysfunction
12,anxiety-disorders,schizophrenia,0.01167,mental or behavioral dysfunction
12,anxiety-disorders,infantile neuroaxonal dystrophy,0.0107,disease or syndrome
12,anxiety-disorders,nicotine,0.00972,hazardous or poisonous substance - organic chemical - pharmacologic substance
12,anxiety-disorders,congenital abnormality,0.00972,congenital abnormality - disease or syndrome
12,anxiety-disorders,bipolar disorder,0.00924,mental or behavioral dysfunction
12,anxiety-disorders,anti-anxiety agents,0.00875,pharmacologic substance
12,anxiety-disorders,blood pressure finding,0.00826,finding
12,anxiety-disorders,behavior therapy,0.00826,therapeutic or preventive procedure
12,anxiety-disorders,suicidal,0.00778,finding
12,anxiety-disorders,magnetic resonance imaging,0.00778,diagnostic procedure
12,anxiety-disorders,substance use disorders,0.00778,mental or behavioral dysfunction
12,anxiety-disorders,caffeine,0.00729,organic chemical - pharmacologic substance - therapeutic or preventive procedure
12,anxiety-disorders,pervasive development disorder,0.00729,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
12,anxiety-disorders,brain injuries,0.00729,injury or poisoning
12,anxiety-disorders,kidney,0.00729,body part, organ, or organ component
12,anxiety-disorders,hypertensive disease,0.00681,biologically active substance - disease or syndrome - finding
12,anxiety-disorders,impaired cognition,0.00632,finding - mental or behavioral dysfunction
12,anxiety-disorders,developmental disabilities,0.00632,mental or behavioral dysfunction
12,anxiety-disorders,disability,0.00583,finding
12,anxiety-disorders,schizoaffective disorder,0.00583,mental or behavioral dysfunction
12,anxiety-disorders,hepatic,0.00583,body location or region
12,anxiety-disorders,substance dependence,0.00583,mental or behavioral dysfunction
12,anxiety-disorders,lung,0.00535,body part, organ, or organ component - disease or syndrome
12,anxiety-disorders,unconscious state,0.00486,disease or syndrome - finding
12,anxiety-disorders,craniocerebral trauma,0.00486,injury or poisoning
12,anxiety-disorders,epilepsy,0.00438,disease or syndrome
12,anxiety-disorders,consciousness related finding,0.00438,finding
12,anxiety-disorders,hypersensitivity,0.00438,clinical attribute - finding - pathologic function
12,anxiety-disorders,alcohol abuse,0.00438,mental or behavioral dysfunction
12,anxiety-disorders,personality disorders,0.00389,mental or behavioral dysfunction
12,anxiety-disorders,breast,0.00389,body part, organ, or organ component
12,anxiety-disorders,eating disorders,0.00389,mental or behavioral dysfunction
12,anxiety-disorders,nervous system disorder,0.00389,disease or syndrome
12,anxiety-disorders,heart diseases,0.0034,disease or syndrome
12,anxiety-disorders,unstable status,0.00292,finding
12,anxiety-disorders,cerebrovascular accident,0.00243,disease or syndrome - therapeutic or preventive procedure
12,anxiety-disorders,suicidality,0.00194,clinical attribute
12,anxiety-disorders,monoamine oxidase inhibitors,0.00194,organic chemical - pharmacologic substance
12,anxiety-disorders,suicide attempt,0.00097,finding - mental or behavioral dysfunction
12,anxiety-disorders,manic,0.00049,finding - mental or behavioral dysfunction
12,anxiety-disorders,psychotic symptoms,0.00049,sign or symptom
12,anxiety-disorders,medical contraindication,0.00049,finding
13,asperger-syndrome,autistic disorder,0.7931,mental or behavioral dysfunction
13,asperger-syndrome,pervasive development disorder,0.51724,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
13,asperger-syndrome,autism spectrum disorders,0.46552,congenital abnormality - mental or behavioral dysfunction
13,asperger-syndrome,intravenous infusion procedures,0.41379,therapeutic or preventive procedure
13,asperger-syndrome,developmental disabilities,0.32759,mental or behavioral dysfunction
13,asperger-syndrome,nitric oxide synthase,0.31034,enzyme
13,asperger-syndrome,anxiety disorders,0.17241,finding - mental or behavioral dysfunction
13,asperger-syndrome,phobia social,0.12069,mental or behavioral dysfunction
13,asperger-syndrome,phobic anxiety disorder,0.12069,mental or behavioral dysfunction
13,asperger-syndrome,attention deficit hyperactivity disorder,0.10345,disease or syndrome - mental or behavioral dysfunction
13,asperger-syndrome,anxiety generalized,0.10345,mental or behavioral dysfunction
13,asperger-syndrome,psychotropic drugs,0.10345,pharmacologic substance
13,asperger-syndrome,generalized anxiety disorder,0.10345,mental or behavioral dysfunction
13,asperger-syndrome,obsessive-compulsive disorder,0.08621,disease or syndrome - mental or behavioral dysfunction
13,asperger-syndrome,mental disorders,0.08621,mental or behavioral dysfunction
13,asperger-syndrome,hyperactive behavior,0.06897,finding
13,asperger-syndrome,behavior disorders,0.06897,injury or poisoning - mental or behavioral dysfunction
13,asperger-syndrome,depressed mood,0.06897,finding - mental or behavioral dysfunction
13,asperger-syndrome,osteochondritis dissecans,0.06897,disease or syndrome - mental or behavioral dysfunction
13,asperger-syndrome,compulsive disorder,0.05172,finding
13,asperger-syndrome,antipsychotic agents,0.05172,pharmacologic substance
13,asperger-syndrome,physical assessment findings,0.05172,finding
13,asperger-syndrome,contraceptive methods,0.05172,therapeutic or preventive procedure
13,asperger-syndrome,tic disorder,0.05172,mental or behavioral dysfunction
13,asperger-syndrome,blind vision,0.03448,disease or syndrome
13,asperger-syndrome,treatment protocols,0.03448,therapeutic or preventive procedure
13,asperger-syndrome,panic disorder,0.03448,disease or syndrome - mental or behavioral dysfunction
13,asperger-syndrome,disability,0.03448,finding
13,asperger-syndrome,pregnancy tests,0.03448,diagnostic procedure
13,asperger-syndrome,fluoxetine,0.03448,organic chemical - pharmacologic substance
13,asperger-syndrome,mood disorders,0.03448,mental or behavioral dysfunction
13,asperger-syndrome,medical history,0.03448,finding
13,asperger-syndrome,pharmacologic substance,0.03448,pharmacologic substance - therapeutic or preventive procedure
13,asperger-syndrome,memantine,0.03448,organic chemical - pharmacologic substance
13,asperger-syndrome,stimulant,0.03448,pharmacologic substance
13,asperger-syndrome,unstable status,0.01724,finding
13,asperger-syndrome,bipolar disorder,0.01724,mental or behavioral dysfunction
13,asperger-syndrome,epilepsy,0.01724,disease or syndrome
13,asperger-syndrome,gene therapy,0.01724,therapeutic or preventive procedure
13,asperger-syndrome,unipolar depression,0.01724,mental or behavioral dysfunction
13,asperger-syndrome,schizophrenia,0.01724,mental or behavioral dysfunction
13,asperger-syndrome,psychotic disorders,0.01724,mental or behavioral dysfunction
13,asperger-syndrome,aggressive behavior,0.01724,mental or behavioral dysfunction
13,asperger-syndrome,pharmacotherapy,0.01724,therapeutic or preventive procedure
13,asperger-syndrome,behavior therapy,0.01724,therapeutic or preventive procedure
13,asperger-syndrome,antidepressive agents,0.01724,pharmacologic substance
13,asperger-syndrome,pharmaceutical preparations,0.01724,pharmacologic substance
13,asperger-syndrome,personal satisfaction,0.01724,finding
13,asperger-syndrome,allergy severity - severe,0.01724,finding
13,asperger-syndrome,active brand of pseudoephedrine-triprolidine,0.01724,organic chemical - pharmacologic substance
13,asperger-syndrome,screening for cancer,0.01724,diagnostic procedure
13,asperger-syndrome,schizoaffective disorder,0.01724,mental or behavioral dysfunction
13,asperger-syndrome,therapeutic brand of coal tar,0.01724,organic chemical - pharmacologic substance - therapeutic or preventive procedure
13,asperger-syndrome,hypersensitivity,0.01724,clinical attribute - finding - pathologic function
13,asperger-syndrome,anticonvulsants,0.01724,pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,attention deficit hyperactivity disorder,0.80154,disease or syndrome - mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,intravenous infusion procedures,0.50923,therapeutic or preventive procedure
14,attention-deficit-and-disruptive-behavior-disorders,hyperactive behavior,0.16308,finding
14,attention-deficit-and-disruptive-behavior-disorders,mental disorders,0.12462,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,negative finding,0.11231,finding
14,attention-deficit-and-disruptive-behavior-disorders,pregnancy tests,0.10615,diagnostic procedure
14,attention-deficit-and-disruptive-behavior-disorders,pharmacologic substance,0.09385,pharmacologic substance - therapeutic or preventive procedure
14,attention-deficit-and-disruptive-behavior-disorders,contraceptive methods,0.08,therapeutic or preventive procedure
14,attention-deficit-and-disruptive-behavior-disorders,physical assessment findings,0.06462,finding
14,attention-deficit-and-disruptive-behavior-disorders,stimulant,0.05692,pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,electrocardiogram,0.05385,diagnostic procedure - finding - organic chemical - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,serum,0.05231,biologically active substance - body substance - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,mood disorders,0.05077,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,moderate adverse event,0.04769,finding
14,attention-deficit-and-disruptive-behavior-disorders,blood pressure finding,0.04615,finding
14,attention-deficit-and-disruptive-behavior-disorders,gravidity,0.04615,finding
14,attention-deficit-and-disruptive-behavior-disorders,schizophrenia,0.04154,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,surgical revision,0.04154,therapeutic or preventive procedure
14,attention-deficit-and-disruptive-behavior-disorders,congenital abnormality,0.04154,congenital abnormality - disease or syndrome
14,attention-deficit-and-disruptive-behavior-disorders,personal satisfaction,0.03692,finding
14,attention-deficit-and-disruptive-behavior-disorders,medical history,0.03538,finding
14,attention-deficit-and-disruptive-behavior-disorders,human chorionic gonadotropin,0.03385,disease or syndrome - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,sexual intercourse - finding,0.03385,finding
14,attention-deficit-and-disruptive-behavior-disorders,integumentary scale,0.03231,body part, organ, or organ component
14,attention-deficit-and-disruptive-behavior-disorders,anxiety disorders,0.03077,finding - mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,depressed mood,0.03077,finding - mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,autistic disorder,0.02769,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,body mass index,0.02615,clinical attribute - diagnostic procedure
14,attention-deficit-and-disruptive-behavior-disorders,relate - vinyl resin,0.02615,organic chemical
14,attention-deficit-and-disruptive-behavior-disorders,operative surgical procedures,0.02462,diagnostic procedure - therapeutic or preventive procedure
14,attention-deficit-and-disruptive-behavior-disorders,psychotropic drugs,0.02308,pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,nitric oxide synthase,0.02308,enzyme
14,attention-deficit-and-disruptive-behavior-disorders,pharmacotherapy,0.02154,therapeutic or preventive procedure
14,attention-deficit-and-disruptive-behavior-disorders,bipolar disorder,0.02154,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,allergy severity - severe,0.02154,finding
14,attention-deficit-and-disruptive-behavior-disorders,mass of body structure,0.02154,finding
14,attention-deficit-and-disruptive-behavior-disorders,pervasive development disorder,0.02,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,ethanol,0.02,organic chemical - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,mild adverse event,0.02,finding
14,attention-deficit-and-disruptive-behavior-disorders,active brand of pseudoephedrine-triprolidine,0.01692,organic chemical - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,autism spectrum disorders,0.01538,congenital abnormality - mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,disability,0.01538,finding
14,attention-deficit-and-disruptive-behavior-disorders,blind vision,0.01538,disease or syndrome
14,attention-deficit-and-disruptive-behavior-disorders,pharmaceutical preparations,0.01385,pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,tic disorder,0.01385,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,benzodiazepines,0.01231,organic chemical - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,nicotine,0.01231,hazardous or poisonous substance - organic chemical - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,substance use disorders,0.01231,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,antipsychotic agents,0.01231,pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,selective serotonin re-uptake inhibitor,0.01231,pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,developmental disabilities,0.01231,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,positive finding,0.01077,finding
14,attention-deficit-and-disruptive-behavior-disorders,osteochondritis dissecans,0.01077,disease or syndrome - mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,screening for cancer,0.01077,diagnostic procedure
14,attention-deficit-and-disruptive-behavior-disorders,antidepressive agents,0.01077,pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,sexually active,0.01077,finding
14,attention-deficit-and-disruptive-behavior-disorders,behavior therapy,0.01077,therapeutic or preventive procedure
14,attention-deficit-and-disruptive-behavior-disorders,psychotic disorders,0.00923,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,obsessive-compulsive disorder,0.00923,disease or syndrome - mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,monoamine oxidase inhibitors,0.00923,organic chemical - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,compulsive disorder,0.00923,finding
14,attention-deficit-and-disruptive-behavior-disorders,hypersensitivity,0.00923,clinical attribute - finding - pathologic function
14,attention-deficit-and-disruptive-behavior-disorders,illicit drugs,0.00769,hazardous or poisonous substance - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,substance abuse problem,0.00769,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,hypertensive disease,0.00769,biologically active substance - disease or syndrome - finding
14,attention-deficit-and-disruptive-behavior-disorders,asthma,0.00615,disease or syndrome
14,attention-deficit-and-disruptive-behavior-disorders,mental retardation,0.00615,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,heart diseases,0.00615,disease or syndrome
14,attention-deficit-and-disruptive-behavior-disorders,heart rate,0.00615,clinical attribute
14,attention-deficit-and-disruptive-behavior-disorders,diagnosis psychiatric,0.00615,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,epilepsy,0.00462,disease or syndrome
14,attention-deficit-and-disruptive-behavior-disorders,nervousness,0.00462,sign or symptom
14,attention-deficit-and-disruptive-behavior-disorders,manic,0.00462,finding - mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,breast,0.00462,body part, organ, or organ component
14,attention-deficit-and-disruptive-behavior-disorders,craniocerebral trauma,0.00462,injury or poisoning
14,attention-deficit-and-disruptive-behavior-disorders,post-traumatic stress disorder,0.00462,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,stress disorders traumatic,0.00462,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,neurological observations,0.00462,finding
14,attention-deficit-and-disruptive-behavior-disorders,diastolic blood pressure,0.00462,clinical attribute - diagnostic procedure - finding
14,attention-deficit-and-disruptive-behavior-disorders,diastole,0.00462,clinical attribute
14,attention-deficit-and-disruptive-behavior-disorders,brain injuries,0.00462,injury or poisoning
14,attention-deficit-and-disruptive-behavior-disorders,major depressive disorder,0.00462,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,suicidal,0.00308,finding
14,attention-deficit-and-disruptive-behavior-disorders,unstable status,0.00308,finding
14,attention-deficit-and-disruptive-behavior-disorders,personality disorders,0.00308,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,cardiovascular diseases,0.00308,disease or syndrome
14,attention-deficit-and-disruptive-behavior-disorders,hepatic,0.00308,body location or region
14,attention-deficit-and-disruptive-behavior-disorders,unipolar depression,0.00308,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,eating disorders,0.00308,mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,injury wounds,0.00308,body substance - injury or poisoning
14,attention-deficit-and-disruptive-behavior-disorders,nervous system disorder,0.00308,disease or syndrome
14,attention-deficit-and-disruptive-behavior-disorders,fever,0.00154,finding
14,attention-deficit-and-disruptive-behavior-disorders,suicide risk,0.00154,finding
14,attention-deficit-and-disruptive-behavior-disorders,suicidality,0.00154,clinical attribute
14,attention-deficit-and-disruptive-behavior-disorders,family history,0.00154,congenital abnormality - disease or syndrome - enzyme - finding
14,attention-deficit-and-disruptive-behavior-disorders,thyroid gland,0.00154,body part, organ, or organ component - disease or syndrome - pharmacologic substance
14,attention-deficit-and-disruptive-behavior-disorders,cardiac arrhythmia,0.00154,finding - pathologic function
14,attention-deficit-and-disruptive-behavior-disorders,psychotherapy,0.00154,therapeutic or preventive procedure
14,attention-deficit-and-disruptive-behavior-disorders,suicide attempt,0.00154,finding - mental or behavioral dysfunction
14,attention-deficit-and-disruptive-behavior-disorders,kidney,0.00154,body part, organ, or organ component
14,attention-deficit-and-disruptive-behavior-disorders,drug abuse,0.00154,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,attention deficit hyperactivity disorder,0.83732,disease or syndrome - mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,intravenous infusion procedures,0.51994,therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,hyperactive behavior,0.17225,finding
15,attention-deficit-disorder-with-hyperactivity,mental disorders,0.126,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,negative finding,0.11324,finding
15,attention-deficit-disorder-with-hyperactivity,pregnancy tests,0.10845,diagnostic procedure
15,attention-deficit-disorder-with-hyperactivity,pharmacologic substance,0.09569,pharmacologic substance - therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,contraceptive methods,0.08134,therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,physical assessment findings,0.06699,finding
15,attention-deficit-disorder-with-hyperactivity,stimulant,0.05742,pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,electrocardiogram,0.05423,diagnostic procedure - finding - organic chemical - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,serum,0.05423,biologically active substance - body substance - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,mood disorders,0.05104,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,blood pressure finding,0.04625,finding
15,attention-deficit-disorder-with-hyperactivity,moderate adverse event,0.04625,finding
15,attention-deficit-disorder-with-hyperactivity,gravidity,0.04625,finding
15,attention-deficit-disorder-with-hyperactivity,surgical revision,0.04306,therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,congenital abnormality,0.04147,congenital abnormality - disease or syndrome
15,attention-deficit-disorder-with-hyperactivity,schizophrenia,0.03987,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,personal satisfaction,0.03828,finding
15,attention-deficit-disorder-with-hyperactivity,medical history,0.03668,finding
15,attention-deficit-disorder-with-hyperactivity,sexual intercourse - finding,0.03509,finding
15,attention-deficit-disorder-with-hyperactivity,human chorionic gonadotropin,0.03349,disease or syndrome - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,depressed mood,0.0319,finding - mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,anxiety disorders,0.0303,finding - mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,integumentary scale,0.0303,body part, organ, or organ component
15,attention-deficit-disorder-with-hyperactivity,autistic disorder,0.0303,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,body mass index,0.02711,clinical attribute - diagnostic procedure
15,attention-deficit-disorder-with-hyperactivity,relate - vinyl resin,0.02711,organic chemical
15,attention-deficit-disorder-with-hyperactivity,operative surgical procedures,0.02552,diagnostic procedure - therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,treatment protocols,0.02392,therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,nitric oxide synthase,0.02392,enzyme
15,attention-deficit-disorder-with-hyperactivity,pharmacotherapy,0.02233,therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,bipolar disorder,0.02233,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,psychotropic drugs,0.02233,pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,allergy severity - severe,0.02233,finding
15,attention-deficit-disorder-with-hyperactivity,mass of body structure,0.02233,finding
15,attention-deficit-disorder-with-hyperactivity,pervasive development disorder,0.02073,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,ethanol,0.02073,organic chemical - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,autism spectrum disorders,0.01754,congenital abnormality - mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,active brand of pseudoephedrine-triprolidine,0.01754,organic chemical - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,disability,0.01595,finding
15,attention-deficit-disorder-with-hyperactivity,mild adverse event,0.01595,finding
15,attention-deficit-disorder-with-hyperactivity,pharmaceutical preparations,0.01435,pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,blind vision,0.01435,disease or syndrome
15,attention-deficit-disorder-with-hyperactivity,benzodiazepines,0.01276,organic chemical - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,nicotine,0.01276,hazardous or poisonous substance - organic chemical - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,substance use disorders,0.01276,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,tic disorder,0.01276,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,psychotic disorders,0.01116,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,positive finding,0.01116,finding
15,attention-deficit-disorder-with-hyperactivity,osteochondritis dissecans,0.01116,disease or syndrome - mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,selective serotonin re-uptake inhibitor,0.01116,pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,screening for cancer,0.01116,diagnostic procedure
15,attention-deficit-disorder-with-hyperactivity,antidepressive agents,0.01116,pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,sexually active,0.01116,finding
15,attention-deficit-disorder-with-hyperactivity,behavior therapy,0.01116,therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,developmental disabilities,0.01116,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,monoamine oxidase inhibitors,0.00957,organic chemical - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,hypersensitivity,0.00957,clinical attribute - finding - pathologic function
15,attention-deficit-disorder-with-hyperactivity,illicit drugs,0.00797,hazardous or poisonous substance - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,antipsychotic agents,0.00797,pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,substance abuse problem,0.00797,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,obsessive-compulsive disorder,0.00797,disease or syndrome - mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,hypertensive disease,0.00797,biologically active substance - disease or syndrome - finding
15,attention-deficit-disorder-with-hyperactivity,compulsive disorder,0.00797,finding
15,attention-deficit-disorder-with-hyperactivity,asthma,0.00638,disease or syndrome
15,attention-deficit-disorder-with-hyperactivity,mental retardation,0.00638,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,heart diseases,0.00638,disease or syndrome
15,attention-deficit-disorder-with-hyperactivity,epilepsy,0.00478,disease or syndrome
15,attention-deficit-disorder-with-hyperactivity,nervousness,0.00478,sign or symptom
15,attention-deficit-disorder-with-hyperactivity,breast,0.00478,body part, organ, or organ component
15,attention-deficit-disorder-with-hyperactivity,craniocerebral trauma,0.00478,injury or poisoning
15,attention-deficit-disorder-with-hyperactivity,unipolar depression,0.00478,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,post-traumatic stress disorder,0.00478,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,stress disorders traumatic,0.00478,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,heart rate,0.00478,clinical attribute
15,attention-deficit-disorder-with-hyperactivity,brain injuries,0.00478,injury or poisoning
15,attention-deficit-disorder-with-hyperactivity,neurological observations,0.00478,finding
15,attention-deficit-disorder-with-hyperactivity,diagnosis psychiatric,0.00478,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,suicidal,0.00319,finding
15,attention-deficit-disorder-with-hyperactivity,unstable status,0.00319,finding
15,attention-deficit-disorder-with-hyperactivity,personality disorders,0.00319,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,manic,0.00319,finding - mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,cardiovascular diseases,0.00319,disease or syndrome
15,attention-deficit-disorder-with-hyperactivity,hepatic,0.00319,body location or region
15,attention-deficit-disorder-with-hyperactivity,eating disorders,0.00319,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,injury wounds,0.00319,body substance - injury or poisoning
15,attention-deficit-disorder-with-hyperactivity,major depressive disorder,0.00319,mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,diastolic blood pressure,0.00319,clinical attribute - diagnostic procedure - finding
15,attention-deficit-disorder-with-hyperactivity,nervous system disorder,0.00319,disease or syndrome
15,attention-deficit-disorder-with-hyperactivity,diastole,0.00319,clinical attribute
15,attention-deficit-disorder-with-hyperactivity,fever,0.00159,finding
15,attention-deficit-disorder-with-hyperactivity,suicide risk,0.00159,finding
15,attention-deficit-disorder-with-hyperactivity,suicidality,0.00159,clinical attribute
15,attention-deficit-disorder-with-hyperactivity,family history,0.00159,congenital abnormality - disease or syndrome - enzyme - finding
15,attention-deficit-disorder-with-hyperactivity,thyroid gland,0.00159,body part, organ, or organ component - disease or syndrome - pharmacologic substance
15,attention-deficit-disorder-with-hyperactivity,cardiac arrhythmia,0.00159,finding - pathologic function
15,attention-deficit-disorder-with-hyperactivity,psychotherapy,0.00159,therapeutic or preventive procedure
15,attention-deficit-disorder-with-hyperactivity,suicide attempt,0.00159,finding - mental or behavioral dysfunction
15,attention-deficit-disorder-with-hyperactivity,kidney,0.00159,body part, organ, or organ component
15,attention-deficit-disorder-with-hyperactivity,drug abuse,0.00159,mental or behavioral dysfunction
16,autistic-disorder,autistic disorder,0.79259,mental or behavioral dysfunction
16,autistic-disorder,autism spectrum disorders,0.41975,congenital abnormality - mental or behavioral dysfunction
16,autistic-disorder,intravenous infusion procedures,0.35556,therapeutic or preventive procedure
16,autistic-disorder,pervasive development disorder,0.22222,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
16,autistic-disorder,developmental disabilities,0.13827,mental or behavioral dysfunction
16,autistic-disorder,nitric oxide synthase,0.1284,enzyme
16,autistic-disorder,mental disorders,0.08642,mental or behavioral dysfunction
16,autistic-disorder,psychotropic drugs,0.08148,pharmacologic substance
16,autistic-disorder,physical assessment findings,0.05679,finding
16,autistic-disorder,anxiety disorders,0.05185,finding - mental or behavioral dysfunction
16,autistic-disorder,integumentary scale,0.05185,body part, organ, or organ component
16,autistic-disorder,pharmacologic substance,0.04938,pharmacologic substance - therapeutic or preventive procedure
16,autistic-disorder,attention deficit hyperactivity disorder,0.04938,disease or syndrome - mental or behavioral dysfunction
16,autistic-disorder,gene therapy,0.04691,therapeutic or preventive procedure
16,autistic-disorder,epilepsy,0.04444,disease or syndrome
16,autistic-disorder,antipsychotic agents,0.04198,pharmacologic substance
16,autistic-disorder,contraceptive methods,0.03951,therapeutic or preventive procedure
16,autistic-disorder,malaise,0.03704,finding - sign or symptom
16,autistic-disorder,pharmaceutical preparations,0.03457,pharmacologic substance
16,autistic-disorder,negative finding,0.0321,finding
16,autistic-disorder,moderate adverse event,0.0321,finding
16,autistic-disorder,fluoxetine,0.02963,organic chemical - pharmacologic substance
16,autistic-disorder,active brand of pseudoephedrine-triprolidine,0.02963,organic chemical - pharmacologic substance
16,autistic-disorder,surgical revision,0.02963,therapeutic or preventive procedure
16,autistic-disorder,dactinomycin,0.02963,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
16,autistic-disorder,behavior disorders,0.02963,injury or poisoning - mental or behavioral dysfunction
16,autistic-disorder,disability,0.02716,finding
16,autistic-disorder,anticonvulsants,0.02716,pharmacologic substance
16,autistic-disorder,pregnancy tests,0.02716,diagnostic procedure
16,autistic-disorder,hyperactive behavior,0.02469,finding
16,autistic-disorder,psychotic disorders,0.02469,mental or behavioral dysfunction
16,autistic-disorder,hearing examination finding,0.02469,finding
16,autistic-disorder,schizophrenia,0.02469,mental or behavioral dysfunction
16,autistic-disorder,hypersensitivity,0.02469,clinical attribute - finding - pathologic function
16,autistic-disorder,relate - vinyl resin,0.02222,organic chemical
16,autistic-disorder,allergy severity - severe,0.02222,finding
16,autistic-disorder,blind vision,0.02222,disease or syndrome
16,autistic-disorder,gravidity,0.01975,finding
16,autistic-disorder,mood disorders,0.01975,mental or behavioral dysfunction
16,autistic-disorder,sexually active,0.01975,finding
16,autistic-disorder,behavior therapy,0.01975,therapeutic or preventive procedure
16,autistic-disorder,bipolar disorder,0.01728,mental or behavioral dysfunction
16,autistic-disorder,selective serotonin re-uptake inhibitor,0.01728,pharmacologic substance
16,autistic-disorder,serum,0.01728,biologically active substance - body substance - pharmacologic substance
16,autistic-disorder,stimulant,0.01728,pharmacologic substance
16,autistic-disorder,follow-up status,0.01728,finding
16,autistic-disorder,depressed mood,0.01728,finding - mental or behavioral dysfunction
16,autistic-disorder,positive finding,0.01481,finding
16,autistic-disorder,mental retardation,0.01481,mental or behavioral dysfunction
16,autistic-disorder,treatment-psychosocial effects,0.01481,finding
16,autistic-disorder,magnetic resonance imaging,0.01235,diagnostic procedure
16,autistic-disorder,aggressive behavior,0.01235,mental or behavioral dysfunction
16,autistic-disorder,schizoaffective disorder,0.00988,mental or behavioral dysfunction
16,autistic-disorder,personal satisfaction,0.00988,finding
16,autistic-disorder,congenital abnormality,0.00988,congenital abnormality - disease or syndrome
16,autistic-disorder,unstable status,0.00988,finding
16,autistic-disorder,suicidal,0.00741,finding
16,autistic-disorder,electrocardiogram,0.00741,diagnostic procedure - finding - organic chemical - pharmacologic substance
16,autistic-disorder,fever,0.00741,finding
16,autistic-disorder,malignant neoplasms,0.00741,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
16,autistic-disorder,paralysed,0.00741,finding
16,autistic-disorder,kidney diseases,0.00494,disease or syndrome
16,autistic-disorder,nervousness,0.00494,sign or symptom
16,autistic-disorder,traumatic brain injury,0.00494,disease or syndrome - injury or poisoning
16,autistic-disorder,injury wounds,0.00494,body substance - injury or poisoning
16,autistic-disorder,asthma,0.00494,disease or syndrome
16,autistic-disorder,heart diseases,0.00494,disease or syndrome
16,autistic-disorder,family history,0.00494,congenital abnormality - disease or syndrome - enzyme - finding
16,autistic-disorder,investigational new drugs,0.00494,pharmacologic substance - therapeutic or preventive procedure
16,autistic-disorder,neurological observations,0.00494,finding
16,autistic-disorder,nervous system disorder,0.00494,disease or syndrome
16,autistic-disorder,therapeutic brand of coal tar,0.00494,organic chemical - pharmacologic substance - therapeutic or preventive procedure
16,autistic-disorder,diagnosis psychiatric,0.00494,mental or behavioral dysfunction
16,autistic-disorder,pathology processes,0.00247,pathologic function
16,autistic-disorder,liver diseases,0.00247,disease or syndrome
16,autistic-disorder,hepatic,0.00247,body location or region
16,autistic-disorder,ethanol,0.00247,organic chemical - pharmacologic substance
16,autistic-disorder,medical history,0.00247,finding
16,autistic-disorder,movement disorders,0.00247,disease or syndrome
16,autistic-disorder,brain injuries,0.00247,injury or poisoning
16,autistic-disorder,antidepressive agents,0.00247,pharmacologic substance
16,autistic-disorder,major depressive disorder,0.00247,mental or behavioral dysfunction
17,behavioral-symptoms,intravenous infusion procedures,0.29791,therapeutic or preventive procedure
17,behavioral-symptoms,depressed mood,0.28933,finding - mental or behavioral dysfunction
17,behavioral-symptoms,major depressive disorder,0.20572,mental or behavioral dysfunction
17,behavioral-symptoms,attention deficit hyperactivity disorder,0.10341,disease or syndrome - mental or behavioral dysfunction
17,behavioral-symptoms,antidepressive agents,0.10253,pharmacologic substance
17,behavioral-symptoms,depressive episode unspecified,0.09197,mental or behavioral dysfunction
17,behavioral-symptoms,contraceptive methods,0.08999,therapeutic or preventive procedure
17,behavioral-symptoms,unipolar depression,0.08713,mental or behavioral dysfunction
17,behavioral-symptoms,mental disorders,0.07327,mental or behavioral dysfunction
17,behavioral-symptoms,body mass index,0.06601,clinical attribute - diagnostic procedure
17,behavioral-symptoms,physical assessment findings,0.06095,finding
17,behavioral-symptoms,negative finding,0.05611,finding
17,behavioral-symptoms,tropical spastic paraparesis,0.05347,disease or syndrome - therapeutic or preventive procedure
17,behavioral-symptoms,moderate adverse event,0.04884,finding
17,behavioral-symptoms,pharmacologic substance,0.04862,pharmacologic substance - therapeutic or preventive procedure
17,behavioral-symptoms,anxiety disorders,0.04488,finding - mental or behavioral dysfunction
17,behavioral-symptoms,multiple endocrine neoplasia,0.04356,antibiotic - neoplastic process - organic chemical
17,behavioral-symptoms,bipolar disorder,0.04246,mental or behavioral dysfunction
17,behavioral-symptoms,pregnancy tests,0.0407,diagnostic procedure
17,behavioral-symptoms,depressive symptoms,0.03872,sign or symptom
17,behavioral-symptoms,severe combined immunodeficiency,0.03806,diagnostic procedure - disease or syndrome
17,behavioral-symptoms,gravidity,0.03762,finding
17,behavioral-symptoms,mass of body structure,0.03388,finding
17,behavioral-symptoms,allergy severity - severe,0.03344,finding
17,behavioral-symptoms,unmarried,0.03256,finding
17,behavioral-symptoms,malignant neoplasms,0.03212,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
17,behavioral-symptoms,active brand of pseudoephedrine-triprolidine,0.03168,organic chemical - pharmacologic substance
17,behavioral-symptoms,personality inventories,0.0286,diagnostic procedure
17,behavioral-symptoms,dysthymic disorder,0.02772,mental or behavioral dysfunction
17,behavioral-symptoms,psychotropic drugs,0.02684,pharmacologic substance
17,behavioral-symptoms,schizophrenia,0.02618,mental or behavioral dysfunction
17,behavioral-symptoms,mild adverse event,0.02618,finding
17,behavioral-symptoms,mood disorders,0.0253,mental or behavioral dysfunction
17,behavioral-symptoms,operative surgical procedures,0.02398,diagnostic procedure - therapeutic or preventive procedure
17,behavioral-symptoms,medical history,0.02398,finding
17,behavioral-symptoms,pharmacotherapy,0.02332,therapeutic or preventive procedure
17,behavioral-symptoms,selective serotonin re-uptake inhibitor,0.02288,pharmacologic substance
17,behavioral-symptoms,antipsychotic agents,0.02266,pharmacologic substance
17,behavioral-symptoms,serum,0.02222,biologically active substance - body substance - pharmacologic substance
17,behavioral-symptoms,relate - vinyl resin,0.022,organic chemical
17,behavioral-symptoms,treatment protocols,0.02178,therapeutic or preventive procedure
17,behavioral-symptoms,positive finding,0.02068,finding
17,behavioral-symptoms,electrocardiogram,0.0198,diagnostic procedure - finding - organic chemical - pharmacologic substance
17,behavioral-symptoms,screening for cancer,0.01892,diagnostic procedure
17,behavioral-symptoms,ethanol,0.0187,organic chemical - pharmacologic substance
17,behavioral-symptoms,psychotic disorders,0.01804,mental or behavioral dysfunction
17,behavioral-symptoms,mini-mental status exam,0.01804,diagnostic procedure
17,behavioral-symptoms,suicidal,0.01782,finding
17,behavioral-symptoms,post-traumatic stress disorder,0.01716,mental or behavioral dysfunction
17,behavioral-symptoms,pharmaceutical preparations,0.0165,pharmacologic substance
17,behavioral-symptoms,blood pressure finding,0.01628,finding
17,behavioral-symptoms,dementia,0.01496,mental or behavioral dysfunction
17,behavioral-symptoms,manic,0.01408,finding - mental or behavioral dysfunction
17,behavioral-symptoms,suicide attempt,0.01408,finding - mental or behavioral dysfunction
17,behavioral-symptoms,psychotherapy,0.01386,therapeutic or preventive procedure
17,behavioral-symptoms,stabilizer - function,0.01342,organ or tissue function
17,behavioral-symptoms,congenital abnormality,0.01298,congenital abnormality - disease or syndrome
17,behavioral-symptoms,neoplasm metastasis,0.01276,neoplastic process
17,behavioral-symptoms,lithium,0.01254,congenital abnormality - disease or syndrome - pharmacologic substance
17,behavioral-symptoms,benign rolandic epilepsy,0.01232,disease or syndrome - therapeutic or preventive procedure
17,behavioral-symptoms,infantile neuroaxonal dystrophy,0.0121,disease or syndrome
17,behavioral-symptoms,fluoxetine,0.0121,organic chemical - pharmacologic substance
17,behavioral-symptoms,magnetic resonance imaging,0.01166,diagnostic procedure
17,behavioral-symptoms,stimulant,0.01144,pharmacologic substance
17,behavioral-symptoms,schizoaffective disorder,0.011,mental or behavioral dysfunction
17,behavioral-symptoms,hypertensive disease,0.011,biologically active substance - disease or syndrome - finding
17,behavioral-symptoms,substance abuse problem,0.01034,mental or behavioral dysfunction
17,behavioral-symptoms,benzodiazepines,0.00968,organic chemical - pharmacologic substance
17,behavioral-symptoms,generalized anxiety disorder,0.00968,mental or behavioral dysfunction
17,behavioral-symptoms,psychiatric problem,0.00968,mental or behavioral dysfunction
17,behavioral-symptoms,disability,0.00792,finding
17,behavioral-symptoms,impaired cognition,0.00792,finding - mental or behavioral dysfunction
17,behavioral-symptoms,injury wounds,0.0077,body substance - injury or poisoning
17,behavioral-symptoms,cerebrovascular accident,0.0077,disease or syndrome - therapeutic or preventive procedure
17,behavioral-symptoms,kidney,0.00726,body part, organ, or organ component
17,behavioral-symptoms,obsessive-compulsive disorder,0.00704,disease or syndrome - mental or behavioral dysfunction
17,behavioral-symptoms,unstable status,0.00682,finding
17,behavioral-symptoms,autistic disorder,0.0066,mental or behavioral dysfunction
17,behavioral-symptoms,panic disorder,0.00638,disease or syndrome - mental or behavioral dysfunction
17,behavioral-symptoms,stress disorders traumatic,0.00638,mental or behavioral dysfunction
17,behavioral-symptoms,hiv,0.00616,disease or syndrome - pharmacologic substance - virus
17,behavioral-symptoms,personality disorders,0.00572,mental or behavioral dysfunction
17,behavioral-symptoms,diabetes,0.00572,disease or syndrome
17,behavioral-symptoms,psychotic symptoms,0.0055,sign or symptom
17,behavioral-symptoms,anticonvulsants,0.00528,pharmacologic substance
17,behavioral-symptoms,hepatic,0.00506,body location or region
17,behavioral-symptoms,alcoholic intoxication chronic,0.00506,mental or behavioral dysfunction
17,behavioral-symptoms,heart diseases,0.00484,disease or syndrome
17,behavioral-symptoms,family history,0.00484,congenital abnormality - disease or syndrome - enzyme - finding
17,behavioral-symptoms,cardiovascular diseases,0.00462,disease or syndrome
17,behavioral-symptoms,mental retardation,0.0044,mental or behavioral dysfunction
17,behavioral-symptoms,compulsive disorder,0.0044,finding
17,behavioral-symptoms,illicit drugs,0.00418,hazardous or poisonous substance - pharmacologic substance
17,behavioral-symptoms,breast,0.00396,body part, organ, or organ component
17,behavioral-symptoms,myocardial infarction,0.00396,disease or syndrome - finding
17,behavioral-symptoms,suicidality,0.00396,clinical attribute
17,behavioral-symptoms,pervasive development disorder,0.00374,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
17,behavioral-symptoms,craniocerebral trauma,0.00374,injury or poisoning
17,behavioral-symptoms,hypersensitivity,0.00374,clinical attribute - finding - pathologic function
17,behavioral-symptoms,thyroid gland,0.00352,body part, organ, or organ component - disease or syndrome - pharmacologic substance
17,behavioral-symptoms,monoamine oxidase inhibitors,0.00352,organic chemical - pharmacologic substance
17,behavioral-symptoms,eating disorders,0.0033,mental or behavioral dysfunction
17,behavioral-symptoms,multiple sclerosis,0.0033,body part, organ, or organ component - disease or syndrome - finding
17,behavioral-symptoms,nervous system disorder,0.00308,disease or syndrome
17,behavioral-symptoms,nicotine,0.00286,hazardous or poisonous substance - organic chemical - pharmacologic substance
17,behavioral-symptoms,lung,0.00286,body part, organ, or organ component - disease or syndrome
17,behavioral-symptoms,developmental disabilities,0.00286,mental or behavioral dysfunction
17,behavioral-symptoms,substance dependence,0.00264,mental or behavioral dysfunction
17,behavioral-symptoms,hypothyroidism,0.00242,disease or syndrome
17,behavioral-symptoms,medical contraindication,0.0022,finding
17,behavioral-symptoms,caffeine,0.00176,organic chemical - pharmacologic substance - therapeutic or preventive procedure
17,behavioral-symptoms,nervousness,0.00154,sign or symptom
17,behavioral-symptoms,alcohol abuse,0.00154,mental or behavioral dysfunction
17,behavioral-symptoms,suicide risk,0.0011,finding
17,behavioral-symptoms,fever,0.0011,finding
17,behavioral-symptoms,drug abuse,0.00088,mental or behavioral dysfunction
17,behavioral-symptoms,investigational new drugs,0.00044,pharmacologic substance - therapeutic or preventive procedure
18,binge-eating-disorder,intravenous infusion procedures,0.40164,therapeutic or preventive procedure
18,binge-eating-disorder,eating disorders,0.37705,mental or behavioral dysfunction
18,binge-eating-disorder,body mass index,0.35246,clinical attribute - diagnostic procedure
18,binge-eating-disorder,mass of body structure,0.19672,finding
18,binge-eating-disorder,obesity,0.12295,disease or syndrome - finding
18,binge-eating-disorder,negative finding,0.08197,finding
18,binge-eating-disorder,mental disorders,0.08197,mental or behavioral dysfunction
18,binge-eating-disorder,contraceptive methods,0.07377,therapeutic or preventive procedure
18,binge-eating-disorder,multiple endocrine neoplasia,0.06557,antibiotic - neoplastic process - organic chemical
18,binge-eating-disorder,ethanol,0.05738,organic chemical - pharmacologic substance
18,binge-eating-disorder,weighing patient,0.05738,diagnostic procedure - finding
18,binge-eating-disorder,pregnancy tests,0.04918,diagnostic procedure
18,binge-eating-disorder,physical assessment findings,0.04918,finding
18,binge-eating-disorder,follow-up status,0.04098,finding
18,binge-eating-disorder,gravidity,0.04098,finding
18,binge-eating-disorder,depressed mood,0.04098,finding - mental or behavioral dysfunction
18,binge-eating-disorder,moderate adverse event,0.03279,finding
18,binge-eating-disorder,alcohol consumption,0.03279,individual behavior
18,binge-eating-disorder,severe combined immunodeficiency,0.03279,diagnostic procedure - disease or syndrome
18,binge-eating-disorder,consumption-archaic term for tb,0.03279,disease or syndrome
18,binge-eating-disorder,unipolar depression,0.02459,mental or behavioral dysfunction
18,binge-eating-disorder,household composition,0.02459,finding
18,binge-eating-disorder,alcoholic intoxication chronic,0.02459,mental or behavioral dysfunction
18,binge-eating-disorder,contraception barrier,0.02459,therapeutic or preventive procedure
18,binge-eating-disorder,active brand of pseudoephedrine-triprolidine,0.02459,organic chemical - pharmacologic substance
18,binge-eating-disorder,hepatic,0.02459,body location or region
18,binge-eating-disorder,thyroid gland,0.02459,body part, organ, or organ component - disease or syndrome - pharmacologic substance
18,binge-eating-disorder,operative surgical procedures,0.02459,diagnostic procedure - therapeutic or preventive procedure
18,binge-eating-disorder,unstable status,0.01639,finding
18,binge-eating-disorder,pregnancy test negative,0.01639,finding - laboratory or test result
18,binge-eating-disorder,bipolar disorder,0.01639,mental or behavioral dysfunction
18,binge-eating-disorder,schizophrenia,0.01639,mental or behavioral dysfunction
18,binge-eating-disorder,electrocardiogram,0.01639,diagnostic procedure - finding - organic chemical - pharmacologic substance
18,binge-eating-disorder,integumentary scale,0.01639,body part, organ, or organ component
18,binge-eating-disorder,suicide risk,0.01639,finding
18,binge-eating-disorder,personality disorders,0.01639,mental or behavioral dysfunction
18,binge-eating-disorder,sexually active,0.01639,finding
18,binge-eating-disorder,cognitive therapy,0.01639,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
18,binge-eating-disorder,psychotherapy,0.01639,therapeutic or preventive procedure
18,binge-eating-disorder,psychotic disorders,0.01639,mental or behavioral dysfunction
18,binge-eating-disorder,opioids,0.01639,hazardous or poisonous substance - organic chemical - pharmacologic substance
18,binge-eating-disorder,psychotropic drugs,0.01639,pharmacologic substance
18,binge-eating-disorder,hypertensive disease,0.0082,biologically active substance - disease or syndrome - finding
18,binge-eating-disorder,relate - vinyl resin,0.0082,organic chemical
18,binge-eating-disorder,allergy severity - severe,0.0082,finding
18,binge-eating-disorder,suicidal,0.0082,finding
18,binge-eating-disorder,fluoxetine,0.0082,organic chemical - pharmacologic substance
18,binge-eating-disorder,oral contraception,0.0082,pharmacologic substance - therapeutic or preventive procedure
18,binge-eating-disorder,behavior therapy,0.0082,therapeutic or preventive procedure
18,binge-eating-disorder,pharmacotherapy,0.0082,therapeutic or preventive procedure
18,binge-eating-disorder,contraceptives oral,0.0082,pharmacologic substance - therapeutic or preventive procedure
18,binge-eating-disorder,suicidality,0.0082,clinical attribute
18,binge-eating-disorder,pharmacologic substance,0.0082,pharmacologic substance - therapeutic or preventive procedure
18,binge-eating-disorder,screening for cancer,0.0082,diagnostic procedure
18,binge-eating-disorder,depressive symptoms,0.0082,sign or symptom
18,binge-eating-disorder,mental retardation,0.0082,mental or behavioral dysfunction
18,binge-eating-disorder,major depressive disorder,0.0082,mental or behavioral dysfunction
19,bipolar-disorder,intravenous infusion procedures,0.49149,therapeutic or preventive procedure
19,bipolar-disorder,bipolar disorder,0.41915,mental or behavioral dysfunction
19,bipolar-disorder,depressed mood,0.24362,finding - mental or behavioral dysfunction
19,bipolar-disorder,contraceptive methods,0.16702,therapeutic or preventive procedure
19,bipolar-disorder,antipsychotic agents,0.14149,pharmacologic substance
19,bipolar-disorder,schizophrenia,0.14043,mental or behavioral dysfunction
19,bipolar-disorder,depressive episode unspecified,0.12128,mental or behavioral dysfunction
19,bipolar-disorder,mental disorders,0.11702,mental or behavioral dysfunction
19,bipolar-disorder,stabilizer - function,0.10213,organ or tissue function
19,bipolar-disorder,lithium,0.10106,congenital abnormality - disease or syndrome - pharmacologic substance
19,bipolar-disorder,nitric oxide synthase,0.0883,enzyme
19,bipolar-disorder,schizoaffective disorder,0.08723,mental or behavioral dysfunction
19,bipolar-disorder,antidepressive agents,0.07979,pharmacologic substance
19,bipolar-disorder,pharmacologic substance,0.07021,pharmacologic substance - therapeutic or preventive procedure
19,bipolar-disorder,severe combined immunodeficiency,0.07021,diagnostic procedure - disease or syndrome
19,bipolar-disorder,mood disorders,0.07021,mental or behavioral dysfunction
19,bipolar-disorder,major depressive disorder,0.06809,mental or behavioral dysfunction
19,bipolar-disorder,physical assessment findings,0.06489,finding
19,bipolar-disorder,negative finding,0.06277,finding
19,bipolar-disorder,multiple endocrine neoplasia,0.06277,antibiotic - neoplastic process - organic chemical
19,bipolar-disorder,unipolar depression,0.05638,mental or behavioral dysfunction
19,bipolar-disorder,psychotic disorders,0.05426,mental or behavioral dysfunction
19,bipolar-disorder,pregnancy tests,0.05426,diagnostic procedure
19,bipolar-disorder,active brand of pseudoephedrine-triprolidine,0.04894,organic chemical - pharmacologic substance
19,bipolar-disorder,allergy severity - severe,0.04787,finding
19,bipolar-disorder,tropical spastic paraparesis,0.04681,disease or syndrome - therapeutic or preventive procedure
19,bipolar-disorder,psychotropic drugs,0.04681,pharmacologic substance
19,bipolar-disorder,valproic acid,0.04681,body part, organ, or organ component - organic chemical - pharmacologic substance
19,bipolar-disorder,operative surgical procedures,0.04574,diagnostic procedure - therapeutic or preventive procedure
19,bipolar-disorder,gravidity,0.04149,finding
19,bipolar-disorder,bleomycin-cisplatin protocol,0.03936,therapeutic or preventive procedure
19,bipolar-disorder,moderate adverse event,0.0383,finding
19,bipolar-disorder,atypia morphology,0.0383,finding
19,bipolar-disorder,ethanol,0.03723,organic chemical - pharmacologic substance
19,bipolar-disorder,anxiety disorders,0.03617,finding - mental or behavioral dysfunction
19,bipolar-disorder,pharmaceutical preparations,0.03404,pharmacologic substance
19,bipolar-disorder,therapeutic brand of coal tar,0.03404,organic chemical - pharmacologic substance - therapeutic or preventive procedure
19,bipolar-disorder,cancer remission,0.03404,finding - neoplastic process
19,bipolar-disorder,body mass index,0.03298,clinical attribute - diagnostic procedure
19,bipolar-disorder,medical history,0.03298,finding
19,bipolar-disorder,serum,0.03191,biologically active substance - body substance - pharmacologic substance
19,bipolar-disorder,treatment protocols,0.02979,therapeutic or preventive procedure
19,bipolar-disorder,contraception barrier,0.02766,therapeutic or preventive procedure
19,bipolar-disorder,sexually active,0.02766,finding
19,bipolar-disorder,surgical revision,0.0266,therapeutic or preventive procedure
19,bipolar-disorder,follow-up status,0.0266,finding
19,bipolar-disorder,electrocardiogram,0.02553,diagnostic procedure - finding - organic chemical - pharmacologic substance
19,bipolar-disorder,depressive symptoms,0.02553,sign or symptom
19,bipolar-disorder,attention deficit hyperactivity disorder,0.02553,disease or syndrome - mental or behavioral dysfunction
19,bipolar-disorder,disease of diaphragm,0.02234,body part, organ, or organ component - disease or syndrome
19,bipolar-disorder,mass of body structure,0.02128,finding
19,bipolar-disorder,oral contraception,0.02021,pharmacologic substance - therapeutic or preventive procedure
19,bipolar-disorder,alcoholic intoxication chronic,0.02021,mental or behavioral dysfunction
19,bipolar-disorder,psychotic symptoms,0.02021,sign or symptom
19,bipolar-disorder,substance abuse problem,0.01915,mental or behavioral dysfunction
19,bipolar-disorder,borderline personality disorder,0.01915,disease or syndrome - mental or behavioral dysfunction
19,bipolar-disorder,screening for cancer,0.01915,diagnostic procedure
19,bipolar-disorder,pharmacotherapy,0.01809,therapeutic or preventive procedure
19,bipolar-disorder,contraceptives oral,0.01809,pharmacologic substance - therapeutic or preventive procedure
19,bipolar-disorder,suicidal,0.01596,finding
19,bipolar-disorder,fluoxetine,0.01489,organic chemical - pharmacologic substance
19,bipolar-disorder,magnetic resonance imaging,0.01489,diagnostic procedure
19,bipolar-disorder,benign rolandic epilepsy,0.01489,disease or syndrome - therapeutic or preventive procedure
19,bipolar-disorder,benzodiazepines,0.01383,organic chemical - pharmacologic substance
19,bipolar-disorder,anticonvulsants,0.01277,pharmacologic substance
19,bipolar-disorder,congenital abnormality,0.01277,congenital abnormality - disease or syndrome
19,bipolar-disorder,personality disorders,0.0117,mental or behavioral dysfunction
19,bipolar-disorder,household composition,0.0117,finding
19,bipolar-disorder,relate - vinyl resin,0.0117,organic chemical
19,bipolar-disorder,post-traumatic stress disorder,0.0117,mental or behavioral dysfunction
19,bipolar-disorder,psychotherapy,0.0117,therapeutic or preventive procedure
19,bipolar-disorder,neoplasm metastasis,0.01064,neoplastic process
19,bipolar-disorder,mental retardation,0.01064,mental or behavioral dysfunction
19,bipolar-disorder,developmental disabilities,0.01064,mental or behavioral dysfunction
19,bipolar-disorder,implantation procedure,0.01064,therapeutic or preventive procedure
19,bipolar-disorder,positive finding,0.00957,finding
19,bipolar-disorder,current therapy,0.00957,therapeutic or preventive procedure
19,bipolar-disorder,pervasive development disorder,0.00851,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
19,bipolar-disorder,autistic disorder,0.00851,mental or behavioral dysfunction
19,bipolar-disorder,stimulant,0.00851,pharmacologic substance
19,bipolar-disorder,infantile neuroaxonal dystrophy,0.00745,disease or syndrome
19,bipolar-disorder,blood pressure finding,0.00745,finding
19,bipolar-disorder,nervous system disorder,0.00745,disease or syndrome
19,bipolar-disorder,malignant neoplasms,0.00745,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
19,bipolar-disorder,breast,0.00638,body part, organ, or organ component
19,bipolar-disorder,substance use disorders,0.00638,mental or behavioral dysfunction
19,bipolar-disorder,suicide attempt,0.00638,finding - mental or behavioral dysfunction
19,bipolar-disorder,diabetes mellitus,0.00532,disease or syndrome - pharmacologic substance
19,bipolar-disorder,hepatic,0.00532,body location or region
19,bipolar-disorder,hypertensive disease,0.00532,biologically active substance - disease or syndrome - finding
19,bipolar-disorder,cocaine,0.00532,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
19,bipolar-disorder,obsessive-compulsive disorder,0.00532,disease or syndrome - mental or behavioral dysfunction
19,bipolar-disorder,unstable status,0.00532,finding
19,bipolar-disorder,medical contraindication,0.00532,finding
19,bipolar-disorder,hiv,0.00426,disease or syndrome - pharmacologic substance - virus
19,bipolar-disorder,nicotine dependence,0.00426,mental or behavioral dysfunction
19,bipolar-disorder,multiple sclerosis,0.00426,body part, organ, or organ component - disease or syndrome - finding
19,bipolar-disorder,substance dependence,0.00426,mental or behavioral dysfunction
19,bipolar-disorder,injury wounds,0.00426,body substance - injury or poisoning
19,bipolar-disorder,hypothyroidism,0.00319,disease or syndrome
19,bipolar-disorder,eating disorders,0.00319,mental or behavioral dysfunction
19,bipolar-disorder,craniocerebral trauma,0.00319,injury or poisoning
19,bipolar-disorder,investigational new drugs,0.00319,pharmacologic substance - therapeutic or preventive procedure
19,bipolar-disorder,hypersensitivity,0.00319,clinical attribute - finding - pathologic function
19,bipolar-disorder,alcohol abuse,0.00319,mental or behavioral dysfunction
19,bipolar-disorder,nervousness,0.00213,sign or symptom
19,bipolar-disorder,heart diseases,0.00213,disease or syndrome
19,bipolar-disorder,monoamine oxidase inhibitors,0.00213,organic chemical - pharmacologic substance
19,bipolar-disorder,brain injuries,0.00213,injury or poisoning
19,bipolar-disorder,neurological observations,0.00213,finding
19,bipolar-disorder,kidney diseases,0.00106,disease or syndrome
19,bipolar-disorder,caffeine,0.00106,organic chemical - pharmacologic substance - therapeutic or preventive procedure
19,bipolar-disorder,drug dependence,0.00106,mental or behavioral dysfunction
19,bipolar-disorder,thyroid gland,0.00106,body part, organ, or organ component - disease or syndrome - pharmacologic substance
19,bipolar-disorder,cerebrovascular accident,0.00106,disease or syndrome - therapeutic or preventive procedure
20,borderline-personality-disorder,borderline personality disorder,0.85075,disease or syndrome - mental or behavioral dysfunction
20,borderline-personality-disorder,personality disorders,0.70149,mental or behavioral dysfunction
20,borderline-personality-disorder,intravenous infusion procedures,0.41791,therapeutic or preventive procedure
20,borderline-personality-disorder,contraceptive methods,0.1194,therapeutic or preventive procedure
20,borderline-personality-disorder,suicidal,0.10448,finding
20,borderline-personality-disorder,severe combined immunodeficiency,0.10448,diagnostic procedure - disease or syndrome
20,borderline-personality-disorder,suicide attempt,0.0597,finding - mental or behavioral dysfunction
20,borderline-personality-disorder,negative finding,0.0597,finding
20,borderline-personality-disorder,depressed mood,0.0597,finding - mental or behavioral dysfunction
20,borderline-personality-disorder,mental disorders,0.0597,mental or behavioral dysfunction
20,borderline-personality-disorder,post-traumatic stress disorder,0.04478,mental or behavioral dysfunction
20,borderline-personality-disorder,allergy severity - severe,0.04478,finding
20,borderline-personality-disorder,benzodiazepines,0.04478,organic chemical - pharmacologic substance
20,borderline-personality-disorder,unipolar depression,0.04478,mental or behavioral dysfunction
20,borderline-personality-disorder,psychotropic drugs,0.04478,pharmacologic substance
20,borderline-personality-disorder,physical assessment findings,0.04478,finding
20,borderline-personality-disorder,personality inventories,0.04478,diagnostic procedure
20,borderline-personality-disorder,multiple endocrine neoplasia,0.04478,antibiotic - neoplastic process - organic chemical
20,borderline-personality-disorder,stress disorders traumatic,0.02985,mental or behavioral dysfunction
20,borderline-personality-disorder,antipsychotic agents,0.02985,pharmacologic substance
20,borderline-personality-disorder,fluoxetine,0.02985,organic chemical - pharmacologic substance
20,borderline-personality-disorder,opiates,0.02985,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
20,borderline-personality-disorder,active brand of pseudoephedrine-triprolidine,0.02985,organic chemical - pharmacologic substance
20,borderline-personality-disorder,gravidity,0.01493,finding
20,borderline-personality-disorder,antidepressive agents,0.01493,pharmacologic substance
20,borderline-personality-disorder,stabilizer - function,0.01493,organ or tissue function
20,borderline-personality-disorder,lithium,0.01493,congenital abnormality - disease or syndrome - pharmacologic substance
20,borderline-personality-disorder,pharmaceutical preparations,0.01493,pharmacologic substance
20,borderline-personality-disorder,drug dependence,0.01493,mental or behavioral dysfunction
20,borderline-personality-disorder,pharmacologic substance,0.01493,pharmacologic substance - therapeutic or preventive procedure
20,borderline-personality-disorder,ethanol,0.01493,organic chemical - pharmacologic substance
20,borderline-personality-disorder,screening for cancer,0.01493,diagnostic procedure
20,borderline-personality-disorder,opiate addiction,0.01493,mental or behavioral dysfunction
20,borderline-personality-disorder,opioids,0.01493,hazardous or poisonous substance - organic chemical - pharmacologic substance
20,borderline-personality-disorder,major depressive disorder,0.01493,mental or behavioral dysfunction
20,borderline-personality-disorder,positive finding,0.01493,finding
21,child-behavior-disorders,attention deficit hyperactivity disorder,0.38272,disease or syndrome - mental or behavioral dysfunction
21,child-behavior-disorders,intravenous infusion procedures,0.32716,therapeutic or preventive procedure
21,child-behavior-disorders,autistic disorder,0.14043,mental or behavioral dysfunction
21,child-behavior-disorders,hyperactive behavior,0.08488,finding
21,child-behavior-disorders,mental disorders,0.07407,mental or behavioral dysfunction
21,child-behavior-disorders,anxiety disorders,0.07099,finding - mental or behavioral dysfunction
21,child-behavior-disorders,depressed mood,0.07099,finding - mental or behavioral dysfunction
21,child-behavior-disorders,autism spectrum disorders,0.06019,congenital abnormality - mental or behavioral dysfunction
21,child-behavior-disorders,pervasive development disorder,0.06019,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
21,child-behavior-disorders,pharmacologic substance,0.05556,pharmacologic substance - therapeutic or preventive procedure
21,child-behavior-disorders,body mass index,0.04784,clinical attribute - diagnostic procedure
21,child-behavior-disorders,mood disorders,0.04475,mental or behavioral dysfunction
21,child-behavior-disorders,stimulant,0.04321,pharmacologic substance
21,child-behavior-disorders,major depressive disorder,0.04321,mental or behavioral dysfunction
21,child-behavior-disorders,negative finding,0.04167,finding
21,child-behavior-disorders,psychotropic drugs,0.04167,pharmacologic substance
21,child-behavior-disorders,physical assessment findings,0.04167,finding
21,child-behavior-disorders,nitric oxide synthase,0.04012,enzyme
21,child-behavior-disorders,sexual intercourse - finding,0.04012,finding
21,child-behavior-disorders,pregnancy tests,0.03858,diagnostic procedure
21,child-behavior-disorders,schizophrenia,0.03704,mental or behavioral dysfunction
21,child-behavior-disorders,phobic anxiety disorder,0.03549,mental or behavioral dysfunction
21,child-behavior-disorders,generalized anxiety disorder,0.03395,mental or behavioral dysfunction
21,child-behavior-disorders,moderate adverse event,0.03395,finding
21,child-behavior-disorders,phobia social,0.03395,mental or behavioral dysfunction
21,child-behavior-disorders,developmental disabilities,0.03395,mental or behavioral dysfunction
21,child-behavior-disorders,anxiety generalized,0.03241,mental or behavioral dysfunction
21,child-behavior-disorders,surgical revision,0.02932,therapeutic or preventive procedure
21,child-behavior-disorders,gravidity,0.02778,finding
21,child-behavior-disorders,allergy severity - severe,0.02778,finding
21,child-behavior-disorders,contraceptive methods,0.02623,therapeutic or preventive procedure
21,child-behavior-disorders,electrocardiogram,0.02469,diagnostic procedure - finding - organic chemical - pharmacologic substance
21,child-behavior-disorders,treatment protocols,0.0216,therapeutic or preventive procedure
21,child-behavior-disorders,antipsychotic agents,0.0216,pharmacologic substance
21,child-behavior-disorders,obsessive-compulsive disorder,0.0216,disease or syndrome - mental or behavioral dysfunction
21,child-behavior-disorders,serum,0.0216,biologically active substance - body substance - pharmacologic substance
21,child-behavior-disorders,relate - vinyl resin,0.02006,organic chemical
21,child-behavior-disorders,active brand of pseudoephedrine-triprolidine,0.02006,organic chemical - pharmacologic substance
21,child-behavior-disorders,blood pressure finding,0.02006,finding
21,child-behavior-disorders,congenital abnormality,0.02006,congenital abnormality - disease or syndrome
21,child-behavior-disorders,post-traumatic stress disorder,0.02006,mental or behavioral dysfunction
21,child-behavior-disorders,positive finding,0.01852,finding
21,child-behavior-disorders,selective serotonin re-uptake inhibitor,0.01852,pharmacologic substance
21,child-behavior-disorders,disability,0.01543,finding
21,child-behavior-disorders,bipolar disorder,0.01543,mental or behavioral dysfunction
21,child-behavior-disorders,osteochondritis dissecans,0.01543,disease or syndrome - mental or behavioral dysfunction
21,child-behavior-disorders,aggressive behavior,0.01543,mental or behavioral dysfunction
21,child-behavior-disorders,tic disorder,0.01389,mental or behavioral dysfunction
21,child-behavior-disorders,medical history,0.01389,finding
21,child-behavior-disorders,unipolar depression,0.01389,mental or behavioral dysfunction
21,child-behavior-disorders,gene therapy,0.01235,therapeutic or preventive procedure
21,child-behavior-disorders,compulsive disorder,0.01235,finding
21,child-behavior-disorders,malignant neoplasms,0.01235,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
21,child-behavior-disorders,epilepsy,0.0108,disease or syndrome
21,child-behavior-disorders,pharmacotherapy,0.0108,therapeutic or preventive procedure
21,child-behavior-disorders,fluoxetine,0.0108,organic chemical - pharmacologic substance
21,child-behavior-disorders,injury wounds,0.0108,body substance - injury or poisoning
21,child-behavior-disorders,screening for cancer,0.0108,diagnostic procedure
21,child-behavior-disorders,antidepressive agents,0.0108,pharmacologic substance
21,child-behavior-disorders,psychotic disorders,0.00926,mental or behavioral dysfunction
21,child-behavior-disorders,behavior therapy,0.00926,therapeutic or preventive procedure
21,child-behavior-disorders,ethanol,0.00772,organic chemical - pharmacologic substance
21,child-behavior-disorders,pharmaceutical preparations,0.00772,pharmacologic substance
21,child-behavior-disorders,substance abuse problem,0.00772,mental or behavioral dysfunction
21,child-behavior-disorders,hypersensitivity,0.00772,clinical attribute - finding - pathologic function
21,child-behavior-disorders,heart diseases,0.00617,disease or syndrome
21,child-behavior-disorders,psychotherapy,0.00617,therapeutic or preventive procedure
21,child-behavior-disorders,kidney,0.00617,body part, organ, or organ component
21,child-behavior-disorders,suicidal,0.00463,finding
21,child-behavior-disorders,anticonvulsants,0.00463,pharmacologic substance
21,child-behavior-disorders,craniocerebral trauma,0.00463,injury or poisoning
21,child-behavior-disorders,unstable status,0.00463,finding
21,child-behavior-disorders,hypertensive disease,0.00463,biologically active substance - disease or syndrome - finding
21,child-behavior-disorders,nervousness,0.00309,sign or symptom
21,child-behavior-disorders,schizoaffective disorder,0.00309,mental or behavioral dysfunction
21,child-behavior-disorders,cardiovascular diseases,0.00309,disease or syndrome
21,child-behavior-disorders,eating disorders,0.00309,mental or behavioral dysfunction
21,child-behavior-disorders,mental retardation,0.00309,mental or behavioral dysfunction
21,child-behavior-disorders,brain injuries,0.00309,injury or poisoning
21,child-behavior-disorders,diagnosis psychiatric,0.00309,mental or behavioral dysfunction
21,child-behavior-disorders,monoamine oxidase inhibitors,0.00154,organic chemical - pharmacologic substance
21,child-behavior-disorders,stress disorders traumatic,0.00154,mental or behavioral dysfunction
21,child-behavior-disorders,neurological observations,0.00154,finding
21,child-behavior-disorders,drug abuse,0.00154,mental or behavioral dysfunction
21,child-behavior-disorders,nervous system disorder,0.00154,disease or syndrome
21,child-behavior-disorders,fever,0.00154,finding
22,cocaine-related-disorders,intravenous infusion procedures,0.4533,therapeutic or preventive procedure
22,cocaine-related-disorders,positive finding,0.25,finding
22,cocaine-related-disorders,contraceptive methods,0.24176,therapeutic or preventive procedure
22,cocaine-related-disorders,pharmacologic substance,0.1511,pharmacologic substance - therapeutic or preventive procedure
22,cocaine-related-disorders,negative finding,0.14011,finding
22,cocaine-related-disorders,ethanol,0.13462,organic chemical - pharmacologic substance
22,cocaine-related-disorders,screening for cancer,0.12637,diagnostic procedure
22,cocaine-related-disorders,physical assessment findings,0.11538,finding
22,cocaine-related-disorders,pregnancy tests,0.10989,diagnostic procedure
22,cocaine-related-disorders,gravidity,0.08242,finding
22,cocaine-related-disorders,pregnancy test negative,0.07692,finding - laboratory or test result
22,cocaine-related-disorders,severe combined immunodeficiency,0.07418,diagnostic procedure - disease or syndrome
22,cocaine-related-disorders,opioids,0.07418,hazardous or poisonous substance - organic chemical - pharmacologic substance
22,cocaine-related-disorders,medical history,0.06868,finding
22,cocaine-related-disorders,opiates,0.06868,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
22,cocaine-related-disorders,opiate addiction,0.06319,mental or behavioral dysfunction
22,cocaine-related-disorders,illicit drugs,0.04945,hazardous or poisonous substance - pharmacologic substance
22,cocaine-related-disorders,pharmaceutical preparations,0.04945,pharmacologic substance
22,cocaine-related-disorders,personal satisfaction,0.04945,finding
22,cocaine-related-disorders,follow-up status,0.04945,finding
22,cocaine-related-disorders,substance abuse problem,0.0467,mental or behavioral dysfunction
22,cocaine-related-disorders,alcoholic intoxication chronic,0.04396,mental or behavioral dysfunction
22,cocaine-related-disorders,operative surgical procedures,0.04396,diagnostic procedure - therapeutic or preventive procedure
22,cocaine-related-disorders,nicotine dependence,0.04121,mental or behavioral dysfunction
22,cocaine-related-disorders,multiple endocrine neoplasia,0.04121,antibiotic - neoplastic process - organic chemical
22,cocaine-related-disorders,spermatocidal agents,0.03571,pharmacologic substance
22,cocaine-related-disorders,body mass index,0.03297,clinical attribute - diagnostic procedure
22,cocaine-related-disorders,mass of body structure,0.03022,finding
22,cocaine-related-disorders,contraception barrier,0.02747,therapeutic or preventive procedure
22,cocaine-related-disorders,depressed mood,0.02747,finding - mental or behavioral dysfunction
22,cocaine-related-disorders,household composition,0.02473,finding
22,cocaine-related-disorders,detoxification procedure,0.02473,therapeutic or preventive procedure
22,cocaine-related-disorders,weighing patient,0.02473,diagnostic procedure - finding
22,cocaine-related-disorders,vital signs,0.02473,clinical attribute
22,cocaine-related-disorders,breast,0.02198,body part, organ, or organ component
22,cocaine-related-disorders,disease of diaphragm,0.02198,body part, organ, or organ component - disease or syndrome
22,cocaine-related-disorders,contraceptives oral,0.02198,pharmacologic substance - therapeutic or preventive procedure
22,cocaine-related-disorders,attention deficit hyperactivity disorder,0.02198,disease or syndrome - mental or behavioral dysfunction
22,cocaine-related-disorders,serum,0.02198,biologically active substance - body substance - pharmacologic substance
22,cocaine-related-disorders,kidney,0.02198,body part, organ, or organ component
22,cocaine-related-disorders,alanine transaminase,0.01923,congenital abnormality - disease or syndrome - enzyme
22,cocaine-related-disorders,oral contraception,0.01923,pharmacologic substance - therapeutic or preventive procedure
22,cocaine-related-disorders,substance dependence,0.01923,mental or behavioral dysfunction
22,cocaine-related-disorders,alcohol consumption,0.01923,individual behavior
22,cocaine-related-disorders,mental disorders,0.01923,mental or behavioral dysfunction
22,cocaine-related-disorders,diastole,0.01648,clinical attribute
22,cocaine-related-disorders,active brand of pseudoephedrine-triprolidine,0.01648,organic chemical - pharmacologic substance
22,cocaine-related-disorders,marihuana,0.01648,mental or behavioral dysfunction - organic chemical - pharmacologic substance
22,cocaine-related-disorders,aspartate transaminase,0.01648,enzyme
22,cocaine-related-disorders,benzodiazepines,0.01374,organic chemical - pharmacologic substance
22,cocaine-related-disorders,liver function,0.01374,organ or tissue function
22,cocaine-related-disorders,blood pressure finding,0.01374,finding
22,cocaine-related-disorders,congenital abnormality,0.01374,congenital abnormality - disease or syndrome
22,cocaine-related-disorders,cardiac arrhythmia,0.01374,finding - pathologic function
22,cocaine-related-disorders,psychotic disorders,0.01099,mental or behavioral dysfunction
22,cocaine-related-disorders,stimulant,0.01099,pharmacologic substance
22,cocaine-related-disorders,drug dependence,0.01099,mental or behavioral dysfunction
22,cocaine-related-disorders,psychotropic drugs,0.01099,pharmacologic substance
22,cocaine-related-disorders,allergy severity - severe,0.01099,finding
22,cocaine-related-disorders,mercury,0.01099,hazardous or poisonous substance
22,cocaine-related-disorders,implantation procedure,0.01099,therapeutic or preventive procedure
22,cocaine-related-disorders,manic,0.00824,finding - mental or behavioral dysfunction
22,cocaine-related-disorders,schizoaffective disorder,0.00824,mental or behavioral dysfunction
22,cocaine-related-disorders,tobacco,0.00824,hazardous or poisonous substance - organic chemical - pharmacologic substance
22,cocaine-related-disorders,schizophrenia,0.00824,mental or behavioral dysfunction
22,cocaine-related-disorders,bipolar disorder,0.00824,mental or behavioral dysfunction
22,cocaine-related-disorders,unipolar depression,0.00824,mental or behavioral dysfunction
22,cocaine-related-disorders,heart rate,0.00824,clinical attribute
22,cocaine-related-disorders,caffeine,0.00549,organic chemical - pharmacologic substance - therapeutic or preventive procedure
22,cocaine-related-disorders,anxiety disorders,0.00549,finding - mental or behavioral dysfunction
22,cocaine-related-disorders,cardiovascular diseases,0.00549,disease or syndrome
22,cocaine-related-disorders,relate - vinyl resin,0.00549,organic chemical
22,cocaine-related-disorders,infantile neuroaxonal dystrophy,0.00549,disease or syndrome
22,cocaine-related-disorders,major depressive disorder,0.00549,mental or behavioral dysfunction
22,cocaine-related-disorders,suicidal,0.00275,finding
22,cocaine-related-disorders,unstable status,0.00275,finding
22,cocaine-related-disorders,antipsychotic agents,0.00275,pharmacologic substance
22,cocaine-related-disorders,pharmacotherapy,0.00275,therapeutic or preventive procedure
22,cocaine-related-disorders,nervousness,0.00275,sign or symptom
22,cocaine-related-disorders,hepatic,0.00275,body location or region
22,cocaine-related-disorders,bleomycin-cisplatin protocol,0.00275,therapeutic or preventive procedure
22,cocaine-related-disorders,heart ventricle,0.00275,body part, organ, or organ component
22,cocaine-related-disorders,systolic pressure,0.00275,clinical attribute - diagnostic procedure
22,cocaine-related-disorders,selective serotonin re-uptake inhibitor,0.00275,pharmacologic substance
22,cocaine-related-disorders,mood disorders,0.00275,mental or behavioral dysfunction
22,cocaine-related-disorders,impaired cognition,0.00275,finding - mental or behavioral dysfunction
22,cocaine-related-disorders,transaminases,0.00275,enzyme
22,cocaine-related-disorders,suicide attempt,0.00275,finding - mental or behavioral dysfunction
22,cocaine-related-disorders,antidepressive agents,0.00275,pharmacologic substance
22,cocaine-related-disorders,drug abuse,0.00275,mental or behavioral dysfunction
22,cocaine-related-disorders,diastolic blood pressure,0.00275,clinical attribute - diagnostic procedure - finding
22,cocaine-related-disorders,nervous system disorder,0.00275,disease or syndrome
22,cocaine-related-disorders,hypersensitivity,0.00275,clinical attribute - finding - pathologic function
22,cocaine-related-disorders,diabetes,0.00275,disease or syndrome
22,cocaine-related-disorders,fever,0.00275,finding
23,cognition-disorders,mini-mental status exam,0.23911,diagnostic procedure
23,cognition-disorders,dactinomycin,0.14806,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
23,cognition-disorders,mild adverse event,0.1445,finding
23,cognition-disorders,intravenous infusion procedures,0.1441,therapeutic or preventive procedure
23,cognition-disorders,impaired cognition,0.10491,finding - mental or behavioral dysfunction
23,cognition-disorders,magnetic resonance imaging,0.09343,diagnostic procedure
23,cognition-disorders,memory observations,0.08432,finding
23,cognition-disorders,relate - vinyl resin,0.07561,organic chemical
23,cognition-disorders,physical assessment findings,0.07324,finding
23,cognition-disorders,contraceptive methods,0.07126,therapeutic or preventive procedure
23,cognition-disorders,depressed mood,0.07007,finding - mental or behavioral dysfunction
23,cognition-disorders,moderate adverse event,0.06097,finding
23,cognition-disorders,schizophrenia,0.06097,mental or behavioral dysfunction
23,cognition-disorders,operative surgical procedures,0.05859,diagnostic procedure - therapeutic or preventive procedure
23,cognition-disorders,multiple endocrine neoplasia,0.05701,antibiotic - neoplastic process - organic chemical
23,cognition-disorders,negative finding,0.05305,finding
23,cognition-disorders,cholinesterase inhibitors,0.05067,organic chemical - pharmacologic substance
23,cognition-disorders,mental disorders,0.04671,mental or behavioral dysfunction
23,cognition-disorders,pharmacologic substance,0.04592,pharmacologic substance - therapeutic or preventive procedure
23,cognition-disorders,body mass index,0.04394,clinical attribute - diagnostic procedure
23,cognition-disorders,antipsychotic agents,0.04196,pharmacologic substance
23,cognition-disorders,memantine,0.04196,organic chemical - pharmacologic substance
23,cognition-disorders,cognitive therapy,0.04117,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
23,cognition-disorders,positive finding,0.03998,finding
23,cognition-disorders,medical history,0.0388,finding
23,cognition-disorders,cerebrovascular accident,0.03721,disease or syndrome - therapeutic or preventive procedure
23,cognition-disorders,pregnancy tests,0.03642,diagnostic procedure
23,cognition-disorders,hearing examination finding,0.03523,finding
23,cognition-disorders,electrocardiogram,0.03484,diagnostic procedure - finding - organic chemical - pharmacologic substance
23,cognition-disorders,neuropsychological tests,0.03405,diagnostic procedure
23,cognition-disorders,sterility,0.03207,pathologic function
23,cognition-disorders,allergy severity - severe,0.03127,finding
23,cognition-disorders,mass of body structure,0.03127,finding
23,cognition-disorders,blood vessel,0.02969,body part, organ, or organ component - finding
23,cognition-disorders,schizoaffective disorder,0.02811,mental or behavioral dysfunction
23,cognition-disorders,gravidity,0.02534,finding
23,cognition-disorders,active brand of pseudoephedrine-triprolidine,0.02415,organic chemical - pharmacologic substance
23,cognition-disorders,congenital abnormality,0.02336,congenital abnormality - disease or syndrome
23,cognition-disorders,treatment protocols,0.02257,therapeutic or preventive procedure
23,cognition-disorders,serum,0.019,biologically active substance - body substance - pharmacologic substance
23,cognition-disorders,nervous system disorder,0.019,disease or syndrome
23,cognition-disorders,pharmaceutical preparations,0.01781,pharmacologic substance
23,cognition-disorders,psychotropic drugs,0.01781,pharmacologic substance
23,cognition-disorders,hypertensive disease,0.01781,biologically active substance - disease or syndrome - finding
23,cognition-disorders,positron-emission tomography,0.01742,diagnostic procedure
23,cognition-disorders,agitation,0.01742,finding - sign or symptom
23,cognition-disorders,antidepressive agents,0.01742,pharmacologic substance
23,cognition-disorders,malignant neoplasms,0.01702,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
23,cognition-disorders,delirium,0.01663,mental or behavioral dysfunction
23,cognition-disorders,multiple sclerosis,0.01623,body part, organ, or organ component - disease or syndrome - finding
23,cognition-disorders,traumatic brain injury,0.01504,disease or syndrome - injury or poisoning
23,cognition-disorders,family history,0.01504,congenital abnormality - disease or syndrome - enzyme - finding
23,cognition-disorders,ethanol,0.01465,organic chemical - pharmacologic substance
23,cognition-disorders,pharmacotherapy,0.01425,therapeutic or preventive procedure
23,cognition-disorders,unipolar depression,0.01346,mental or behavioral dysfunction
23,cognition-disorders,blood pressure finding,0.01306,finding
23,cognition-disorders,psychotic disorders,0.01267,mental or behavioral dysfunction
23,cognition-disorders,arteries,0.01227,body part, organ, or organ component
23,cognition-disorders,injury wounds,0.01227,body substance - injury or poisoning
23,cognition-disorders,screening for cancer,0.01227,diagnostic procedure
23,cognition-disorders,consciousness related finding,0.01227,finding
23,cognition-disorders,household composition,0.01188,finding
23,cognition-disorders,brain injuries,0.01188,injury or poisoning
23,cognition-disorders,mental retardation,0.01069,mental or behavioral dysfunction
23,cognition-disorders,epilepsy,0.01029,disease or syndrome
23,cognition-disorders,neoplasm metastasis,0.01029,neoplastic process
23,cognition-disorders,disability,0.0099,finding
23,cognition-disorders,benzodiazepines,0.0095,organic chemical - pharmacologic substance
23,cognition-disorders,hepatic,0.00911,body location or region
23,cognition-disorders,hiv,0.00792,disease or syndrome - pharmacologic substance - virus
23,cognition-disorders,substance abuse problem,0.00752,mental or behavioral dysfunction
23,cognition-disorders,pathology processes,0.00752,pathologic function
23,cognition-disorders,thyroid gland,0.00752,body part, organ, or organ component - disease or syndrome - pharmacologic substance
23,cognition-disorders,unstable status,0.00752,finding
23,cognition-disorders,alanine transaminase,0.00673,congenital abnormality - disease or syndrome - enzyme
23,cognition-disorders,neurological observations,0.00673,finding
23,cognition-disorders,diastole,0.00673,clinical attribute
23,cognition-disorders,craniocerebral trauma,0.00633,injury or poisoning
23,cognition-disorders,nervousness,0.00633,sign or symptom
23,cognition-disorders,unconscious state,0.00594,disease or syndrome - finding
23,cognition-disorders,anxiety disorders,0.00515,finding - mental or behavioral dysfunction
23,cognition-disorders,major depressive disorder,0.00515,mental or behavioral dysfunction
23,cognition-disorders,bipolar disorder,0.00475,mental or behavioral dysfunction
23,cognition-disorders,insulin,0.00475,pharmacologic substance
23,cognition-disorders,hypersensitivity,0.00475,clinical attribute - finding - pathologic function
23,cognition-disorders,systolic pressure,0.00435,clinical attribute - diagnostic procedure
23,cognition-disorders,lung,0.00435,body part, organ, or organ component - disease or syndrome
23,cognition-disorders,cardiovascular diseases,0.00396,disease or syndrome
23,cognition-disorders,cardiac arrhythmia,0.00396,finding - pathologic function
23,cognition-disorders,congestive heart failure,0.00356,congenital abnormality - disease or syndrome
23,cognition-disorders,breast,0.00356,body part, organ, or organ component
23,cognition-disorders,alcoholic intoxication chronic,0.00356,mental or behavioral dysfunction
23,cognition-disorders,liver diseases,0.00356,disease or syndrome
23,cognition-disorders,angina pectoris,0.00356,sign or symptom
23,cognition-disorders,medical contraindication,0.00356,finding
23,cognition-disorders,alcohol abuse,0.00356,mental or behavioral dysfunction
23,cognition-disorders,suicidal,0.00317,finding
23,cognition-disorders,hypothyroidism,0.00317,disease or syndrome
23,cognition-disorders,heart diseases,0.00317,disease or syndrome
23,cognition-disorders,investigational new drugs,0.00317,pharmacologic substance - therapeutic or preventive procedure
23,cognition-disorders,diabetes mellitus,0.00277,disease or syndrome - pharmacologic substance
23,cognition-disorders,myocardial infarction,0.00277,disease or syndrome - finding
23,cognition-disorders,drug abuse,0.00277,mental or behavioral dysfunction
23,cognition-disorders,kidney diseases,0.00198,disease or syndrome
23,cognition-disorders,claustrophobia,4e-04,mental or behavioral dysfunction
24,combat-disorders,post-traumatic stress disorder,0.54255,mental or behavioral dysfunction
24,combat-disorders,intravenous infusion procedures,0.17021,therapeutic or preventive procedure
24,combat-disorders,active brand of pseudoephedrine-triprolidine,0.15957,organic chemical - pharmacologic substance
24,combat-disorders,relate - vinyl resin,0.1383,organic chemical
24,combat-disorders,injury wounds,0.1383,body substance - injury or poisoning
24,combat-disorders,stress disorders traumatic,0.12766,mental or behavioral dysfunction
24,combat-disorders,psychotropic drugs,0.11702,pharmacologic substance
24,combat-disorders,traumatic brain injury,0.08511,disease or syndrome - injury or poisoning
24,combat-disorders,valproic acid,0.08511,body part, organ, or organ component - organic chemical - pharmacologic substance
24,combat-disorders,brain injuries,0.06383,injury or poisoning
24,combat-disorders,contraceptive methods,0.06383,therapeutic or preventive procedure
24,combat-disorders,allergy severity - severe,0.05319,finding
24,combat-disorders,moderate adverse event,0.05319,finding
24,combat-disorders,negative finding,0.05319,finding
24,combat-disorders,gravidity,0.04255,finding
24,combat-disorders,pregnancy tests,0.04255,diagnostic procedure
24,combat-disorders,ethanol,0.03191,organic chemical - pharmacologic substance
24,combat-disorders,pregnancy test negative,0.03191,finding - laboratory or test result
24,combat-disorders,asleep,0.03191,finding
24,combat-disorders,treatment protocols,0.03191,therapeutic or preventive procedure
24,combat-disorders,fluoxetine,0.03191,organic chemical - pharmacologic substance
24,combat-disorders,physical assessment findings,0.03191,finding
24,combat-disorders,anxiety disorders,0.03191,finding - mental or behavioral dysfunction
24,combat-disorders,follow-up status,0.03191,finding
24,combat-disorders,pharmacologic substance,0.03191,pharmacologic substance - therapeutic or preventive procedure
24,combat-disorders,multiple endocrine neoplasia,0.03191,antibiotic - neoplastic process - organic chemical
24,combat-disorders,hypertensive disease,0.02128,biologically active substance - disease or syndrome - finding
24,combat-disorders,depressed mood,0.02128,finding - mental or behavioral dysfunction
24,combat-disorders,angina pectoris,0.02128,sign or symptom
24,combat-disorders,psychotic disorders,0.02128,mental or behavioral dysfunction
24,combat-disorders,substance dependence,0.02128,mental or behavioral dysfunction
24,combat-disorders,sexually active,0.02128,finding
24,combat-disorders,unstable status,0.02128,finding
24,combat-disorders,neoplasm metastasis,0.02128,neoplastic process
24,combat-disorders,memory observations,0.02128,finding
24,combat-disorders,positive finding,0.02128,finding
24,combat-disorders,angina unstable,0.02128,disease or syndrome
24,combat-disorders,medical history,0.01064,finding
24,combat-disorders,investigational new drugs,0.01064,pharmacologic substance - therapeutic or preventive procedure
24,combat-disorders,schizophrenia,0.01064,mental or behavioral dysfunction
24,combat-disorders,kidney,0.01064,body part, organ, or organ component
24,combat-disorders,hepatic,0.01064,body location or region
24,combat-disorders,congestive heart failure,0.01064,congenital abnormality - disease or syndrome
24,combat-disorders,bipolar disorder,0.01064,mental or behavioral dysfunction
24,combat-disorders,disability,0.01064,finding
24,combat-disorders,antipsychotic agents,0.01064,pharmacologic substance
24,combat-disorders,unconscious state,0.01064,disease or syndrome - finding
24,combat-disorders,diabetes mellitus,0.01064,disease or syndrome - pharmacologic substance
24,combat-disorders,schizoaffective disorder,0.01064,mental or behavioral dysfunction
24,combat-disorders,consciousness related finding,0.01064,finding
24,combat-disorders,myocardial infarction,0.01064,disease or syndrome - finding
24,combat-disorders,selective serotonin re-uptake inhibitor,0.01064,pharmacologic substance
24,combat-disorders,substance abuse problem,0.01064,mental or behavioral dysfunction
25,communication-disorders,cerebrovascular accident,0.11399,disease or syndrome - therapeutic or preventive procedure
25,communication-disorders,malignant neoplasms,0.10881,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
25,communication-disorders,intravenous infusion procedures,0.06995,therapeutic or preventive procedure
25,communication-disorders,hearing examination finding,0.0544,finding
25,communication-disorders,frontotemporal dementia,0.0544,disease or syndrome
25,communication-disorders,magnetic resonance imaging,0.05181,diagnostic procedure
25,communication-disorders,moderate adverse event,0.04145,finding
25,communication-disorders,relate - vinyl resin,0.03886,organic chemical
25,communication-disorders,mini-mental status exam,0.03886,diagnostic procedure
25,communication-disorders,autistic disorder,0.03886,mental or behavioral dysfunction
25,communication-disorders,unmarried,0.03368,finding
25,communication-disorders,allergy severity - severe,0.03109,finding
25,communication-disorders,mild adverse event,0.03109,finding
25,communication-disorders,depressed mood,0.02591,finding - mental or behavioral dysfunction
25,communication-disorders,hypertensive disease,0.02332,biologically active substance - disease or syndrome - finding
25,communication-disorders,physical assessment findings,0.02332,finding
25,communication-disorders,autism spectrum disorders,0.02332,congenital abnormality - mental or behavioral dysfunction
25,communication-disorders,positive finding,0.02332,finding
25,communication-disorders,gene therapy,0.02073,therapeutic or preventive procedure
25,communication-disorders,gravidity,0.02073,finding
25,communication-disorders,attention deficit hyperactivity disorder,0.02073,disease or syndrome - mental or behavioral dysfunction
25,communication-disorders,disability,0.02073,finding
25,communication-disorders,pharmacotherapy,0.02073,therapeutic or preventive procedure
25,communication-disorders,contraceptive methods,0.02073,therapeutic or preventive procedure
25,communication-disorders,memory observations,0.02073,finding
25,communication-disorders,mental disorders,0.02073,mental or behavioral dysfunction
25,communication-disorders,diabetes,0.01813,disease or syndrome
25,communication-disorders,paralysed,0.01813,finding
25,communication-disorders,active brand of pseudoephedrine-triprolidine,0.01554,organic chemical - pharmacologic substance
25,communication-disorders,brain injuries,0.01295,injury or poisoning
25,communication-disorders,impaired cognition,0.01295,finding - mental or behavioral dysfunction
25,communication-disorders,pregnancy tests,0.01295,diagnostic procedure
25,communication-disorders,operative surgical procedures,0.01295,diagnostic procedure - therapeutic or preventive procedure
25,communication-disorders,mental retardation,0.01295,mental or behavioral dysfunction
25,communication-disorders,pharmaceutical preparations,0.01036,pharmacologic substance
25,communication-disorders,epilepsy,0.01036,disease or syndrome
25,communication-disorders,psychotropic drugs,0.01036,pharmacologic substance
25,communication-disorders,kidney,0.01036,body part, organ, or organ component
25,communication-disorders,neurological observations,0.01036,finding
25,communication-disorders,pervasive development disorder,0.01036,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
25,communication-disorders,pharmacologic substance,0.01036,pharmacologic substance - therapeutic or preventive procedure
25,communication-disorders,breast,0.01036,body part, organ, or organ component
25,communication-disorders,hepatic,0.01036,body location or region
25,communication-disorders,traumatic brain injury,0.01036,disease or syndrome - injury or poisoning
25,communication-disorders,nervousness,0.00777,sign or symptom
25,communication-disorders,cardiovascular diseases,0.00777,disease or syndrome
25,communication-disorders,developmental disabilities,0.00777,mental or behavioral dysfunction
25,communication-disorders,congenital abnormality,0.00518,congenital abnormality - disease or syndrome
25,communication-disorders,nervous system disorder,0.00518,disease or syndrome
25,communication-disorders,schizophrenia,0.00518,mental or behavioral dysfunction
25,communication-disorders,injury wounds,0.00518,body substance - injury or poisoning
25,communication-disorders,ethanol,0.00518,organic chemical - pharmacologic substance
25,communication-disorders,psychotic disorders,0.00518,mental or behavioral dysfunction
25,communication-disorders,unstable status,0.00259,finding
25,communication-disorders,craniocerebral trauma,0.00259,injury or poisoning
25,communication-disorders,unipolar depression,0.00259,mental or behavioral dysfunction
25,communication-disorders,blood vessel,0.00259,body part, organ, or organ component - finding
25,communication-disorders,drug abuse,0.00259,mental or behavioral dysfunction
25,communication-disorders,hypersensitivity,0.00259,clinical attribute - finding - pathologic function
25,communication-disorders,substance abuse problem,0.00259,mental or behavioral dysfunction
26,compulsive-behavior,intravenous infusion procedures,0.29218,therapeutic or preventive procedure
26,compulsive-behavior,osteochondritis dissecans,0.15638,disease or syndrome - mental or behavioral dysfunction
26,compulsive-behavior,pharmacologic substance,0.107,pharmacologic substance - therapeutic or preventive procedure
26,compulsive-behavior,opioids,0.10288,hazardous or poisonous substance - organic chemical - pharmacologic substance
26,compulsive-behavior,obsessive-compulsive disorder,0.09877,disease or syndrome - mental or behavioral dysfunction
26,compulsive-behavior,contraceptive methods,0.09465,therapeutic or preventive procedure
26,compulsive-behavior,positive finding,0.09465,finding
26,compulsive-behavior,physical assessment findings,0.09465,finding
26,compulsive-behavior,ethanol,0.08642,organic chemical - pharmacologic substance
26,compulsive-behavior,opiate addiction,0.08642,mental or behavioral dysfunction
26,compulsive-behavior,negative finding,0.07819,finding
26,compulsive-behavior,opiates,0.07819,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
26,compulsive-behavior,smoker,0.07407,finding
26,compulsive-behavior,anxiety disorders,0.06584,finding - mental or behavioral dysfunction
26,compulsive-behavior,medical history,0.06173,finding
26,compulsive-behavior,electrocardiogram,0.0535,diagnostic procedure - finding - organic chemical - pharmacologic substance
26,compulsive-behavior,mental disorders,0.0535,mental or behavioral dysfunction
26,compulsive-behavior,psychotropic drugs,0.04938,pharmacologic substance
26,compulsive-behavior,multiple endocrine neoplasia,0.04938,antibiotic - neoplastic process - organic chemical
26,compulsive-behavior,pregnancy tests,0.04527,diagnostic procedure
26,compulsive-behavior,severe combined immunodeficiency,0.04115,diagnostic procedure - disease or syndrome
26,compulsive-behavior,post-traumatic stress disorder,0.04115,mental or behavioral dysfunction
26,compulsive-behavior,compulsive disorder,0.04115,finding
26,compulsive-behavior,nicotine dependence,0.03704,mental or behavioral dysfunction
26,compulsive-behavior,pharmaceutical preparations,0.03704,pharmacologic substance
26,compulsive-behavior,generalized anxiety disorder,0.03704,mental or behavioral dysfunction
26,compulsive-behavior,gravidity,0.03704,finding
26,compulsive-behavior,pregnancy test negative,0.03704,finding - laboratory or test result
26,compulsive-behavior,depressed mood,0.03704,finding - mental or behavioral dysfunction
26,compulsive-behavior,vital signs,0.03704,clinical attribute
26,compulsive-behavior,anxiety generalized,0.03292,mental or behavioral dysfunction
26,compulsive-behavior,screening for cancer,0.03292,diagnostic procedure
26,compulsive-behavior,diastole,0.03292,clinical attribute
26,compulsive-behavior,alanine transaminase,0.02881,congenital abnormality - disease or syndrome - enzyme
26,compulsive-behavior,body mass index,0.02881,clinical attribute - diagnostic procedure
26,compulsive-behavior,detoxification procedure,0.02881,therapeutic or preventive procedure
26,compulsive-behavior,active brand of pseudoephedrine-triprolidine,0.02881,organic chemical - pharmacologic substance
26,compulsive-behavior,mercury,0.02881,hazardous or poisonous substance
26,compulsive-behavior,autistic disorder,0.02881,mental or behavioral dysfunction
26,compulsive-behavior,stimulant,0.02881,pharmacologic substance
26,compulsive-behavior,phobic anxiety disorder,0.02881,mental or behavioral dysfunction
26,compulsive-behavior,autism spectrum disorders,0.02469,congenital abnormality - mental or behavioral dysfunction
26,compulsive-behavior,drug dependence,0.02469,mental or behavioral dysfunction
26,compulsive-behavior,smoke,0.02469,hazardous or poisonous substance - individual behavior
26,compulsive-behavior,cardiac arrhythmia,0.02469,finding - pathologic function
26,compulsive-behavior,attention deficit hyperactivity disorder,0.02469,disease or syndrome - mental or behavioral dysfunction
26,compulsive-behavior,bilirubin,0.02469,biologically active substance - laboratory or test result - organic chemical
26,compulsive-behavior,fluoxetine,0.02469,organic chemical - pharmacologic substance
26,compulsive-behavior,aspartate transaminase,0.02469,enzyme
26,compulsive-behavior,panic disorder,0.02058,disease or syndrome - mental or behavioral dysfunction
26,compulsive-behavior,pervasive development disorder,0.02058,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
26,compulsive-behavior,infantile neuroaxonal dystrophy,0.02058,disease or syndrome
26,compulsive-behavior,alcoholic intoxication chronic,0.02058,mental or behavioral dysfunction
26,compulsive-behavior,liver function,0.02058,organ or tissue function
26,compulsive-behavior,tic disorder,0.02058,mental or behavioral dysfunction
26,compulsive-behavior,selective serotonin re-uptake inhibitor,0.02058,pharmacologic substance
26,compulsive-behavior,moderate adverse event,0.02058,finding
26,compulsive-behavior,allergy severity - severe,0.02058,finding
26,compulsive-behavior,marihuana,0.02058,mental or behavioral dysfunction - organic chemical - pharmacologic substance
26,compulsive-behavior,implantation procedure,0.02058,therapeutic or preventive procedure
26,compulsive-behavior,major depressive disorder,0.02058,mental or behavioral dysfunction
26,compulsive-behavior,substance dependence,0.01646,mental or behavioral dysfunction
26,compulsive-behavior,tobacco,0.01646,hazardous or poisonous substance - organic chemical - pharmacologic substance
26,compulsive-behavior,magnetic resonance imaging,0.01646,diagnostic procedure
26,compulsive-behavior,schizophrenia,0.01646,mental or behavioral dysfunction
26,compulsive-behavior,antipsychotic agents,0.01646,pharmacologic substance
26,compulsive-behavior,blood pressure finding,0.01646,finding
26,compulsive-behavior,eating disorders,0.01646,mental or behavioral dysfunction
26,compulsive-behavior,psychotherapy,0.01646,therapeutic or preventive procedure
26,compulsive-behavior,breast,0.01235,body part, organ, or organ component
26,compulsive-behavior,illicit drugs,0.01235,hazardous or poisonous substance - pharmacologic substance
26,compulsive-behavior,relate - vinyl resin,0.01235,organic chemical
26,compulsive-behavior,oral contraception,0.01235,pharmacologic substance - therapeutic or preventive procedure
26,compulsive-behavior,operative surgical procedures,0.01235,diagnostic procedure - therapeutic or preventive procedure
26,compulsive-behavior,consumption-archaic term for tb,0.01235,disease or syndrome
26,compulsive-behavior,serum,0.01235,biologically active substance - body substance - pharmacologic substance
26,compulsive-behavior,drug abuse,0.01235,mental or behavioral dysfunction
26,compulsive-behavior,psychotic disorders,0.00823,mental or behavioral dysfunction
26,compulsive-behavior,psychiatric problem,0.00823,mental or behavioral dysfunction
26,compulsive-behavior,schizoaffective disorder,0.00823,mental or behavioral dysfunction
26,compulsive-behavior,caffeine,0.00823,organic chemical - pharmacologic substance - therapeutic or preventive procedure
26,compulsive-behavior,mood disorders,0.00823,mental or behavioral dysfunction
26,compulsive-behavior,sterility,0.00823,pathologic function
26,compulsive-behavior,substance abuse problem,0.00823,mental or behavioral dysfunction
26,compulsive-behavior,malignant neoplasms,0.00823,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
26,compulsive-behavior,developmental disabilities,0.00823,mental or behavioral dysfunction
26,compulsive-behavior,suicidal,0.00412,finding
26,compulsive-behavior,unstable status,0.00412,finding
26,compulsive-behavior,epilepsy,0.00412,disease or syndrome
26,compulsive-behavior,benzodiazepines,0.00412,organic chemical - pharmacologic substance
26,compulsive-behavior,cognitive therapy,0.00412,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
26,compulsive-behavior,hepatic,0.00412,body location or region
26,compulsive-behavior,bipolar disorder,0.00412,mental or behavioral dysfunction
26,compulsive-behavior,claustrophobia,0.00412,mental or behavioral dysfunction
26,compulsive-behavior,congenital abnormality,0.00412,congenital abnormality - disease or syndrome
26,compulsive-behavior,injury wounds,0.00412,body substance - injury or poisoning
26,compulsive-behavior,unipolar depression,0.00412,mental or behavioral dysfunction
26,compulsive-behavior,systolic pressure,0.00412,clinical attribute - diagnostic procedure
26,compulsive-behavior,hypertensive disease,0.00412,biologically active substance - disease or syndrome - finding
26,compulsive-behavior,antidepressive agents,0.00412,pharmacologic substance
26,compulsive-behavior,nervous system disorder,0.00412,disease or syndrome
26,compulsive-behavior,current therapy,0.00412,therapeutic or preventive procedure
26,compulsive-behavior,mental retardation,0.00412,mental or behavioral dysfunction
26,compulsive-behavior,alcohol consumption,0.00412,individual behavior
26,compulsive-behavior,diabetes,0.00412,disease or syndrome
27,conduct-disorder,intravenous infusion procedures,0.27534,therapeutic or preventive procedure
27,conduct-disorder,depressed mood,0.21958,finding - mental or behavioral dysfunction
27,conduct-disorder,major depressive disorder,0.15415,mental or behavioral dysfunction
27,conduct-disorder,attention deficit hyperactivity disorder,0.08757,disease or syndrome - mental or behavioral dysfunction
27,conduct-disorder,contraceptive methods,0.08134,therapeutic or preventive procedure
27,conduct-disorder,antidepressive agents,0.07773,pharmacologic substance
27,conduct-disorder,depressive episode unspecified,0.06888,mental or behavioral dysfunction
27,conduct-disorder,unipolar depression,0.06674,mental or behavioral dysfunction
27,conduct-disorder,mental disorders,0.06215,mental or behavioral dysfunction
27,conduct-disorder,physical assessment findings,0.05756,finding
27,conduct-disorder,pharmacologic substance,0.05494,pharmacologic substance - therapeutic or preventive procedure
27,conduct-disorder,body mass index,0.05346,clinical attribute - diagnostic procedure
27,conduct-disorder,negative finding,0.05313,finding
27,conduct-disorder,multiple endocrine neoplasia,0.04854,antibiotic - neoplastic process - organic chemical
27,conduct-disorder,moderate adverse event,0.04657,finding
27,conduct-disorder,anxiety disorders,0.04641,finding - mental or behavioral dysfunction
27,conduct-disorder,tropical spastic paraparesis,0.04034,disease or syndrome - therapeutic or preventive procedure
27,conduct-disorder,ethanol,0.04001,organic chemical - pharmacologic substance
27,conduct-disorder,pregnancy tests,0.0369,diagnostic procedure
27,conduct-disorder,gravidity,0.03624,finding
27,conduct-disorder,bipolar disorder,0.03591,mental or behavioral dysfunction
27,conduct-disorder,active brand of pseudoephedrine-triprolidine,0.03493,organic chemical - pharmacologic substance
27,conduct-disorder,severe combined immunodeficiency,0.03378,diagnostic procedure - disease or syndrome
27,conduct-disorder,positive finding,0.03313,finding
27,conduct-disorder,malignant neoplasms,0.03247,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
27,conduct-disorder,allergy severity - severe,0.03067,finding
27,conduct-disorder,schizophrenia,0.0287,mental or behavioral dysfunction
27,conduct-disorder,psychotropic drugs,0.02853,pharmacologic substance
27,conduct-disorder,depressive symptoms,0.02821,sign or symptom
27,conduct-disorder,unmarried,0.02624,finding
27,conduct-disorder,mass of body structure,0.02624,finding
27,conduct-disorder,post-traumatic stress disorder,0.02476,mental or behavioral dysfunction
27,conduct-disorder,medical history,0.02378,finding
27,conduct-disorder,mild adverse event,0.02345,finding
27,conduct-disorder,relate - vinyl resin,0.02279,organic chemical
27,conduct-disorder,antipsychotic agents,0.02181,pharmacologic substance
27,conduct-disorder,operative surgical procedures,0.02132,diagnostic procedure - therapeutic or preventive procedure
27,conduct-disorder,mood disorders,0.02033,mental or behavioral dysfunction
27,conduct-disorder,pharmacotherapy,0.02017,therapeutic or preventive procedure
27,conduct-disorder,electrocardiogram,0.02017,diagnostic procedure - finding - organic chemical - pharmacologic substance
27,conduct-disorder,pharmaceutical preparations,0.01902,pharmacologic substance
27,conduct-disorder,follow-up status,0.01902,finding
27,conduct-disorder,selective serotonin re-uptake inhibitor,0.01853,pharmacologic substance
27,conduct-disorder,screening for cancer,0.01853,diagnostic procedure
27,conduct-disorder,blood pressure finding,0.01705,finding
27,conduct-disorder,psychotic disorders,0.0164,mental or behavioral dysfunction
27,conduct-disorder,mini-mental status exam,0.01591,diagnostic procedure
27,conduct-disorder,autistic disorder,0.01541,mental or behavioral dysfunction
27,conduct-disorder,hiv,0.01427,disease or syndrome - pharmacologic substance - virus
27,conduct-disorder,generalized anxiety disorder,0.01427,mental or behavioral dysfunction
27,conduct-disorder,dementia,0.01427,mental or behavioral dysfunction
27,conduct-disorder,schizoaffective disorder,0.01361,mental or behavioral dysfunction
27,conduct-disorder,hypertensive disease,0.01361,biologically active substance - disease or syndrome - finding
27,conduct-disorder,substance abuse problem,0.01312,mental or behavioral dysfunction
27,conduct-disorder,infantile neuroaxonal dystrophy,0.01279,disease or syndrome
27,conduct-disorder,suicidal,0.01214,finding
27,conduct-disorder,manic,0.01214,finding - mental or behavioral dysfunction
27,conduct-disorder,congenital abnormality,0.01214,congenital abnormality - disease or syndrome
27,conduct-disorder,neoplasm metastasis,0.01197,neoplastic process
27,conduct-disorder,fluoxetine,0.01148,organic chemical - pharmacologic substance
27,conduct-disorder,alcoholic intoxication chronic,0.01115,mental or behavioral dysfunction
27,conduct-disorder,psychotherapy,0.01099,therapeutic or preventive procedure
27,conduct-disorder,stimulant,0.01066,pharmacologic substance
27,conduct-disorder,stabilizer - function,0.0105,organ or tissue function
27,conduct-disorder,cognitive therapy,0.0105,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
27,conduct-disorder,magnetic resonance imaging,0.01033,diagnostic procedure
27,conduct-disorder,benzodiazepines,0.00968,organic chemical - pharmacologic substance
27,conduct-disorder,benign rolandic epilepsy,0.00918,disease or syndrome - therapeutic or preventive procedure
27,conduct-disorder,injury wounds,0.00886,body substance - injury or poisoning
27,conduct-disorder,psychiatric problem,0.00869,mental or behavioral dysfunction
27,conduct-disorder,impaired cognition,0.00836,finding - mental or behavioral dysfunction
27,conduct-disorder,panic disorder,0.0082,disease or syndrome - mental or behavioral dysfunction
27,conduct-disorder,obsessive-compulsive disorder,0.0082,disease or syndrome - mental or behavioral dysfunction
27,conduct-disorder,cerebrovascular accident,0.0082,disease or syndrome - therapeutic or preventive procedure
27,conduct-disorder,disability,0.00804,finding
27,conduct-disorder,diabetes,0.00787,disease or syndrome
27,conduct-disorder,kidney,0.00771,body part, organ, or organ component
27,conduct-disorder,pervasive development disorder,0.00738,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
27,conduct-disorder,suicide attempt,0.00705,finding - mental or behavioral dysfunction
27,conduct-disorder,unstable status,0.00623,finding
27,conduct-disorder,stress disorders traumatic,0.00607,mental or behavioral dysfunction
27,conduct-disorder,illicit drugs,0.00574,hazardous or poisonous substance - pharmacologic substance
27,conduct-disorder,personality disorders,0.00558,mental or behavioral dysfunction
27,conduct-disorder,alcohol abuse,0.00541,mental or behavioral dysfunction
27,conduct-disorder,cardiovascular diseases,0.00525,disease or syndrome
27,conduct-disorder,heart diseases,0.00508,disease or syndrome
27,conduct-disorder,hepatic,0.00492,body location or region
27,conduct-disorder,psychotic symptoms,0.00492,sign or symptom
27,conduct-disorder,compulsive disorder,0.00476,finding
27,conduct-disorder,nicotine,0.00459,hazardous or poisonous substance - organic chemical - pharmacologic substance
27,conduct-disorder,developmental disabilities,0.00459,mental or behavioral dysfunction
27,conduct-disorder,breast,0.00394,body part, organ, or organ component
27,conduct-disorder,hypersensitivity,0.00394,clinical attribute - finding - pathologic function
27,conduct-disorder,substance dependence,0.00377,mental or behavioral dysfunction
27,conduct-disorder,myocardial infarction,0.00361,disease or syndrome - finding
27,conduct-disorder,mental retardation,0.00344,mental or behavioral dysfunction
27,conduct-disorder,craniocerebral trauma,0.00312,injury or poisoning
27,conduct-disorder,thyroid gland,0.00312,body part, organ, or organ component - disease or syndrome - pharmacologic substance
27,conduct-disorder,monoamine oxidase inhibitors,0.00295,organic chemical - pharmacologic substance
27,conduct-disorder,suicidality,0.00279,clinical attribute
27,conduct-disorder,nervous system disorder,0.00279,disease or syndrome
27,conduct-disorder,eating disorders,0.00262,mental or behavioral dysfunction
27,conduct-disorder,caffeine,0.00213,organic chemical - pharmacologic substance - therapeutic or preventive procedure
27,conduct-disorder,drug abuse,0.00213,mental or behavioral dysfunction
27,conduct-disorder,investigational new drugs,0.00033,pharmacologic substance - therapeutic or preventive procedure
28,consciousness-disorders,consciousness related finding,0.10734,finding
28,consciousness-disorders,allergy severity - severe,0.09605,finding
28,consciousness-disorders,brain injuries,0.0904,injury or poisoning
28,consciousness-disorders,unconscious state,0.0904,disease or syndrome - finding
28,consciousness-disorders,physical assessment findings,0.07345,finding
28,consciousness-disorders,injury wounds,0.05085,body substance - injury or poisoning
28,consciousness-disorders,traumatic brain injury,0.03955,disease or syndrome - injury or poisoning
28,consciousness-disorders,body mass index,0.03955,clinical attribute - diagnostic procedure
28,consciousness-disorders,positive finding,0.03955,finding
28,consciousness-disorders,negative finding,0.02825,finding
28,consciousness-disorders,intravenous infusion procedures,0.02825,therapeutic or preventive procedure
28,consciousness-disorders,cardiac arrhythmia,0.02825,finding - pathologic function
28,consciousness-disorders,cerebrovascular accident,0.02825,disease or syndrome - therapeutic or preventive procedure
28,consciousness-disorders,life expectancy,0.0226,group attribute
28,consciousness-disorders,pharmaceutical preparations,0.0226,pharmacologic substance
28,consciousness-disorders,active brand of pseudoephedrine-triprolidine,0.0226,organic chemical - pharmacologic substance
28,consciousness-disorders,mass of body structure,0.0226,finding
28,consciousness-disorders,blood pressure finding,0.01695,finding
28,consciousness-disorders,craniocerebral trauma,0.01695,injury or poisoning
28,consciousness-disorders,disability,0.01695,finding
28,consciousness-disorders,implantation procedure,0.01695,therapeutic or preventive procedure
28,consciousness-disorders,pathology processes,0.01695,pathologic function
28,consciousness-disorders,contraceptive methods,0.01695,therapeutic or preventive procedure
28,consciousness-disorders,pregnancy tests,0.01695,diagnostic procedure
28,consciousness-disorders,arteries,0.01695,body part, organ, or organ component
28,consciousness-disorders,congenital abnormality,0.0113,congenital abnormality - disease or syndrome
28,consciousness-disorders,congestive heart failure,0.0113,congenital abnormality - disease or syndrome
28,consciousness-disorders,gravidity,0.0113,finding
28,consciousness-disorders,lung,0.0113,body part, organ, or organ component - disease or syndrome
28,consciousness-disorders,ethanol,0.0113,organic chemical - pharmacologic substance
28,consciousness-disorders,hepatic,0.0113,body location or region
28,consciousness-disorders,nervous system disorder,0.0113,disease or syndrome
28,consciousness-disorders,follow-up status,0.0113,finding
28,consciousness-disorders,pharmacologic substance,0.0113,pharmacologic substance - therapeutic or preventive procedure
28,consciousness-disorders,heart ventricle,0.0113,body part, organ, or organ component
28,consciousness-disorders,malignant neoplasms,0.0113,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
28,consciousness-disorders,hearing examination finding,0.0113,finding
28,consciousness-disorders,heart diseases,0.0113,disease or syndrome
28,consciousness-disorders,relate - vinyl resin,0.0113,organic chemical
28,consciousness-disorders,hypertensive disease,0.00565,biologically active substance - disease or syndrome - finding
28,consciousness-disorders,kidney diseases,0.00565,disease or syndrome
28,consciousness-disorders,substance abuse problem,0.00565,mental or behavioral dysfunction
28,consciousness-disorders,epilepsy,0.00565,disease or syndrome
28,consciousness-disorders,alcohol abuse,0.00565,mental or behavioral dysfunction
28,consciousness-disorders,myocardial infarction,0.00565,disease or syndrome - finding
28,consciousness-disorders,magnetic resonance imaging,0.00565,diagnostic procedure
29,conversion-disorder,contraceptive methods,0.11602,therapeutic or preventive procedure
29,conversion-disorder,neoplasm metastasis,0.09392,neoplastic process
29,conversion-disorder,pharmacologic substance,0.07182,pharmacologic substance - therapeutic or preventive procedure
29,conversion-disorder,operative surgical procedures,0.07182,diagnostic procedure - therapeutic or preventive procedure
29,conversion-disorder,negative finding,0.0663,finding
29,conversion-disorder,relate - vinyl resin,0.0663,organic chemical
29,conversion-disorder,treatment protocols,0.06077,therapeutic or preventive procedure
29,conversion-disorder,epilepsy,0.05525,disease or syndrome
29,conversion-disorder,intravenous infusion procedures,0.04972,therapeutic or preventive procedure
29,conversion-disorder,malignant neoplasms,0.04972,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
29,conversion-disorder,pharmaceutical preparations,0.0442,pharmacologic substance
29,conversion-disorder,unmarried,0.0442,finding
29,conversion-disorder,gravidity,0.0442,finding
29,conversion-disorder,pregnancy tests,0.0442,diagnostic procedure
29,conversion-disorder,positive finding,0.03867,finding
29,conversion-disorder,blood pressure finding,0.03867,finding
29,conversion-disorder,follow-up status,0.03867,finding
29,conversion-disorder,arteries,0.03315,body part, organ, or organ component
29,conversion-disorder,active brand of pseudoephedrine-triprolidine,0.03315,organic chemical - pharmacologic substance
29,conversion-disorder,systolic pressure,0.03315,clinical attribute - diagnostic procedure
29,conversion-disorder,pregnancy test negative,0.03315,finding - laboratory or test result
29,conversion-disorder,mild adverse event,0.03315,finding
29,conversion-disorder,multiple sclerosis,0.03315,body part, organ, or organ component - disease or syndrome - finding
29,conversion-disorder,skeletal bone,0.02762,body location or region - body part, organ, or organ component - body substance - disease or syndrome
29,conversion-disorder,magnetic resonance imaging,0.02762,diagnostic procedure
29,conversion-disorder,allergy severity - severe,0.02762,finding
29,conversion-disorder,multiple endocrine neoplasia,0.02762,antibiotic - neoplastic process - organic chemical
29,conversion-disorder,diastolic blood pressure,0.0221,clinical attribute - diagnostic procedure - finding
29,conversion-disorder,body mass index,0.0221,clinical attribute - diagnostic procedure
29,conversion-disorder,physical assessment findings,0.0221,finding
29,conversion-disorder,myocardial infarction,0.0221,disease or syndrome - finding
29,conversion-disorder,injury wounds,0.0221,body substance - injury or poisoning
29,conversion-disorder,hypertensive disease,0.0221,biologically active substance - disease or syndrome - finding
29,conversion-disorder,electrocardiogram,0.0221,diagnostic procedure - finding - organic chemical - pharmacologic substance
29,conversion-disorder,adrenal cortex hormones,0.0221,pharmacologic substance
29,conversion-disorder,aspartate transaminase,0.0221,enzyme
29,conversion-disorder,contraceptives oral,0.0221,pharmacologic substance - therapeutic or preventive procedure
29,conversion-disorder,diastole,0.0221,clinical attribute
29,conversion-disorder,creatinine clearance,0.01657,finding
29,conversion-disorder,transaminases,0.01657,enzyme
29,conversion-disorder,alanine transaminase,0.01657,congenital abnormality - disease or syndrome - enzyme
29,conversion-disorder,lung,0.01657,body part, organ, or organ component - disease or syndrome
29,conversion-disorder,blood vessel,0.01657,body part, organ, or organ component - finding
29,conversion-disorder,cardiac arrhythmia,0.01657,finding - pathologic function
29,conversion-disorder,opioids,0.01657,hazardous or poisonous substance - organic chemical - pharmacologic substance
29,conversion-disorder,impaired cognition,0.01657,finding - mental or behavioral dysfunction
29,conversion-disorder,dementia,0.01657,mental or behavioral dysfunction
29,conversion-disorder,bilirubin,0.01657,biologically active substance - laboratory or test result - organic chemical
29,conversion-disorder,cerebrovascular accident,0.01657,disease or syndrome - therapeutic or preventive procedure
29,conversion-disorder,congestive heart failure,0.01105,congenital abnormality - disease or syndrome
29,conversion-disorder,pharmacotherapy,0.01105,therapeutic or preventive procedure
29,conversion-disorder,hepatic,0.01105,body location or region
29,conversion-disorder,schizophrenia,0.01105,mental or behavioral dysfunction
29,conversion-disorder,diabetes mellitus,0.01105,disease or syndrome - pharmacologic substance
29,conversion-disorder,antipsychotic agents,0.01105,pharmacologic substance
29,conversion-disorder,ethanol,0.01105,organic chemical - pharmacologic substance
29,conversion-disorder,moderate adverse event,0.01105,finding
29,conversion-disorder,unstable status,0.01105,finding
29,conversion-disorder,angina pectoris,0.01105,sign or symptom
29,conversion-disorder,hypersensitivity,0.01105,clinical attribute - finding - pathologic function
29,conversion-disorder,depressed mood,0.01105,finding - mental or behavioral dysfunction
29,conversion-disorder,medical contraindication,0.01105,finding
29,conversion-disorder,kidney diseases,0.00552,disease or syndrome
29,conversion-disorder,psychotic disorders,0.00552,mental or behavioral dysfunction
29,conversion-disorder,pathology processes,0.00552,pathologic function
29,conversion-disorder,heart ventricle,0.00552,body part, organ, or organ component
29,conversion-disorder,disease of diaphragm,0.00552,body part, organ, or organ component - disease or syndrome
29,conversion-disorder,congenital abnormality,0.00552,congenital abnormality - disease or syndrome
29,conversion-disorder,benzodiazepines,0.00552,organic chemical - pharmacologic substance
29,conversion-disorder,nervous system disorder,0.00552,disease or syndrome
29,conversion-disorder,liver diseases,0.00552,disease or syndrome
30,delirium,mini-mental status exam,0.27914,diagnostic procedure
30,delirium,dactinomycin,0.17528,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
30,delirium,mild adverse event,0.16682,finding
30,delirium,intravenous infusion procedures,0.12218,therapeutic or preventive procedure
30,delirium,impaired cognition,0.11748,finding - mental or behavioral dysfunction
30,delirium,magnetic resonance imaging,0.10385,diagnostic procedure
30,delirium,memory observations,0.09633,finding
30,delirium,relate - vinyl resin,0.08365,organic chemical
30,delirium,physical assessment findings,0.07707,finding
30,delirium,contraceptive methods,0.06767,therapeutic or preventive procedure
30,delirium,operative surgical procedures,0.06626,diagnostic procedure - therapeutic or preventive procedure
30,delirium,depressed mood,0.06485,finding - mental or behavioral dysfunction
30,delirium,moderate adverse event,0.06015,finding
30,delirium,cholinesterase inhibitors,0.06015,organic chemical - pharmacologic substance
30,delirium,multiple endocrine neoplasia,0.06015,antibiotic - neoplastic process - organic chemical
30,delirium,memantine,0.04981,organic chemical - pharmacologic substance
30,delirium,mental disorders,0.04793,mental or behavioral dysfunction
30,delirium,cognitive therapy,0.04652,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
30,delirium,body mass index,0.04558,clinical attribute - diagnostic procedure
30,delirium,negative finding,0.04558,finding
30,delirium,medical history,0.04323,finding
30,delirium,pharmacologic substance,0.04229,pharmacologic substance - therapeutic or preventive procedure
30,delirium,electrocardiogram,0.03806,diagnostic procedure - finding - organic chemical - pharmacologic substance
30,delirium,hearing examination finding,0.03759,finding
30,delirium,cerebrovascular accident,0.03759,disease or syndrome - therapeutic or preventive procedure
30,delirium,sterility,0.03712,pathologic function
30,delirium,neuropsychological tests,0.03712,diagnostic procedure
30,delirium,pregnancy tests,0.03712,diagnostic procedure
30,delirium,positive finding,0.03665,finding
30,delirium,mass of body structure,0.03571,finding
30,delirium,blood vessel,0.03524,body part, organ, or organ component - finding
30,delirium,allergy severity - severe,0.03008,finding
30,delirium,congenital abnormality,0.02632,congenital abnormality - disease or syndrome
30,delirium,antipsychotic agents,0.02444,pharmacologic substance
30,delirium,gravidity,0.02444,finding
30,delirium,positron-emission tomography,0.02068,diagnostic procedure
30,delirium,agitation,0.02068,finding - sign or symptom
30,delirium,active brand of pseudoephedrine-triprolidine,0.01974,organic chemical - pharmacologic substance
30,delirium,pharmaceutical preparations,0.01927,pharmacologic substance
30,delirium,delirium,0.01927,mental or behavioral dysfunction
30,delirium,nervous system disorder,0.0188,disease or syndrome
30,delirium,hypertensive disease,0.01833,biologically active substance - disease or syndrome - finding
30,delirium,serum,0.01833,biologically active substance - body substance - pharmacologic substance
30,delirium,family history,0.01692,congenital abnormality - disease or syndrome - enzyme - finding
30,delirium,malignant neoplasms,0.01692,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
30,delirium,psychotropic drugs,0.01645,pharmacologic substance
30,delirium,antidepressive agents,0.01645,pharmacologic substance
30,delirium,schizophrenia,0.01598,mental or behavioral dysfunction
30,delirium,frontotemporal dementia,0.01504,disease or syndrome
30,delirium,arteries,0.01457,body part, organ, or organ component
30,delirium,household composition,0.0141,finding
30,delirium,pharmacotherapy,0.01363,therapeutic or preventive procedure
30,delirium,ethanol,0.01316,organic chemical - pharmacologic substance
30,delirium,blood pressure finding,0.01269,finding
30,delirium,injury wounds,0.01222,body substance - injury or poisoning
30,delirium,mental retardation,0.01222,mental or behavioral dysfunction
30,delirium,consciousness related finding,0.01175,finding
30,delirium,unipolar depression,0.01081,mental or behavioral dysfunction
30,delirium,traumatic brain injury,0.01081,disease or syndrome - injury or poisoning
30,delirium,multiple sclerosis,0.01034,body part, organ, or organ component - disease or syndrome - finding
30,delirium,hepatic,0.01034,body location or region
30,delirium,screening for cancer,0.01034,diagnostic procedure
30,delirium,brain injuries,0.01034,injury or poisoning
30,delirium,epilepsy,0.0094,disease or syndrome
30,delirium,pathology processes,0.00893,pathologic function
30,delirium,neoplasm metastasis,0.00893,neoplastic process
30,delirium,alanine transaminase,0.00752,congenital abnormality - disease or syndrome - enzyme
30,delirium,thyroid gland,0.00752,body part, organ, or organ component - disease or syndrome - pharmacologic substance
30,delirium,neurological observations,0.00752,finding
30,delirium,disability,0.00705,finding
30,delirium,nervousness,0.00705,sign or symptom
30,delirium,hiv,0.00705,disease or syndrome - pharmacologic substance - virus
30,delirium,psychotic disorders,0.00705,mental or behavioral dysfunction
30,delirium,unstable status,0.00658,finding
30,delirium,craniocerebral trauma,0.00611,injury or poisoning
30,delirium,substance abuse problem,0.00611,mental or behavioral dysfunction
30,delirium,benzodiazepines,0.00611,organic chemical - pharmacologic substance
30,delirium,diastole,0.00611,clinical attribute
30,delirium,blind vision,0.00564,disease or syndrome
30,delirium,insulin,0.00517,pharmacologic substance
30,delirium,hypersensitivity,0.0047,clinical attribute - finding - pathologic function
30,delirium,diastolic blood pressure,0.00423,clinical attribute - diagnostic procedure - finding
30,delirium,cardiovascular diseases,0.00423,disease or syndrome
30,delirium,liver diseases,0.00423,disease or syndrome
30,delirium,systolic pressure,0.00423,clinical attribute - diagnostic procedure
30,delirium,congestive heart failure,0.00376,congenital abnormality - disease or syndrome
30,delirium,lung,0.00376,body part, organ, or organ component - disease or syndrome
30,delirium,cardiac arrhythmia,0.00376,finding - pathologic function
30,delirium,angina pectoris,0.00376,sign or symptom
30,delirium,investigational new drugs,0.00376,pharmacologic substance - therapeutic or preventive procedure
30,delirium,alcohol abuse,0.00376,mental or behavioral dysfunction
30,delirium,diabetes mellitus,0.00329,disease or syndrome - pharmacologic substance
30,delirium,anxiety disorders,0.00329,finding - mental or behavioral dysfunction
30,delirium,breast,0.00329,body part, organ, or organ component
30,delirium,bipolar disorder,0.00329,mental or behavioral dysfunction
30,delirium,unconscious state,0.00329,disease or syndrome - finding
30,delirium,heart diseases,0.00329,disease or syndrome
30,delirium,medical contraindication,0.00329,finding
30,delirium,hypothyroidism,0.00282,disease or syndrome
30,delirium,alcoholic intoxication chronic,0.00282,mental or behavioral dysfunction
30,delirium,kidney diseases,0.00235,disease or syndrome
30,delirium,myocardial infarction,0.00235,disease or syndrome - finding
30,delirium,major depressive disorder,0.00235,mental or behavioral dysfunction
30,delirium,drug abuse,0.00188,mental or behavioral dysfunction
30,delirium,claustrophobia,0.00047,mental or behavioral dysfunction
31,dementia,mini-mental status exam,0.27631,diagnostic procedure
31,dementia,dactinomycin,0.17339,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
31,dementia,mild adverse event,0.16504,finding
31,dementia,intravenous infusion procedures,0.12239,therapeutic or preventive procedure
31,dementia,impaired cognition,0.11822,finding - mental or behavioral dysfunction
31,dementia,magnetic resonance imaging,0.10385,diagnostic procedure
31,dementia,memory observations,0.09689,finding
31,dementia,relate - vinyl resin,0.08299,organic chemical
31,dementia,physical assessment findings,0.0765,finding
31,dementia,contraceptive methods,0.06861,therapeutic or preventive procedure
31,dementia,depressed mood,0.0663,finding - mental or behavioral dysfunction
31,dementia,operative surgical procedures,0.06444,diagnostic procedure - therapeutic or preventive procedure
31,dementia,cholinesterase inhibitors,0.05934,organic chemical - pharmacologic substance
31,dementia,moderate adverse event,0.05888,finding
31,dementia,multiple endocrine neoplasia,0.05888,antibiotic - neoplastic process - organic chemical
31,dementia,memantine,0.04914,organic chemical - pharmacologic substance
31,dementia,mental disorders,0.04868,mental or behavioral dysfunction
31,dementia,negative finding,0.04682,finding
31,dementia,cognitive therapy,0.04682,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
31,dementia,body mass index,0.0459,clinical attribute - diagnostic procedure
31,dementia,pharmacologic substance,0.04358,pharmacologic substance - therapeutic or preventive procedure
31,dementia,medical history,0.04265,finding
31,dementia,pregnancy tests,0.03802,diagnostic procedure
31,dementia,cerebrovascular accident,0.03802,disease or syndrome - therapeutic or preventive procedure
31,dementia,positive finding,0.03755,finding
31,dementia,neuropsychological tests,0.03755,diagnostic procedure
31,dementia,electrocardiogram,0.03755,diagnostic procedure - finding - organic chemical - pharmacologic substance
31,dementia,hearing examination finding,0.03662,finding
31,dementia,sterility,0.03662,pathologic function
31,dementia,mass of body structure,0.03662,finding
31,dementia,blood vessel,0.03477,body part, organ, or organ component - finding
31,dementia,allergy severity - severe,0.02921,finding
31,dementia,congenital abnormality,0.02596,congenital abnormality - disease or syndrome
31,dementia,gravidity,0.02457,finding
31,dementia,antipsychotic agents,0.02411,pharmacologic substance
31,dementia,pharmaceutical preparations,0.0204,pharmacologic substance
31,dementia,active brand of pseudoephedrine-triprolidine,0.0204,organic chemical - pharmacologic substance
31,dementia,positron-emission tomography,0.0204,diagnostic procedure
31,dementia,treatment protocols,0.01994,therapeutic or preventive procedure
31,dementia,agitation,0.01994,finding - sign or symptom
31,dementia,delirium,0.01901,mental or behavioral dysfunction
31,dementia,hypertensive disease,0.01854,biologically active substance - disease or syndrome - finding
31,dementia,serum,0.01854,biologically active substance - body substance - pharmacologic substance
31,dementia,nervous system disorder,0.01854,disease or syndrome
31,dementia,schizophrenia,0.01715,mental or behavioral dysfunction
31,dementia,follow-up status,0.01715,finding
31,dementia,psychotropic drugs,0.01669,pharmacologic substance
31,dementia,family history,0.01669,congenital abnormality - disease or syndrome - enzyme - finding
31,dementia,malignant neoplasms,0.01669,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
31,dementia,antidepressive agents,0.01623,pharmacologic substance
31,dementia,frontotemporal dementia,0.01484,disease or syndrome
31,dementia,pharmacotherapy,0.01437,therapeutic or preventive procedure
31,dementia,arteries,0.01391,body part, organ, or organ component
31,dementia,household composition,0.01391,finding
31,dementia,ethanol,0.01344,organic chemical - pharmacologic substance
31,dementia,blood pressure finding,0.01298,finding
31,dementia,mental retardation,0.01205,mental or behavioral dysfunction
31,dementia,injury wounds,0.01205,body substance - injury or poisoning
31,dementia,consciousness related finding,0.01159,finding
31,dementia,unipolar depression,0.01113,mental or behavioral dysfunction
31,dementia,traumatic brain injury,0.01066,disease or syndrome - injury or poisoning
31,dementia,brain injuries,0.01066,injury or poisoning
31,dementia,multiple sclerosis,0.0102,body part, organ, or organ component - disease or syndrome - finding
31,dementia,hepatic,0.0102,body location or region
31,dementia,screening for cancer,0.0102,diagnostic procedure
31,dementia,epilepsy,0.00974,disease or syndrome
31,dementia,hiv,0.00927,disease or syndrome - pharmacologic substance - virus
31,dementia,neoplasm metastasis,0.00927,neoplastic process
31,dementia,pathology processes,0.00881,pathologic function
31,dementia,alanine transaminase,0.00834,congenital abnormality - disease or syndrome - enzyme
31,dementia,thyroid gland,0.00742,body part, organ, or organ component - disease or syndrome - pharmacologic substance
31,dementia,neurological observations,0.00742,finding
31,dementia,nervousness,0.00695,sign or symptom
31,dementia,psychotic disorders,0.00695,mental or behavioral dysfunction
31,dementia,disability,0.00649,finding
31,dementia,unstable status,0.00649,finding
31,dementia,craniocerebral trauma,0.00603,injury or poisoning
31,dementia,substance abuse problem,0.00603,mental or behavioral dysfunction
31,dementia,blind vision,0.00603,disease or syndrome
31,dementia,benzodiazepines,0.00603,organic chemical - pharmacologic substance
31,dementia,diastole,0.00603,clinical attribute
31,dementia,insulin,0.0051,pharmacologic substance
31,dementia,cardiovascular diseases,0.00464,disease or syndrome
31,dementia,systolic pressure,0.00464,clinical attribute - diagnostic procedure
31,dementia,hypersensitivity,0.00464,clinical attribute - finding - pathologic function
31,dementia,diastolic blood pressure,0.00417,clinical attribute - diagnostic procedure - finding
31,dementia,bipolar disorder,0.00417,mental or behavioral dysfunction
31,dementia,liver diseases,0.00417,disease or syndrome
31,dementia,congestive heart failure,0.00371,congenital abnormality - disease or syndrome
31,dementia,anxiety disorders,0.00371,finding - mental or behavioral dysfunction
31,dementia,lung,0.00371,body part, organ, or organ component - disease or syndrome
31,dementia,cardiac arrhythmia,0.00371,finding - pathologic function
31,dementia,angina pectoris,0.00371,sign or symptom
31,dementia,investigational new drugs,0.00371,pharmacologic substance - therapeutic or preventive procedure
31,dementia,medical contraindication,0.00371,finding
31,dementia,alcohol abuse,0.00371,mental or behavioral dysfunction
31,dementia,diabetes mellitus,0.00325,disease or syndrome - pharmacologic substance
31,dementia,breast,0.00325,body part, organ, or organ component
31,dementia,unconscious state,0.00325,disease or syndrome - finding
31,dementia,heart diseases,0.00325,disease or syndrome
31,dementia,hypothyroidism,0.00278,disease or syndrome
31,dementia,alcoholic intoxication chronic,0.00278,mental or behavioral dysfunction
31,dementia,kidney diseases,0.00232,disease or syndrome
31,dementia,myocardial infarction,0.00232,disease or syndrome - finding
31,dementia,major depressive disorder,0.00232,mental or behavioral dysfunction
31,dementia,suicidal,0.00185,finding
31,dementia,drug abuse,0.00185,mental or behavioral dysfunction
31,dementia,claustrophobia,0.00046,mental or behavioral dysfunction
32,depression,depressed mood,0.4036,finding - mental or behavioral dysfunction
32,depression,intravenous infusion procedures,0.31874,therapeutic or preventive procedure
32,depression,major depressive disorder,0.28246,mental or behavioral dysfunction
32,depression,antidepressive agents,0.13703,pharmacologic substance
32,depression,depressive episode unspecified,0.12894,mental or behavioral dysfunction
32,depression,unipolar depression,0.12144,mental or behavioral dysfunction
32,depression,contraceptive methods,0.10375,therapeutic or preventive procedure
32,depression,mental disorders,0.07706,mental or behavioral dysfunction
32,depression,tropical spastic paraparesis,0.07436,disease or syndrome - therapeutic or preventive procedure
32,depression,bipolar disorder,0.06207,mental or behavioral dysfunction
32,depression,anxiety disorders,0.05727,finding - mental or behavioral dysfunction
32,depression,physical assessment findings,0.05547,finding
32,depression,depressive symptoms,0.05397,sign or symptom
32,depression,severe combined immunodeficiency,0.05307,diagnostic procedure - disease or syndrome
32,depression,moderate adverse event,0.05217,finding
32,depression,negative finding,0.04918,finding
32,depression,pharmacologic substance,0.04768,pharmacologic substance - therapeutic or preventive procedure
32,depression,multiple endocrine neoplasia,0.04678,antibiotic - neoplastic process - organic chemical
32,depression,gravidity,0.04168,finding
32,depression,unmarried,0.04108,finding
32,depression,malignant neoplasms,0.04018,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
32,depression,dysthymic disorder,0.03928,mental or behavioral dysfunction
32,depression,allergy severity - severe,0.03688,finding
32,depression,pregnancy tests,0.03418,diagnostic procedure
32,depression,body mass index,0.03328,clinical attribute - diagnostic procedure
32,depression,personality inventories,0.03298,diagnostic procedure
32,depression,active brand of pseudoephedrine-triprolidine,0.03238,organic chemical - pharmacologic substance
32,depression,selective serotonin re-uptake inhibitor,0.03028,pharmacologic substance
32,depression,mood disorders,0.02909,mental or behavioral dysfunction
32,depression,mild adverse event,0.02879,finding
32,depression,psychotropic drugs,0.02789,pharmacologic substance
32,depression,operative surgical procedures,0.02699,diagnostic procedure - therapeutic or preventive procedure
32,depression,post-traumatic stress disorder,0.02609,mental or behavioral dysfunction
32,depression,antipsychotic agents,0.02549,pharmacologic substance
32,depression,medical history,0.02459,finding
32,depression,schizophrenia,0.02429,mental or behavioral dysfunction
32,depression,ethanol,0.02429,organic chemical - pharmacologic substance
32,depression,treatment protocols,0.02399,therapeutic or preventive procedure
32,depression,manic,0.02399,finding - mental or behavioral dysfunction
32,depression,pharmacotherapy,0.02309,therapeutic or preventive procedure
32,depression,screening for cancer,0.02099,diagnostic procedure
32,depression,lithium,0.01979,congenital abnormality - disease or syndrome - pharmacologic substance
32,depression,psychotic disorders,0.01949,mental or behavioral dysfunction
32,depression,relate - vinyl resin,0.01949,organic chemical
32,depression,positive finding,0.01919,finding
32,depression,stabilizer - function,0.01889,organ or tissue function
32,depression,psychotherapy,0.01889,therapeutic or preventive procedure
32,depression,mini-mental status exam,0.01829,diagnostic procedure
32,depression,cancer remission,0.01829,finding - neoplastic process
32,depression,suicidal,0.01769,finding
32,depression,pharmaceutical preparations,0.01739,pharmacologic substance
32,depression,benign rolandic epilepsy,0.01709,disease or syndrome - therapeutic or preventive procedure
32,depression,electrocardiogram,0.01559,diagnostic procedure - finding - organic chemical - pharmacologic substance
32,depression,fluoxetine,0.01529,organic chemical - pharmacologic substance
32,depression,generalized anxiety disorder,0.01469,mental or behavioral dysfunction
32,depression,substance abuse problem,0.01439,mental or behavioral dysfunction
32,depression,schizoaffective disorder,0.01409,mental or behavioral dysfunction
32,depression,infantile neuroaxonal dystrophy,0.01409,disease or syndrome
32,depression,neoplasm metastasis,0.01349,neoplastic process
32,depression,therapeutic brand of coal tar,0.01349,organic chemical - pharmacologic substance - therapeutic or preventive procedure
32,depression,benzodiazepines,0.01229,organic chemical - pharmacologic substance
32,depression,magnetic resonance imaging,0.01199,diagnostic procedure
32,depression,anxiety generalized,0.01199,mental or behavioral dysfunction
32,depression,dementia,0.01199,mental or behavioral dysfunction
32,depression,impaired cognition,0.01139,finding - mental or behavioral dysfunction
32,depression,blood pressure finding,0.01109,finding
32,depression,suicide attempt,0.0099,finding - mental or behavioral dysfunction
32,depression,congenital abnormality,0.0096,congenital abnormality - disease or syndrome
32,depression,psychiatric problem,0.0096,mental or behavioral dysfunction
32,depression,stress disorders traumatic,0.0093,mental or behavioral dysfunction
32,depression,hiv,0.009,disease or syndrome - pharmacologic substance - virus
32,depression,hypertensive disease,0.009,biologically active substance - disease or syndrome - finding
32,depression,panic disorder,0.0087,disease or syndrome - mental or behavioral dysfunction
32,depression,injury wounds,0.0087,body substance - injury or poisoning
32,depression,cerebrovascular accident,0.0087,disease or syndrome - therapeutic or preventive procedure
32,depression,alcoholic intoxication chronic,0.0084,mental or behavioral dysfunction
32,depression,obsessive-compulsive disorder,0.0078,disease or syndrome - mental or behavioral dysfunction
32,depression,anticonvulsants,0.0066,pharmacologic substance
32,depression,heart diseases,0.0066,disease or syndrome
32,depression,unstable status,0.0066,finding
32,depression,psychotic symptoms,0.0063,sign or symptom
32,depression,diabetes,0.0057,disease or syndrome
32,depression,hepatic,0.0051,body location or region
32,depression,stimulation procedure,0.0051,therapeutic or preventive procedure
32,depression,personality disorders,0.0048,mental or behavioral dysfunction
32,depression,breast,0.0045,body part, organ, or organ component
32,depression,suicidality,0.0045,clinical attribute
32,depression,compulsive disorder,0.0045,finding
32,depression,multiple sclerosis,0.0042,body part, organ, or organ component - disease or syndrome - finding
32,depression,illicit drugs,0.0042,hazardous or poisonous substance - pharmacologic substance
32,depression,myocardial infarction,0.0039,disease or syndrome - finding
32,depression,nervous system disorder,0.0039,disease or syndrome
32,depression,thyroid gland,0.0036,body part, organ, or organ component - disease or syndrome - pharmacologic substance
32,depression,monoamine oxidase inhibitors,0.0036,organic chemical - pharmacologic substance
32,depression,substance dependence,0.003,mental or behavioral dysfunction
32,depression,hypothyroidism,0.0027,disease or syndrome
32,depression,craniocerebral trauma,0.0027,injury or poisoning
32,depression,kidney diseases,0.0024,disease or syndrome
32,depression,alcohol abuse,0.0024,mental or behavioral dysfunction
32,depression,substance use disorders,0.0024,mental or behavioral dysfunction
32,depression,eating disorders,0.0024,mental or behavioral dysfunction
32,depression,mental retardation,0.0024,mental or behavioral dysfunction
32,depression,medical contraindication,0.0024,finding
32,depression,nicotine,0.0021,hazardous or poisonous substance - organic chemical - pharmacologic substance
32,depression,lung,0.0018,body part, organ, or organ component - disease or syndrome
32,depression,hypersensitivity,0.0018,clinical attribute - finding - pathologic function
32,depression,caffeine,0.0015,organic chemical - pharmacologic substance - therapeutic or preventive procedure
32,depression,delirium,0.0015,mental or behavioral dysfunction
32,depression,drug abuse,0.0012,mental or behavioral dysfunction
32,depression,investigational new drugs,6e-04,pharmacologic substance - therapeutic or preventive procedure
32,depression,suicide risk,3e-04,finding
33,depressive-disorder,depressed mood,0.4036,finding - mental or behavioral dysfunction
33,depressive-disorder,intravenous infusion procedures,0.32024,therapeutic or preventive procedure
33,depressive-disorder,major depressive disorder,0.28246,mental or behavioral dysfunction
33,depressive-disorder,antidepressive agents,0.13703,pharmacologic substance
33,depressive-disorder,depressive episode unspecified,0.12894,mental or behavioral dysfunction
33,depressive-disorder,unipolar depression,0.12144,mental or behavioral dysfunction
33,depressive-disorder,contraceptive methods,0.10375,therapeutic or preventive procedure
33,depressive-disorder,mental disorders,0.07706,mental or behavioral dysfunction
33,depressive-disorder,tropical spastic paraparesis,0.07466,disease or syndrome - therapeutic or preventive procedure
33,depressive-disorder,bipolar disorder,0.06387,mental or behavioral dysfunction
33,depressive-disorder,anxiety disorders,0.05757,finding - mental or behavioral dysfunction
33,depressive-disorder,physical assessment findings,0.05517,finding
33,depressive-disorder,depressive symptoms,0.05457,sign or symptom
33,depressive-disorder,severe combined immunodeficiency,0.05307,diagnostic procedure - disease or syndrome
33,depressive-disorder,moderate adverse event,0.05217,finding
33,depressive-disorder,negative finding,0.04948,finding
33,depressive-disorder,pharmacologic substance,0.04798,pharmacologic substance - therapeutic or preventive procedure
33,depressive-disorder,multiple endocrine neoplasia,0.04678,antibiotic - neoplastic process - organic chemical
33,depressive-disorder,gravidity,0.04168,finding
33,depressive-disorder,unmarried,0.04138,finding
33,depressive-disorder,malignant neoplasms,0.04078,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
33,depressive-disorder,dysthymic disorder,0.03898,mental or behavioral dysfunction
33,depressive-disorder,allergy severity - severe,0.03658,finding
33,depressive-disorder,pregnancy tests,0.03448,diagnostic procedure
33,depressive-disorder,body mass index,0.03358,clinical attribute - diagnostic procedure
33,depressive-disorder,personality inventories,0.03298,diagnostic procedure
33,depressive-disorder,active brand of pseudoephedrine-triprolidine,0.03268,organic chemical - pharmacologic substance
33,depressive-disorder,selective serotonin re-uptake inhibitor,0.03028,pharmacologic substance
33,depressive-disorder,mild adverse event,0.02909,finding
33,depressive-disorder,mood disorders,0.02879,mental or behavioral dysfunction
33,depressive-disorder,psychotropic drugs,0.02789,pharmacologic substance
33,depressive-disorder,antipsychotic agents,0.02669,pharmacologic substance
33,depressive-disorder,manic,0.02639,finding - mental or behavioral dysfunction
33,depressive-disorder,operative surgical procedures,0.02639,diagnostic procedure - therapeutic or preventive procedure
33,depressive-disorder,post-traumatic stress disorder,0.02609,mental or behavioral dysfunction
33,depressive-disorder,schizophrenia,0.02459,mental or behavioral dysfunction
33,depressive-disorder,medical history,0.02459,finding
33,depressive-disorder,ethanol,0.02429,organic chemical - pharmacologic substance
33,depressive-disorder,treatment protocols,0.02399,therapeutic or preventive procedure
33,depressive-disorder,pharmacotherapy,0.02309,therapeutic or preventive procedure
33,depressive-disorder,screening for cancer,0.02099,diagnostic procedure
33,depressive-disorder,lithium,0.02009,congenital abnormality - disease or syndrome - pharmacologic substance
33,depressive-disorder,psychotic disorders,0.01979,mental or behavioral dysfunction
33,depressive-disorder,stabilizer - function,0.01949,organ or tissue function
33,depressive-disorder,relate - vinyl resin,0.01949,organic chemical
33,depressive-disorder,positive finding,0.01919,finding
33,depressive-disorder,psychotherapy,0.01889,therapeutic or preventive procedure
33,depressive-disorder,cancer remission,0.01829,finding - neoplastic process
33,depressive-disorder,pharmaceutical preparations,0.01799,pharmacologic substance
33,depressive-disorder,mini-mental status exam,0.01799,diagnostic procedure
33,depressive-disorder,suicidal,0.01769,finding
33,depressive-disorder,benign rolandic epilepsy,0.01709,disease or syndrome - therapeutic or preventive procedure
33,depressive-disorder,electrocardiogram,0.01559,diagnostic procedure - finding - organic chemical - pharmacologic substance
33,depressive-disorder,fluoxetine,0.01529,organic chemical - pharmacologic substance
33,depressive-disorder,generalized anxiety disorder,0.01499,mental or behavioral dysfunction
33,depressive-disorder,infantile neuroaxonal dystrophy,0.01439,disease or syndrome
33,depressive-disorder,substance abuse problem,0.01409,mental or behavioral dysfunction
33,depressive-disorder,therapeutic brand of coal tar,0.01409,organic chemical - pharmacologic substance - therapeutic or preventive procedure
33,depressive-disorder,neoplasm metastasis,0.01379,neoplastic process
33,depressive-disorder,schizoaffective disorder,0.01349,mental or behavioral dysfunction
33,depressive-disorder,anxiety generalized,0.01229,mental or behavioral dysfunction
33,depressive-disorder,dementia,0.01229,mental or behavioral dysfunction
33,depressive-disorder,benzodiazepines,0.01229,organic chemical - pharmacologic substance
33,depressive-disorder,magnetic resonance imaging,0.01169,diagnostic procedure
33,depressive-disorder,impaired cognition,0.01169,finding - mental or behavioral dysfunction
33,depressive-disorder,blood pressure finding,0.01109,finding
33,depressive-disorder,psychiatric problem,0.0099,mental or behavioral dysfunction
33,depressive-disorder,congenital abnormality,0.0096,congenital abnormality - disease or syndrome
33,depressive-disorder,suicide attempt,0.0096,finding - mental or behavioral dysfunction
33,depressive-disorder,stress disorders traumatic,0.0093,mental or behavioral dysfunction
33,depressive-disorder,hiv,0.009,disease or syndrome - pharmacologic substance - virus
33,depressive-disorder,injury wounds,0.009,body substance - injury or poisoning
33,depressive-disorder,hypertensive disease,0.009,biologically active substance - disease or syndrome - finding
33,depressive-disorder,panic disorder,0.0087,disease or syndrome - mental or behavioral dysfunction
33,depressive-disorder,cerebrovascular accident,0.0087,disease or syndrome - therapeutic or preventive procedure
33,depressive-disorder,alcoholic intoxication chronic,0.0084,mental or behavioral dysfunction
33,depressive-disorder,obsessive-compulsive disorder,0.0078,disease or syndrome - mental or behavioral dysfunction
33,depressive-disorder,anticonvulsants,0.0066,pharmacologic substance
33,depressive-disorder,unstable status,0.0066,finding
33,depressive-disorder,heart diseases,0.0063,disease or syndrome
33,depressive-disorder,diabetes,0.0057,disease or syndrome
33,depressive-disorder,psychotic symptoms,0.0057,sign or symptom
33,depressive-disorder,hepatic,0.0051,body location or region
33,depressive-disorder,cardiovascular diseases,0.0051,disease or syndrome
33,depressive-disorder,stimulation procedure,0.0051,therapeutic or preventive procedure
33,depressive-disorder,personality disorders,0.0048,mental or behavioral dysfunction
33,depressive-disorder,suicidality,0.0045,clinical attribute
33,depressive-disorder,compulsive disorder,0.0045,finding
33,depressive-disorder,breast,0.0042,body part, organ, or organ component
33,depressive-disorder,multiple sclerosis,0.0042,body part, organ, or organ component - disease or syndrome - finding
33,depressive-disorder,illicit drugs,0.0042,hazardous or poisonous substance - pharmacologic substance
33,depressive-disorder,nervous system disorder,0.0039,disease or syndrome
33,depressive-disorder,myocardial infarction,0.0036,disease or syndrome - finding
33,depressive-disorder,thyroid gland,0.0036,body part, organ, or organ component - disease or syndrome - pharmacologic substance
33,depressive-disorder,monoamine oxidase inhibitors,0.0036,organic chemical - pharmacologic substance
33,depressive-disorder,substance dependence,0.003,mental or behavioral dysfunction
33,depressive-disorder,hypothyroidism,0.0027,disease or syndrome
33,depressive-disorder,craniocerebral trauma,0.0027,injury or poisoning
33,depressive-disorder,kidney diseases,0.0024,disease or syndrome
33,depressive-disorder,alcohol abuse,0.0024,mental or behavioral dysfunction
33,depressive-disorder,eating disorders,0.0024,mental or behavioral dysfunction
33,depressive-disorder,mental retardation,0.0024,mental or behavioral dysfunction
33,depressive-disorder,medical contraindication,0.0024,finding
33,depressive-disorder,nicotine,0.0021,hazardous or poisonous substance - organic chemical - pharmacologic substance
33,depressive-disorder,delirium,0.0018,mental or behavioral dysfunction
33,depressive-disorder,lung,0.0018,body part, organ, or organ component - disease or syndrome
33,depressive-disorder,hypersensitivity,0.0018,clinical attribute - finding - pathologic function
33,depressive-disorder,caffeine,0.0015,organic chemical - pharmacologic substance - therapeutic or preventive procedure
33,depressive-disorder,drug abuse,0.0012,mental or behavioral dysfunction
33,depressive-disorder,investigational new drugs,9e-04,pharmacologic substance - therapeutic or preventive procedure
33,depressive-disorder,suicide risk,3e-04,finding
34,developmental-disabilities,autistic disorder,0.71461,mental or behavioral dysfunction
34,developmental-disabilities,autism spectrum disorders,0.37753,congenital abnormality - mental or behavioral dysfunction
34,developmental-disabilities,intravenous infusion procedures,0.33258,therapeutic or preventive procedure
34,developmental-disabilities,pervasive development disorder,0.20674,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
34,developmental-disabilities,developmental disabilities,0.14382,mental or behavioral dysfunction
34,developmental-disabilities,nitric oxide synthase,0.12135,enzyme
34,developmental-disabilities,mental disorders,0.0809,mental or behavioral dysfunction
34,developmental-disabilities,psychotropic drugs,0.07416,pharmacologic substance
34,developmental-disabilities,physical assessment findings,0.06517,finding
34,developmental-disabilities,integumentary scale,0.04944,body part, organ, or organ component
34,developmental-disabilities,disability,0.04719,finding
34,developmental-disabilities,anxiety disorders,0.04719,finding - mental or behavioral dysfunction
34,developmental-disabilities,attention deficit hyperactivity disorder,0.04719,disease or syndrome - mental or behavioral dysfunction
34,developmental-disabilities,pharmacologic substance,0.0427,pharmacologic substance - therapeutic or preventive procedure
34,developmental-disabilities,gene therapy,0.0382,therapeutic or preventive procedure
34,developmental-disabilities,epilepsy,0.03596,disease or syndrome
34,developmental-disabilities,contraceptive methods,0.03596,therapeutic or preventive procedure
34,developmental-disabilities,malaise,0.03596,finding - sign or symptom
34,developmental-disabilities,antipsychotic agents,0.03596,pharmacologic substance
34,developmental-disabilities,moderate adverse event,0.03371,finding
34,developmental-disabilities,pharmaceutical preparations,0.03146,pharmacologic substance
34,developmental-disabilities,negative finding,0.02921,finding
34,developmental-disabilities,surgical revision,0.02921,therapeutic or preventive procedure
34,developmental-disabilities,mental retardation,0.02921,mental or behavioral dysfunction
34,developmental-disabilities,allergy severity - severe,0.02921,finding
34,developmental-disabilities,dactinomycin,0.02921,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
34,developmental-disabilities,behavior disorders,0.02921,injury or poisoning - mental or behavioral dysfunction
34,developmental-disabilities,hyperactive behavior,0.02472,finding
34,developmental-disabilities,fluoxetine,0.02472,organic chemical - pharmacologic substance
34,developmental-disabilities,active brand of pseudoephedrine-triprolidine,0.02472,organic chemical - pharmacologic substance
34,developmental-disabilities,pregnancy tests,0.02472,diagnostic procedure
34,developmental-disabilities,psychotic disorders,0.02247,mental or behavioral dysfunction
34,developmental-disabilities,hearing examination finding,0.02247,finding
34,developmental-disabilities,schizophrenia,0.02247,mental or behavioral dysfunction
34,developmental-disabilities,relate - vinyl resin,0.02247,organic chemical
34,developmental-disabilities,anticonvulsants,0.02247,pharmacologic substance
34,developmental-disabilities,hypersensitivity,0.02247,clinical attribute - finding - pathologic function
34,developmental-disabilities,blind vision,0.02022,disease or syndrome
34,developmental-disabilities,positive finding,0.01798,finding
34,developmental-disabilities,gravidity,0.01798,finding
34,developmental-disabilities,bipolar disorder,0.01573,mental or behavioral dysfunction
34,developmental-disabilities,mood disorders,0.01573,mental or behavioral dysfunction
34,developmental-disabilities,aggressive behavior,0.01573,mental or behavioral dysfunction
34,developmental-disabilities,behavior therapy,0.01573,therapeutic or preventive procedure
34,developmental-disabilities,stimulant,0.01573,pharmacologic substance
34,developmental-disabilities,follow-up status,0.01573,finding
34,developmental-disabilities,treatment-psychosocial effects,0.01348,finding
34,developmental-disabilities,serum,0.01348,biologically active substance - body substance - pharmacologic substance
34,developmental-disabilities,sexually active,0.01348,finding
34,developmental-disabilities,depressed mood,0.01348,finding - mental or behavioral dysfunction
34,developmental-disabilities,electrocardiogram,0.01124,diagnostic procedure - finding - organic chemical - pharmacologic substance
34,developmental-disabilities,unstable status,0.01124,finding
34,developmental-disabilities,schizoaffective disorder,0.00899,mental or behavioral dysfunction
34,developmental-disabilities,magnetic resonance imaging,0.00899,diagnostic procedure
34,developmental-disabilities,personal satisfaction,0.00899,finding
34,developmental-disabilities,congenital abnormality,0.00899,congenital abnormality - disease or syndrome
34,developmental-disabilities,paralysed,0.00899,finding
34,developmental-disabilities,suicidal,0.00674,finding
34,developmental-disabilities,traumatic brain injury,0.00674,disease or syndrome - injury or poisoning
34,developmental-disabilities,medical history,0.00674,finding
34,developmental-disabilities,family history,0.00674,congenital abnormality - disease or syndrome - enzyme - finding
34,developmental-disabilities,nervous system disorder,0.00674,disease or syndrome
34,developmental-disabilities,fever,0.00674,finding
34,developmental-disabilities,malignant neoplasms,0.00674,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
34,developmental-disabilities,kidney diseases,0.00449,disease or syndrome
34,developmental-disabilities,nervousness,0.00449,sign or symptom
34,developmental-disabilities,injury wounds,0.00449,body substance - injury or poisoning
34,developmental-disabilities,heart diseases,0.00449,disease or syndrome
34,developmental-disabilities,neurological observations,0.00449,finding
34,developmental-disabilities,therapeutic brand of coal tar,0.00449,organic chemical - pharmacologic substance - therapeutic or preventive procedure
34,developmental-disabilities,diagnosis psychiatric,0.00449,mental or behavioral dysfunction
34,developmental-disabilities,hepatic,0.00225,body location or region
34,developmental-disabilities,ethanol,0.00225,organic chemical - pharmacologic substance
34,developmental-disabilities,brain injuries,0.00225,injury or poisoning
34,developmental-disabilities,antidepressive agents,0.00225,pharmacologic substance
34,developmental-disabilities,major depressive disorder,0.00225,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,contraceptive methods,0.34667,therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,contraception barrier,0.22667,therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,operative surgical procedures,0.21333,diagnostic procedure - therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,sterility,0.2,pathologic function
35,disorders-of-excessive-somnolence,personal satisfaction,0.2,finding
35,disorders-of-excessive-somnolence,spermatocidal agents,0.2,pharmacologic substance
35,disorders-of-excessive-somnolence,physical assessment findings,0.18667,finding
35,disorders-of-excessive-somnolence,pharmacologic substance,0.17333,pharmacologic substance - therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,electrocardiogram,0.17333,diagnostic procedure - finding - organic chemical - pharmacologic substance
35,disorders-of-excessive-somnolence,serum,0.16,biologically active substance - body substance - pharmacologic substance
35,disorders-of-excessive-somnolence,ethanol,0.13333,organic chemical - pharmacologic substance
35,disorders-of-excessive-somnolence,negative finding,0.13333,finding
35,disorders-of-excessive-somnolence,pregnancy tests,0.12,diagnostic procedure
35,disorders-of-excessive-somnolence,integumentary scale,0.10667,body part, organ, or organ component
35,disorders-of-excessive-somnolence,positive finding,0.10667,finding
35,disorders-of-excessive-somnolence,screening for cancer,0.09333,diagnostic procedure
35,disorders-of-excessive-somnolence,relate - vinyl resin,0.08,organic chemical
35,disorders-of-excessive-somnolence,active brand of pseudoephedrine-triprolidine,0.08,organic chemical - pharmacologic substance
35,disorders-of-excessive-somnolence,intravenous infusion procedures,0.08,therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,hypertensive disease,0.08,biologically active substance - disease or syndrome - finding
35,disorders-of-excessive-somnolence,sexually active,0.08,finding
35,disorders-of-excessive-somnolence,stimulant,0.08,pharmacologic substance
35,disorders-of-excessive-somnolence,mental disorders,0.08,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,treatment protocols,0.06667,therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,illicit drugs,0.06667,hazardous or poisonous substance - pharmacologic substance
35,disorders-of-excessive-somnolence,pharmaceutical preparations,0.06667,pharmacologic substance
35,disorders-of-excessive-somnolence,mass of body structure,0.06667,finding
35,disorders-of-excessive-somnolence,blood pressure finding,0.05333,finding
35,disorders-of-excessive-somnolence,traumatic brain injury,0.05333,disease or syndrome - injury or poisoning
35,disorders-of-excessive-somnolence,sleeplessness,0.05333,finding - sign or symptom
35,disorders-of-excessive-somnolence,selective serotonin re-uptake inhibitor,0.05333,pharmacologic substance
35,disorders-of-excessive-somnolence,moderate adverse event,0.05333,finding
35,disorders-of-excessive-somnolence,gravidity,0.05333,finding
35,disorders-of-excessive-somnolence,blind vision,0.05333,disease or syndrome
35,disorders-of-excessive-somnolence,major depressive disorder,0.05333,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,multiple endocrine neoplasia,0.05333,antibiotic - neoplastic process - organic chemical
35,disorders-of-excessive-somnolence,benzodiazepines,0.04,organic chemical - pharmacologic substance
35,disorders-of-excessive-somnolence,neoplasm metastasis,0.04,neoplastic process
35,disorders-of-excessive-somnolence,body mass index,0.04,clinical attribute - diagnostic procedure
35,disorders-of-excessive-somnolence,infantile neuroaxonal dystrophy,0.04,disease or syndrome
35,disorders-of-excessive-somnolence,caffeine,0.04,organic chemical - pharmacologic substance - therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,craniocerebral trauma,0.04,injury or poisoning
35,disorders-of-excessive-somnolence,limb structure,0.04,body part, organ, or organ component
35,disorders-of-excessive-somnolence,allergy severity - severe,0.04,finding
35,disorders-of-excessive-somnolence,mild adverse event,0.04,finding
35,disorders-of-excessive-somnolence,observation of attack,0.04,finding
35,disorders-of-excessive-somnolence,contraceptives oral,0.04,pharmacologic substance - therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,mini-mental status exam,0.04,diagnostic procedure
35,disorders-of-excessive-somnolence,depressed mood,0.04,finding - mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,epilepsy,0.02667,disease or syndrome
35,disorders-of-excessive-somnolence,substance abuse problem,0.02667,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,breast,0.02667,body part, organ, or organ component
35,disorders-of-excessive-somnolence,movement disorders,0.02667,disease or syndrome
35,disorders-of-excessive-somnolence,drugs non-prescription,0.02667,pharmacologic substance - therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,anticonvulsants,0.02667,pharmacologic substance
35,disorders-of-excessive-somnolence,depressive symptoms,0.02667,sign or symptom
35,disorders-of-excessive-somnolence,unstable status,0.02667,finding
35,disorders-of-excessive-somnolence,counter brand of terbufos,0.02667,hazardous or poisonous substance
35,disorders-of-excessive-somnolence,consumption-archaic term for tb,0.02667,disease or syndrome
35,disorders-of-excessive-somnolence,investigational new drugs,0.02667,pharmacologic substance - therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,injury wounds,0.02667,body substance - injury or poisoning
35,disorders-of-excessive-somnolence,narcotics,0.02667,biologically active substance - hazardous or poisonous substance - pharmacologic substance
35,disorders-of-excessive-somnolence,cerebrovascular accident,0.02667,disease or syndrome - therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,drug abuse,0.02667,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,alcohol abuse,0.02667,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,suicidal,0.01333,finding
35,disorders-of-excessive-somnolence,hypothyroidism,0.01333,disease or syndrome
35,disorders-of-excessive-somnolence,smoking,0.01333,hazardous or poisonous substance - individual behavior
35,disorders-of-excessive-somnolence,restless legs syndrome,0.01333,disease or syndrome
35,disorders-of-excessive-somnolence,nervousness,0.01333,sign or symptom
35,disorders-of-excessive-somnolence,anxiety disorders,0.01333,finding - mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,psychotic disorders,0.01333,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,schizophrenia,0.01333,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,fever,0.01333,finding
35,disorders-of-excessive-somnolence,bipolar disorder,0.01333,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,leg,0.01333,body location or region
35,disorders-of-excessive-somnolence,psychotropic drugs,0.01333,pharmacologic substance
35,disorders-of-excessive-somnolence,unconscious state,0.01333,disease or syndrome - finding
35,disorders-of-excessive-somnolence,heart diseases,0.01333,disease or syndrome
35,disorders-of-excessive-somnolence,unipolar depression,0.01333,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,atypia morphology,0.01333,finding
35,disorders-of-excessive-somnolence,cardiac arrhythmia,0.01333,finding - pathologic function
35,disorders-of-excessive-somnolence,consciousness related finding,0.01333,finding
35,disorders-of-excessive-somnolence,monoamine oxidase inhibitors,0.01333,organic chemical - pharmacologic substance
35,disorders-of-excessive-somnolence,agitation,0.01333,finding - sign or symptom
35,disorders-of-excessive-somnolence,brain injuries,0.01333,injury or poisoning
35,disorders-of-excessive-somnolence,dementia,0.01333,mental or behavioral dysfunction
35,disorders-of-excessive-somnolence,neurological observations,0.01333,finding
35,disorders-of-excessive-somnolence,nervous system disorder,0.01333,disease or syndrome
35,disorders-of-excessive-somnolence,diastole,0.01333,clinical attribute
35,disorders-of-excessive-somnolence,malignant neoplasms,0.01333,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
35,disorders-of-excessive-somnolence,paralysed,0.01333,finding
36,disorders-of-sex-development,gene therapy,0.09091,therapeutic or preventive procedure
36,disorders-of-sex-development,negative finding,0.08612,finding
36,disorders-of-sex-development,positive finding,0.08612,finding
36,disorders-of-sex-development,skeletal bone,0.07177,body location or region - body part, organ, or organ component - body substance - disease or syndrome
36,disorders-of-sex-development,serum,0.07177,biologically active substance - body substance - pharmacologic substance
36,disorders-of-sex-development,contraceptive methods,0.05742,therapeutic or preventive procedure
36,disorders-of-sex-development,gravidity,0.05742,finding
36,disorders-of-sex-development,thyroid gland,0.05263,body part, organ, or organ component - disease or syndrome - pharmacologic substance
36,disorders-of-sex-development,body mass index,0.05263,clinical attribute - diagnostic procedure
36,disorders-of-sex-development,pregnancy tests,0.04785,diagnostic procedure
36,disorders-of-sex-development,multiple endocrine neoplasia,0.04785,antibiotic - neoplastic process - organic chemical
36,disorders-of-sex-development,pregnancy test negative,0.03828,finding - laboratory or test result
36,disorders-of-sex-development,sexual intercourse - finding,0.03349,finding
36,disorders-of-sex-development,physical assessment findings,0.03349,finding
36,disorders-of-sex-development,follow-up status,0.03349,finding
36,disorders-of-sex-development,mass of body structure,0.03349,finding
36,disorders-of-sex-development,active brand of pseudoephedrine-triprolidine,0.02871,organic chemical - pharmacologic substance
36,disorders-of-sex-development,allergy severity - severe,0.02871,finding
36,disorders-of-sex-development,pharmacologic substance,0.02392,pharmacologic substance - therapeutic or preventive procedure
36,disorders-of-sex-development,magnetic resonance imaging,0.02392,diagnostic procedure
36,disorders-of-sex-development,congenital abnormality,0.01914,congenital abnormality - disease or syndrome
36,disorders-of-sex-development,blood pressure finding,0.01435,finding
36,disorders-of-sex-development,intravenous infusion procedures,0.01435,therapeutic or preventive procedure
36,disorders-of-sex-development,aspartate transaminase,0.01435,enzyme
36,disorders-of-sex-development,pharmaceutical preparations,0.01435,pharmacologic substance
36,disorders-of-sex-development,obesity,0.01435,disease or syndrome - finding
36,disorders-of-sex-development,alanine transaminase,0.01435,congenital abnormality - disease or syndrome - enzyme
36,disorders-of-sex-development,transaminases,0.00957,enzyme
36,disorders-of-sex-development,insulin,0.00957,pharmacologic substance
36,disorders-of-sex-development,mental disorders,0.00957,mental or behavioral dysfunction
36,disorders-of-sex-development,chronic disease,0.00957,disease or syndrome
36,disorders-of-sex-development,kidney diseases,0.00478,disease or syndrome
36,disorders-of-sex-development,diabetes mellitus,0.00478,disease or syndrome - pharmacologic substance
36,disorders-of-sex-development,hypothyroidism,0.00478,disease or syndrome
36,disorders-of-sex-development,liver diseases,0.00478,disease or syndrome
36,disorders-of-sex-development,malignant neoplasms,0.00478,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
36,disorders-of-sex-development,oral contraception,0.00478,pharmacologic substance - therapeutic or preventive procedure
36,disorders-of-sex-development,contraceptives oral,0.00478,pharmacologic substance - therapeutic or preventive procedure
36,disorders-of-sex-development,lung,0.00478,body part, organ, or organ component - disease or syndrome
37,dissociative-disorders,operative surgical procedures,0.10938,diagnostic procedure - therapeutic or preventive procedure
37,dissociative-disorders,relate - vinyl resin,0.07812,organic chemical
37,dissociative-disorders,intravenous infusion procedures,0.0625,therapeutic or preventive procedure
37,dissociative-disorders,follow-up status,0.0625,finding
37,dissociative-disorders,neoplasm metastasis,0.0625,neoplastic process
37,dissociative-disorders,unmarried,0.04688,finding
37,dissociative-disorders,negative finding,0.04688,finding
37,dissociative-disorders,post-traumatic stress disorder,0.04688,mental or behavioral dysfunction
37,dissociative-disorders,movement disorders,0.04688,disease or syndrome
37,dissociative-disorders,stress disorders traumatic,0.03125,mental or behavioral dysfunction
37,dissociative-disorders,active brand of pseudoephedrine-triprolidine,0.03125,organic chemical - pharmacologic substance
37,dissociative-disorders,borderline personality disorder,0.03125,disease or syndrome - mental or behavioral dysfunction
37,dissociative-disorders,positive finding,0.03125,finding
37,dissociative-disorders,blood vessel,0.01562,body part, organ, or organ component - finding
37,dissociative-disorders,depressed mood,0.01562,finding - mental or behavioral dysfunction
37,dissociative-disorders,moderate adverse event,0.01562,finding
37,dissociative-disorders,pregnancy tests,0.01562,diagnostic procedure
37,dissociative-disorders,schizophrenia,0.01562,mental or behavioral dysfunction
37,dissociative-disorders,psychotic disorders,0.01562,mental or behavioral dysfunction
37,dissociative-disorders,allergy severity - severe,0.01562,finding
37,dissociative-disorders,epilepsy,0.01562,disease or syndrome
37,dissociative-disorders,adrenal cortex hormones,0.01562,pharmacologic substance
37,dissociative-disorders,antipsychotic agents,0.01562,pharmacologic substance
37,dissociative-disorders,personality disorders,0.01562,mental or behavioral dysfunction
37,dissociative-disorders,physical assessment findings,0.01562,finding
37,dissociative-disorders,anxiety disorders,0.01562,finding - mental or behavioral dysfunction
37,dissociative-disorders,pharmacologic substance,0.01562,pharmacologic substance - therapeutic or preventive procedure
37,dissociative-disorders,psychotropic drugs,0.01562,pharmacologic substance
37,dissociative-disorders,ethanol,0.01562,organic chemical - pharmacologic substance
37,dissociative-disorders,contraceptive methods,0.01562,therapeutic or preventive procedure
37,dissociative-disorders,mental disorders,0.01562,mental or behavioral dysfunction
38,drinking-behavior,ethanol,0.57604,organic chemical - pharmacologic substance
38,drinking-behavior,alcohol consumption,0.24885,individual behavior
38,drinking-behavior,multiple endocrine neoplasia,0.1659,antibiotic - neoplastic process - organic chemical
38,drinking-behavior,intravenous infusion procedures,0.16129,therapeutic or preventive procedure
38,drinking-behavior,alcoholic intoxication chronic,0.13825,mental or behavioral dysfunction
38,drinking-behavior,contraceptive methods,0.09677,therapeutic or preventive procedure
38,drinking-behavior,alcohol abuse,0.09677,mental or behavioral dysfunction
38,drinking-behavior,consumption-archaic term for tb,0.09677,disease or syndrome
38,drinking-behavior,physical assessment findings,0.06452,finding
38,drinking-behavior,relate - vinyl resin,0.05991,organic chemical
38,drinking-behavior,negative finding,0.0553,finding
38,drinking-behavior,moderate adverse event,0.05069,finding
38,drinking-behavior,pregnancy tests,0.05069,diagnostic procedure
38,drinking-behavior,follow-up status,0.05069,finding
38,drinking-behavior,active brand of pseudoephedrine-triprolidine,0.05069,organic chemical - pharmacologic substance
38,drinking-behavior,body mass index,0.05069,clinical attribute - diagnostic procedure
38,drinking-behavior,electrocardiogram,0.04608,diagnostic procedure - finding - organic chemical - pharmacologic substance
38,drinking-behavior,pharmacologic substance,0.04608,pharmacologic substance - therapeutic or preventive procedure
38,drinking-behavior,positive finding,0.04608,finding
38,drinking-behavior,post-traumatic stress disorder,0.03687,mental or behavioral dysfunction
38,drinking-behavior,mass of body structure,0.03687,finding
38,drinking-behavior,hiv,0.03687,disease or syndrome - pharmacologic substance - virus
38,drinking-behavior,smoker,0.03687,finding
38,drinking-behavior,medical history,0.03226,finding
38,drinking-behavior,gravidity,0.03226,finding
38,drinking-behavior,anxiety disorders,0.03226,finding - mental or behavioral dysfunction
38,drinking-behavior,contraceptives oral,0.03226,pharmacologic substance - therapeutic or preventive procedure
38,drinking-behavior,impaired cognition,0.03226,finding - mental or behavioral dysfunction
38,drinking-behavior,sexually active,0.02765,finding
38,drinking-behavior,screening for cancer,0.02765,diagnostic procedure
38,drinking-behavior,operative surgical procedures,0.02765,diagnostic procedure - therapeutic or preventive procedure
38,drinking-behavior,substance use disorders,0.02304,mental or behavioral dysfunction
38,drinking-behavior,marihuana,0.02304,mental or behavioral dysfunction - organic chemical - pharmacologic substance
38,drinking-behavior,smoking,0.02304,hazardous or poisonous substance - individual behavior
38,drinking-behavior,valproic acid,0.02304,body part, organ, or organ component - organic chemical - pharmacologic substance
38,drinking-behavior,mental disorders,0.02304,mental or behavioral dysfunction
38,drinking-behavior,detoxification procedure,0.01843,therapeutic or preventive procedure
38,drinking-behavior,serum,0.01843,biologically active substance - body substance - pharmacologic substance
38,drinking-behavior,substance abuse problem,0.01843,mental or behavioral dysfunction
38,drinking-behavior,pharmaceutical preparations,0.01843,pharmacologic substance
38,drinking-behavior,depressed mood,0.01843,finding - mental or behavioral dysfunction
38,drinking-behavior,unipolar depression,0.01382,mental or behavioral dysfunction
38,drinking-behavior,allergy severity - severe,0.01382,finding
38,drinking-behavior,infantile neuroaxonal dystrophy,0.01382,disease or syndrome
38,drinking-behavior,injury wounds,0.01382,body substance - injury or poisoning
38,drinking-behavior,bipolar disorder,0.01382,mental or behavioral dysfunction
38,drinking-behavior,major depressive disorder,0.00922,mental or behavioral dysfunction
38,drinking-behavior,liver diseases,0.00922,disease or syndrome
38,drinking-behavior,opiates,0.00922,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
38,drinking-behavior,manic,0.00922,finding - mental or behavioral dysfunction
38,drinking-behavior,opioids,0.00922,hazardous or poisonous substance - organic chemical - pharmacologic substance
38,drinking-behavior,caffeine,0.00461,organic chemical - pharmacologic substance - therapeutic or preventive procedure
38,drinking-behavior,schizophrenia,0.00461,mental or behavioral dysfunction
38,drinking-behavior,psychotropic drugs,0.00461,pharmacologic substance
38,drinking-behavior,antidepressive agents,0.00461,pharmacologic substance
38,drinking-behavior,substance dependence,0.00461,mental or behavioral dysfunction
38,drinking-behavior,antipsychotic agents,0.00461,pharmacologic substance
38,drinking-behavior,drug dependence,0.00461,mental or behavioral dysfunction
38,drinking-behavior,personality disorders,0.00461,mental or behavioral dysfunction
38,drinking-behavior,hypersensitivity,0.00461,clinical attribute - finding - pathologic function
38,drinking-behavior,alanine transaminase,0.00461,congenital abnormality - disease or syndrome - enzyme
38,drinking-behavior,schizoaffective disorder,0.00461,mental or behavioral dysfunction
38,drinking-behavior,nicotine dependence,0.00461,mental or behavioral dysfunction
38,drinking-behavior,borderline personality disorder,0.00461,disease or syndrome - mental or behavioral dysfunction
38,drinking-behavior,eating disorders,0.00461,mental or behavioral dysfunction
38,drinking-behavior,hepatic,0.00461,body location or region
39,dyssomnias,sleeplessness,0.18636,finding - sign or symptom
39,dyssomnias,body mass index,0.1295,clinical attribute - diagnostic procedure
39,dyssomnias,intravenous infusion procedures,0.08465,therapeutic or preventive procedure
39,dyssomnias,moderate adverse event,0.07896,finding
39,dyssomnias,contraceptive methods,0.07328,therapeutic or preventive procedure
39,dyssomnias,mass of body structure,0.07328,finding
39,dyssomnias,restless legs syndrome,0.06633,disease or syndrome
39,dyssomnias,allergy severity - severe,0.05559,finding
39,dyssomnias,physical assessment findings,0.05306,finding
39,dyssomnias,hypertensive disease,0.04359,biologically active substance - disease or syndrome - finding
39,dyssomnias,pharmacologic substance,0.04232,pharmacologic substance - therapeutic or preventive procedure
39,dyssomnias,negative finding,0.04232,finding
39,dyssomnias,multiple endocrine neoplasia,0.04232,antibiotic - neoplastic process - organic chemical
39,dyssomnias,leg,0.03917,body location or region
39,dyssomnias,operative surgical procedures,0.0379,diagnostic procedure - therapeutic or preventive procedure
39,dyssomnias,mental disorders,0.03601,mental or behavioral dysfunction
39,dyssomnias,agitation,0.03474,finding - sign or symptom
39,dyssomnias,positive finding,0.03285,finding
39,dyssomnias,pregnancy tests,0.03285,diagnostic procedure
39,dyssomnias,gravidity,0.03222,finding
39,dyssomnias,asleep,0.03159,finding
39,dyssomnias,active brand of pseudoephedrine-triprolidine,0.03159,organic chemical - pharmacologic substance
39,dyssomnias,mild adverse event,0.03095,finding
39,dyssomnias,depressed mood,0.03095,finding - mental or behavioral dysfunction
39,dyssomnias,treatment protocols,0.0278,therapeutic or preventive procedure
39,dyssomnias,electrocardiogram,0.02653,diagnostic procedure - finding - organic chemical - pharmacologic substance
39,dyssomnias,malignant neoplasms,0.02653,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
39,dyssomnias,relate - vinyl resin,0.02464,organic chemical
39,dyssomnias,medical history,0.02274,finding
39,dyssomnias,ethanol,0.02211,organic chemical - pharmacologic substance
39,dyssomnias,pharmacotherapy,0.02085,therapeutic or preventive procedure
39,dyssomnias,pharmaceutical preparations,0.02021,pharmacologic substance
39,dyssomnias,serum,0.02021,biologically active substance - body substance - pharmacologic substance
39,dyssomnias,obesity,0.01895,disease or syndrome - finding
39,dyssomnias,cerebrovascular accident,0.01895,disease or syndrome - therapeutic or preventive procedure
39,dyssomnias,post-traumatic stress disorder,0.01706,mental or behavioral dysfunction
39,dyssomnias,arteries,0.01516,body part, organ, or organ component
39,dyssomnias,major depressive disorder,0.01516,mental or behavioral dysfunction
39,dyssomnias,blood pressure finding,0.01453,finding
39,dyssomnias,psychotropic drugs,0.0139,pharmacologic substance
39,dyssomnias,benzodiazepines,0.01327,organic chemical - pharmacologic substance
39,dyssomnias,neoplasm metastasis,0.01327,neoplastic process
39,dyssomnias,anxiety disorders,0.01263,finding - mental or behavioral dysfunction
39,dyssomnias,chronic obstructive airway disease,0.01074,disease or syndrome
39,dyssomnias,limb structure,0.01074,body part, organ, or organ component
39,dyssomnias,antidepressive agents,0.01074,pharmacologic substance
39,dyssomnias,screening for cancer,0.00948,diagnostic procedure
39,dyssomnias,unipolar depression,0.00884,mental or behavioral dysfunction
39,dyssomnias,heart ventricle,0.00821,body part, organ, or organ component
39,dyssomnias,exercise pain management,0.00821,therapeutic or preventive procedure
39,dyssomnias,caffeine,0.00758,organic chemical - pharmacologic substance - therapeutic or preventive procedure
39,dyssomnias,systolic pressure,0.00695,clinical attribute - diagnostic procedure
39,dyssomnias,injury wounds,0.00695,body substance - injury or poisoning
39,dyssomnias,smoking,0.00695,hazardous or poisonous substance - individual behavior
39,dyssomnias,opioids,0.00695,hazardous or poisonous substance - organic chemical - pharmacologic substance
39,dyssomnias,dementia,0.00695,mental or behavioral dysfunction
39,dyssomnias,congestive heart failure,0.00632,congenital abnormality - disease or syndrome
39,dyssomnias,impaired cognition,0.00632,finding - mental or behavioral dysfunction
39,dyssomnias,consumption-archaic term for tb,0.00632,disease or syndrome
39,dyssomnias,epilepsy,0.00569,disease or syndrome
39,dyssomnias,bipolar disorder,0.00569,mental or behavioral dysfunction
39,dyssomnias,antipsychotic agents,0.00569,pharmacologic substance
39,dyssomnias,stimulant,0.00569,pharmacologic substance
39,dyssomnias,hypersensitivity,0.00569,clinical attribute - finding - pathologic function
39,dyssomnias,diabetes mellitus,0.00505,disease or syndrome - pharmacologic substance
39,dyssomnias,asthma,0.00505,disease or syndrome
39,dyssomnias,household composition,0.00505,finding
39,dyssomnias,movement disorders,0.00505,disease or syndrome
39,dyssomnias,congenital abnormality,0.00505,congenital abnormality - disease or syndrome
39,dyssomnias,schizophrenia,0.00505,mental or behavioral dysfunction
39,dyssomnias,unstable status,0.00505,finding
39,dyssomnias,breast,0.00505,body part, organ, or organ component
39,dyssomnias,substance abuse problem,0.00442,mental or behavioral dysfunction
39,dyssomnias,cardiovascular diseases,0.00442,disease or syndrome
39,dyssomnias,psychotic disorders,0.00379,mental or behavioral dysfunction
39,dyssomnias,myocardial infarction,0.00379,disease or syndrome - finding
39,dyssomnias,heart diseases,0.00379,disease or syndrome
39,dyssomnias,drug abuse,0.00379,mental or behavioral dysfunction
39,dyssomnias,suicidal,0.00316,finding
39,dyssomnias,hepatic,0.00316,body location or region
39,dyssomnias,angina pectoris,0.00316,sign or symptom
39,dyssomnias,investigational new drugs,0.00316,pharmacologic substance - therapeutic or preventive procedure
39,dyssomnias,kidney diseases,0.00253,disease or syndrome
39,dyssomnias,narcotics,0.00253,biologically active substance - hazardous or poisonous substance - pharmacologic substance
39,dyssomnias,craniocerebral trauma,0.0019,injury or poisoning
39,dyssomnias,nervousness,0.0019,sign or symptom
39,dyssomnias,alcohol abuse,0.0019,mental or behavioral dysfunction
39,dyssomnias,drugs non-prescription,0.0019,pharmacologic substance - therapeutic or preventive procedure
39,dyssomnias,counter brand of terbufos,0.0019,hazardous or poisonous substance
39,dyssomnias,neurological observations,0.0019,finding
39,dyssomnias,nervous system disorder,0.0019,disease or syndrome
39,dyssomnias,cardiac arrhythmia,0.0019,finding - pathologic function
39,dyssomnias,chronic disease,0.0019,disease or syndrome
39,dyssomnias,anti-anxiety agents,0.00126,pharmacologic substance
39,dyssomnias,anticonvulsants,0.00126,pharmacologic substance
39,dyssomnias,angina unstable,0.00126,disease or syndrome
39,dyssomnias,liver diseases,0.00063,disease or syndrome
40,dysthymic-disorder,dysthymic disorder,0.69697,mental or behavioral dysfunction
40,dysthymic-disorder,intravenous infusion procedures,0.48485,therapeutic or preventive procedure
40,dysthymic-disorder,major depressive disorder,0.42424,mental or behavioral dysfunction
40,dysthymic-disorder,unipolar depression,0.33333,mental or behavioral dysfunction
40,dysthymic-disorder,anxiety disorders,0.13636,finding - mental or behavioral dysfunction
40,dysthymic-disorder,nitric oxide synthase,0.13636,enzyme
40,dysthymic-disorder,contraceptive methods,0.09091,therapeutic or preventive procedure
40,dysthymic-disorder,moderate adverse event,0.07576,finding
40,dysthymic-disorder,tropical spastic paraparesis,0.07576,disease or syndrome - therapeutic or preventive procedure
40,dysthymic-disorder,severe combined immunodeficiency,0.06061,diagnostic procedure - disease or syndrome
40,dysthymic-disorder,post-traumatic stress disorder,0.06061,mental or behavioral dysfunction
40,dysthymic-disorder,generalized anxiety disorder,0.06061,mental or behavioral dysfunction
40,dysthymic-disorder,personality inventories,0.06061,diagnostic procedure
40,dysthymic-disorder,negative finding,0.06061,finding
40,dysthymic-disorder,cancer remission,0.06061,finding - neoplastic process
40,dysthymic-disorder,panic disorder,0.04545,disease or syndrome - mental or behavioral dysfunction
40,dysthymic-disorder,anxiety generalized,0.04545,mental or behavioral dysfunction
40,dysthymic-disorder,obsessive-compulsive disorder,0.04545,disease or syndrome - mental or behavioral dysfunction
40,dysthymic-disorder,pregnancy tests,0.04545,diagnostic procedure
40,dysthymic-disorder,stress disorders traumatic,0.04545,mental or behavioral dysfunction
40,dysthymic-disorder,screening for cancer,0.04545,diagnostic procedure
40,dysthymic-disorder,mental disorders,0.04545,mental or behavioral dysfunction
40,dysthymic-disorder,injury wounds,0.0303,body substance - injury or poisoning
40,dysthymic-disorder,gravidity,0.0303,finding
40,dysthymic-disorder,pregnancy test negative,0.0303,finding - laboratory or test result
40,dysthymic-disorder,substance use disorders,0.0303,mental or behavioral dysfunction
40,dysthymic-disorder,phobia social,0.0303,mental or behavioral dysfunction
40,dysthymic-disorder,depressive episode unspecified,0.0303,mental or behavioral dysfunction
40,dysthymic-disorder,sexual intercourse - finding,0.0303,finding
40,dysthymic-disorder,benzodiazepines,0.0303,organic chemical - pharmacologic substance
40,dysthymic-disorder,follow-up status,0.0303,finding
40,dysthymic-disorder,mood disorders,0.0303,mental or behavioral dysfunction
40,dysthymic-disorder,pharmacologic substance,0.0303,pharmacologic substance - therapeutic or preventive procedure
40,dysthymic-disorder,ethanol,0.0303,organic chemical - pharmacologic substance
40,dysthymic-disorder,magnetic resonance imaging,0.0303,diagnostic procedure
40,dysthymic-disorder,selective serotonin re-uptake inhibitor,0.0303,pharmacologic substance
40,dysthymic-disorder,positive finding,0.0303,finding
40,dysthymic-disorder,bipolar disorder,0.01515,mental or behavioral dysfunction
40,dysthymic-disorder,illicit drugs,0.01515,hazardous or poisonous substance - pharmacologic substance
40,dysthymic-disorder,medical history,0.01515,finding
40,dysthymic-disorder,dementia,0.01515,mental or behavioral dysfunction
40,dysthymic-disorder,compulsive disorder,0.01515,finding
40,dysthymic-disorder,psychotherapy,0.01515,therapeutic or preventive procedure
40,dysthymic-disorder,electrocardiogram,0.01515,diagnostic procedure - finding - organic chemical - pharmacologic substance
40,dysthymic-disorder,suicide attempt,0.01515,finding - mental or behavioral dysfunction
40,dysthymic-disorder,hearing examination finding,0.01515,finding
40,dysthymic-disorder,substance dependence,0.01515,mental or behavioral dysfunction
40,dysthymic-disorder,serum,0.01515,biologically active substance - body substance - pharmacologic substance
40,dysthymic-disorder,borderline personality disorder,0.01515,disease or syndrome - mental or behavioral dysfunction
40,dysthymic-disorder,personality disorders,0.01515,mental or behavioral dysfunction
40,dysthymic-disorder,lithium,0.01515,congenital abnormality - disease or syndrome - pharmacologic substance
40,dysthymic-disorder,pharmaceutical preparations,0.01515,pharmacologic substance
40,dysthymic-disorder,mercury,0.01515,hazardous or poisonous substance
40,dysthymic-disorder,fluoxetine,0.01515,organic chemical - pharmacologic substance
40,dysthymic-disorder,active brand of pseudoephedrine-triprolidine,0.01515,organic chemical - pharmacologic substance
40,dysthymic-disorder,physical assessment findings,0.01515,finding
40,dysthymic-disorder,alcoholic intoxication chronic,0.01515,mental or behavioral dysfunction
40,dysthymic-disorder,schizoaffective disorder,0.01515,mental or behavioral dysfunction
40,dysthymic-disorder,allergy severity - severe,0.01515,finding
40,dysthymic-disorder,therapeutic brand of coal tar,0.01515,organic chemical - pharmacologic substance - therapeutic or preventive procedure
40,dysthymic-disorder,malignant neoplasms,0.01515,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
40,dysthymic-disorder,impaired cognition,0.01515,finding - mental or behavioral dysfunction
40,dysthymic-disorder,infantile neuroaxonal dystrophy,0.01515,disease or syndrome
40,dysthymic-disorder,unstable status,0.01515,finding
41,eating-disorders,body mass index,0.41739,clinical attribute - diagnostic procedure
41,eating-disorders,intravenous infusion procedures,0.21739,therapeutic or preventive procedure
41,eating-disorders,eating disorders,0.17391,mental or behavioral dysfunction
41,eating-disorders,mass of body structure,0.16522,finding
41,eating-disorders,obesity,0.08478,disease or syndrome - finding
41,eating-disorders,weighing patient,0.06739,diagnostic procedure - finding
41,eating-disorders,mental disorders,0.06304,mental or behavioral dysfunction
41,eating-disorders,physical assessment findings,0.05652,finding
41,eating-disorders,multiple endocrine neoplasia,0.05217,antibiotic - neoplastic process - organic chemical
41,eating-disorders,contraceptive methods,0.04348,therapeutic or preventive procedure
41,eating-disorders,negative finding,0.03478,finding
41,eating-disorders,gravidity,0.03043,finding
41,eating-disorders,malignant neoplasms,0.03043,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
41,eating-disorders,insulin,0.02609,pharmacologic substance
41,eating-disorders,moderate adverse event,0.02391,finding
41,eating-disorders,active brand of pseudoephedrine-triprolidine,0.02391,organic chemical - pharmacologic substance
41,eating-disorders,sexual intercourse - finding,0.02391,finding
41,eating-disorders,pregnancy tests,0.02391,diagnostic procedure
41,eating-disorders,depressed mood,0.02391,finding - mental or behavioral dysfunction
41,eating-disorders,smoker,0.02391,finding
41,eating-disorders,smoking,0.02174,hazardous or poisonous substance - individual behavior
41,eating-disorders,psychotropic drugs,0.01957,pharmacologic substance
41,eating-disorders,blood pressure finding,0.01957,finding
41,eating-disorders,operative surgical procedures,0.01739,diagnostic procedure - therapeutic or preventive procedure
41,eating-disorders,medical history,0.01739,finding
41,eating-disorders,allergy severity - severe,0.01739,finding
41,eating-disorders,anxiety disorders,0.01522,finding - mental or behavioral dysfunction
41,eating-disorders,ethanol,0.01522,organic chemical - pharmacologic substance
41,eating-disorders,unipolar depression,0.01304,mental or behavioral dysfunction
41,eating-disorders,pregnancy test negative,0.01304,finding - laboratory or test result
41,eating-disorders,psychotherapy,0.01304,therapeutic or preventive procedure
41,eating-disorders,hypertensive disease,0.01304,biologically active substance - disease or syndrome - finding
41,eating-disorders,psychotic disorders,0.01087,mental or behavioral dysfunction
41,eating-disorders,psychiatric problem,0.01087,mental or behavioral dysfunction
41,eating-disorders,positive finding,0.01087,finding
41,eating-disorders,schizophrenia,0.01087,mental or behavioral dysfunction
41,eating-disorders,thyroid gland,0.01087,body part, organ, or organ component - disease or syndrome - pharmacologic substance
41,eating-disorders,contraceptives oral,0.01087,pharmacologic substance - therapeutic or preventive procedure
41,eating-disorders,hypersensitivity,0.01087,clinical attribute - finding - pathologic function
41,eating-disorders,skeletal bone,0.0087,body location or region - body part, organ, or organ component - body substance - disease or syndrome
41,eating-disorders,personality disorders,0.0087,mental or behavioral dysfunction
41,eating-disorders,infantile neuroaxonal dystrophy,0.0087,disease or syndrome
41,eating-disorders,antipsychotic agents,0.0087,pharmacologic substance
41,eating-disorders,exercise pain management,0.0087,therapeutic or preventive procedure
41,eating-disorders,antidepressive agents,0.0087,pharmacologic substance
41,eating-disorders,chronic disease,0.0087,disease or syndrome
41,eating-disorders,substance abuse problem,0.00652,mental or behavioral dysfunction
41,eating-disorders,pharmacologic substance,0.00652,pharmacologic substance - therapeutic or preventive procedure
41,eating-disorders,hepatic,0.00652,body location or region
41,eating-disorders,bipolar disorder,0.00652,mental or behavioral dysfunction
41,eating-disorders,pharmaceutical preparations,0.00652,pharmacologic substance
41,eating-disorders,congenital abnormality,0.00652,congenital abnormality - disease or syndrome
41,eating-disorders,cognitive therapy,0.00652,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
41,eating-disorders,suicidal,0.00435,finding
41,eating-disorders,disability,0.00435,finding
41,eating-disorders,magnetic resonance imaging,0.00435,diagnostic procedure
41,eating-disorders,alcoholic intoxication chronic,0.00435,mental or behavioral dysfunction
41,eating-disorders,suicidality,0.00435,clinical attribute
41,eating-disorders,unstable status,0.00435,finding
41,eating-disorders,cerebrovascular accident,0.00435,disease or syndrome - therapeutic or preventive procedure
41,eating-disorders,breast,0.00435,body part, organ, or organ component
41,eating-disorders,epilepsy,0.00217,disease or syndrome
41,eating-disorders,arteries,0.00217,body part, organ, or organ component
41,eating-disorders,liver diseases,0.00217,disease or syndrome
41,eating-disorders,alcohol abuse,0.00217,mental or behavioral dysfunction
41,eating-disorders,cardiovascular diseases,0.00217,disease or syndrome
41,eating-disorders,mental retardation,0.00217,mental or behavioral dysfunction
41,eating-disorders,heart diseases,0.00217,disease or syndrome
41,eating-disorders,dementia,0.00217,mental or behavioral dysfunction
41,eating-disorders,adrenal cortex hormones,0.00217,pharmacologic substance
42,erectile-dysfunction,multiple endocrine neoplasia,0.21107,antibiotic - neoplastic process - organic chemical
42,erectile-dysfunction,malignant neoplasms,0.11073,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
42,erectile-dysfunction,body mass index,0.06574,clinical attribute - diagnostic procedure
42,erectile-dysfunction,mild adverse event,0.06574,finding
42,erectile-dysfunction,mass of body structure,0.05882,finding
42,erectile-dysfunction,active brand of pseudoephedrine-triprolidine,0.0519,organic chemical - pharmacologic substance
42,erectile-dysfunction,hypertensive disease,0.04844,biologically active substance - disease or syndrome - finding
42,erectile-dysfunction,sexually active,0.04844,finding
42,erectile-dysfunction,pharmacologic substance,0.04498,pharmacologic substance - therapeutic or preventive procedure
42,erectile-dysfunction,physical assessment findings,0.04152,finding
42,erectile-dysfunction,arteries,0.03806,body part, organ, or organ component
42,erectile-dysfunction,weighing patient,0.03806,diagnostic procedure - finding
42,erectile-dysfunction,positive finding,0.0346,finding
42,erectile-dysfunction,negative finding,0.03114,finding
42,erectile-dysfunction,blood pressure finding,0.02768,finding
42,erectile-dysfunction,moderate adverse event,0.02768,finding
42,erectile-dysfunction,pathology processes,0.02768,pathologic function
42,erectile-dysfunction,electrocardiogram,0.02768,diagnostic procedure - finding - organic chemical - pharmacologic substance
42,erectile-dysfunction,sexual intercourse - finding,0.02768,finding
42,erectile-dysfunction,follow-up status,0.02768,finding
42,erectile-dysfunction,neoplasm metastasis,0.02422,neoplastic process
42,erectile-dysfunction,medical history,0.02422,finding
42,erectile-dysfunction,pharmacotherapy,0.02076,therapeutic or preventive procedure
42,erectile-dysfunction,life expectancy,0.02076,group attribute
42,erectile-dysfunction,mental disorders,0.02076,mental or behavioral dysfunction
42,erectile-dysfunction,psychiatric problem,0.0173,mental or behavioral dysfunction
42,erectile-dysfunction,relate - vinyl resin,0.0173,organic chemical
42,erectile-dysfunction,gravidity,0.0173,finding
42,erectile-dysfunction,intravenous infusion procedures,0.0173,therapeutic or preventive procedure
42,erectile-dysfunction,operative surgical procedures,0.01384,diagnostic procedure - therapeutic or preventive procedure
42,erectile-dysfunction,allergy severity - severe,0.01384,finding
42,erectile-dysfunction,implantation procedure,0.01384,therapeutic or preventive procedure
42,erectile-dysfunction,myocardial infarction,0.01038,disease or syndrome - finding
42,erectile-dysfunction,drugs non-prescription,0.01038,pharmacologic substance - therapeutic or preventive procedure
42,erectile-dysfunction,congenital abnormality,0.01038,congenital abnormality - disease or syndrome
42,erectile-dysfunction,blood vessel,0.01038,body part, organ, or organ component - finding
42,erectile-dysfunction,mercury,0.01038,hazardous or poisonous substance
42,erectile-dysfunction,counter brand of terbufos,0.01038,hazardous or poisonous substance
42,erectile-dysfunction,blind vision,0.01038,disease or syndrome
42,erectile-dysfunction,diastole,0.01038,clinical attribute
42,erectile-dysfunction,diastolic blood pressure,0.00692,clinical attribute - diagnostic procedure - finding
42,erectile-dysfunction,bleomycin-cisplatin protocol,0.00692,therapeutic or preventive procedure
42,erectile-dysfunction,ethanol,0.00692,organic chemical - pharmacologic substance
42,erectile-dysfunction,systolic pressure,0.00692,clinical attribute - diagnostic procedure
42,erectile-dysfunction,unstable status,0.00692,finding
42,erectile-dysfunction,angina pectoris,0.00692,sign or symptom
42,erectile-dysfunction,heart rate,0.00692,clinical attribute
42,erectile-dysfunction,hypersensitivity,0.00692,clinical attribute - finding - pathologic function
42,erectile-dysfunction,kidney diseases,0.00346,disease or syndrome
42,erectile-dysfunction,alanine transaminase,0.00346,congenital abnormality - disease or syndrome - enzyme
42,erectile-dysfunction,tobacco,0.00346,hazardous or poisonous substance - organic chemical - pharmacologic substance
42,erectile-dysfunction,cardiovascular diseases,0.00346,disease or syndrome
42,erectile-dysfunction,pharmaceutical preparations,0.00346,pharmacologic substance
42,erectile-dysfunction,heart ventricle,0.00346,body part, organ, or organ component
42,erectile-dysfunction,heart diseases,0.00346,disease or syndrome
42,erectile-dysfunction,cardiac arrhythmia,0.00346,finding - pathologic function
42,erectile-dysfunction,angina unstable,0.00346,disease or syndrome
42,erectile-dysfunction,aspartate transaminase,0.00346,enzyme
42,erectile-dysfunction,depressed mood,0.00346,finding - mental or behavioral dysfunction
42,erectile-dysfunction,cerebrovascular accident,0.00346,disease or syndrome - therapeutic or preventive procedure
42,erectile-dysfunction,medical contraindication,0.00346,finding
43,food-habits,body mass index,0.34524,clinical attribute - diagnostic procedure
43,food-habits,mass of body structure,0.10714,finding
43,food-habits,physical assessment findings,0.07143,finding
43,food-habits,multiple endocrine neoplasia,0.07143,antibiotic - neoplastic process - organic chemical
43,food-habits,obesity,0.04762,disease or syndrome - finding
43,food-habits,moderate adverse event,0.03571,finding
43,food-habits,treatment protocols,0.03571,therapeutic or preventive procedure
43,food-habits,observation of attack,0.03571,finding
43,food-habits,follow-up status,0.03571,finding
43,food-habits,consumption-archaic term for tb,0.03571,disease or syndrome
43,food-habits,positive finding,0.03571,finding
43,food-habits,gravidity,0.02381,finding
43,food-habits,smoker,0.02381,finding
43,food-habits,allergy severity - severe,0.02381,finding
43,food-habits,hepatic,0.02381,body location or region
43,food-habits,hypersensitivity,0.02381,clinical attribute - finding - pathologic function
43,food-habits,active brand of pseudoephedrine-triprolidine,0.02381,organic chemical - pharmacologic substance
43,food-habits,pharmacologic substance,0.02381,pharmacologic substance - therapeutic or preventive procedure
43,food-habits,ethanol,0.02381,organic chemical - pharmacologic substance
43,food-habits,smoking,0.02381,hazardous or poisonous substance - individual behavior
43,food-habits,therapeutic brand of coal tar,0.02381,organic chemical - pharmacologic substance - therapeutic or preventive procedure
43,food-habits,malignant neoplasms,0.02381,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
43,food-habits,liver diseases,0.0119,disease or syndrome
43,food-habits,arteries,0.0119,body part, organ, or organ component
43,food-habits,life expectancy,0.0119,group attribute
43,food-habits,exercise pain management,0.0119,therapeutic or preventive procedure
43,food-habits,diastole,0.0119,clinical attribute
43,food-habits,alcohol consumption,0.0119,individual behavior
43,food-habits,neoplasm metastasis,0.0119,neoplastic process
43,food-habits,cerebrovascular accident,0.0119,disease or syndrome - therapeutic or preventive procedure
43,food-habits,operative surgical procedures,0.0119,diagnostic procedure - therapeutic or preventive procedure
43,food-habits,mental disorders,0.0119,mental or behavioral dysfunction
43,food-habits,heart diseases,0.0119,disease or syndrome
44,frontotemporal-dementia,frontotemporal dementia,0.34783,disease or syndrome
44,frontotemporal-dementia,mini-mental status exam,0.23188,diagnostic procedure
44,frontotemporal-dementia,magnetic resonance imaging,0.17391,diagnostic procedure
44,frontotemporal-dementia,dactinomycin,0.13043,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
44,frontotemporal-dementia,contraceptive methods,0.11594,therapeutic or preventive procedure
44,frontotemporal-dementia,memory observations,0.10145,finding
44,frontotemporal-dementia,pregnancy tests,0.10145,diagnostic procedure
44,frontotemporal-dementia,serum,0.08696,biologically active substance - body substance - pharmacologic substance
44,frontotemporal-dementia,treatment protocols,0.07246,therapeutic or preventive procedure
44,frontotemporal-dementia,negative finding,0.07246,finding
44,frontotemporal-dementia,relate - vinyl resin,0.07246,organic chemical
44,frontotemporal-dementia,creatinine clearance,0.05797,finding
44,frontotemporal-dementia,pharmacologic substance,0.05797,pharmacologic substance - therapeutic or preventive procedure
44,frontotemporal-dementia,personality inventories,0.05797,diagnostic procedure
44,frontotemporal-dementia,hearing examination finding,0.05797,finding
44,frontotemporal-dementia,mild adverse event,0.05797,finding
44,frontotemporal-dementia,transaminases,0.05797,enzyme
44,frontotemporal-dementia,neurological observations,0.05797,finding
44,frontotemporal-dementia,cognitive therapy,0.05797,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
44,frontotemporal-dementia,paralysed,0.05797,finding
44,frontotemporal-dementia,epilepsy,0.04348,disease or syndrome
44,frontotemporal-dementia,nervousness,0.04348,sign or symptom
44,frontotemporal-dementia,human chorionic gonadotropin,0.04348,disease or syndrome - pharmacologic substance
44,frontotemporal-dementia,hepatic,0.04348,body location or region
44,frontotemporal-dementia,cholinesterase inhibitors,0.04348,organic chemical - pharmacologic substance
44,frontotemporal-dementia,psychotropic drugs,0.04348,pharmacologic substance
44,frontotemporal-dementia,neuropsychological tests,0.04348,diagnostic procedure
44,frontotemporal-dementia,gravidity,0.04348,finding
44,frontotemporal-dementia,family history,0.04348,congenital abnormality - disease or syndrome - enzyme - finding
44,frontotemporal-dementia,intravenous infusion procedures,0.04348,therapeutic or preventive procedure
44,frontotemporal-dementia,impaired cognition,0.04348,finding - mental or behavioral dysfunction
44,frontotemporal-dementia,bilirubin,0.04348,biologically active substance - laboratory or test result - organic chemical
44,frontotemporal-dementia,kidney,0.04348,body part, organ, or organ component
44,frontotemporal-dementia,life expectancy,0.04348,group attribute
44,frontotemporal-dementia,physical assessment findings,0.04348,finding
44,frontotemporal-dementia,depressed mood,0.04348,finding - mental or behavioral dysfunction
44,frontotemporal-dementia,memantine,0.04348,organic chemical - pharmacologic substance
44,frontotemporal-dementia,multiple endocrine neoplasia,0.04348,antibiotic - neoplastic process - organic chemical
44,frontotemporal-dementia,moderate adverse event,0.02899,finding
44,frontotemporal-dementia,sterility,0.02899,pathologic function
44,frontotemporal-dementia,alanine transaminase,0.02899,congenital abnormality - disease or syndrome - enzyme
44,frontotemporal-dementia,positive finding,0.02899,finding
44,frontotemporal-dementia,alcoholic intoxication chronic,0.02899,mental or behavioral dysfunction
44,frontotemporal-dementia,pharmaceutical preparations,0.02899,pharmacologic substance
44,frontotemporal-dementia,heart ventricle,0.02899,body part, organ, or organ component
44,frontotemporal-dementia,operative surgical procedures,0.02899,diagnostic procedure - therapeutic or preventive procedure
44,frontotemporal-dementia,limb structure,0.02899,body part, organ, or organ component
44,frontotemporal-dementia,positron-emission tomography,0.02899,diagnostic procedure
44,frontotemporal-dementia,aspartate transaminase,0.02899,enzyme
44,frontotemporal-dementia,mental disorders,0.02899,mental or behavioral dysfunction
44,frontotemporal-dementia,skeletal bone,0.01449,body location or region - body part, organ, or organ component - body substance - disease or syndrome
44,frontotemporal-dementia,unconscious state,0.01449,disease or syndrome - finding
44,frontotemporal-dementia,disability,0.01449,finding
44,frontotemporal-dementia,pharmacotherapy,0.01449,therapeutic or preventive procedure
44,frontotemporal-dementia,household composition,0.01449,finding
44,frontotemporal-dementia,malaise,0.01449,finding - sign or symptom
44,frontotemporal-dementia,breast,0.01449,body part, organ, or organ component
44,frontotemporal-dementia,neoplasm metastasis,0.01449,neoplastic process
44,frontotemporal-dementia,multiple sclerosis,0.01449,body part, organ, or organ component - disease or syndrome - finding
44,frontotemporal-dementia,cardiovascular diseases,0.01449,disease or syndrome
44,frontotemporal-dementia,active brand of pseudoephedrine-triprolidine,0.01449,organic chemical - pharmacologic substance
44,frontotemporal-dementia,injury wounds,0.01449,body substance - injury or poisoning
44,frontotemporal-dementia,congenital abnormality,0.01449,congenital abnormality - disease or syndrome
44,frontotemporal-dementia,craniocerebral trauma,0.01449,injury or poisoning
44,frontotemporal-dementia,blood vessel,0.01449,body part, organ, or organ component - finding
44,frontotemporal-dementia,atypia morphology,0.01449,finding
44,frontotemporal-dementia,screening for cancer,0.01449,diagnostic procedure
44,frontotemporal-dementia,consciousness related finding,0.01449,finding
44,frontotemporal-dementia,hypertensive disease,0.01449,biologically active substance - disease or syndrome - finding
44,frontotemporal-dementia,brain injuries,0.01449,injury or poisoning
44,frontotemporal-dementia,behavior disorders,0.01449,injury or poisoning - mental or behavioral dysfunction
44,frontotemporal-dementia,hypersensitivity,0.01449,clinical attribute - finding - pathologic function
44,frontotemporal-dementia,follow-up status,0.01449,finding
44,frontotemporal-dementia,cerebrovascular accident,0.01449,disease or syndrome - therapeutic or preventive procedure
44,frontotemporal-dementia,malignant neoplasms,0.01449,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,frontotemporal dementia,0.4,disease or syndrome
45,frontotemporal-lobar-degeneration,mini-mental status exam,0.23636,diagnostic procedure
45,frontotemporal-lobar-degeneration,magnetic resonance imaging,0.2,diagnostic procedure
45,frontotemporal-lobar-degeneration,memory observations,0.12727,finding
45,frontotemporal-lobar-degeneration,dactinomycin,0.12727,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,contraceptive methods,0.10909,therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,creatinine clearance,0.07273,finding
45,frontotemporal-lobar-degeneration,relate - vinyl resin,0.07273,organic chemical
45,frontotemporal-lobar-degeneration,personality inventories,0.07273,diagnostic procedure
45,frontotemporal-lobar-degeneration,hearing examination finding,0.07273,finding
45,frontotemporal-lobar-degeneration,mild adverse event,0.07273,finding
45,frontotemporal-lobar-degeneration,pregnancy tests,0.07273,diagnostic procedure
45,frontotemporal-lobar-degeneration,transaminases,0.07273,enzyme
45,frontotemporal-lobar-degeneration,neurological observations,0.07273,finding
45,frontotemporal-lobar-degeneration,paralysed,0.07273,finding
45,frontotemporal-lobar-degeneration,epilepsy,0.05455,disease or syndrome
45,frontotemporal-lobar-degeneration,treatment protocols,0.05455,therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,nervousness,0.05455,sign or symptom
45,frontotemporal-lobar-degeneration,pharmacologic substance,0.05455,pharmacologic substance - therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,hepatic,0.05455,body location or region
45,frontotemporal-lobar-degeneration,cholinesterase inhibitors,0.05455,organic chemical - pharmacologic substance
45,frontotemporal-lobar-degeneration,neuropsychological tests,0.05455,diagnostic procedure
45,frontotemporal-lobar-degeneration,gravidity,0.05455,finding
45,frontotemporal-lobar-degeneration,family history,0.05455,congenital abnormality - disease or syndrome - enzyme - finding
45,frontotemporal-lobar-degeneration,serum,0.05455,biologically active substance - body substance - pharmacologic substance
45,frontotemporal-lobar-degeneration,bilirubin,0.05455,biologically active substance - laboratory or test result - organic chemical
45,frontotemporal-lobar-degeneration,cognitive therapy,0.05455,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,depressed mood,0.05455,finding - mental or behavioral dysfunction
45,frontotemporal-lobar-degeneration,memantine,0.05455,organic chemical - pharmacologic substance
45,frontotemporal-lobar-degeneration,multiple endocrine neoplasia,0.05455,antibiotic - neoplastic process - organic chemical
45,frontotemporal-lobar-degeneration,negative finding,0.03636,finding
45,frontotemporal-lobar-degeneration,moderate adverse event,0.03636,finding
45,frontotemporal-lobar-degeneration,sterility,0.03636,pathologic function
45,frontotemporal-lobar-degeneration,alanine transaminase,0.03636,congenital abnormality - disease or syndrome - enzyme
45,frontotemporal-lobar-degeneration,positive finding,0.03636,finding
45,frontotemporal-lobar-degeneration,alcoholic intoxication chronic,0.03636,mental or behavioral dysfunction
45,frontotemporal-lobar-degeneration,pharmaceutical preparations,0.03636,pharmacologic substance
45,frontotemporal-lobar-degeneration,psychotropic drugs,0.03636,pharmacologic substance
45,frontotemporal-lobar-degeneration,heart ventricle,0.03636,body part, organ, or organ component
45,frontotemporal-lobar-degeneration,operative surgical procedures,0.03636,diagnostic procedure - therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,limb structure,0.03636,body part, organ, or organ component
45,frontotemporal-lobar-degeneration,positron-emission tomography,0.03636,diagnostic procedure
45,frontotemporal-lobar-degeneration,intravenous infusion procedures,0.03636,therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,impaired cognition,0.03636,finding - mental or behavioral dysfunction
45,frontotemporal-lobar-degeneration,aspartate transaminase,0.03636,enzyme
45,frontotemporal-lobar-degeneration,kidney,0.03636,body part, organ, or organ component
45,frontotemporal-lobar-degeneration,physical assessment findings,0.03636,finding
45,frontotemporal-lobar-degeneration,mental disorders,0.03636,mental or behavioral dysfunction
45,frontotemporal-lobar-degeneration,skeletal bone,0.01818,body location or region - body part, organ, or organ component - body substance - disease or syndrome
45,frontotemporal-lobar-degeneration,unconscious state,0.01818,disease or syndrome - finding
45,frontotemporal-lobar-degeneration,disability,0.01818,finding
45,frontotemporal-lobar-degeneration,pharmacotherapy,0.01818,therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,household composition,0.01818,finding
45,frontotemporal-lobar-degeneration,malaise,0.01818,finding - sign or symptom
45,frontotemporal-lobar-degeneration,breast,0.01818,body part, organ, or organ component
45,frontotemporal-lobar-degeneration,cardiovascular diseases,0.01818,disease or syndrome
45,frontotemporal-lobar-degeneration,active brand of pseudoephedrine-triprolidine,0.01818,organic chemical - pharmacologic substance
45,frontotemporal-lobar-degeneration,injury wounds,0.01818,body substance - injury or poisoning
45,frontotemporal-lobar-degeneration,congenital abnormality,0.01818,congenital abnormality - disease or syndrome
45,frontotemporal-lobar-degeneration,craniocerebral trauma,0.01818,injury or poisoning
45,frontotemporal-lobar-degeneration,atypia morphology,0.01818,finding
45,frontotemporal-lobar-degeneration,consciousness related finding,0.01818,finding
45,frontotemporal-lobar-degeneration,hypertensive disease,0.01818,biologically active substance - disease or syndrome - finding
45,frontotemporal-lobar-degeneration,brain injuries,0.01818,injury or poisoning
45,frontotemporal-lobar-degeneration,behavior disorders,0.01818,injury or poisoning - mental or behavioral dysfunction
45,frontotemporal-lobar-degeneration,hypersensitivity,0.01818,clinical attribute - finding - pathologic function
45,frontotemporal-lobar-degeneration,follow-up status,0.01818,finding
45,frontotemporal-lobar-degeneration,cerebrovascular accident,0.01818,disease or syndrome - therapeutic or preventive procedure
45,frontotemporal-lobar-degeneration,malignant neoplasms,0.01818,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
46,gambling,intravenous infusion procedures,0.31944,therapeutic or preventive procedure
46,gambling,negative finding,0.15278,finding
46,gambling,contraceptive methods,0.15278,therapeutic or preventive procedure
46,gambling,pregnancy tests,0.15278,diagnostic procedure
46,gambling,screening for cancer,0.11111,diagnostic procedure
46,gambling,positive finding,0.11111,finding
46,gambling,pharmacologic substance,0.09722,pharmacologic substance - therapeutic or preventive procedure
46,gambling,moderate adverse event,0.08333,finding
46,gambling,congenital abnormality,0.06944,congenital abnormality - disease or syndrome
46,gambling,gravidity,0.06944,finding
46,gambling,multiple endocrine neoplasia,0.06944,antibiotic - neoplastic process - organic chemical
46,gambling,physical assessment findings,0.06944,finding
46,gambling,pharmacotherapy,0.05556,therapeutic or preventive procedure
46,gambling,serum,0.05556,biologically active substance - body substance - pharmacologic substance
46,gambling,operative surgical procedures,0.05556,diagnostic procedure - therapeutic or preventive procedure
46,gambling,cocaine,0.04167,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
46,gambling,electrocardiogram,0.04167,diagnostic procedure - finding - organic chemical - pharmacologic substance
46,gambling,sexual intercourse - finding,0.04167,finding
46,gambling,hypersensitivity,0.04167,clinical attribute - finding - pathologic function
46,gambling,personal satisfaction,0.04167,finding
46,gambling,opiates,0.04167,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
46,gambling,ethanol,0.04167,organic chemical - pharmacologic substance
46,gambling,weighing patient,0.04167,diagnostic procedure - finding
46,gambling,mental disorders,0.04167,mental or behavioral dysfunction
46,gambling,spermatocidal agents,0.04167,pharmacologic substance
46,gambling,allergy severity - severe,0.02778,finding
46,gambling,relate - vinyl resin,0.02778,organic chemical
46,gambling,substance use disorders,0.02778,mental or behavioral dysfunction
46,gambling,contraception barrier,0.02778,therapeutic or preventive procedure
46,gambling,malaise,0.02778,finding - sign or symptom
46,gambling,psychotropic drugs,0.02778,pharmacologic substance
46,gambling,alcohol abuse,0.02778,mental or behavioral dysfunction
46,gambling,body mass index,0.02778,clinical attribute - diagnostic procedure
46,gambling,malignant neoplasms,0.02778,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
46,gambling,depressed mood,0.01389,finding - mental or behavioral dysfunction
46,gambling,severe combined immunodeficiency,0.01389,diagnostic procedure - disease or syndrome
46,gambling,impaired cognition,0.01389,finding - mental or behavioral dysfunction
46,gambling,neoplasm metastasis,0.01389,neoplastic process
46,gambling,benzodiazepines,0.01389,organic chemical - pharmacologic substance
46,gambling,nervous system disorder,0.01389,disease or syndrome
46,gambling,nicotine dependence,0.01389,mental or behavioral dysfunction
46,gambling,pharmaceutical preparations,0.01389,pharmacologic substance
46,gambling,cardiac arrhythmia,0.01389,finding - pathologic function
46,gambling,contraceptives oral,0.01389,pharmacologic substance - therapeutic or preventive procedure
46,gambling,marihuana,0.01389,mental or behavioral dysfunction - organic chemical - pharmacologic substance
46,gambling,household composition,0.01389,finding
46,gambling,active brand of pseudoephedrine-triprolidine,0.01389,organic chemical - pharmacologic substance
46,gambling,hepatic,0.01389,body location or region
46,gambling,psychotic disorders,0.01389,mental or behavioral dysfunction
47,habits,smoke,0.11754,hazardous or poisonous substance - individual behavior
47,habits,intravenous infusion procedures,0.06612,therapeutic or preventive procedure
47,habits,tobacco,0.05969,hazardous or poisonous substance - organic chemical - pharmacologic substance
47,habits,body mass index,0.05693,clinical attribute - diagnostic procedure
47,habits,contraceptive methods,0.05601,therapeutic or preventive procedure
47,habits,active brand of pseudoephedrine-triprolidine,0.05234,organic chemical - pharmacologic substance
47,habits,gravidity,0.05234,finding
47,habits,ethanol,0.04591,organic chemical - pharmacologic substance
47,habits,physical assessment findings,0.03949,finding
47,habits,follow-up status,0.03857,finding
47,habits,negative finding,0.03581,finding
47,habits,nicotine dependence,0.03581,mental or behavioral dysfunction
47,habits,schizophrenia,0.0303,mental or behavioral dysfunction
47,habits,malignant neoplasms,0.0303,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
47,habits,multiple endocrine neoplasia,0.0303,antibiotic - neoplastic process - organic chemical
47,habits,pregnancy tests,0.02847,diagnostic procedure
47,habits,pharmacologic substance,0.02479,pharmacologic substance - therapeutic or preventive procedure
47,habits,infantile neuroaxonal dystrophy,0.02296,disease or syndrome
47,habits,depressed mood,0.02204,finding - mental or behavioral dysfunction
47,habits,positive finding,0.02112,finding
47,habits,marihuana,0.02112,mental or behavioral dysfunction - organic chemical - pharmacologic substance
47,habits,operative surgical procedures,0.01928,diagnostic procedure - therapeutic or preventive procedure
47,habits,pharmaceutical preparations,0.01837,pharmacologic substance
47,habits,moderate adverse event,0.01837,finding
47,habits,mass of body structure,0.01837,finding
47,habits,chronic obstructive airway disease,0.01469,disease or syndrome
47,habits,antipsychotic agents,0.01469,pharmacologic substance
47,habits,pharmacotherapy,0.01194,therapeutic or preventive procedure
47,habits,anxiety disorders,0.01194,finding - mental or behavioral dysfunction
47,habits,illicit drugs,0.01194,hazardous or poisonous substance - pharmacologic substance
47,habits,consumption-archaic term for tb,0.01194,disease or syndrome
47,habits,unipolar depression,0.01102,mental or behavioral dysfunction
47,habits,mental disorders,0.01102,mental or behavioral dysfunction
47,habits,alcoholic intoxication chronic,0.0101,mental or behavioral dysfunction
47,habits,screening for cancer,0.0101,diagnostic procedure
47,habits,unstable status,0.0101,finding
47,habits,hypertensive disease,0.0101,biologically active substance - disease or syndrome - finding
47,habits,psychotic disorders,0.00918,mental or behavioral dysfunction
47,habits,arteries,0.00918,body part, organ, or organ component
47,habits,myocardial infarction,0.00918,disease or syndrome - finding
47,habits,bipolar disorder,0.00826,mental or behavioral dysfunction
47,habits,substance abuse problem,0.00826,mental or behavioral dysfunction
47,habits,blood pressure finding,0.00826,finding
47,habits,observation of attack,0.00826,finding
47,habits,angina pectoris,0.00826,sign or symptom
47,habits,alcohol consumption,0.00826,individual behavior
47,habits,diabetes,0.00826,disease or syndrome
47,habits,asthma,0.00735,disease or syndrome
47,habits,blood vessel,0.00735,body part, organ, or organ component - finding
47,habits,psychotropic drugs,0.00735,pharmacologic substance
47,habits,lung,0.00735,body part, organ, or organ component - disease or syndrome
47,habits,electrocardiogram,0.00735,diagnostic procedure - finding - organic chemical - pharmacologic substance
47,habits,hypersensitivity,0.00735,clinical attribute - finding - pathologic function
47,habits,breast,0.00735,body part, organ, or organ component
47,habits,cardiovascular diseases,0.00643,disease or syndrome
47,habits,heart diseases,0.00643,disease or syndrome
47,habits,allergy severity - severe,0.00643,finding
47,habits,angina unstable,0.00643,disease or syndrome
47,habits,antidepressive agents,0.00643,pharmacologic substance
47,habits,suicidal,0.00551,finding
47,habits,hepatic,0.00551,body location or region
47,habits,investigational new drugs,0.00551,pharmacologic substance - therapeutic or preventive procedure
47,habits,major depressive disorder,0.00551,mental or behavioral dysfunction
47,habits,alcohol abuse,0.00459,mental or behavioral dysfunction
47,habits,cerebrovascular accident,0.00459,disease or syndrome - therapeutic or preventive procedure
47,habits,congenital abnormality,0.00367,congenital abnormality - disease or syndrome
47,habits,cardiac arrhythmia,0.00367,finding - pathologic function
47,habits,diastole,0.00367,clinical attribute
47,habits,injury wounds,0.00275,body substance - injury or poisoning
47,habits,kidney diseases,0.00184,disease or syndrome
47,habits,benzodiazepines,0.00184,organic chemical - pharmacologic substance
47,habits,monoamine oxidase inhibitors,0.00184,organic chemical - pharmacologic substance
47,habits,epilepsy,0.00092,disease or syndrome
47,habits,liver diseases,0.00092,disease or syndrome
47,habits,craniocerebral trauma,0.00092,injury or poisoning
47,habits,dementia,0.00092,mental or behavioral dysfunction
47,habits,drug abuse,0.00092,mental or behavioral dysfunction
48,heroin-dependence,intravenous infusion procedures,0.46067,therapeutic or preventive procedure
48,heroin-dependence,opiate addiction,0.44944,mental or behavioral dysfunction
48,heroin-dependence,opioids,0.39326,hazardous or poisonous substance - organic chemical - pharmacologic substance
48,heroin-dependence,opiates,0.32584,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
48,heroin-dependence,contraceptive methods,0.2809,therapeutic or preventive procedure
48,heroin-dependence,pharmacologic substance,0.25843,pharmacologic substance - therapeutic or preventive procedure
48,heroin-dependence,positive finding,0.22472,finding
48,heroin-dependence,substance abuse problem,0.10112,mental or behavioral dysfunction
48,heroin-dependence,physical assessment findings,0.10112,finding
48,heroin-dependence,negative finding,0.08989,finding
48,heroin-dependence,detoxification procedure,0.07865,therapeutic or preventive procedure
48,heroin-dependence,cocaine,0.07865,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
48,heroin-dependence,relate - vinyl resin,0.06742,organic chemical
48,heroin-dependence,active brand of pseudoephedrine-triprolidine,0.06742,organic chemical - pharmacologic substance
48,heroin-dependence,drug dependence,0.05618,mental or behavioral dysfunction
48,heroin-dependence,gravidity,0.05618,finding
48,heroin-dependence,sexually active,0.05618,finding
48,heroin-dependence,mental disorders,0.05618,mental or behavioral dysfunction
48,heroin-dependence,narcotics,0.04494,biologically active substance - hazardous or poisonous substance - pharmacologic substance
48,heroin-dependence,severe combined immunodeficiency,0.03371,diagnostic procedure - disease or syndrome
48,heroin-dependence,personal satisfaction,0.03371,finding
48,heroin-dependence,psychotropic drugs,0.03371,pharmacologic substance
48,heroin-dependence,ethanol,0.03371,organic chemical - pharmacologic substance
48,heroin-dependence,disease of diaphragm,0.03371,body part, organ, or organ component - disease or syndrome
48,heroin-dependence,screening for cancer,0.03371,diagnostic procedure
48,heroin-dependence,pregnancy tests,0.03371,diagnostic procedure
48,heroin-dependence,blood pressure finding,0.02247,finding
48,heroin-dependence,psychotic disorders,0.02247,mental or behavioral dysfunction
48,heroin-dependence,manic,0.02247,finding - mental or behavioral dysfunction
48,heroin-dependence,schizophrenia,0.02247,mental or behavioral dysfunction
48,heroin-dependence,bipolar disorder,0.02247,mental or behavioral dysfunction
48,heroin-dependence,pharmaceutical preparations,0.02247,pharmacologic substance
48,heroin-dependence,systolic pressure,0.02247,clinical attribute - diagnostic procedure
48,heroin-dependence,unconscious state,0.02247,disease or syndrome - finding
48,heroin-dependence,congenital abnormality,0.02247,congenital abnormality - disease or syndrome
48,heroin-dependence,medical history,0.02247,finding
48,heroin-dependence,mercury,0.02247,hazardous or poisonous substance
48,heroin-dependence,spermatocidal agents,0.02247,pharmacologic substance
48,heroin-dependence,unstable status,0.02247,finding
48,heroin-dependence,contraceptives oral,0.02247,pharmacologic substance - therapeutic or preventive procedure
48,heroin-dependence,suicide risk,0.02247,finding
48,heroin-dependence,hypertensive disease,0.02247,biologically active substance - disease or syndrome - finding
48,heroin-dependence,suicide attempt,0.02247,finding - mental or behavioral dysfunction
48,heroin-dependence,implantation procedure,0.02247,therapeutic or preventive procedure
48,heroin-dependence,diabetes,0.02247,disease or syndrome
48,heroin-dependence,therapeutic brand of coal tar,0.02247,organic chemical - pharmacologic substance - therapeutic or preventive procedure
48,heroin-dependence,pharmacotherapy,0.01124,therapeutic or preventive procedure
48,heroin-dependence,anxiety disorders,0.01124,finding - mental or behavioral dysfunction
48,heroin-dependence,nicotine dependence,0.01124,mental or behavioral dysfunction
48,heroin-dependence,cardiovascular diseases,0.01124,disease or syndrome
48,heroin-dependence,infantile neuroaxonal dystrophy,0.01124,disease or syndrome
48,heroin-dependence,oral contraception,0.01124,pharmacologic substance - therapeutic or preventive procedure
48,heroin-dependence,substance dependence,0.01124,mental or behavioral dysfunction
48,heroin-dependence,operative surgical procedures,0.01124,diagnostic procedure - therapeutic or preventive procedure
48,heroin-dependence,unipolar depression,0.01124,mental or behavioral dysfunction
48,heroin-dependence,electrocardiogram,0.01124,diagnostic procedure - finding - organic chemical - pharmacologic substance
48,heroin-dependence,psychotherapy,0.01124,therapeutic or preventive procedure
48,heroin-dependence,depressed mood,0.01124,finding - mental or behavioral dysfunction
49,impulse-control-disorders,intravenous infusion procedures,0.43011,therapeutic or preventive procedure
49,impulse-control-disorders,multiple endocrine neoplasia,0.13978,antibiotic - neoplastic process - organic chemical
49,impulse-control-disorders,contraceptive methods,0.11828,therapeutic or preventive procedure
49,impulse-control-disorders,pregnancy tests,0.10753,diagnostic procedure
49,impulse-control-disorders,negative finding,0.09677,finding
49,impulse-control-disorders,physical assessment findings,0.09677,finding
49,impulse-control-disorders,mental disorders,0.07527,mental or behavioral dysfunction
49,impulse-control-disorders,screening for cancer,0.06452,diagnostic procedure
49,impulse-control-disorders,moderate adverse event,0.05376,finding
49,impulse-control-disorders,blood pressure finding,0.04301,finding
49,impulse-control-disorders,congenital abnormality,0.04301,congenital abnormality - disease or syndrome
49,impulse-control-disorders,electrocardiogram,0.04301,diagnostic procedure - finding - organic chemical - pharmacologic substance
49,impulse-control-disorders,psychotropic drugs,0.04301,pharmacologic substance
49,impulse-control-disorders,medical history,0.03226,finding
49,impulse-control-disorders,mercury,0.03226,hazardous or poisonous substance
49,impulse-control-disorders,bleomycin-cisplatin protocol,0.03226,therapeutic or preventive procedure
49,impulse-control-disorders,anxiety disorders,0.03226,finding - mental or behavioral dysfunction
49,impulse-control-disorders,integumentary scale,0.03226,body part, organ, or organ component
49,impulse-control-disorders,obsessive-compulsive disorder,0.03226,disease or syndrome - mental or behavioral dysfunction
49,impulse-control-disorders,active brand of pseudoephedrine-triprolidine,0.03226,organic chemical - pharmacologic substance
49,impulse-control-disorders,depressed mood,0.03226,finding - mental or behavioral dysfunction
49,impulse-control-disorders,osteochondritis dissecans,0.03226,disease or syndrome - mental or behavioral dysfunction
49,impulse-control-disorders,body mass index,0.03226,clinical attribute - diagnostic procedure
49,impulse-control-disorders,personality inventories,0.03226,diagnostic procedure
49,impulse-control-disorders,ethanol,0.03226,organic chemical - pharmacologic substance
49,impulse-control-disorders,severe combined immunodeficiency,0.02151,diagnostic procedure - disease or syndrome
49,impulse-control-disorders,gravidity,0.02151,finding
49,impulse-control-disorders,attention deficit hyperactivity disorder,0.02151,disease or syndrome - mental or behavioral dysfunction
49,impulse-control-disorders,relate - vinyl resin,0.02151,organic chemical
49,impulse-control-disorders,allergy severity - severe,0.02151,finding
49,impulse-control-disorders,compulsive disorder,0.02151,finding
49,impulse-control-disorders,aggressive behavior,0.02151,mental or behavioral dysfunction
49,impulse-control-disorders,substance use disorders,0.02151,mental or behavioral dysfunction
49,impulse-control-disorders,infantile neuroaxonal dystrophy,0.02151,disease or syndrome
49,impulse-control-disorders,contraceptives oral,0.02151,pharmacologic substance - therapeutic or preventive procedure
49,impulse-control-disorders,pharmacologic substance,0.02151,pharmacologic substance - therapeutic or preventive procedure
49,impulse-control-disorders,malaise,0.02151,finding - sign or symptom
49,impulse-control-disorders,phobic anxiety disorder,0.02151,mental or behavioral dysfunction
49,impulse-control-disorders,diagnosis psychiatric,0.02151,mental or behavioral dysfunction
49,impulse-control-disorders,selective serotonin re-uptake inhibitor,0.02151,pharmacologic substance
49,impulse-control-disorders,magnetic resonance imaging,0.02151,diagnostic procedure
49,impulse-control-disorders,operative surgical procedures,0.02151,diagnostic procedure - therapeutic or preventive procedure
49,impulse-control-disorders,alcohol abuse,0.02151,mental or behavioral dysfunction
49,impulse-control-disorders,craniocerebral trauma,0.01075,injury or poisoning
49,impulse-control-disorders,drugs non-prescription,0.01075,pharmacologic substance - therapeutic or preventive procedure
49,impulse-control-disorders,pharmacotherapy,0.01075,therapeutic or preventive procedure
49,impulse-control-disorders,fluoxetine,0.01075,organic chemical - pharmacologic substance
49,impulse-control-disorders,benzodiazepines,0.01075,organic chemical - pharmacologic substance
49,impulse-control-disorders,nervous system disorder,0.01075,disease or syndrome
49,impulse-control-disorders,psychiatric problem,0.01075,mental or behavioral dysfunction
49,impulse-control-disorders,cognitive therapy,0.01075,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
49,impulse-control-disorders,opiates,0.01075,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
49,impulse-control-disorders,counter brand of terbufos,0.01075,hazardous or poisonous substance
49,impulse-control-disorders,unipolar depression,0.01075,mental or behavioral dysfunction
49,impulse-control-disorders,stimulant,0.01075,pharmacologic substance
49,impulse-control-disorders,nicotine dependence,0.01075,mental or behavioral dysfunction
49,impulse-control-disorders,tic disorder,0.01075,mental or behavioral dysfunction
49,impulse-control-disorders,opioids,0.01075,hazardous or poisonous substance - organic chemical - pharmacologic substance
49,impulse-control-disorders,impaired cognition,0.01075,finding - mental or behavioral dysfunction
49,impulse-control-disorders,movement disorders,0.01075,disease or syndrome
49,impulse-control-disorders,treatment-psychosocial effects,0.01075,finding
49,impulse-control-disorders,stimulation procedure,0.01075,therapeutic or preventive procedure
49,impulse-control-disorders,positive finding,0.01075,finding
49,impulse-control-disorders,lung,0.01075,body part, organ, or organ component - disease or syndrome
49,impulse-control-disorders,cancer remission,0.01075,finding - neoplastic process
50,impulsive-behavior,intravenous infusion procedures,0.28879,therapeutic or preventive procedure
50,impulsive-behavior,physical assessment findings,0.125,finding
50,impulsive-behavior,pharmacologic substance,0.12069,pharmacologic substance - therapeutic or preventive procedure
50,impulsive-behavior,positive finding,0.11638,finding
50,impulsive-behavior,contraceptive methods,0.11207,therapeutic or preventive procedure
50,impulsive-behavior,ethanol,0.10776,organic chemical - pharmacologic substance
50,impulsive-behavior,opioids,0.10776,hazardous or poisonous substance - organic chemical - pharmacologic substance
50,impulsive-behavior,opiate addiction,0.09052,mental or behavioral dysfunction
50,impulsive-behavior,negative finding,0.08621,finding
50,impulsive-behavior,smoker,0.08621,finding
50,impulsive-behavior,opiates,0.0819,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
50,impulsive-behavior,electrocardiogram,0.07328,diagnostic procedure - finding - organic chemical - pharmacologic substance
50,impulsive-behavior,attention deficit hyperactivity disorder,0.06897,disease or syndrome - mental or behavioral dysfunction
50,impulsive-behavior,medical history,0.06466,finding
50,impulsive-behavior,pregnancy tests,0.05603,diagnostic procedure
50,impulsive-behavior,severe combined immunodeficiency,0.04741,diagnostic procedure - disease or syndrome
50,impulsive-behavior,pharmaceutical preparations,0.04741,pharmacologic substance
50,impulsive-behavior,gravidity,0.04741,finding
50,impulsive-behavior,pregnancy test negative,0.04741,finding - laboratory or test result
50,impulsive-behavior,screening for cancer,0.04741,diagnostic procedure
50,impulsive-behavior,nicotine dependence,0.0431,mental or behavioral dysfunction
50,impulsive-behavior,body mass index,0.0431,clinical attribute - diagnostic procedure
50,impulsive-behavior,vital signs,0.0431,clinical attribute
50,impulsive-behavior,multiple endocrine neoplasia,0.0431,antibiotic - neoplastic process - organic chemical
50,impulsive-behavior,mental disorders,0.03879,mental or behavioral dysfunction
50,impulsive-behavior,alcoholic intoxication chronic,0.03448,mental or behavioral dysfunction
50,impulsive-behavior,detoxification procedure,0.03448,therapeutic or preventive procedure
50,impulsive-behavior,diastole,0.03448,clinical attribute
50,impulsive-behavior,alanine transaminase,0.03017,congenital abnormality - disease or syndrome - enzyme
50,impulsive-behavior,drug dependence,0.03017,mental or behavioral dysfunction
50,impulsive-behavior,personal satisfaction,0.03017,finding
50,impulsive-behavior,active brand of pseudoephedrine-triprolidine,0.03017,organic chemical - pharmacologic substance
50,impulsive-behavior,psychotropic drugs,0.03017,pharmacologic substance
50,impulsive-behavior,smoke,0.03017,hazardous or poisonous substance - individual behavior
50,impulsive-behavior,mercury,0.03017,hazardous or poisonous substance
50,impulsive-behavior,magnetic resonance imaging,0.02586,diagnostic procedure
50,impulsive-behavior,operative surgical procedures,0.02586,diagnostic procedure - therapeutic or preventive procedure
50,impulsive-behavior,blood pressure finding,0.02586,finding
50,impulsive-behavior,post-traumatic stress disorder,0.02586,mental or behavioral dysfunction
50,impulsive-behavior,cardiac arrhythmia,0.02586,finding - pathologic function
50,impulsive-behavior,marihuana,0.02586,mental or behavioral dysfunction - organic chemical - pharmacologic substance
50,impulsive-behavior,bilirubin,0.02586,biologically active substance - laboratory or test result - organic chemical
50,impulsive-behavior,aspartate transaminase,0.02586,enzyme
50,impulsive-behavior,stimulant,0.02586,pharmacologic substance
50,impulsive-behavior,hyperactive behavior,0.02155,finding
50,impulsive-behavior,oral contraception,0.02155,pharmacologic substance - therapeutic or preventive procedure
50,impulsive-behavior,liver function,0.02155,organ or tissue function
50,impulsive-behavior,consumption-archaic term for tb,0.02155,disease or syndrome
50,impulsive-behavior,follow-up status,0.02155,finding
50,impulsive-behavior,substance dependence,0.01724,mental or behavioral dysfunction
50,impulsive-behavior,breast,0.01724,body part, organ, or organ component
50,impulsive-behavior,illicit drugs,0.01724,hazardous or poisonous substance - pharmacologic substance
50,impulsive-behavior,schizophrenia,0.01724,mental or behavioral dysfunction
50,impulsive-behavior,infantile neuroaxonal dystrophy,0.01724,disease or syndrome
50,impulsive-behavior,depressed mood,0.01724,finding - mental or behavioral dysfunction
50,impulsive-behavior,anxiety disorders,0.01293,finding - mental or behavioral dysfunction
50,impulsive-behavior,schizoaffective disorder,0.01293,mental or behavioral dysfunction
50,impulsive-behavior,tobacco,0.01293,hazardous or poisonous substance - organic chemical - pharmacologic substance
50,impulsive-behavior,substance use disorders,0.01293,mental or behavioral dysfunction
50,impulsive-behavior,caffeine,0.01293,organic chemical - pharmacologic substance - therapeutic or preventive procedure
50,impulsive-behavior,antipsychotic agents,0.01293,pharmacologic substance
50,impulsive-behavior,moderate adverse event,0.01293,finding
50,impulsive-behavior,positron-emission tomography,0.01293,diagnostic procedure
50,impulsive-behavior,contraception barrier,0.01293,therapeutic or preventive procedure
50,impulsive-behavior,psychotherapy,0.01293,therapeutic or preventive procedure
50,impulsive-behavior,substance abuse problem,0.01293,mental or behavioral dysfunction
50,impulsive-behavior,implantation procedure,0.01293,therapeutic or preventive procedure
50,impulsive-behavior,drug abuse,0.01293,mental or behavioral dysfunction
50,impulsive-behavior,alcohol consumption,0.01293,individual behavior
50,impulsive-behavior,medical contraindication,0.01293,finding
50,impulsive-behavior,personality disorders,0.00862,mental or behavioral dysfunction
50,impulsive-behavior,pervasive development disorder,0.00862,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
50,impulsive-behavior,household composition,0.00862,finding
50,impulsive-behavior,relate - vinyl resin,0.00862,organic chemical
50,impulsive-behavior,allergy severity - severe,0.00862,finding
50,impulsive-behavior,claustrophobia,0.00862,mental or behavioral dysfunction
50,impulsive-behavior,congenital abnormality,0.00862,congenital abnormality - disease or syndrome
50,impulsive-behavior,serum,0.00862,biologically active substance - body substance - pharmacologic substance
50,impulsive-behavior,nervous system disorder,0.00862,disease or syndrome
50,impulsive-behavior,malignant neoplasms,0.00862,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
50,impulsive-behavior,suicidal,0.00431,finding
50,impulsive-behavior,psychotic disorders,0.00431,mental or behavioral dysfunction
50,impulsive-behavior,disability,0.00431,finding
50,impulsive-behavior,diastolic blood pressure,0.00431,clinical attribute - diagnostic procedure - finding
50,impulsive-behavior,bipolar disorder,0.00431,mental or behavioral dysfunction
50,impulsive-behavior,injury wounds,0.00431,body substance - injury or poisoning
50,impulsive-behavior,systolic pressure,0.00431,clinical attribute - diagnostic procedure
50,impulsive-behavior,unipolar depression,0.00431,mental or behavioral dysfunction
50,impulsive-behavior,observation of attack,0.00431,finding
50,impulsive-behavior,mood disorders,0.00431,mental or behavioral dysfunction
50,impulsive-behavior,sterility,0.00431,pathologic function
50,impulsive-behavior,unstable status,0.00431,finding
50,impulsive-behavior,hypertensive disease,0.00431,biologically active substance - disease or syndrome - finding
50,impulsive-behavior,blind vision,0.00431,disease or syndrome
50,impulsive-behavior,heart rate,0.00431,clinical attribute
50,impulsive-behavior,suicide attempt,0.00431,finding - mental or behavioral dysfunction
50,impulsive-behavior,benzodiazepines,0.00431,organic chemical - pharmacologic substance
50,impulsive-behavior,hypersensitivity,0.00431,clinical attribute - finding - pathologic function
50,impulsive-behavior,current therapy,0.00431,therapeutic or preventive procedure
50,impulsive-behavior,mental retardation,0.00431,mental or behavioral dysfunction
50,impulsive-behavior,diabetes,0.00431,disease or syndrome
51,learning-disorders,malignant neoplasms,0.06957,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
51,learning-disorders,cerebrovascular accident,0.05009,disease or syndrome - therapeutic or preventive procedure
51,learning-disorders,body mass index,0.04824,clinical attribute - diagnostic procedure
51,learning-disorders,intravenous infusion procedures,0.04638,therapeutic or preventive procedure
51,learning-disorders,multiple endocrine neoplasia,0.04082,antibiotic - neoplastic process - organic chemical
51,learning-disorders,active brand of pseudoephedrine-triprolidine,0.03432,organic chemical - pharmacologic substance
51,learning-disorders,physical assessment findings,0.03154,finding
51,learning-disorders,hypertensive disease,0.02876,biologically active substance - disease or syndrome - finding
51,learning-disorders,asthma,0.02783,disease or syndrome
51,learning-disorders,moderate adverse event,0.0269,finding
51,learning-disorders,pharmacotherapy,0.02597,therapeutic or preventive procedure
51,learning-disorders,allergy severity - severe,0.02505,finding
51,learning-disorders,hearing examination finding,0.02412,finding
51,learning-disorders,follow-up status,0.02412,finding
51,learning-disorders,gravidity,0.02134,finding
51,learning-disorders,depressed mood,0.02134,finding - mental or behavioral dysfunction
51,learning-disorders,mental disorders,0.01948,mental or behavioral dysfunction
51,learning-disorders,arteries,0.01763,body part, organ, or organ component
51,learning-disorders,exercise pain management,0.01763,therapeutic or preventive procedure
51,learning-disorders,disability,0.0167,finding
51,learning-disorders,neoplasm metastasis,0.01577,neoplastic process
51,learning-disorders,positive finding,0.01577,finding
51,learning-disorders,heart diseases,0.01484,disease or syndrome
51,learning-disorders,lung,0.01391,body part, organ, or organ component - disease or syndrome
51,learning-disorders,insulin,0.01391,pharmacologic substance
51,learning-disorders,pharmacologic substance,0.01391,pharmacologic substance - therapeutic or preventive procedure
51,learning-disorders,angina pectoris,0.01299,sign or symptom
51,learning-disorders,ethanol,0.01206,organic chemical - pharmacologic substance
51,learning-disorders,operative surgical procedures,0.01206,diagnostic procedure - therapeutic or preventive procedure
51,learning-disorders,limb structure,0.01113,body part, organ, or organ component
51,learning-disorders,unstable status,0.01113,finding
51,learning-disorders,myocardial infarction,0.0102,disease or syndrome - finding
51,learning-disorders,substance abuse problem,0.00835,mental or behavioral dysfunction
51,learning-disorders,injury wounds,0.00742,body substance - injury or poisoning
51,learning-disorders,impaired cognition,0.00742,finding - mental or behavioral dysfunction
51,learning-disorders,dementia,0.00649,mental or behavioral dysfunction
51,learning-disorders,pharmaceutical preparations,0.00649,pharmacologic substance
51,learning-disorders,psychotic disorders,0.00649,mental or behavioral dysfunction
51,learning-disorders,life expectancy,0.00557,group attribute
51,learning-disorders,epilepsy,0.00464,disease or syndrome
51,learning-disorders,craniocerebral trauma,0.00464,injury or poisoning
51,learning-disorders,hypersensitivity,0.00371,clinical attribute - finding - pathologic function
51,learning-disorders,kidney diseases,0.00278,disease or syndrome
52,marijuana-abuse,marihuana,0.66522,mental or behavioral dysfunction - organic chemical - pharmacologic substance
52,marijuana-abuse,intravenous infusion procedures,0.26522,therapeutic or preventive procedure
52,marijuana-abuse,contraceptive methods,0.23043,therapeutic or preventive procedure
52,marijuana-abuse,pharmacologic substance,0.13043,pharmacologic substance - therapeutic or preventive procedure
52,marijuana-abuse,positive finding,0.12609,finding
52,marijuana-abuse,ethanol,0.07826,organic chemical - pharmacologic substance
52,marijuana-abuse,schizophrenia,0.07826,mental or behavioral dysfunction
52,marijuana-abuse,negative finding,0.07391,finding
52,marijuana-abuse,pregnancy tests,0.06957,diagnostic procedure
52,marijuana-abuse,smoker,0.06522,finding
52,marijuana-abuse,multiple endocrine neoplasia,0.06522,antibiotic - neoplastic process - organic chemical
52,marijuana-abuse,pharmaceutical preparations,0.06087,pharmacologic substance
52,marijuana-abuse,contraceptives oral,0.05217,pharmacologic substance - therapeutic or preventive procedure
52,marijuana-abuse,heart rate,0.05217,clinical attribute
52,marijuana-abuse,multiple sclerosis,0.04783,body part, organ, or organ component - disease or syndrome - finding
52,marijuana-abuse,active brand of pseudoephedrine-triprolidine,0.04783,organic chemical - pharmacologic substance
52,marijuana-abuse,gravidity,0.04783,finding
52,marijuana-abuse,antipsychotic agents,0.04348,pharmacologic substance
52,marijuana-abuse,moderate adverse event,0.04348,finding
52,marijuana-abuse,physical assessment findings,0.04348,finding
52,marijuana-abuse,electrocardiogram,0.03913,diagnostic procedure - finding - organic chemical - pharmacologic substance
52,marijuana-abuse,schizoaffective disorder,0.03478,mental or behavioral dysfunction
52,marijuana-abuse,tobacco,0.03478,hazardous or poisonous substance - organic chemical - pharmacologic substance
52,marijuana-abuse,oral contraception,0.03478,pharmacologic substance - therapeutic or preventive procedure
52,marijuana-abuse,disease of diaphragm,0.03478,body part, organ, or organ component - disease or syndrome
52,marijuana-abuse,blood pressure finding,0.03478,finding
52,marijuana-abuse,screening for cancer,0.03478,diagnostic procedure
52,marijuana-abuse,medical history,0.03043,finding
52,marijuana-abuse,body mass index,0.02609,clinical attribute - diagnostic procedure
52,marijuana-abuse,systolic pressure,0.02609,clinical attribute - diagnostic procedure
52,marijuana-abuse,allergy severity - severe,0.02609,finding
52,marijuana-abuse,serum,0.02609,biologically active substance - body substance - pharmacologic substance
52,marijuana-abuse,diastolic blood pressure,0.02609,clinical attribute - diagnostic procedure - finding
52,marijuana-abuse,diastole,0.02609,clinical attribute
52,marijuana-abuse,substance abuse problem,0.02174,mental or behavioral dysfunction
52,marijuana-abuse,illicit drugs,0.02174,hazardous or poisonous substance - pharmacologic substance
52,marijuana-abuse,mass of body structure,0.02174,finding
52,marijuana-abuse,blood vessel,0.01739,body part, organ, or organ component - finding
52,marijuana-abuse,relate - vinyl resin,0.01739,organic chemical
52,marijuana-abuse,congenital abnormality,0.01739,congenital abnormality - disease or syndrome
52,marijuana-abuse,mercury,0.01739,hazardous or poisonous substance
52,marijuana-abuse,attention deficit hyperactivity disorder,0.01739,disease or syndrome - mental or behavioral dysfunction
52,marijuana-abuse,opioids,0.01739,hazardous or poisonous substance - organic chemical - pharmacologic substance
52,marijuana-abuse,implantation procedure,0.01739,therapeutic or preventive procedure
52,marijuana-abuse,sexually active,0.01739,finding
52,marijuana-abuse,malignant neoplasms,0.01739,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
52,marijuana-abuse,mental disorders,0.01739,mental or behavioral dysfunction
52,marijuana-abuse,psychotic disorders,0.01304,mental or behavioral dysfunction
52,marijuana-abuse,psychiatric problem,0.01304,mental or behavioral dysfunction
52,marijuana-abuse,breast,0.01304,body part, organ, or organ component
52,marijuana-abuse,nicotine dependence,0.01304,mental or behavioral dysfunction
52,marijuana-abuse,infantile neuroaxonal dystrophy,0.01304,disease or syndrome
52,marijuana-abuse,substance use disorders,0.01304,mental or behavioral dysfunction
52,marijuana-abuse,alcoholic intoxication chronic,0.01304,mental or behavioral dysfunction
52,marijuana-abuse,bleomycin-cisplatin protocol,0.01304,therapeutic or preventive procedure
52,marijuana-abuse,injury wounds,0.01304,body substance - injury or poisoning
52,marijuana-abuse,sexual intercourse - finding,0.01304,finding
52,marijuana-abuse,drug abuse,0.01304,mental or behavioral dysfunction
52,marijuana-abuse,follow-up status,0.01304,finding
52,marijuana-abuse,major depressive disorder,0.01304,mental or behavioral dysfunction
52,marijuana-abuse,disability,0.0087,finding
52,marijuana-abuse,anxiety disorders,0.0087,finding - mental or behavioral dysfunction
52,marijuana-abuse,caffeine,0.0087,organic chemical - pharmacologic substance - therapeutic or preventive procedure
52,marijuana-abuse,psychotropic drugs,0.0087,pharmacologic substance
52,marijuana-abuse,craniocerebral trauma,0.0087,injury or poisoning
52,marijuana-abuse,unipolar depression,0.0087,mental or behavioral dysfunction
52,marijuana-abuse,cocaine,0.0087,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
52,marijuana-abuse,opiates,0.0087,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
52,marijuana-abuse,hypersensitivity,0.0087,clinical attribute - finding - pathologic function
52,marijuana-abuse,current therapy,0.0087,therapeutic or preventive procedure
52,marijuana-abuse,depressed mood,0.0087,finding - mental or behavioral dysfunction
52,marijuana-abuse,alcohol abuse,0.0087,mental or behavioral dysfunction
52,marijuana-abuse,suicidal,0.00435,finding
52,marijuana-abuse,diabetes mellitus,0.00435,disease or syndrome - pharmacologic substance
52,marijuana-abuse,arteries,0.00435,body part, organ, or organ component
52,marijuana-abuse,pharmacotherapy,0.00435,therapeutic or preventive procedure
52,marijuana-abuse,benzodiazepines,0.00435,organic chemical - pharmacologic substance
52,marijuana-abuse,manic,0.00435,finding - mental or behavioral dysfunction
52,marijuana-abuse,chronic obstructive airway disease,0.00435,disease or syndrome
52,marijuana-abuse,drug dependence,0.00435,mental or behavioral dysfunction
52,marijuana-abuse,claustrophobia,0.00435,mental or behavioral dysfunction
52,marijuana-abuse,eating disorders,0.00435,mental or behavioral dysfunction
52,marijuana-abuse,drugs non-prescription,0.00435,pharmacologic substance - therapeutic or preventive procedure
52,marijuana-abuse,unconscious state,0.00435,disease or syndrome - finding
52,marijuana-abuse,mental retardation,0.00435,mental or behavioral dysfunction
52,marijuana-abuse,heart diseases,0.00435,disease or syndrome
52,marijuana-abuse,family history,0.00435,congenital abnormality - disease or syndrome - enzyme - finding
52,marijuana-abuse,unstable status,0.00435,finding
52,marijuana-abuse,counter brand of terbufos,0.00435,hazardous or poisonous substance
52,marijuana-abuse,mood disorders,0.00435,mental or behavioral dysfunction
52,marijuana-abuse,consciousness related finding,0.00435,finding
52,marijuana-abuse,hypertensive disease,0.00435,biologically active substance - disease or syndrome - finding
52,marijuana-abuse,adrenal cortex hormones,0.00435,pharmacologic substance
52,marijuana-abuse,antidepressive agents,0.00435,pharmacologic substance
52,marijuana-abuse,psychotic symptoms,0.00435,sign or symptom
53,mental-disorders,intravenous infusion procedures,0.28397,therapeutic or preventive procedure
53,mental-disorders,depressed mood,0.11835,finding - mental or behavioral dysfunction
53,mental-disorders,contraceptive methods,0.10996,therapeutic or preventive procedure
53,mental-disorders,schizophrenia,0.10617,mental or behavioral dysfunction
53,mental-disorders,negative finding,0.07372,finding
53,mental-disorders,physical assessment findings,0.07142,finding
53,mental-disorders,major depressive disorder,0.07056,mental or behavioral dysfunction
53,mental-disorders,mental disorders,0.06856,mental or behavioral dysfunction
53,mental-disorders,pharmacologic substance,0.06455,pharmacologic substance - therapeutic or preventive procedure
53,mental-disorders,antipsychotic agents,0.06211,pharmacologic substance
53,mental-disorders,ethanol,0.05258,organic chemical - pharmacologic substance
53,mental-disorders,multiple endocrine neoplasia,0.05079,antibiotic - neoplastic process - organic chemical
53,mental-disorders,body mass index,0.04986,clinical attribute - diagnostic procedure
53,mental-disorders,pregnancy tests,0.04886,diagnostic procedure
53,mental-disorders,mini-mental status exam,0.04735,diagnostic procedure
53,mental-disorders,schizoaffective disorder,0.04528,mental or behavioral dysfunction
53,mental-disorders,moderate adverse event,0.04506,finding
53,mental-disorders,positive finding,0.04499,finding
53,mental-disorders,anxiety disorders,0.04363,finding - mental or behavioral dysfunction
53,mental-disorders,gravidity,0.04291,finding
53,mental-disorders,antidepressive agents,0.04212,pharmacologic substance
53,mental-disorders,attention deficit hyperactivity disorder,0.04091,disease or syndrome - mental or behavioral dysfunction
53,mental-disorders,mild adverse event,0.03997,finding
53,mental-disorders,post-traumatic stress disorder,0.03847,mental or behavioral dysfunction
53,mental-disorders,active brand of pseudoephedrine-triprolidine,0.03747,organic chemical - pharmacologic substance
53,mental-disorders,operative surgical procedures,0.03618,diagnostic procedure - therapeutic or preventive procedure
53,mental-disorders,bipolar disorder,0.0346,mental or behavioral dysfunction
53,mental-disorders,dementia,0.03453,mental or behavioral dysfunction
53,mental-disorders,medical history,0.03439,finding
53,mental-disorders,unipolar depression,0.03388,mental or behavioral dysfunction
53,mental-disorders,mass of body structure,0.03324,finding
53,mental-disorders,depressive episode unspecified,0.03209,mental or behavioral dysfunction
53,mental-disorders,electrocardiogram,0.03195,diagnostic procedure - finding - organic chemical - pharmacologic substance
53,mental-disorders,relate - vinyl resin,0.03145,organic chemical
53,mental-disorders,severe combined immunodeficiency,0.0293,diagnostic procedure - disease or syndrome
53,mental-disorders,allergy severity - severe,0.0293,finding
53,mental-disorders,dactinomycin,0.02901,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
53,mental-disorders,psychotropic drugs,0.02622,pharmacologic substance
53,mental-disorders,psychotic disorders,0.02522,mental or behavioral dysfunction
53,mental-disorders,pharmaceutical preparations,0.02457,pharmacologic substance
53,mental-disorders,autistic disorder,0.02407,mental or behavioral dysfunction
53,mental-disorders,serum,0.02393,biologically active substance - body substance - pharmacologic substance
53,mental-disorders,magnetic resonance imaging,0.02343,diagnostic procedure
53,mental-disorders,sleeplessness,0.02335,finding - sign or symptom
53,mental-disorders,impaired cognition,0.02264,finding - mental or behavioral dysfunction
53,mental-disorders,malignant neoplasms,0.02206,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
53,mental-disorders,treatment protocols,0.02199,therapeutic or preventive procedure
53,mental-disorders,screening for cancer,0.02149,diagnostic procedure
53,mental-disorders,alcoholic intoxication chronic,0.02128,mental or behavioral dysfunction
53,mental-disorders,manic,0.01784,finding - mental or behavioral dysfunction
53,mental-disorders,substance abuse problem,0.01676,mental or behavioral dysfunction
53,mental-disorders,opioids,0.01655,hazardous or poisonous substance - organic chemical - pharmacologic substance
53,mental-disorders,pharmacotherapy,0.01641,therapeutic or preventive procedure
53,mental-disorders,mood disorders,0.01641,mental or behavioral dysfunction
53,mental-disorders,congenital abnormality,0.01497,congenital abnormality - disease or syndrome
53,mental-disorders,marihuana,0.01418,mental or behavioral dysfunction - organic chemical - pharmacologic substance
53,mental-disorders,blood pressure finding,0.01325,finding
53,mental-disorders,selective serotonin re-uptake inhibitor,0.01268,pharmacologic substance
53,mental-disorders,injury wounds,0.01175,body substance - injury or poisoning
53,mental-disorders,opiates,0.01103,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
53,mental-disorders,benzodiazepines,0.01089,organic chemical - pharmacologic substance
53,mental-disorders,infantile neuroaxonal dystrophy,0.01089,disease or syndrome
53,mental-disorders,hypertensive disease,0.01053,biologically active substance - disease or syndrome - finding
53,mental-disorders,neoplasm metastasis,0.01024,neoplastic process
53,mental-disorders,cerebrovascular accident,0.0091,disease or syndrome - therapeutic or preventive procedure
53,mental-disorders,fluoxetine,0.00881,organic chemical - pharmacologic substance
53,mental-disorders,pervasive development disorder,0.00838,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
53,mental-disorders,psychotherapy,0.00802,therapeutic or preventive procedure
53,mental-disorders,stress disorders traumatic,0.00802,mental or behavioral dysfunction
53,mental-disorders,hiv,0.00781,disease or syndrome - pharmacologic substance - virus
53,mental-disorders,nicotine,0.00781,hazardous or poisonous substance - organic chemical - pharmacologic substance
53,mental-disorders,obsessive-compulsive disorder,0.00759,disease or syndrome - mental or behavioral dysfunction
53,mental-disorders,suicidal,0.00738,finding
53,mental-disorders,stimulant,0.00724,pharmacologic substance
53,mental-disorders,unstable status,0.00716,finding
53,mental-disorders,illicit drugs,0.00709,hazardous or poisonous substance - pharmacologic substance
53,mental-disorders,epilepsy,0.00688,disease or syndrome
53,mental-disorders,hepatic,0.00681,body location or region
53,mental-disorders,blood vessel,0.00673,body part, organ, or organ component - finding
53,mental-disorders,diastole,0.0063,clinical attribute
53,mental-disorders,developmental disabilities,0.00616,mental or behavioral dysfunction
53,mental-disorders,nervous system disorder,0.00609,disease or syndrome
53,mental-disorders,personality disorders,0.00602,mental or behavioral dysfunction
53,mental-disorders,alcohol abuse,0.00595,mental or behavioral dysfunction
53,mental-disorders,eating disorders,0.00573,mental or behavioral dysfunction
53,mental-disorders,mental retardation,0.00566,mental or behavioral dysfunction
53,mental-disorders,hypersensitivity,0.00544,clinical attribute - finding - pathologic function
53,mental-disorders,alanine transaminase,0.0053,congenital abnormality - disease or syndrome - enzyme
53,mental-disorders,breast,0.00501,body part, organ, or organ component
53,mental-disorders,multiple sclerosis,0.00437,body part, organ, or organ component - disease or syndrome - finding
53,mental-disorders,caffeine,0.00423,organic chemical - pharmacologic substance - therapeutic or preventive procedure
53,mental-disorders,substance dependence,0.00401,mental or behavioral dysfunction
53,mental-disorders,craniocerebral trauma,0.00401,injury or poisoning
53,mental-disorders,heart diseases,0.00394,disease or syndrome
53,mental-disorders,lung,0.00387,body part, organ, or organ component - disease or syndrome
53,mental-disorders,consciousness related finding,0.00387,finding
53,mental-disorders,brain injuries,0.00373,injury or poisoning
53,mental-disorders,suicide attempt,0.00373,finding - mental or behavioral dysfunction
53,mental-disorders,thyroid gland,0.00344,body part, organ, or organ component - disease or syndrome - pharmacologic substance
53,mental-disorders,diabetes mellitus,0.00337,disease or syndrome - pharmacologic substance
53,mental-disorders,nervousness,0.00337,sign or symptom
53,mental-disorders,cardiovascular diseases,0.00337,disease or syndrome
53,mental-disorders,neurological observations,0.00337,finding
53,mental-disorders,drug abuse,0.00308,mental or behavioral dysfunction
53,mental-disorders,myocardial infarction,0.00294,disease or syndrome - finding
53,mental-disorders,cardiac arrhythmia,0.00294,finding - pathologic function
53,mental-disorders,medical contraindication,0.00294,finding
53,mental-disorders,unconscious state,0.00258,disease or syndrome - finding
53,mental-disorders,angina pectoris,0.00258,sign or symptom
53,mental-disorders,liver diseases,0.00251,disease or syndrome
53,mental-disorders,investigational new drugs,0.00236,pharmacologic substance - therapeutic or preventive procedure
53,mental-disorders,monoamine oxidase inhibitors,0.00236,organic chemical - pharmacologic substance
53,mental-disorders,kidney diseases,0.00222,disease or syndrome
54,mental-disorders-diagnosed-in-childhood,attention deficit hyperactivity disorder,0.4255,disease or syndrome - mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,intravenous infusion procedures,0.41514,therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,autistic disorder,0.25976,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,autism spectrum disorders,0.13466,congenital abnormality - mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,mental disorders,0.10279,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,hyperactive behavior,0.09084,finding
54,mental-disorders-diagnosed-in-childhood,negative finding,0.08127,finding
54,mental-disorders-diagnosed-in-childhood,pervasive development disorder,0.07968,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,pregnancy tests,0.07649,diagnostic procedure
54,mental-disorders-diagnosed-in-childhood,pharmacologic substance,0.07092,pharmacologic substance - therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,physical assessment findings,0.07012,finding
54,mental-disorders-diagnosed-in-childhood,contraceptive methods,0.06932,therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,developmental disabilities,0.05498,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,nitric oxide synthase,0.05339,enzyme
54,mental-disorders-diagnosed-in-childhood,tic disorder,0.05339,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,anxiety disorders,0.04542,finding - mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,moderate adverse event,0.04542,finding
54,mental-disorders-diagnosed-in-childhood,psychotropic drugs,0.04143,pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,serum,0.03904,biologically active substance - body substance - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,gravidity,0.03825,finding
54,mental-disorders-diagnosed-in-childhood,integumentary scale,0.03745,body part, organ, or organ component
54,mental-disorders-diagnosed-in-childhood,schizophrenia,0.03665,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,stimulant,0.03586,pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,surgical revision,0.03347,therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,electrocardiogram,0.03347,diagnostic procedure - finding - organic chemical - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,mood disorders,0.03347,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,disability,0.03267,finding
54,mental-disorders-diagnosed-in-childhood,congenital abnormality,0.03267,congenital abnormality - disease or syndrome
54,mental-disorders-diagnosed-in-childhood,antipsychotic agents,0.03028,pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,malaise,0.02789,finding - sign or symptom
54,mental-disorders-diagnosed-in-childhood,allergy severity - severe,0.02789,finding
54,mental-disorders-diagnosed-in-childhood,sexual intercourse - finding,0.02789,finding
54,mental-disorders-diagnosed-in-childhood,relate - vinyl resin,0.02709,organic chemical
54,mental-disorders-diagnosed-in-childhood,mental retardation,0.02629,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,personal satisfaction,0.0255,finding
54,mental-disorders-diagnosed-in-childhood,blood pressure finding,0.0247,finding
54,mental-disorders-diagnosed-in-childhood,pharmaceutical preparations,0.0239,pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,active brand of pseudoephedrine-triprolidine,0.02311,organic chemical - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,medical history,0.02231,finding
54,mental-disorders-diagnosed-in-childhood,depressed mood,0.02151,finding - mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,body mass index,0.02072,clinical attribute - diagnostic procedure
54,mental-disorders-diagnosed-in-childhood,ethanol,0.02072,organic chemical - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,generalized anxiety disorder,0.01992,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,epilepsy,0.01912,disease or syndrome
54,mental-disorders-diagnosed-in-childhood,gene therapy,0.01833,therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,anxiety generalized,0.01753,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,obsessive-compulsive disorder,0.01753,disease or syndrome - mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,bipolar disorder,0.01673,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,blind vision,0.01673,disease or syndrome
54,mental-disorders-diagnosed-in-childhood,psychotic disorders,0.01594,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,pharmacotherapy,0.01514,therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,osteochondritis dissecans,0.01514,disease or syndrome - mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,mild adverse event,0.01514,finding
54,mental-disorders-diagnosed-in-childhood,mass of body structure,0.01434,finding
54,mental-disorders-diagnosed-in-childhood,fluoxetine,0.01355,organic chemical - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,hypersensitivity,0.01355,clinical attribute - finding - pathologic function
54,mental-disorders-diagnosed-in-childhood,positive finding,0.01275,finding
54,mental-disorders-diagnosed-in-childhood,screening for cancer,0.01275,diagnostic procedure
54,mental-disorders-diagnosed-in-childhood,aggressive behavior,0.01275,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,hearing examination finding,0.01195,finding
54,mental-disorders-diagnosed-in-childhood,compulsive disorder,0.01195,finding
54,mental-disorders-diagnosed-in-childhood,sexually active,0.01195,finding
54,mental-disorders-diagnosed-in-childhood,behavior therapy,0.01195,therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,selective serotonin re-uptake inhibitor,0.01116,pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,movement disorders,0.01036,disease or syndrome
54,mental-disorders-diagnosed-in-childhood,anticonvulsants,0.00876,pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,antidepressive agents,0.00876,pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,nervousness,0.00797,sign or symptom
54,mental-disorders-diagnosed-in-childhood,magnetic resonance imaging,0.00797,diagnostic procedure
54,mental-disorders-diagnosed-in-childhood,nicotine,0.00797,hazardous or poisonous substance - organic chemical - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,neurological observations,0.00797,finding
54,mental-disorders-diagnosed-in-childhood,substance abuse problem,0.00717,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,unstable status,0.00717,finding
54,mental-disorders-diagnosed-in-childhood,benzodiazepines,0.00717,organic chemical - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,schizoaffective disorder,0.00637,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,heart diseases,0.00637,disease or syndrome
54,mental-disorders-diagnosed-in-childhood,kidney,0.00637,body part, organ, or organ component
54,mental-disorders-diagnosed-in-childhood,hepatic,0.00558,body location or region
54,mental-disorders-diagnosed-in-childhood,monoamine oxidase inhibitors,0.00558,organic chemical - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,caffeine,0.00558,organic chemical - pharmacologic substance - therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,traumatic brain injury,0.00558,disease or syndrome - injury or poisoning
54,mental-disorders-diagnosed-in-childhood,hypertensive disease,0.00558,biologically active substance - disease or syndrome - finding
54,mental-disorders-diagnosed-in-childhood,paralysed,0.00558,finding
54,mental-disorders-diagnosed-in-childhood,illicit drugs,0.00478,hazardous or poisonous substance - pharmacologic substance
54,mental-disorders-diagnosed-in-childhood,brain injuries,0.00478,injury or poisoning
54,mental-disorders-diagnosed-in-childhood,nervous system disorder,0.00478,disease or syndrome
54,mental-disorders-diagnosed-in-childhood,suicidal,0.00398,finding
54,mental-disorders-diagnosed-in-childhood,cardiovascular diseases,0.00398,disease or syndrome
54,mental-disorders-diagnosed-in-childhood,malignant neoplasms,0.00398,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,diagnosis psychiatric,0.00398,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,asthma,0.00319,disease or syndrome
54,mental-disorders-diagnosed-in-childhood,unipolar depression,0.00319,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,injury wounds,0.00319,body substance - injury or poisoning
54,mental-disorders-diagnosed-in-childhood,fever,0.00319,finding
54,mental-disorders-diagnosed-in-childhood,major depressive disorder,0.00319,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,craniocerebral trauma,0.00239,injury or poisoning
54,mental-disorders-diagnosed-in-childhood,post-traumatic stress disorder,0.00239,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,family history,0.00239,congenital abnormality - disease or syndrome - enzyme - finding
54,mental-disorders-diagnosed-in-childhood,stress disorders traumatic,0.00239,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,investigational new drugs,0.00239,pharmacologic substance - therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,eating disorders,0.00159,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,drug abuse,0.00159,mental or behavioral dysfunction
54,mental-disorders-diagnosed-in-childhood,suicidality,8e-04,clinical attribute
54,mental-disorders-diagnosed-in-childhood,cardiac arrhythmia,8e-04,finding - pathologic function
54,mental-disorders-diagnosed-in-childhood,psychotherapy,8e-04,therapeutic or preventive procedure
54,mental-disorders-diagnosed-in-childhood,suicide attempt,8e-04,finding - mental or behavioral dysfunction
55,mental-fatigue,malignant neoplasms,0.39344,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
55,mental-fatigue,pharmacotherapy,0.2623,therapeutic or preventive procedure
55,mental-fatigue,active brand of pseudoephedrine-triprolidine,0.11475,organic chemical - pharmacologic substance
55,mental-fatigue,gravidity,0.07377,finding
55,mental-fatigue,depressed mood,0.07377,finding - mental or behavioral dysfunction
55,mental-fatigue,intravenous infusion procedures,0.06557,therapeutic or preventive procedure
55,mental-fatigue,treatment protocols,0.05738,therapeutic or preventive procedure
55,mental-fatigue,sleeplessness,0.05738,finding - sign or symptom
55,mental-fatigue,physical assessment findings,0.05738,finding
55,mental-fatigue,negative finding,0.04918,finding
55,mental-fatigue,psychotic disorders,0.04918,mental or behavioral dysfunction
55,mental-fatigue,moderate adverse event,0.04918,finding
55,mental-fatigue,pregnancy tests,0.04918,diagnostic procedure
55,mental-fatigue,impaired cognition,0.04918,finding - mental or behavioral dysfunction
55,mental-fatigue,major depressive disorder,0.04918,mental or behavioral dysfunction
55,mental-fatigue,neoplasm metastasis,0.04098,neoplastic process
55,mental-fatigue,contraceptive methods,0.04098,therapeutic or preventive procedure
55,mental-fatigue,asleep,0.04098,finding
55,mental-fatigue,pharmaceutical preparations,0.04098,pharmacologic substance
55,mental-fatigue,skeletal bone,0.03279,body location or region - body part, organ, or organ component - body substance - disease or syndrome
55,mental-fatigue,anxiety disorders,0.03279,finding - mental or behavioral dysfunction
55,mental-fatigue,pharmacologic substance,0.03279,pharmacologic substance - therapeutic or preventive procedure
55,mental-fatigue,multiple sclerosis,0.03279,body part, organ, or organ component - disease or syndrome - finding
55,mental-fatigue,schizophrenia,0.03279,mental or behavioral dysfunction
55,mental-fatigue,relate - vinyl resin,0.03279,organic chemical
55,mental-fatigue,operative surgical procedures,0.03279,diagnostic procedure - therapeutic or preventive procedure
55,mental-fatigue,unipolar depression,0.03279,mental or behavioral dysfunction
55,mental-fatigue,pregnancy test negative,0.03279,finding - laboratory or test result
55,mental-fatigue,exercise pain management,0.03279,therapeutic or preventive procedure
55,mental-fatigue,antidepressive agents,0.03279,pharmacologic substance
55,mental-fatigue,life expectancy,0.03279,group attribute
55,mental-fatigue,body mass index,0.02459,clinical attribute - diagnostic procedure
55,mental-fatigue,benzodiazepines,0.02459,organic chemical - pharmacologic substance
55,mental-fatigue,current therapy,0.02459,therapeutic or preventive procedure
55,mental-fatigue,cardiovascular diseases,0.02459,disease or syndrome
55,mental-fatigue,unmarried,0.02459,finding
55,mental-fatigue,substance abuse problem,0.02459,mental or behavioral dysfunction
55,mental-fatigue,allergy severity - severe,0.02459,finding
55,mental-fatigue,electrocardiogram,0.02459,diagnostic procedure - finding - organic chemical - pharmacologic substance
55,mental-fatigue,hypertensive disease,0.02459,biologically active substance - disease or syndrome - finding
55,mental-fatigue,hypersensitivity,0.02459,clinical attribute - finding - pathologic function
55,mental-fatigue,cognitive therapy,0.02459,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
55,mental-fatigue,smoker,0.02459,finding
55,mental-fatigue,mass of body structure,0.02459,finding
55,mental-fatigue,mental disorders,0.02459,mental or behavioral dysfunction
55,mental-fatigue,epilepsy,0.01639,disease or syndrome
55,mental-fatigue,congestive heart failure,0.01639,congenital abnormality - disease or syndrome
55,mental-fatigue,restless legs syndrome,0.01639,disease or syndrome
55,mental-fatigue,hepatic,0.01639,body location or region
55,mental-fatigue,bipolar disorder,0.01639,mental or behavioral dysfunction
55,mental-fatigue,leg,0.01639,body location or region
55,mental-fatigue,traumatic brain injury,0.01639,disease or syndrome - injury or poisoning
55,mental-fatigue,injury wounds,0.01639,body substance - injury or poisoning
55,mental-fatigue,blood pressure finding,0.01639,finding
55,mental-fatigue,smoking,0.01639,hazardous or poisonous substance - individual behavior
55,mental-fatigue,agitation,0.01639,finding - sign or symptom
55,mental-fatigue,brain injuries,0.01639,injury or poisoning
55,mental-fatigue,narcotics,0.01639,biologically active substance - hazardous or poisonous substance - pharmacologic substance
55,mental-fatigue,cardiac arrhythmia,0.01639,finding - pathologic function
55,mental-fatigue,follow-up status,0.01639,finding
55,mental-fatigue,therapeutic brand of coal tar,0.01639,organic chemical - pharmacologic substance - therapeutic or preventive procedure
55,mental-fatigue,suicidal,0.0082,finding
55,mental-fatigue,ethanol,0.0082,organic chemical - pharmacologic substance
55,mental-fatigue,disability,0.0082,finding
55,mental-fatigue,psychiatric problem,0.0082,mental or behavioral dysfunction
55,mental-fatigue,household composition,0.0082,finding
55,mental-fatigue,manic,0.0082,finding - mental or behavioral dysfunction
55,mental-fatigue,alcohol abuse,0.0082,mental or behavioral dysfunction
55,mental-fatigue,caffeine,0.0082,organic chemical - pharmacologic substance - therapeutic or preventive procedure
55,mental-fatigue,myocardial infarction,0.0082,disease or syndrome - finding
55,mental-fatigue,unconscious state,0.0082,disease or syndrome - finding
55,mental-fatigue,craniocerebral trauma,0.0082,injury or poisoning
55,mental-fatigue,illicit drugs,0.0082,hazardous or poisonous substance - pharmacologic substance
55,mental-fatigue,unstable status,0.0082,finding
55,mental-fatigue,angina pectoris,0.0082,sign or symptom
55,mental-fatigue,dementia,0.0082,mental or behavioral dysfunction
55,mental-fatigue,adrenal cortex hormones,0.0082,pharmacologic substance
55,mental-fatigue,cerebrovascular accident,0.0082,disease or syndrome - therapeutic or preventive procedure
55,mental-fatigue,chronic disease,0.0082,disease or syndrome
56,mental-retardation,gene therapy,0.11215,therapeutic or preventive procedure
56,mental-retardation,gravidity,0.08411,finding
56,mental-retardation,mental retardation,0.07788,mental or behavioral dysfunction
56,mental-retardation,congenital abnormality,0.07477,congenital abnormality - disease or syndrome
56,mental-retardation,body mass index,0.06854,clinical attribute - diagnostic procedure
56,mental-retardation,contraceptive methods,0.06231,therapeutic or preventive procedure
56,mental-retardation,disability,0.05607,finding
56,mental-retardation,moderate adverse event,0.04984,finding
56,mental-retardation,negative finding,0.04673,finding
56,mental-retardation,physical assessment findings,0.04673,finding
56,mental-retardation,epilepsy,0.04361,disease or syndrome
56,mental-retardation,treatment protocols,0.03738,therapeutic or preventive procedure
56,mental-retardation,pregnancy tests,0.03738,diagnostic procedure
56,mental-retardation,mass of body structure,0.03738,finding
56,mental-retardation,positive finding,0.03427,finding
56,mental-retardation,magnetic resonance imaging,0.03427,diagnostic procedure
56,mental-retardation,atypia morphology,0.03427,finding
56,mental-retardation,autistic disorder,0.03427,mental or behavioral dysfunction
56,mental-retardation,skeletal bone,0.03115,body location or region - body part, organ, or organ component - body substance - disease or syndrome
56,mental-retardation,pharmacotherapy,0.03115,therapeutic or preventive procedure
56,mental-retardation,obesity,0.03115,disease or syndrome - finding
56,mental-retardation,mild adverse event,0.03115,finding
56,mental-retardation,intravenous infusion procedures,0.03115,therapeutic or preventive procedure
56,mental-retardation,serum,0.03115,biologically active substance - body substance - pharmacologic substance
56,mental-retardation,autism spectrum disorders,0.02804,congenital abnormality - mental or behavioral dysfunction
56,mental-retardation,hearing examination finding,0.02804,finding
56,mental-retardation,personal satisfaction,0.02804,finding
56,mental-retardation,allergy severity - severe,0.02804,finding
56,mental-retardation,sexual intercourse - finding,0.02804,finding
56,mental-retardation,pharmacologic substance,0.02492,pharmacologic substance - therapeutic or preventive procedure
56,mental-retardation,relate - vinyl resin,0.02492,organic chemical
56,mental-retardation,medical history,0.02492,finding
56,mental-retardation,electrocardiogram,0.02492,diagnostic procedure - finding - organic chemical - pharmacologic substance
56,mental-retardation,weighing patient,0.02181,diagnostic procedure - finding
56,mental-retardation,antipsychotic agents,0.01869,pharmacologic substance
56,mental-retardation,pharmaceutical preparations,0.01869,pharmacologic substance
56,mental-retardation,active brand of pseudoephedrine-triprolidine,0.01869,organic chemical - pharmacologic substance
56,mental-retardation,creatinine clearance,0.01558,finding
56,mental-retardation,hepatic,0.01558,body location or region
56,mental-retardation,psychotropic drugs,0.01558,pharmacologic substance
56,mental-retardation,thyroid gland,0.01558,body part, organ, or organ component - disease or syndrome - pharmacologic substance
56,mental-retardation,operative surgical procedures,0.01246,diagnostic procedure - therapeutic or preventive procedure
56,mental-retardation,heart diseases,0.01246,disease or syndrome
56,mental-retardation,lung,0.01246,body part, organ, or organ component - disease or syndrome
56,mental-retardation,kidney,0.01246,body part, organ, or organ component
56,mental-retardation,liver diseases,0.01246,disease or syndrome
56,mental-retardation,depressed mood,0.01246,finding - mental or behavioral dysfunction
56,mental-retardation,mental disorders,0.01246,mental or behavioral dysfunction
56,mental-retardation,schizophrenia,0.00935,mental or behavioral dysfunction
56,mental-retardation,insulin,0.00935,pharmacologic substance
56,mental-retardation,family history,0.00935,congenital abnormality - disease or syndrome - enzyme - finding
56,mental-retardation,unstable status,0.00935,finding
56,mental-retardation,hypertensive disease,0.00935,biologically active substance - disease or syndrome - finding
56,mental-retardation,major depressive disorder,0.00935,mental or behavioral dysfunction
56,mental-retardation,nervous system disorder,0.00935,disease or syndrome
56,mental-retardation,malignant neoplasms,0.00935,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
56,mental-retardation,psychotic disorders,0.00623,mental or behavioral dysfunction
56,mental-retardation,asthma,0.00623,disease or syndrome
56,mental-retardation,dementia,0.00623,mental or behavioral dysfunction
56,mental-retardation,substance abuse problem,0.00312,mental or behavioral dysfunction
56,mental-retardation,cardiovascular diseases,0.00312,disease or syndrome
56,mental-retardation,ethanol,0.00312,organic chemical - pharmacologic substance
56,mental-retardation,investigational new drugs,0.00312,pharmacologic substance - therapeutic or preventive procedure
56,mental-retardation,memantine,0.00312,organic chemical - pharmacologic substance
56,mental-retardation,medical contraindication,0.00312,finding
57,mood-disorders,depressed mood,0.37342,finding - mental or behavioral dysfunction
57,mood-disorders,intravenous infusion procedures,0.35452,therapeutic or preventive procedure
57,mood-disorders,major depressive disorder,0.26027,mental or behavioral dysfunction
57,mood-disorders,antidepressive agents,0.12849,pharmacologic substance
57,mood-disorders,depressive episode unspecified,0.12027,mental or behavioral dysfunction
57,mood-disorders,contraceptive methods,0.12,therapeutic or preventive procedure
57,mood-disorders,bipolar disorder,0.11452,mental or behavioral dysfunction
57,mood-disorders,unipolar depression,0.11288,mental or behavioral dysfunction
57,mood-disorders,mental disorders,0.08301,mental or behavioral dysfunction
57,mood-disorders,tropical spastic paraparesis,0.07096,disease or syndrome - therapeutic or preventive procedure
57,mood-disorders,manic,0.06356,finding - mental or behavioral dysfunction
57,mood-disorders,physical assessment findings,0.06192,finding
57,mood-disorders,negative finding,0.0589,finding
57,mood-disorders,anxiety disorders,0.05781,finding - mental or behavioral dysfunction
57,mood-disorders,severe combined immunodeficiency,0.05507,diagnostic procedure - disease or syndrome
57,mood-disorders,pharmacologic substance,0.05425,pharmacologic substance - therapeutic or preventive procedure
57,mood-disorders,multiple endocrine neoplasia,0.05151,antibiotic - neoplastic process - organic chemical
57,mood-disorders,moderate adverse event,0.05123,finding
57,mood-disorders,depressive symptoms,0.04849,sign or symptom
57,mood-disorders,pregnancy tests,0.04521,diagnostic procedure
57,mood-disorders,antipsychotic agents,0.04493,pharmacologic substance
57,mood-disorders,gravidity,0.04384,finding
57,mood-disorders,schizophrenia,0.04329,mental or behavioral dysfunction
57,mood-disorders,mood disorders,0.04164,mental or behavioral dysfunction
57,mood-disorders,body mass index,0.04137,clinical attribute - diagnostic procedure
57,mood-disorders,allergy severity - severe,0.03918,finding
57,mood-disorders,unmarried,0.0389,finding
57,mood-disorders,dysthymic disorder,0.03589,mental or behavioral dysfunction
57,mood-disorders,active brand of pseudoephedrine-triprolidine,0.03562,organic chemical - pharmacologic substance
57,mood-disorders,medical history,0.03123,finding
57,mood-disorders,operative surgical procedures,0.03096,diagnostic procedure - therapeutic or preventive procedure
57,mood-disorders,nitric oxide synthase,0.03068,enzyme
57,mood-disorders,malignant neoplasms,0.02986,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
57,mood-disorders,ethanol,0.02959,organic chemical - pharmacologic substance
57,mood-disorders,psychotropic drugs,0.02959,pharmacologic substance
57,mood-disorders,lithium,0.02959,congenital abnormality - disease or syndrome - pharmacologic substance
57,mood-disorders,mild adverse event,0.02959,finding
57,mood-disorders,stabilizer - function,0.02904,organ or tissue function
57,mood-disorders,mass of body structure,0.02877,finding
57,mood-disorders,personality inventories,0.02849,diagnostic procedure
57,mood-disorders,surgical revision,0.02795,therapeutic or preventive procedure
57,mood-disorders,serum,0.02712,biologically active substance - body substance - pharmacologic substance
57,mood-disorders,selective serotonin re-uptake inhibitor,0.02685,pharmacologic substance
57,mood-disorders,treatment protocols,0.02521,therapeutic or preventive procedure
57,mood-disorders,schizoaffective disorder,0.02521,mental or behavioral dysfunction
57,mood-disorders,electrocardiogram,0.02384,diagnostic procedure - finding - organic chemical - pharmacologic substance
57,mood-disorders,psychotic disorders,0.02356,mental or behavioral dysfunction
57,mood-disorders,screening for cancer,0.02274,diagnostic procedure
57,mood-disorders,cancer remission,0.02137,finding - neoplastic process
57,mood-disorders,relate - vinyl resin,0.01945,organic chemical
57,mood-disorders,pharmacotherapy,0.01918,therapeutic or preventive procedure
57,mood-disorders,positive finding,0.01836,finding
57,mood-disorders,pharmaceutical preparations,0.01836,pharmacologic substance
57,mood-disorders,post-traumatic stress disorder,0.01836,mental or behavioral dysfunction
57,mood-disorders,psychotherapy,0.01836,therapeutic or preventive procedure
57,mood-disorders,suicidal,0.01699,finding
57,mood-disorders,generalized anxiety disorder,0.01644,mental or behavioral dysfunction
57,mood-disorders,fluoxetine,0.01616,organic chemical - pharmacologic substance
57,mood-disorders,mini-mental status exam,0.01616,diagnostic procedure
57,mood-disorders,benign rolandic epilepsy,0.01562,disease or syndrome - therapeutic or preventive procedure
57,mood-disorders,therapeutic brand of coal tar,0.01534,organic chemical - pharmacologic substance - therapeutic or preventive procedure
57,mood-disorders,substance abuse problem,0.01479,mental or behavioral dysfunction
57,mood-disorders,contraceptives oral,0.01479,pharmacologic substance - therapeutic or preventive procedure
57,mood-disorders,anxiety generalized,0.0137,mental or behavioral dysfunction
57,mood-disorders,blood pressure finding,0.0137,finding
57,mood-disorders,infantile neuroaxonal dystrophy,0.01315,disease or syndrome
57,mood-disorders,benzodiazepines,0.01178,organic chemical - pharmacologic substance
57,mood-disorders,neoplasm metastasis,0.01151,neoplastic process
57,mood-disorders,magnetic resonance imaging,0.01123,diagnostic procedure
57,mood-disorders,alcoholic intoxication chronic,0.01068,mental or behavioral dysfunction
57,mood-disorders,congenital abnormality,0.01041,congenital abnormality - disease or syndrome
57,mood-disorders,impaired cognition,0.01014,finding - mental or behavioral dysfunction
57,mood-disorders,panic disorder,0.00986,disease or syndrome - mental or behavioral dysfunction
57,mood-disorders,suicide attempt,0.00877,finding - mental or behavioral dysfunction
57,mood-disorders,hypertensive disease,0.00822,biologically active substance - disease or syndrome - finding
57,mood-disorders,psychotic symptoms,0.00822,sign or symptom
57,mood-disorders,hiv,0.00795,disease or syndrome - pharmacologic substance - virus
57,mood-disorders,obsessive-compulsive disorder,0.00767,disease or syndrome - mental or behavioral dysfunction
57,mood-disorders,injury wounds,0.00712,body substance - injury or poisoning
57,mood-disorders,anticonvulsants,0.00712,pharmacologic substance
57,mood-disorders,stress disorders traumatic,0.00658,mental or behavioral dysfunction
57,mood-disorders,cerebrovascular accident,0.00658,disease or syndrome - therapeutic or preventive procedure
57,mood-disorders,diabetes mellitus,0.00603,disease or syndrome - pharmacologic substance
57,mood-disorders,unstable status,0.00603,finding
57,mood-disorders,personality disorders,0.00548,mental or behavioral dysfunction
57,mood-disorders,stimulation procedure,0.00521,therapeutic or preventive procedure
57,mood-disorders,multiple sclerosis,0.00493,body part, organ, or organ component - disease or syndrome - finding
57,mood-disorders,heart diseases,0.00493,disease or syndrome
57,mood-disorders,cardiovascular diseases,0.00466,disease or syndrome
57,mood-disorders,hepatic,0.00466,body location or region
57,mood-disorders,nervous system disorder,0.00466,disease or syndrome
57,mood-disorders,breast,0.00438,body part, organ, or organ component
57,mood-disorders,illicit drugs,0.00438,hazardous or poisonous substance - pharmacologic substance
57,mood-disorders,compulsive disorder,0.00438,finding
57,mood-disorders,suicidality,0.00384,clinical attribute
57,mood-disorders,thyroid gland,0.00384,body part, organ, or organ component - disease or syndrome - pharmacologic substance
57,mood-disorders,mental retardation,0.00356,mental or behavioral dysfunction
57,mood-disorders,monoamine oxidase inhibitors,0.00356,organic chemical - pharmacologic substance
57,mood-disorders,substance dependence,0.00329,mental or behavioral dysfunction
57,mood-disorders,substance use disorders,0.00329,mental or behavioral dysfunction
57,mood-disorders,developmental disabilities,0.00329,mental or behavioral dysfunction
57,mood-disorders,hypothyroidism,0.00301,disease or syndrome
57,mood-disorders,craniocerebral trauma,0.00301,injury or poisoning
57,mood-disorders,medical contraindication,0.00301,finding
57,mood-disorders,eating disorders,0.00274,mental or behavioral dysfunction
57,mood-disorders,alcohol abuse,0.00274,mental or behavioral dysfunction
57,mood-disorders,kidney diseases,0.00247,disease or syndrome
57,mood-disorders,pervasive development disorder,0.00247,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
57,mood-disorders,hypersensitivity,0.00247,clinical attribute - finding - pathologic function
57,mood-disorders,myocardial infarction,0.00219,disease or syndrome - finding
57,mood-disorders,lung,0.00219,body part, organ, or organ component - disease or syndrome
57,mood-disorders,nicotine,0.00192,hazardous or poisonous substance - organic chemical - pharmacologic substance
57,mood-disorders,nervousness,0.00164,sign or symptom
57,mood-disorders,investigational new drugs,0.00137,pharmacologic substance - therapeutic or preventive procedure
57,mood-disorders,caffeine,0.0011,organic chemical - pharmacologic substance - therapeutic or preventive procedure
57,mood-disorders,liver diseases,0.0011,disease or syndrome
57,mood-disorders,suicide risk,0.00027,finding
58,neurocirculatory-asthenia,blood pressure finding,0.13559,finding
58,neurocirculatory-asthenia,systolic pressure,0.12712,clinical attribute - diagnostic procedure
58,neurocirculatory-asthenia,heart rate,0.12712,clinical attribute
58,neurocirculatory-asthenia,allergy severity - severe,0.07627,finding
58,neurocirculatory-asthenia,negative finding,0.0678,finding
58,neurocirculatory-asthenia,pregnancy tests,0.0678,diagnostic procedure
58,neurocirculatory-asthenia,smoker,0.0678,finding
58,neurocirculatory-asthenia,diastolic blood pressure,0.0678,clinical attribute - diagnostic procedure - finding
58,neurocirculatory-asthenia,diastole,0.0678,clinical attribute
58,neurocirculatory-asthenia,positive finding,0.05932,finding
58,neurocirculatory-asthenia,bleomycin-cisplatin protocol,0.05932,therapeutic or preventive procedure
58,neurocirculatory-asthenia,operative surgical procedures,0.05932,diagnostic procedure - therapeutic or preventive procedure
58,neurocirculatory-asthenia,moderate adverse event,0.05932,finding
58,neurocirculatory-asthenia,body mass index,0.05085,clinical attribute - diagnostic procedure
58,neurocirculatory-asthenia,heart diseases,0.05085,disease or syndrome
58,neurocirculatory-asthenia,mercury,0.05085,hazardous or poisonous substance
58,neurocirculatory-asthenia,hypertensive disease,0.05085,biologically active substance - disease or syndrome - finding
58,neurocirculatory-asthenia,physical assessment findings,0.05085,finding
58,neurocirculatory-asthenia,hepatic,0.04237,body location or region
58,neurocirculatory-asthenia,pharmacologic substance,0.0339,pharmacologic substance - therapeutic or preventive procedure
58,neurocirculatory-asthenia,human chorionic gonadotropin,0.0339,disease or syndrome - pharmacologic substance
58,neurocirculatory-asthenia,heart ventricle,0.0339,body part, organ, or organ component
58,neurocirculatory-asthenia,intravenous infusion procedures,0.0339,therapeutic or preventive procedure
58,neurocirculatory-asthenia,follow-up status,0.0339,finding
58,neurocirculatory-asthenia,mass of body structure,0.0339,finding
58,neurocirculatory-asthenia,congestive heart failure,0.02542,congenital abnormality - disease or syndrome
58,neurocirculatory-asthenia,nervousness,0.02542,sign or symptom
58,neurocirculatory-asthenia,blood vessel,0.02542,body part, organ, or organ component - finding
58,neurocirculatory-asthenia,pharmaceutical preparations,0.02542,pharmacologic substance
58,neurocirculatory-asthenia,congenital abnormality,0.02542,congenital abnormality - disease or syndrome
58,neurocirculatory-asthenia,medical history,0.02542,finding
58,neurocirculatory-asthenia,gravidity,0.02542,finding
58,neurocirculatory-asthenia,smoking,0.02542,hazardous or poisonous substance - individual behavior
58,neurocirculatory-asthenia,exercise pain management,0.02542,therapeutic or preventive procedure
58,neurocirculatory-asthenia,neurological observations,0.02542,finding
58,neurocirculatory-asthenia,kidney diseases,0.01695,disease or syndrome
58,neurocirculatory-asthenia,pathology processes,0.01695,pathologic function
58,neurocirculatory-asthenia,contraceptive methods,0.01695,therapeutic or preventive procedure
58,neurocirculatory-asthenia,neoplasm metastasis,0.01695,neoplastic process
58,neurocirculatory-asthenia,ethanol,0.01695,organic chemical - pharmacologic substance
58,neurocirculatory-asthenia,injury wounds,0.01695,body substance - injury or poisoning
58,neurocirculatory-asthenia,dementia,0.01695,mental or behavioral dysfunction
58,neurocirculatory-asthenia,implantation procedure,0.01695,therapeutic or preventive procedure
58,neurocirculatory-asthenia,epilepsy,0.00847,disease or syndrome
58,neurocirculatory-asthenia,diabetes mellitus,0.00847,disease or syndrome - pharmacologic substance
58,neurocirculatory-asthenia,household composition,0.00847,finding
58,neurocirculatory-asthenia,myocardial infarction,0.00847,disease or syndrome - finding
58,neurocirculatory-asthenia,caffeine,0.00847,organic chemical - pharmacologic substance - therapeutic or preventive procedure
58,neurocirculatory-asthenia,electrocardiogram,0.00847,diagnostic procedure - finding - organic chemical - pharmacologic substance
58,neurocirculatory-asthenia,cardiac arrhythmia,0.00847,finding - pathologic function
58,neurocirculatory-asthenia,unstable status,0.00847,finding
58,neurocirculatory-asthenia,angina pectoris,0.00847,sign or symptom
58,neurocirculatory-asthenia,angina unstable,0.00847,disease or syndrome
58,neurocirculatory-asthenia,life expectancy,0.00847,group attribute
58,neurocirculatory-asthenia,cerebrovascular accident,0.00847,disease or syndrome - therapeutic or preventive procedure
58,neurocirculatory-asthenia,multiple endocrine neoplasia,0.00847,antibiotic - neoplastic process - organic chemical
59,obsessive-behavior,osteochondritis dissecans,0.56667,disease or syndrome - mental or behavioral dysfunction
59,obsessive-behavior,intravenous infusion procedures,0.4,therapeutic or preventive procedure
59,obsessive-behavior,obsessive-compulsive disorder,0.36667,disease or syndrome - mental or behavioral dysfunction
59,obsessive-behavior,anxiety disorders,0.25,finding - mental or behavioral dysfunction
59,obsessive-behavior,compulsive disorder,0.16667,finding
59,obsessive-behavior,generalized anxiety disorder,0.15,mental or behavioral dysfunction
59,obsessive-behavior,anxiety generalized,0.13333,mental or behavioral dysfunction
59,obsessive-behavior,psychotropic drugs,0.11667,pharmacologic substance
59,obsessive-behavior,depressed mood,0.11667,finding - mental or behavioral dysfunction
59,obsessive-behavior,phobic anxiety disorder,0.11667,mental or behavioral dysfunction
59,obsessive-behavior,attention deficit hyperactivity disorder,0.1,disease or syndrome - mental or behavioral dysfunction
59,obsessive-behavior,phobia social,0.1,mental or behavioral dysfunction
59,obsessive-behavior,autism spectrum disorders,0.08333,congenital abnormality - mental or behavioral dysfunction
59,obsessive-behavior,panic disorder,0.08333,disease or syndrome - mental or behavioral dysfunction
59,obsessive-behavior,autistic disorder,0.08333,mental or behavioral dysfunction
59,obsessive-behavior,major depressive disorder,0.08333,mental or behavioral dysfunction
59,obsessive-behavior,mental disorders,0.08333,mental or behavioral dysfunction
59,obsessive-behavior,tic disorder,0.06667,mental or behavioral dysfunction
59,obsessive-behavior,post-traumatic stress disorder,0.06667,mental or behavioral dysfunction
59,obsessive-behavior,multiple endocrine neoplasia,0.06667,antibiotic - neoplastic process - organic chemical
59,obsessive-behavior,stress disorders traumatic,0.05,mental or behavioral dysfunction
59,obsessive-behavior,hyperactive behavior,0.05,finding
59,obsessive-behavior,schizophrenia,0.05,mental or behavioral dysfunction
59,obsessive-behavior,negative finding,0.05,finding
59,obsessive-behavior,behavior disorders,0.05,injury or poisoning - mental or behavioral dysfunction
59,obsessive-behavior,pervasive development disorder,0.05,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
59,obsessive-behavior,eating disorders,0.05,mental or behavioral dysfunction
59,obsessive-behavior,fluoxetine,0.05,organic chemical - pharmacologic substance
59,obsessive-behavior,contraceptive methods,0.05,therapeutic or preventive procedure
59,obsessive-behavior,moderate adverse event,0.03333,finding
59,obsessive-behavior,neoplasm metastasis,0.03333,neoplastic process
59,obsessive-behavior,allergy severity - severe,0.03333,finding
59,obsessive-behavior,implantation procedure,0.03333,therapeutic or preventive procedure
59,obsessive-behavior,gravidity,0.03333,finding
59,obsessive-behavior,bipolar disorder,0.01667,mental or behavioral dysfunction
59,obsessive-behavior,congenital abnormality,0.01667,congenital abnormality - disease or syndrome
59,obsessive-behavior,psychotic disorders,0.01667,mental or behavioral dysfunction
59,obsessive-behavior,psychotherapy,0.01667,therapeutic or preventive procedure
59,obsessive-behavior,nervous system disorder,0.01667,disease or syndrome
59,obsessive-behavior,anti-anxiety agents,0.01667,pharmacologic substance
59,obsessive-behavior,antipsychotic agents,0.01667,pharmacologic substance
59,obsessive-behavior,psychiatric problem,0.01667,mental or behavioral dysfunction
59,obsessive-behavior,claustrophobia,0.01667,mental or behavioral dysfunction
59,obsessive-behavior,current therapy,0.01667,therapeutic or preventive procedure
59,obsessive-behavior,physical assessment findings,0.01667,finding
59,obsessive-behavior,pharmacologic substance,0.01667,pharmacologic substance - therapeutic or preventive procedure
59,obsessive-behavior,antidepressive agents,0.01667,pharmacologic substance
59,obsessive-behavior,medical history,0.01667,finding
59,obsessive-behavior,schizoaffective disorder,0.01667,mental or behavioral dysfunction
59,obsessive-behavior,active brand of pseudoephedrine-triprolidine,0.01667,organic chemical - pharmacologic substance
59,obsessive-behavior,developmental disabilities,0.01667,mental or behavioral dysfunction
59,obsessive-behavior,cognitive therapy,0.01667,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
59,obsessive-behavior,selective serotonin re-uptake inhibitor,0.01667,pharmacologic substance
59,obsessive-behavior,relate - vinyl resin,0.01667,organic chemical
60,obsessive-compulsive-disorder,osteochondritis dissecans,0.64948,disease or syndrome - mental or behavioral dysfunction
60,obsessive-compulsive-disorder,intravenous infusion procedures,0.47938,therapeutic or preventive procedure
60,obsessive-compulsive-disorder,obsessive-compulsive disorder,0.33505,disease or syndrome - mental or behavioral dysfunction
60,obsessive-compulsive-disorder,compulsive disorder,0.15979,finding
60,obsessive-compulsive-disorder,anxiety disorders,0.15464,finding - mental or behavioral dysfunction
60,obsessive-compulsive-disorder,selective serotonin re-uptake inhibitor,0.11856,pharmacologic substance
60,obsessive-compulsive-disorder,contraceptive methods,0.1134,therapeutic or preventive procedure
60,obsessive-compulsive-disorder,fluoxetine,0.08247,organic chemical - pharmacologic substance
60,obsessive-compulsive-disorder,pharmacologic substance,0.08247,pharmacologic substance - therapeutic or preventive procedure
60,obsessive-compulsive-disorder,negative finding,0.08247,finding
60,obsessive-compulsive-disorder,moderate adverse event,0.07732,finding
60,obsessive-compulsive-disorder,antipsychotic agents,0.07216,pharmacologic substance
60,obsessive-compulsive-disorder,generalized anxiety disorder,0.07216,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,mental disorders,0.07216,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,tic disorder,0.06701,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,anxiety generalized,0.06186,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,allergy severity - severe,0.06186,finding
60,obsessive-compulsive-disorder,pregnancy tests,0.06186,diagnostic procedure
60,obsessive-compulsive-disorder,behavior therapy,0.06186,therapeutic or preventive procedure
60,obsessive-compulsive-disorder,depressed mood,0.06186,finding - mental or behavioral dysfunction
60,obsessive-compulsive-disorder,severe combined immunodeficiency,0.0567,diagnostic procedure - disease or syndrome
60,obsessive-compulsive-disorder,cognitive therapy,0.0567,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
60,obsessive-compulsive-disorder,multiple endocrine neoplasia,0.0567,antibiotic - neoplastic process - organic chemical
60,obsessive-compulsive-disorder,psychotropic drugs,0.04639,pharmacologic substance
60,obsessive-compulsive-disorder,physical assessment findings,0.04639,finding
60,obsessive-compulsive-disorder,phobic anxiety disorder,0.04639,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,phobia social,0.04124,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,treatment protocols,0.03608,therapeutic or preventive procedure
60,obsessive-compulsive-disorder,panic disorder,0.03608,disease or syndrome - mental or behavioral dysfunction
60,obsessive-compulsive-disorder,schizophrenia,0.03608,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,attention deficit hyperactivity disorder,0.03608,disease or syndrome - mental or behavioral dysfunction
60,obsessive-compulsive-disorder,serum,0.03608,biologically active substance - body substance - pharmacologic substance
60,obsessive-compulsive-disorder,hyperactive behavior,0.03093,finding
60,obsessive-compulsive-disorder,pharmacotherapy,0.03093,therapeutic or preventive procedure
60,obsessive-compulsive-disorder,post-traumatic stress disorder,0.03093,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,autistic disorder,0.03093,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,psychotherapy,0.03093,therapeutic or preventive procedure
60,obsessive-compulsive-disorder,antidepressive agents,0.03093,pharmacologic substance
60,obsessive-compulsive-disorder,autism spectrum disorders,0.02577,congenital abnormality - mental or behavioral dysfunction
60,obsessive-compulsive-disorder,pervasive development disorder,0.02577,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
60,obsessive-compulsive-disorder,neoplasm metastasis,0.02577,neoplastic process
60,obsessive-compulsive-disorder,pharmaceutical preparations,0.02577,pharmacologic substance
60,obsessive-compulsive-disorder,congenital abnormality,0.02577,congenital abnormality - disease or syndrome
60,obsessive-compulsive-disorder,gravidity,0.02577,finding
60,obsessive-compulsive-disorder,atypia morphology,0.02577,finding
60,obsessive-compulsive-disorder,treatment-psychosocial effects,0.02577,finding
60,obsessive-compulsive-disorder,major depressive disorder,0.02577,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,relate - vinyl resin,0.02062,organic chemical
60,obsessive-compulsive-disorder,infantile neuroaxonal dystrophy,0.02062,disease or syndrome
60,obsessive-compulsive-disorder,active brand of pseudoephedrine-triprolidine,0.02062,organic chemical - pharmacologic substance
60,obsessive-compulsive-disorder,ethanol,0.02062,organic chemical - pharmacologic substance
60,obsessive-compulsive-disorder,stress disorders traumatic,0.02062,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,cancer remission,0.02062,finding - neoplastic process
60,obsessive-compulsive-disorder,lithium,0.01546,congenital abnormality - disease or syndrome - pharmacologic substance
60,obsessive-compulsive-disorder,operative surgical procedures,0.01546,diagnostic procedure - therapeutic or preventive procedure
60,obsessive-compulsive-disorder,medical history,0.01546,finding
60,obsessive-compulsive-disorder,electrocardiogram,0.01546,diagnostic procedure - finding - organic chemical - pharmacologic substance
60,obsessive-compulsive-disorder,eating disorders,0.01546,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,hypertensive disease,0.01546,biologically active substance - disease or syndrome - finding
60,obsessive-compulsive-disorder,implantation procedure,0.01546,therapeutic or preventive procedure
60,obsessive-compulsive-disorder,benzodiazepines,0.01546,organic chemical - pharmacologic substance
60,obsessive-compulsive-disorder,nervous system disorder,0.01546,disease or syndrome
60,obsessive-compulsive-disorder,hypersensitivity,0.01546,clinical attribute - finding - pathologic function
60,obsessive-compulsive-disorder,therapeutic brand of coal tar,0.01546,organic chemical - pharmacologic substance - therapeutic or preventive procedure
60,obsessive-compulsive-disorder,developmental disabilities,0.01546,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,unstable status,0.01031,finding
60,obsessive-compulsive-disorder,substance abuse problem,0.01031,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,anti-anxiety agents,0.01031,pharmacologic substance
60,obsessive-compulsive-disorder,schizoaffective disorder,0.01031,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,magnetic resonance imaging,0.01031,diagnostic procedure
60,obsessive-compulsive-disorder,positive finding,0.01031,finding
60,obsessive-compulsive-disorder,bipolar disorder,0.01031,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,mood disorders,0.01031,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,screening for cancer,0.01031,diagnostic procedure
60,obsessive-compulsive-disorder,liver function,0.01031,organ or tissue function
60,obsessive-compulsive-disorder,current therapy,0.01031,therapeutic or preventive procedure
60,obsessive-compulsive-disorder,diagnosis psychiatric,0.01031,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,suicidal,0.00515,finding
60,obsessive-compulsive-disorder,epilepsy,0.00515,disease or syndrome
60,obsessive-compulsive-disorder,psychotic disorders,0.00515,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,psychiatric problem,0.00515,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,personality disorders,0.00515,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,tropical spastic paraparesis,0.00515,disease or syndrome - therapeutic or preventive procedure
60,obsessive-compulsive-disorder,hepatic,0.00515,body location or region
60,obsessive-compulsive-disorder,myocardial infarction,0.00515,disease or syndrome - finding
60,obsessive-compulsive-disorder,alcoholic intoxication chronic,0.00515,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,claustrophobia,0.00515,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,heart diseases,0.00515,disease or syndrome
60,obsessive-compulsive-disorder,craniocerebral trauma,0.00515,injury or poisoning
60,obsessive-compulsive-disorder,unipolar depression,0.00515,mental or behavioral dysfunction
60,obsessive-compulsive-disorder,sexual intercourse - finding,0.00515,finding
60,obsessive-compulsive-disorder,impaired cognition,0.00515,finding - mental or behavioral dysfunction
60,obsessive-compulsive-disorder,monoamine oxidase inhibitors,0.00515,organic chemical - pharmacologic substance
60,obsessive-compulsive-disorder,investigational new drugs,0.00515,pharmacologic substance - therapeutic or preventive procedure
60,obsessive-compulsive-disorder,injury wounds,0.00515,body substance - injury or poisoning
60,obsessive-compulsive-disorder,medical contraindication,0.00515,finding
61,opioid-related-disorders,opioids,0.43529,hazardous or poisonous substance - organic chemical - pharmacologic substance
61,opioid-related-disorders,opiate addiction,0.4,mental or behavioral dysfunction
61,opioid-related-disorders,intravenous infusion procedures,0.28,therapeutic or preventive procedure
61,opioid-related-disorders,opiates,0.23529,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
61,opioid-related-disorders,contraceptive methods,0.18118,therapeutic or preventive procedure
61,opioid-related-disorders,pharmacologic substance,0.15765,pharmacologic substance - therapeutic or preventive procedure
61,opioid-related-disorders,positive finding,0.13882,finding
61,opioid-related-disorders,negative finding,0.10824,finding
61,opioid-related-disorders,physical assessment findings,0.09647,finding
61,opioid-related-disorders,gravidity,0.07059,finding
61,opioid-related-disorders,pregnancy tests,0.06353,diagnostic procedure
61,opioid-related-disorders,screening for cancer,0.06353,diagnostic procedure
61,opioid-related-disorders,mental disorders,0.04941,mental or behavioral dysfunction
61,opioid-related-disorders,pharmaceutical preparations,0.04706,pharmacologic substance
61,opioid-related-disorders,ethanol,0.04706,organic chemical - pharmacologic substance
61,opioid-related-disorders,medical history,0.04471,finding
61,opioid-related-disorders,detoxification procedure,0.04235,therapeutic or preventive procedure
61,opioid-related-disorders,body mass index,0.04,clinical attribute - diagnostic procedure
61,opioid-related-disorders,substance abuse problem,0.04,mental or behavioral dysfunction
61,opioid-related-disorders,personal satisfaction,0.03765,finding
61,opioid-related-disorders,mass of body structure,0.03765,finding
61,opioid-related-disorders,hiv,0.03529,disease or syndrome - pharmacologic substance - virus
61,opioid-related-disorders,active brand of pseudoephedrine-triprolidine,0.03529,organic chemical - pharmacologic substance
61,opioid-related-disorders,pregnancy test negative,0.03529,finding - laboratory or test result
61,opioid-related-disorders,electrocardiogram,0.03294,diagnostic procedure - finding - organic chemical - pharmacologic substance
61,opioid-related-disorders,illicit drugs,0.03059,hazardous or poisonous substance - pharmacologic substance
61,opioid-related-disorders,operative surgical procedures,0.03059,diagnostic procedure - therapeutic or preventive procedure
61,opioid-related-disorders,disease of diaphragm,0.02824,body part, organ, or organ component - disease or syndrome
61,opioid-related-disorders,sterility,0.02588,pathologic function
61,opioid-related-disorders,severe combined immunodeficiency,0.02588,diagnostic procedure - disease or syndrome
61,opioid-related-disorders,drug dependence,0.02588,mental or behavioral dysfunction
61,opioid-related-disorders,spermatocidal agents,0.02588,pharmacologic substance
61,opioid-related-disorders,follow-up status,0.02588,finding
61,opioid-related-disorders,relate - vinyl resin,0.02118,organic chemical
61,opioid-related-disorders,sexually active,0.02118,finding
61,opioid-related-disorders,pharmacotherapy,0.01882,therapeutic or preventive procedure
61,opioid-related-disorders,alanine transaminase,0.01882,congenital abnormality - disease or syndrome - enzyme
61,opioid-related-disorders,benzodiazepines,0.01647,organic chemical - pharmacologic substance
61,opioid-related-disorders,serum,0.01647,biologically active substance - body substance - pharmacologic substance
61,opioid-related-disorders,aspartate transaminase,0.01647,enzyme
61,opioid-related-disorders,infantile neuroaxonal dystrophy,0.01176,disease or syndrome
61,opioid-related-disorders,psychotropic drugs,0.01176,pharmacologic substance
61,opioid-related-disorders,blood pressure finding,0.01176,finding
61,opioid-related-disorders,transaminases,0.01176,enzyme
61,opioid-related-disorders,bilirubin,0.01176,biologically active substance - laboratory or test result - organic chemical
61,opioid-related-disorders,malignant neoplasms,0.01176,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
61,opioid-related-disorders,psychotic disorders,0.00941,mental or behavioral dysfunction
61,opioid-related-disorders,congenital abnormality,0.00941,congenital abnormality - disease or syndrome
61,opioid-related-disorders,depressed mood,0.00941,finding - mental or behavioral dysfunction
61,opioid-related-disorders,nicotine,0.00706,hazardous or poisonous substance - organic chemical - pharmacologic substance
61,opioid-related-disorders,allergy severity - severe,0.00706,finding
61,opioid-related-disorders,caffeine,0.00706,organic chemical - pharmacologic substance - therapeutic or preventive procedure
61,opioid-related-disorders,systolic pressure,0.00706,clinical attribute - diagnostic procedure
61,opioid-related-disorders,unconscious state,0.00706,disease or syndrome - finding
61,opioid-related-disorders,impaired cognition,0.00706,finding - mental or behavioral dysfunction
61,opioid-related-disorders,manic,0.00471,finding - mental or behavioral dysfunction
61,opioid-related-disorders,tobacco,0.00471,hazardous or poisonous substance - organic chemical - pharmacologic substance
61,opioid-related-disorders,cardiovascular diseases,0.00471,disease or syndrome
61,opioid-related-disorders,schizophrenia,0.00471,mental or behavioral dysfunction
61,opioid-related-disorders,bipolar disorder,0.00471,mental or behavioral dysfunction
61,opioid-related-disorders,unipolar depression,0.00471,mental or behavioral dysfunction
61,opioid-related-disorders,mercury,0.00471,hazardous or poisonous substance
61,opioid-related-disorders,marihuana,0.00471,mental or behavioral dysfunction - organic chemical - pharmacologic substance
61,opioid-related-disorders,unstable status,0.00471,finding
61,opioid-related-disorders,suicide risk,0.00471,finding
61,opioid-related-disorders,hypertensive disease,0.00471,biologically active substance - disease or syndrome - finding
61,opioid-related-disorders,suicide attempt,0.00471,finding - mental or behavioral dysfunction
61,opioid-related-disorders,suicidal,0.00235,finding
61,opioid-related-disorders,breast,0.00235,body part, organ, or organ component
61,opioid-related-disorders,drugs non-prescription,0.00235,pharmacologic substance - therapeutic or preventive procedure
61,opioid-related-disorders,heart diseases,0.00235,disease or syndrome
61,opioid-related-disorders,diastolic blood pressure,0.00235,clinical attribute - diagnostic procedure - finding
61,opioid-related-disorders,hypersensitivity,0.00235,clinical attribute - finding - pathologic function
61,opioid-related-disorders,diastole,0.00235,clinical attribute
61,opioid-related-disorders,alcoholic intoxication chronic,0.00235,mental or behavioral dysfunction
62,panic-disorder,intravenous infusion procedures,0.39098,therapeutic or preventive procedure
62,panic-disorder,anxiety disorders,0.32331,finding - mental or behavioral dysfunction
62,panic-disorder,generalized anxiety disorder,0.21805,mental or behavioral dysfunction
62,panic-disorder,anxiety generalized,0.18797,mental or behavioral dysfunction
62,panic-disorder,depressed mood,0.15789,finding - mental or behavioral dysfunction
62,panic-disorder,observation of attack,0.14286,finding
62,panic-disorder,major depressive disorder,0.12782,mental or behavioral dysfunction
62,panic-disorder,contraceptive methods,0.1203,therapeutic or preventive procedure
62,panic-disorder,post-traumatic stress disorder,0.11278,mental or behavioral dysfunction
62,panic-disorder,mental disorders,0.10526,mental or behavioral dysfunction
62,panic-disorder,phobia social,0.08271,mental or behavioral dysfunction
62,panic-disorder,phobic anxiety disorder,0.08271,mental or behavioral dysfunction
62,panic-disorder,pharmacologic substance,0.07519,pharmacologic substance - therapeutic or preventive procedure
62,panic-disorder,anti-anxiety agents,0.06015,pharmacologic substance
62,panic-disorder,negative finding,0.06015,finding
62,panic-disorder,psychotropic drugs,0.05263,pharmacologic substance
62,panic-disorder,operative surgical procedures,0.05263,diagnostic procedure - therapeutic or preventive procedure
62,panic-disorder,unipolar depression,0.05263,mental or behavioral dysfunction
62,panic-disorder,pregnancy tests,0.05263,diagnostic procedure
62,panic-disorder,mood disorders,0.05263,mental or behavioral dysfunction
62,panic-disorder,stress disorders traumatic,0.05263,mental or behavioral dysfunction
62,panic-disorder,fluoxetine,0.04511,organic chemical - pharmacologic substance
62,panic-disorder,gravidity,0.04511,finding
62,panic-disorder,allergy severity - severe,0.04511,finding
62,panic-disorder,obsessive-compulsive disorder,0.04511,disease or syndrome - mental or behavioral dysfunction
62,panic-disorder,contraception barrier,0.04511,therapeutic or preventive procedure
62,panic-disorder,dysthymic disorder,0.03759,mental or behavioral dysfunction
62,panic-disorder,bleomycin-cisplatin protocol,0.03759,therapeutic or preventive procedure
62,panic-disorder,nitric oxide synthase,0.03759,enzyme
62,panic-disorder,moderate adverse event,0.03759,finding
62,panic-disorder,benzodiazepines,0.03759,organic chemical - pharmacologic substance
62,panic-disorder,physical assessment findings,0.03759,finding
62,panic-disorder,cognitive therapy,0.03759,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
62,panic-disorder,neoplasm metastasis,0.03008,neoplastic process
62,panic-disorder,tropical spastic paraparesis,0.03008,disease or syndrome - therapeutic or preventive procedure
62,panic-disorder,severe combined immunodeficiency,0.03008,diagnostic procedure - disease or syndrome
62,panic-disorder,antipsychotic agents,0.03008,pharmacologic substance
62,panic-disorder,injury wounds,0.03008,body substance - injury or poisoning
62,panic-disorder,selective serotonin re-uptake inhibitor,0.03008,pharmacologic substance
62,panic-disorder,pregnancy test negative,0.03008,finding - laboratory or test result
62,panic-disorder,electrocardiogram,0.03008,diagnostic procedure - finding - organic chemical - pharmacologic substance
62,panic-disorder,follow-up status,0.03008,finding
62,panic-disorder,multiple endocrine neoplasia,0.03008,antibiotic - neoplastic process - organic chemical
62,panic-disorder,suicidal,0.02256,finding
62,panic-disorder,substance abuse problem,0.02256,mental or behavioral dysfunction
62,panic-disorder,pharmacotherapy,0.02256,therapeutic or preventive procedure
62,panic-disorder,body mass index,0.02256,clinical attribute - diagnostic procedure
62,panic-disorder,positive finding,0.02256,finding
62,panic-disorder,unmarried,0.02256,finding
62,panic-disorder,alcoholic intoxication chronic,0.02256,mental or behavioral dysfunction
62,panic-disorder,osteochondritis dissecans,0.02256,disease or syndrome - mental or behavioral dysfunction
62,panic-disorder,compulsive disorder,0.02256,finding
62,panic-disorder,behavior therapy,0.02256,therapeutic or preventive procedure
62,panic-disorder,congenital abnormality,0.01504,congenital abnormality - disease or syndrome
62,panic-disorder,asthma,0.01504,disease or syndrome
62,panic-disorder,hepatic,0.01504,body location or region
62,panic-disorder,relate - vinyl resin,0.01504,organic chemical
62,panic-disorder,infantile neuroaxonal dystrophy,0.01504,disease or syndrome
62,panic-disorder,oral contraception,0.01504,pharmacologic substance - therapeutic or preventive procedure
62,panic-disorder,pharmaceutical preparations,0.01504,pharmacologic substance
62,panic-disorder,active brand of pseudoephedrine-triprolidine,0.01504,organic chemical - pharmacologic substance
62,panic-disorder,surgical revision,0.01504,therapeutic or preventive procedure
62,panic-disorder,ethanol,0.01504,organic chemical - pharmacologic substance
62,panic-disorder,diagnosis psychiatric,0.01504,mental or behavioral dysfunction
62,panic-disorder,unstable status,0.00752,finding
62,panic-disorder,congestive heart failure,0.00752,congenital abnormality - disease or syndrome
62,panic-disorder,craniocerebral trauma,0.00752,injury or poisoning
62,panic-disorder,arteries,0.00752,body part, organ, or organ component
62,panic-disorder,personality disorders,0.00752,mental or behavioral dysfunction
62,panic-disorder,schizoaffective disorder,0.00752,mental or behavioral dysfunction
62,panic-disorder,lithium,0.00752,congenital abnormality - disease or syndrome - pharmacologic substance
62,panic-disorder,magnetic resonance imaging,0.00752,diagnostic procedure
62,panic-disorder,schizophrenia,0.00752,mental or behavioral dysfunction
62,panic-disorder,bipolar disorder,0.00752,mental or behavioral dysfunction
62,panic-disorder,caffeine,0.00752,organic chemical - pharmacologic substance - therapeutic or preventive procedure
62,panic-disorder,disability,0.00752,finding
62,panic-disorder,thyroid gland,0.00752,body part, organ, or organ component - disease or syndrome - pharmacologic substance
62,panic-disorder,cardiac arrhythmia,0.00752,finding - pathologic function
62,panic-disorder,contraceptives oral,0.00752,pharmacologic substance - therapeutic or preventive procedure
62,panic-disorder,screening for cancer,0.00752,diagnostic procedure
62,panic-disorder,psychotherapy,0.00752,therapeutic or preventive procedure
62,panic-disorder,eating disorders,0.00752,mental or behavioral dysfunction
62,panic-disorder,attention deficit hyperactivity disorder,0.00752,disease or syndrome - mental or behavioral dysfunction
62,panic-disorder,nervous system disorder,0.00752,disease or syndrome
62,panic-disorder,current therapy,0.00752,therapeutic or preventive procedure
62,panic-disorder,alcohol consumption,0.00752,individual behavior
63,parasomnias,sleeplessness,0.17719,finding - sign or symptom
63,parasomnias,body mass index,0.12456,clinical attribute - diagnostic procedure
63,parasomnias,intravenous infusion procedures,0.08246,therapeutic or preventive procedure
63,parasomnias,moderate adverse event,0.07661,finding
63,parasomnias,contraceptive methods,0.07368,therapeutic or preventive procedure
63,parasomnias,mass of body structure,0.07018,finding
63,parasomnias,restless legs syndrome,0.06257,disease or syndrome
63,parasomnias,allergy severity - severe,0.05322,finding
63,parasomnias,physical assessment findings,0.05322,finding
63,parasomnias,hypertensive disease,0.04327,biologically active substance - disease or syndrome - finding
63,parasomnias,negative finding,0.04269,finding
63,parasomnias,multiple endocrine neoplasia,0.04094,antibiotic - neoplastic process - organic chemical
63,parasomnias,pharmacologic substance,0.03977,pharmacologic substance - therapeutic or preventive procedure
63,parasomnias,leg,0.03743,body location or region
63,parasomnias,operative surgical procedures,0.03567,diagnostic procedure - therapeutic or preventive procedure
63,parasomnias,mental disorders,0.03567,mental or behavioral dysfunction
63,parasomnias,malignant neoplasms,0.0345,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
63,parasomnias,positive finding,0.03392,finding
63,parasomnias,gravidity,0.03392,finding
63,parasomnias,agitation,0.03392,finding - sign or symptom
63,parasomnias,active brand of pseudoephedrine-triprolidine,0.03333,organic chemical - pharmacologic substance
63,parasomnias,pregnancy tests,0.03333,diagnostic procedure
63,parasomnias,asleep,0.03216,finding
63,parasomnias,depressed mood,0.03158,finding - mental or behavioral dysfunction
63,parasomnias,treatment protocols,0.02924,therapeutic or preventive procedure
63,parasomnias,mild adverse event,0.02924,finding
63,parasomnias,electrocardiogram,0.02632,diagnostic procedure - finding - organic chemical - pharmacologic substance
63,parasomnias,pharmacotherapy,0.02515,therapeutic or preventive procedure
63,parasomnias,relate - vinyl resin,0.02456,organic chemical
63,parasomnias,medical history,0.02222,finding
63,parasomnias,ethanol,0.02164,organic chemical - pharmacologic substance
63,parasomnias,pharmaceutical preparations,0.01988,pharmacologic substance
63,parasomnias,serum,0.01988,biologically active substance - body substance - pharmacologic substance
63,parasomnias,post-traumatic stress disorder,0.01871,mental or behavioral dysfunction
63,parasomnias,obesity,0.01813,disease or syndrome - finding
63,parasomnias,cerebrovascular accident,0.01813,disease or syndrome - therapeutic or preventive procedure
63,parasomnias,blood pressure finding,0.01462,finding
63,parasomnias,arteries,0.01404,body part, organ, or organ component
63,parasomnias,psychotropic drugs,0.01404,pharmacologic substance
63,parasomnias,major depressive disorder,0.01404,mental or behavioral dysfunction
63,parasomnias,anxiety disorders,0.01345,finding - mental or behavioral dysfunction
63,parasomnias,benzodiazepines,0.01345,organic chemical - pharmacologic substance
63,parasomnias,neoplasm metastasis,0.01287,neoplastic process
63,parasomnias,chronic obstructive airway disease,0.01287,disease or syndrome
63,parasomnias,antidepressive agents,0.01228,pharmacologic substance
63,parasomnias,limb structure,0.01111,body part, organ, or organ component
63,parasomnias,screening for cancer,0.00994,diagnostic procedure
63,parasomnias,dementia,0.00936,mental or behavioral dysfunction
63,parasomnias,unipolar depression,0.00877,mental or behavioral dysfunction
63,parasomnias,heart ventricle,0.00819,body part, organ, or organ component
63,parasomnias,exercise pain management,0.00819,therapeutic or preventive procedure
63,parasomnias,congestive heart failure,0.0076,congenital abnormality - disease or syndrome
63,parasomnias,injury wounds,0.0076,body substance - injury or poisoning
63,parasomnias,caffeine,0.00702,organic chemical - pharmacologic substance - therapeutic or preventive procedure
63,parasomnias,smoking,0.00702,hazardous or poisonous substance - individual behavior
63,parasomnias,opioids,0.00702,hazardous or poisonous substance - organic chemical - pharmacologic substance
63,parasomnias,impaired cognition,0.00702,finding - mental or behavioral dysfunction
63,parasomnias,household composition,0.00643,finding
63,parasomnias,epilepsy,0.00585,disease or syndrome
63,parasomnias,movement disorders,0.00585,disease or syndrome
63,parasomnias,unstable status,0.00585,finding
63,parasomnias,consumption-archaic term for tb,0.00585,disease or syndrome
63,parasomnias,psychotic disorders,0.00526,mental or behavioral dysfunction
63,parasomnias,asthma,0.00526,disease or syndrome
63,parasomnias,bipolar disorder,0.00526,mental or behavioral dysfunction
63,parasomnias,antipsychotic agents,0.00526,pharmacologic substance
63,parasomnias,stimulant,0.00526,pharmacologic substance
63,parasomnias,schizophrenia,0.00526,mental or behavioral dysfunction
63,parasomnias,hypersensitivity,0.00526,clinical attribute - finding - pathologic function
63,parasomnias,diabetes mellitus,0.00468,disease or syndrome - pharmacologic substance
63,parasomnias,substance abuse problem,0.00468,mental or behavioral dysfunction
63,parasomnias,breast,0.00468,body part, organ, or organ component
63,parasomnias,heart diseases,0.00468,disease or syndrome
63,parasomnias,congenital abnormality,0.00468,congenital abnormality - disease or syndrome
63,parasomnias,cardiovascular diseases,0.00409,disease or syndrome
63,parasomnias,hepatic,0.00409,body location or region
63,parasomnias,myocardial infarction,0.00409,disease or syndrome - finding
63,parasomnias,suicidal,0.00351,finding
63,parasomnias,narcotics,0.00351,biologically active substance - hazardous or poisonous substance - pharmacologic substance
63,parasomnias,craniocerebral trauma,0.00351,injury or poisoning
63,parasomnias,angina pectoris,0.00351,sign or symptom
63,parasomnias,drug abuse,0.00351,mental or behavioral dysfunction
63,parasomnias,nervousness,0.00292,sign or symptom
63,parasomnias,investigational new drugs,0.00292,pharmacologic substance - therapeutic or preventive procedure
63,parasomnias,kidney diseases,0.00234,disease or syndrome
63,parasomnias,anti-anxiety agents,0.00234,pharmacologic substance
63,parasomnias,drugs non-prescription,0.00234,pharmacologic substance - therapeutic or preventive procedure
63,parasomnias,counter brand of terbufos,0.00234,hazardous or poisonous substance
63,parasomnias,neurological observations,0.00234,finding
63,parasomnias,cardiac arrhythmia,0.00234,finding - pathologic function
63,parasomnias,alcohol abuse,0.00175,mental or behavioral dysfunction
63,parasomnias,angina unstable,0.00175,disease or syndrome
63,parasomnias,nervous system disorder,0.00175,disease or syndrome
63,parasomnias,chronic disease,0.00175,disease or syndrome
63,parasomnias,liver diseases,0.00058,disease or syndrome
64,personality-disorders,intravenous infusion procedures,0.36257,therapeutic or preventive procedure
64,personality-disorders,osteochondritis dissecans,0.35673,disease or syndrome - mental or behavioral dysfunction
64,personality-disorders,obsessive-compulsive disorder,0.18713,disease or syndrome - mental or behavioral dysfunction
64,personality-disorders,personality disorders,0.18421,mental or behavioral dysfunction
64,personality-disorders,borderline personality disorder,0.16959,disease or syndrome - mental or behavioral dysfunction
64,personality-disorders,anxiety disorders,0.09942,finding - mental or behavioral dysfunction
64,personality-disorders,contraceptive methods,0.09357,therapeutic or preventive procedure
64,personality-disorders,compulsive disorder,0.08772,finding
64,personality-disorders,depressed mood,0.07018,finding - mental or behavioral dysfunction
64,personality-disorders,selective serotonin re-uptake inhibitor,0.06725,pharmacologic substance
64,personality-disorders,mental disorders,0.06433,mental or behavioral dysfunction
64,personality-disorders,pharmacologic substance,0.05848,pharmacologic substance - therapeutic or preventive procedure
64,personality-disorders,severe combined immunodeficiency,0.05556,diagnostic procedure - disease or syndrome
64,personality-disorders,negative finding,0.05556,finding
64,personality-disorders,fluoxetine,0.05263,organic chemical - pharmacologic substance
64,personality-disorders,antipsychotic agents,0.04971,pharmacologic substance
64,personality-disorders,moderate adverse event,0.04386,finding
64,personality-disorders,allergy severity - severe,0.04386,finding
64,personality-disorders,psychotropic drugs,0.03801,pharmacologic substance
64,personality-disorders,pregnancy tests,0.03801,diagnostic procedure
64,personality-disorders,physical assessment findings,0.03801,finding
64,personality-disorders,multiple endocrine neoplasia,0.03801,antibiotic - neoplastic process - organic chemical
64,personality-disorders,generalized anxiety disorder,0.03509,mental or behavioral dysfunction
64,personality-disorders,behavior therapy,0.03509,therapeutic or preventive procedure
64,personality-disorders,cognitive therapy,0.03509,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
64,personality-disorders,schizophrenia,0.03216,mental or behavioral dysfunction
64,personality-disorders,anxiety generalized,0.03216,mental or behavioral dysfunction
64,personality-disorders,tic disorder,0.03216,mental or behavioral dysfunction
64,personality-disorders,antidepressive agents,0.03216,pharmacologic substance
64,personality-disorders,treatment protocols,0.02924,therapeutic or preventive procedure
64,personality-disorders,post-traumatic stress disorder,0.02924,mental or behavioral dysfunction
64,personality-disorders,gravidity,0.02632,finding
64,personality-disorders,attention deficit hyperactivity disorder,0.02632,disease or syndrome - mental or behavioral dysfunction
64,personality-disorders,suicidal,0.02339,finding
64,personality-disorders,ethanol,0.02339,organic chemical - pharmacologic substance
64,personality-disorders,pharmaceutical preparations,0.02339,pharmacologic substance
64,personality-disorders,major depressive disorder,0.02339,mental or behavioral dysfunction
64,personality-disorders,phobic anxiety disorder,0.02339,mental or behavioral dysfunction
64,personality-disorders,panic disorder,0.02047,disease or syndrome - mental or behavioral dysfunction
64,personality-disorders,benzodiazepines,0.02047,organic chemical - pharmacologic substance
64,personality-disorders,neoplasm metastasis,0.02047,neoplastic process
64,personality-disorders,unipolar depression,0.02047,mental or behavioral dysfunction
64,personality-disorders,stress disorders traumatic,0.02047,mental or behavioral dysfunction
64,personality-disorders,hyperactive behavior,0.01754,finding
64,personality-disorders,psychotic disorders,0.01754,mental or behavioral dysfunction
64,personality-disorders,pharmacotherapy,0.01754,therapeutic or preventive procedure
64,personality-disorders,relate - vinyl resin,0.01754,organic chemical
64,personality-disorders,active brand of pseudoephedrine-triprolidine,0.01754,organic chemical - pharmacologic substance
64,personality-disorders,autistic disorder,0.01754,mental or behavioral dysfunction
64,personality-disorders,psychotherapy,0.01754,therapeutic or preventive procedure
64,personality-disorders,treatment-psychosocial effects,0.01754,finding
64,personality-disorders,schizoaffective disorder,0.01462,mental or behavioral dysfunction
64,personality-disorders,bipolar disorder,0.01462,mental or behavioral dysfunction
64,personality-disorders,congenital abnormality,0.01462,congenital abnormality - disease or syndrome
64,personality-disorders,electrocardiogram,0.01462,diagnostic procedure - finding - organic chemical - pharmacologic substance
64,personality-disorders,nervous system disorder,0.01462,disease or syndrome
64,personality-disorders,pervasive development disorder,0.0117,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
64,personality-disorders,eating disorders,0.0117,mental or behavioral dysfunction
64,personality-disorders,mood disorders,0.0117,mental or behavioral dysfunction
64,personality-disorders,hypertensive disease,0.0117,biologically active substance - disease or syndrome - finding
64,personality-disorders,suicide attempt,0.0117,finding - mental or behavioral dysfunction
64,personality-disorders,implantation procedure,0.0117,therapeutic or preventive procedure
64,personality-disorders,malignant neoplasms,0.0117,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
64,personality-disorders,positive finding,0.00877,finding
64,personality-disorders,injury wounds,0.00877,body substance - injury or poisoning
64,personality-disorders,screening for cancer,0.00877,diagnostic procedure
64,personality-disorders,unstable status,0.00877,finding
64,personality-disorders,hypersensitivity,0.00877,clinical attribute - finding - pathologic function
64,personality-disorders,therapeutic brand of coal tar,0.00877,organic chemical - pharmacologic substance - therapeutic or preventive procedure
64,personality-disorders,substance abuse problem,0.00585,mental or behavioral dysfunction
64,personality-disorders,anti-anxiety agents,0.00585,pharmacologic substance
64,personality-disorders,magnetic resonance imaging,0.00585,diagnostic procedure
64,personality-disorders,craniocerebral trauma,0.00585,injury or poisoning
64,personality-disorders,brain injuries,0.00585,injury or poisoning
64,personality-disorders,current therapy,0.00585,therapeutic or preventive procedure
64,personality-disorders,developmental disabilities,0.00585,mental or behavioral dysfunction
64,personality-disorders,epilepsy,0.00292,disease or syndrome
64,personality-disorders,psychiatric problem,0.00292,mental or behavioral dysfunction
64,personality-disorders,hepatic,0.00292,body location or region
64,personality-disorders,claustrophobia,0.00292,mental or behavioral dysfunction
64,personality-disorders,mental retardation,0.00292,mental or behavioral dysfunction
64,personality-disorders,monoamine oxidase inhibitors,0.00292,organic chemical - pharmacologic substance
64,personality-disorders,dementia,0.00292,mental or behavioral dysfunction
64,personality-disorders,kidney,0.00292,body part, organ, or organ component
64,personality-disorders,psychotic symptoms,0.00292,sign or symptom
65,phobic-disorders,phobia social,0.61438,mental or behavioral dysfunction
65,phobic-disorders,anxiety disorders,0.56863,finding - mental or behavioral dysfunction
65,phobic-disorders,intravenous infusion procedures,0.48366,therapeutic or preventive procedure
65,phobic-disorders,phobic anxiety disorder,0.47059,mental or behavioral dysfunction
65,phobic-disorders,generalized anxiety disorder,0.23529,mental or behavioral dysfunction
65,phobic-disorders,anxiety generalized,0.16993,mental or behavioral dysfunction
65,phobic-disorders,contraceptive methods,0.10458,therapeutic or preventive procedure
65,phobic-disorders,negative finding,0.08497,finding
65,phobic-disorders,pregnancy tests,0.08497,diagnostic procedure
65,phobic-disorders,panic disorder,0.0719,disease or syndrome - mental or behavioral dysfunction
65,phobic-disorders,mental disorders,0.0719,mental or behavioral dysfunction
65,phobic-disorders,obsessive-compulsive disorder,0.06536,disease or syndrome - mental or behavioral dysfunction
65,phobic-disorders,depressed mood,0.06536,finding - mental or behavioral dysfunction
65,phobic-disorders,post-traumatic stress disorder,0.05882,mental or behavioral dysfunction
65,phobic-disorders,physical assessment findings,0.05882,finding
65,phobic-disorders,ethanol,0.05882,organic chemical - pharmacologic substance
65,phobic-disorders,serum,0.05229,biologically active substance - body substance - pharmacologic substance
65,phobic-disorders,medical history,0.04575,finding
65,phobic-disorders,multiple endocrine neoplasia,0.04575,antibiotic - neoplastic process - organic chemical
65,phobic-disorders,attention deficit hyperactivity disorder,0.03922,disease or syndrome - mental or behavioral dysfunction
65,phobic-disorders,diagnosis psychiatric,0.03922,mental or behavioral dysfunction
65,phobic-disorders,autistic disorder,0.03268,mental or behavioral dysfunction
65,phobic-disorders,tropical spastic paraparesis,0.03268,disease or syndrome - therapeutic or preventive procedure
65,phobic-disorders,major depressive disorder,0.03268,mental or behavioral dysfunction
65,phobic-disorders,dysthymic disorder,0.02614,mental or behavioral dysfunction
65,phobic-disorders,compulsive disorder,0.02614,finding
65,phobic-disorders,electrocardiogram,0.02614,diagnostic procedure - finding - organic chemical - pharmacologic substance
65,phobic-disorders,stress disorders traumatic,0.02614,mental or behavioral dysfunction
65,phobic-disorders,pharmacologic substance,0.02614,pharmacologic substance - therapeutic or preventive procedure
65,phobic-disorders,psychotropic drugs,0.02614,pharmacologic substance
65,phobic-disorders,osteochondritis dissecans,0.02614,disease or syndrome - mental or behavioral dysfunction
65,phobic-disorders,cognitive therapy,0.02614,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
65,phobic-disorders,operative surgical procedures,0.02614,diagnostic procedure - therapeutic or preventive procedure
65,phobic-disorders,relate - vinyl resin,0.02614,organic chemical
65,phobic-disorders,congenital abnormality,0.01961,congenital abnormality - disease or syndrome
65,phobic-disorders,sexual intercourse - finding,0.01961,finding
65,phobic-disorders,severe combined immunodeficiency,0.01961,diagnostic procedure - disease or syndrome
65,phobic-disorders,fluoxetine,0.01961,organic chemical - pharmacologic substance
65,phobic-disorders,alcoholic intoxication chronic,0.01961,mental or behavioral dysfunction
65,phobic-disorders,tic disorder,0.01961,mental or behavioral dysfunction
65,phobic-disorders,selective serotonin re-uptake inhibitor,0.01961,pharmacologic substance
65,phobic-disorders,gravidity,0.01307,finding
65,phobic-disorders,benzodiazepines,0.01307,organic chemical - pharmacologic substance
65,phobic-disorders,psychotherapy,0.01307,therapeutic or preventive procedure
65,phobic-disorders,pharmacotherapy,0.01307,therapeutic or preventive procedure
65,phobic-disorders,pervasive development disorder,0.01307,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
65,phobic-disorders,screening for cancer,0.01307,diagnostic procedure
65,phobic-disorders,schizoaffective disorder,0.01307,mental or behavioral dysfunction
65,phobic-disorders,body mass index,0.01307,clinical attribute - diagnostic procedure
65,phobic-disorders,therapeutic brand of coal tar,0.01307,organic chemical - pharmacologic substance - therapeutic or preventive procedure
65,phobic-disorders,neoplasm metastasis,0.01307,neoplastic process
65,phobic-disorders,antidepressive agents,0.01307,pharmacologic substance
65,phobic-disorders,magnetic resonance imaging,0.01307,diagnostic procedure
65,phobic-disorders,injury wounds,0.00654,body substance - injury or poisoning
65,phobic-disorders,unipolar depression,0.00654,mental or behavioral dysfunction
65,phobic-disorders,schizophrenia,0.00654,mental or behavioral dysfunction
65,phobic-disorders,bipolar disorder,0.00654,mental or behavioral dysfunction
65,phobic-disorders,anti-anxiety agents,0.00654,pharmacologic substance
65,phobic-disorders,behavior therapy,0.00654,therapeutic or preventive procedure
65,phobic-disorders,claustrophobia,0.00654,mental or behavioral dysfunction
65,phobic-disorders,contraceptives oral,0.00654,pharmacologic substance - therapeutic or preventive procedure
65,phobic-disorders,hypersensitivity,0.00654,clinical attribute - finding - pathologic function
65,phobic-disorders,allergy severity - severe,0.00654,finding
65,phobic-disorders,mood disorders,0.00654,mental or behavioral dysfunction
65,phobic-disorders,treatment-psychosocial effects,0.00654,finding
65,phobic-disorders,eating disorders,0.00654,mental or behavioral dysfunction
66,pick-disease-of-the-brain,frontotemporal dementia,0.3,disease or syndrome
66,pick-disease-of-the-brain,mini-mental status exam,0.175,diagnostic procedure
66,pick-disease-of-the-brain,magnetic resonance imaging,0.1625,diagnostic procedure
66,pick-disease-of-the-brain,contraceptive methods,0.1,therapeutic or preventive procedure
66,pick-disease-of-the-brain,memory observations,0.1,finding
66,pick-disease-of-the-brain,pregnancy tests,0.1,diagnostic procedure
66,pick-disease-of-the-brain,dactinomycin,0.1,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
66,pick-disease-of-the-brain,negative finding,0.075,finding
66,pick-disease-of-the-brain,pharmacologic substance,0.075,pharmacologic substance - therapeutic or preventive procedure
66,pick-disease-of-the-brain,serum,0.075,biologically active substance - body substance - pharmacologic substance
66,pick-disease-of-the-brain,treatment protocols,0.0625,therapeutic or preventive procedure
66,pick-disease-of-the-brain,relate - vinyl resin,0.0625,organic chemical
66,pick-disease-of-the-brain,neurological observations,0.0625,finding
66,pick-disease-of-the-brain,epilepsy,0.05,disease or syndrome
66,pick-disease-of-the-brain,creatinine clearance,0.05,finding
66,pick-disease-of-the-brain,hearing examination finding,0.05,finding
66,pick-disease-of-the-brain,nervousness,0.05,sign or symptom
66,pick-disease-of-the-brain,neoplasm metastasis,0.05,neoplastic process
66,pick-disease-of-the-brain,cholinesterase inhibitors,0.05,organic chemical - pharmacologic substance
66,pick-disease-of-the-brain,personality inventories,0.05,diagnostic procedure
66,pick-disease-of-the-brain,mild adverse event,0.05,finding
66,pick-disease-of-the-brain,intravenous infusion procedures,0.05,therapeutic or preventive procedure
66,pick-disease-of-the-brain,transaminases,0.05,enzyme
66,pick-disease-of-the-brain,cognitive therapy,0.05,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
66,pick-disease-of-the-brain,paralysed,0.05,finding
66,pick-disease-of-the-brain,memantine,0.05,organic chemical - pharmacologic substance
66,pick-disease-of-the-brain,human chorionic gonadotropin,0.0375,disease or syndrome - pharmacologic substance
66,pick-disease-of-the-brain,physical assessment findings,0.0375,finding
66,pick-disease-of-the-brain,hepatic,0.0375,body location or region
66,pick-disease-of-the-brain,positive finding,0.0375,finding
66,pick-disease-of-the-brain,alcoholic intoxication chronic,0.0375,mental or behavioral dysfunction
66,pick-disease-of-the-brain,neuropsychological tests,0.0375,diagnostic procedure
66,pick-disease-of-the-brain,gravidity,0.0375,finding
66,pick-disease-of-the-brain,family history,0.0375,congenital abnormality - disease or syndrome - enzyme - finding
66,pick-disease-of-the-brain,bilirubin,0.0375,biologically active substance - laboratory or test result - organic chemical
66,pick-disease-of-the-brain,life expectancy,0.0375,group attribute
66,pick-disease-of-the-brain,depressed mood,0.0375,finding - mental or behavioral dysfunction
66,pick-disease-of-the-brain,multiple endocrine neoplasia,0.0375,antibiotic - neoplastic process - organic chemical
66,pick-disease-of-the-brain,pharmacotherapy,0.025,therapeutic or preventive procedure
66,pick-disease-of-the-brain,sterility,0.025,pathologic function
66,pick-disease-of-the-brain,household composition,0.025,finding
66,pick-disease-of-the-brain,alanine transaminase,0.025,congenital abnormality - disease or syndrome - enzyme
66,pick-disease-of-the-brain,pharmaceutical preparations,0.025,pharmacologic substance
66,pick-disease-of-the-brain,psychotropic drugs,0.025,pharmacologic substance
66,pick-disease-of-the-brain,heart ventricle,0.025,body part, organ, or organ component
66,pick-disease-of-the-brain,operative surgical procedures,0.025,diagnostic procedure - therapeutic or preventive procedure
66,pick-disease-of-the-brain,moderate adverse event,0.025,finding
66,pick-disease-of-the-brain,limb structure,0.025,body part, organ, or organ component
66,pick-disease-of-the-brain,positron-emission tomography,0.025,diagnostic procedure
66,pick-disease-of-the-brain,impaired cognition,0.025,finding - mental or behavioral dysfunction
66,pick-disease-of-the-brain,hypertensive disease,0.025,biologically active substance - disease or syndrome - finding
66,pick-disease-of-the-brain,aspartate transaminase,0.025,enzyme
66,pick-disease-of-the-brain,cerebrovascular accident,0.025,disease or syndrome - therapeutic or preventive procedure
66,pick-disease-of-the-brain,malignant neoplasms,0.025,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
66,pick-disease-of-the-brain,mental disorders,0.025,mental or behavioral dysfunction
66,pick-disease-of-the-brain,skeletal bone,0.0125,body location or region - body part, organ, or organ component - body substance - disease or syndrome
66,pick-disease-of-the-brain,unconscious state,0.0125,disease or syndrome - finding
66,pick-disease-of-the-brain,disability,0.0125,finding
66,pick-disease-of-the-brain,malaise,0.0125,finding - sign or symptom
66,pick-disease-of-the-brain,breast,0.0125,body part, organ, or organ component
66,pick-disease-of-the-brain,cardiovascular diseases,0.0125,disease or syndrome
66,pick-disease-of-the-brain,claustrophobia,0.0125,mental or behavioral dysfunction
66,pick-disease-of-the-brain,mercury,0.0125,hazardous or poisonous substance
66,pick-disease-of-the-brain,active brand of pseudoephedrine-triprolidine,0.0125,organic chemical - pharmacologic substance
66,pick-disease-of-the-brain,ethanol,0.0125,organic chemical - pharmacologic substance
66,pick-disease-of-the-brain,congenital abnormality,0.0125,congenital abnormality - disease or syndrome
66,pick-disease-of-the-brain,craniocerebral trauma,0.0125,injury or poisoning
66,pick-disease-of-the-brain,blood vessel,0.0125,body part, organ, or organ component - finding
66,pick-disease-of-the-brain,allergy severity - severe,0.0125,finding
66,pick-disease-of-the-brain,atypia morphology,0.0125,finding
66,pick-disease-of-the-brain,observation of attack,0.0125,finding
66,pick-disease-of-the-brain,screening for cancer,0.0125,diagnostic procedure
66,pick-disease-of-the-brain,consciousness related finding,0.0125,finding
66,pick-disease-of-the-brain,brain injuries,0.0125,injury or poisoning
66,pick-disease-of-the-brain,injury wounds,0.0125,body substance - injury or poisoning
66,pick-disease-of-the-brain,behavior disorders,0.0125,injury or poisoning - mental or behavioral dysfunction
66,pick-disease-of-the-brain,hypersensitivity,0.0125,clinical attribute - finding - pathologic function
66,pick-disease-of-the-brain,multiple sclerosis,0.0125,body part, organ, or organ component - disease or syndrome - finding
66,pick-disease-of-the-brain,follow-up status,0.0125,finding
67,psychotic-disorders,intravenous infusion procedures,0.29217,therapeutic or preventive procedure
67,psychotic-disorders,depressed mood,0.12142,finding - mental or behavioral dysfunction
67,psychotic-disorders,contraceptive methods,0.11152,therapeutic or preventive procedure
67,psychotic-disorders,schizophrenia,0.10901,mental or behavioral dysfunction
67,psychotic-disorders,negative finding,0.07504,finding
67,psychotic-disorders,major depressive disorder,0.07267,mental or behavioral dysfunction
67,psychotic-disorders,physical assessment findings,0.07245,finding
67,psychotic-disorders,mental disorders,0.06979,mental or behavioral dysfunction
67,psychotic-disorders,pharmacologic substance,0.06536,pharmacologic substance - therapeutic or preventive procedure
67,psychotic-disorders,antipsychotic agents,0.06359,pharmacologic substance
67,psychotic-disorders,ethanol,0.05399,organic chemical - pharmacologic substance
67,psychotic-disorders,multiple endocrine neoplasia,0.05192,antibiotic - neoplastic process - organic chemical
67,psychotic-disorders,pregnancy tests,0.04963,diagnostic procedure
67,psychotic-disorders,body mass index,0.04948,clinical attribute - diagnostic procedure
67,psychotic-disorders,mini-mental status exam,0.0483,diagnostic procedure
67,psychotic-disorders,schizoaffective disorder,0.04631,mental or behavioral dysfunction
67,psychotic-disorders,positive finding,0.04527,finding
67,psychotic-disorders,moderate adverse event,0.0449,finding
67,psychotic-disorders,anxiety disorders,0.04439,finding - mental or behavioral dysfunction
67,psychotic-disorders,antidepressive agents,0.04335,pharmacologic substance
67,psychotic-disorders,attention deficit hyperactivity disorder,0.04202,disease or syndrome - mental or behavioral dysfunction
67,psychotic-disorders,mild adverse event,0.04069,finding
67,psychotic-disorders,gravidity,0.0404,finding
67,psychotic-disorders,post-traumatic stress disorder,0.03951,mental or behavioral dysfunction
67,psychotic-disorders,active brand of pseudoephedrine-triprolidine,0.03722,organic chemical - pharmacologic substance
67,psychotic-disorders,operative surgical procedures,0.03663,diagnostic procedure - therapeutic or preventive procedure
67,psychotic-disorders,bipolar disorder,0.03538,mental or behavioral dysfunction
67,psychotic-disorders,dementia,0.03501,mental or behavioral dysfunction
67,psychotic-disorders,medical history,0.03493,finding
67,psychotic-disorders,unipolar depression,0.03479,mental or behavioral dysfunction
67,psychotic-disorders,mass of body structure,0.03316,finding
67,psychotic-disorders,depressive episode unspecified,0.03309,mental or behavioral dysfunction
67,psychotic-disorders,electrocardiogram,0.03257,diagnostic procedure - finding - organic chemical - pharmacologic substance
67,psychotic-disorders,relate - vinyl resin,0.03168,organic chemical
67,psychotic-disorders,severe combined immunodeficiency,0.03013,diagnostic procedure - disease or syndrome
67,psychotic-disorders,dactinomycin,0.02984,antibiotic - body part, organ, or organ component - disease or syndrome - therapeutic or preventive procedure
67,psychotic-disorders,allergy severity - severe,0.02873,finding
67,psychotic-disorders,psychotropic drugs,0.02688,pharmacologic substance
67,psychotic-disorders,psychotic disorders,0.02578,mental or behavioral dysfunction
67,psychotic-disorders,pharmaceutical preparations,0.02474,pharmacologic substance
67,psychotic-disorders,autistic disorder,0.02467,mental or behavioral dysfunction
67,psychotic-disorders,sleeplessness,0.024,finding - sign or symptom
67,psychotic-disorders,serum,0.024,biologically active substance - body substance - pharmacologic substance
67,psychotic-disorders,magnetic resonance imaging,0.02319,diagnostic procedure
67,psychotic-disorders,impaired cognition,0.02304,finding - mental or behavioral dysfunction
67,psychotic-disorders,alcoholic intoxication chronic,0.02194,mental or behavioral dysfunction
67,psychotic-disorders,screening for cancer,0.02186,diagnostic procedure
67,psychotic-disorders,malignant neoplasms,0.02171,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
67,psychotic-disorders,smoking,0.01883,hazardous or poisonous substance - individual behavior
67,psychotic-disorders,generalized anxiety disorder,0.01846,mental or behavioral dysfunction
67,psychotic-disorders,manic,0.01839,finding - mental or behavioral dysfunction
67,psychotic-disorders,substance abuse problem,0.01706,mental or behavioral dysfunction
67,psychotic-disorders,opioids,0.01699,hazardous or poisonous substance - organic chemical - pharmacologic substance
67,psychotic-disorders,mood disorders,0.01684,mental or behavioral dysfunction
67,psychotic-disorders,pharmacotherapy,0.01588,therapeutic or preventive procedure
67,psychotic-disorders,marihuana,0.01455,mental or behavioral dysfunction - organic chemical - pharmacologic substance
67,psychotic-disorders,congenital abnormality,0.01418,congenital abnormality - disease or syndrome
67,psychotic-disorders,blood pressure finding,0.01315,finding
67,psychotic-disorders,selective serotonin re-uptake inhibitor,0.013,pharmacologic substance
67,psychotic-disorders,cognitive therapy,0.01256,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
67,psychotic-disorders,injury wounds,0.01182,body substance - injury or poisoning
67,psychotic-disorders,opiates,0.01137,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
67,psychotic-disorders,benzodiazepines,0.011,organic chemical - pharmacologic substance
67,psychotic-disorders,infantile neuroaxonal dystrophy,0.01093,disease or syndrome
67,psychotic-disorders,hypertensive disease,0.01034,biologically active substance - disease or syndrome - finding
67,psychotic-disorders,neoplasm metastasis,0.0099,neoplastic process
67,psychotic-disorders,cocaine,0.00982,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
67,psychotic-disorders,fluoxetine,0.00901,organic chemical - pharmacologic substance
67,psychotic-disorders,pervasive development disorder,0.00857,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
67,psychotic-disorders,cerebrovascular accident,0.00835,disease or syndrome - therapeutic or preventive procedure
67,psychotic-disorders,psychotherapy,0.0082,therapeutic or preventive procedure
67,psychotic-disorders,stress disorders traumatic,0.0082,mental or behavioral dysfunction
67,psychotic-disorders,nicotine,0.00805,hazardous or poisonous substance - organic chemical - pharmacologic substance
67,psychotic-disorders,hiv,0.00775,disease or syndrome - pharmacologic substance - virus
67,psychotic-disorders,obsessive-compulsive disorder,0.00775,disease or syndrome - mental or behavioral dysfunction
67,psychotic-disorders,suicidal,0.00761,finding
67,psychotic-disorders,stimulant,0.00739,pharmacologic substance
67,psychotic-disorders,illicit drugs,0.00724,hazardous or poisonous substance - pharmacologic substance
67,psychotic-disorders,unstable status,0.00694,finding
67,psychotic-disorders,blood vessel,0.00672,body part, organ, or organ component - finding
67,psychotic-disorders,epilepsy,0.00643,disease or syndrome
67,psychotic-disorders,developmental disabilities,0.00628,mental or behavioral dysfunction
67,psychotic-disorders,personality disorders,0.0062,mental or behavioral dysfunction
67,psychotic-disorders,diastole,0.0062,clinical attribute
67,psychotic-disorders,alcohol abuse,0.00613,mental or behavioral dysfunction
67,psychotic-disorders,eating disorders,0.00591,mental or behavioral dysfunction
67,psychotic-disorders,nervous system disorder,0.00591,disease or syndrome
67,psychotic-disorders,hepatic,0.00569,body location or region
67,psychotic-disorders,mental retardation,0.00569,mental or behavioral dysfunction
67,psychotic-disorders,alanine transaminase,0.00517,congenital abnormality - disease or syndrome - enzyme
67,psychotic-disorders,breast,0.00517,body part, organ, or organ component
67,psychotic-disorders,hypersensitivity,0.0051,clinical attribute - finding - pathologic function
67,psychotic-disorders,caffeine,0.00436,organic chemical - pharmacologic substance - therapeutic or preventive procedure
67,psychotic-disorders,substance dependence,0.00406,mental or behavioral dysfunction
67,psychotic-disorders,diabetes,0.00406,disease or syndrome
67,psychotic-disorders,multiple sclerosis,0.00391,body part, organ, or organ component - disease or syndrome - finding
67,psychotic-disorders,craniocerebral trauma,0.00384,injury or poisoning
67,psychotic-disorders,suicide attempt,0.00384,finding - mental or behavioral dysfunction
67,psychotic-disorders,brain injuries,0.00377,injury or poisoning
67,psychotic-disorders,consciousness related finding,0.00362,finding
67,psychotic-disorders,heart diseases,0.00332,disease or syndrome
67,psychotic-disorders,lung,0.00332,body part, organ, or organ component - disease or syndrome
67,psychotic-disorders,nervousness,0.00318,sign or symptom
67,psychotic-disorders,thyroid gland,0.00318,body part, organ, or organ component - disease or syndrome - pharmacologic substance
67,psychotic-disorders,neurological observations,0.00318,finding
67,psychotic-disorders,cardiovascular diseases,0.00303,disease or syndrome
67,psychotic-disorders,drug abuse,0.00303,mental or behavioral dysfunction
67,psychotic-disorders,cardiac arrhythmia,0.00281,finding - pathologic function
67,psychotic-disorders,myocardial infarction,0.00273,disease or syndrome - finding
67,psychotic-disorders,unconscious state,0.00251,disease or syndrome - finding
67,psychotic-disorders,medical contraindication,0.00244,finding
67,psychotic-disorders,investigational new drugs,0.00236,pharmacologic substance - therapeutic or preventive procedure
67,psychotic-disorders,monoamine oxidase inhibitors,0.00236,organic chemical - pharmacologic substance
67,psychotic-disorders,angina pectoris,0.00236,sign or symptom
67,psychotic-disorders,liver diseases,0.00207,disease or syndrome
67,psychotic-disorders,kidney diseases,0.00192,disease or syndrome
68,quality-of-life,malignant neoplasms,0.22858,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
68,quality-of-life,pharmacotherapy,0.09527,therapeutic or preventive procedure
68,quality-of-life,neoplasm metastasis,0.05916,neoplastic process
68,quality-of-life,contraceptive methods,0.05225,therapeutic or preventive procedure
68,quality-of-life,intravenous infusion procedures,0.04879,therapeutic or preventive procedure
68,quality-of-life,active brand of pseudoephedrine-triprolidine,0.04764,organic chemical - pharmacologic substance
68,quality-of-life,moderate adverse event,0.04572,finding
68,quality-of-life,operative surgical procedures,0.04456,diagnostic procedure - therapeutic or preventive procedure
68,quality-of-life,negative finding,0.04149,finding
68,quality-of-life,life expectancy,0.04034,group attribute
68,quality-of-life,body mass index,0.0388,clinical attribute - diagnostic procedure
68,quality-of-life,allergy severity - severe,0.03765,finding
68,quality-of-life,treatment protocols,0.03726,therapeutic or preventive procedure
68,quality-of-life,positive finding,0.03688,finding
68,quality-of-life,physical assessment findings,0.0365,finding
68,quality-of-life,multiple endocrine neoplasia,0.03573,antibiotic - neoplastic process - organic chemical
68,quality-of-life,kidney,0.03534,body part, organ, or organ component
68,quality-of-life,follow-up status,0.03265,finding
68,quality-of-life,pregnancy tests,0.02997,diagnostic procedure
68,quality-of-life,chronic obstructive airway disease,0.02958,disease or syndrome
68,quality-of-life,gravidity,0.02843,finding
68,quality-of-life,pharmacologic substance,0.02843,pharmacologic substance - therapeutic or preventive procedure
68,quality-of-life,lung,0.02766,body part, organ, or organ component - disease or syndrome
68,quality-of-life,hepatic,0.02689,body location or region
68,quality-of-life,hypertensive disease,0.02497,biologically active substance - disease or syndrome - finding
68,quality-of-life,serum,0.0242,biologically active substance - body substance - pharmacologic substance
68,quality-of-life,skeletal bone,0.02343,body location or region - body part, organ, or organ component - body substance - disease or syndrome
68,quality-of-life,bilirubin,0.02075,biologically active substance - laboratory or test result - organic chemical
68,quality-of-life,relate - vinyl resin,0.01921,organic chemical
68,quality-of-life,arteries,0.01806,body part, organ, or organ component
68,quality-of-life,pharmaceutical preparations,0.01806,pharmacologic substance
68,quality-of-life,exercise pain management,0.01767,therapeutic or preventive procedure
68,quality-of-life,depressed mood,0.0169,finding - mental or behavioral dysfunction
68,quality-of-life,hiv,0.01421,disease or syndrome - pharmacologic substance - virus
68,quality-of-life,adrenal cortex hormones,0.01421,pharmacologic substance
68,quality-of-life,hypersensitivity,0.01345,clinical attribute - finding - pathologic function
68,quality-of-life,asthma,0.01268,disease or syndrome
68,quality-of-life,mental disorders,0.01191,mental or behavioral dysfunction
68,quality-of-life,blood pressure finding,0.01114,finding
68,quality-of-life,psychiatric problem,0.01114,mental or behavioral dysfunction
68,quality-of-life,cerebrovascular accident,0.01076,disease or syndrome - therapeutic or preventive procedure
68,quality-of-life,impaired cognition,0.01076,finding - mental or behavioral dysfunction
68,quality-of-life,angina pectoris,0.01037,sign or symptom
68,quality-of-life,diabetes,0.00999,disease or syndrome
68,quality-of-life,dementia,0.00999,mental or behavioral dysfunction
68,quality-of-life,heart diseases,0.0096,disease or syndrome
68,quality-of-life,schizophrenia,0.00884,mental or behavioral dysfunction
68,quality-of-life,myocardial infarction,0.00884,disease or syndrome - finding
68,quality-of-life,congestive heart failure,0.00845,congenital abnormality - disease or syndrome
68,quality-of-life,medical contraindication,0.00807,finding
68,quality-of-life,congenital abnormality,0.0073,congenital abnormality - disease or syndrome
68,quality-of-life,liver diseases,0.00615,disease or syndrome
68,quality-of-life,unstable status,0.00615,finding
68,quality-of-life,angina unstable,0.00461,disease or syndrome
68,quality-of-life,cardiac arrhythmia,0.00384,finding - pathologic function
68,quality-of-life,investigational new drugs,0.00346,pharmacologic substance - therapeutic or preventive procedure
68,quality-of-life,ethanol,0.00307,organic chemical - pharmacologic substance
68,quality-of-life,psychotic disorders,0.00231,mental or behavioral dysfunction
68,quality-of-life,substance abuse problem,0.00154,mental or behavioral dysfunction
69,restless-legs-syndrome,restless legs syndrome,0.76744,disease or syndrome
69,restless-legs-syndrome,leg,0.41085,body location or region
69,restless-legs-syndrome,agitation,0.34884,finding - sign or symptom
69,restless-legs-syndrome,moderate adverse event,0.14729,finding
69,restless-legs-syndrome,body mass index,0.13178,clinical attribute - diagnostic procedure
69,restless-legs-syndrome,mass of body structure,0.11628,finding
69,restless-legs-syndrome,contraceptive methods,0.10853,therapeutic or preventive procedure
69,restless-legs-syndrome,allergy severity - severe,0.10853,finding
69,restless-legs-syndrome,negative finding,0.08527,finding
69,restless-legs-syndrome,physical assessment findings,0.08527,finding
69,restless-legs-syndrome,treatment protocols,0.07752,therapeutic or preventive procedure
69,restless-legs-syndrome,pharmacologic substance,0.06977,pharmacologic substance - therapeutic or preventive procedure
69,restless-legs-syndrome,medical history,0.06977,finding
69,restless-legs-syndrome,pregnancy tests,0.06202,diagnostic procedure
69,restless-legs-syndrome,electrocardiogram,0.05426,diagnostic procedure - finding - organic chemical - pharmacologic substance
69,restless-legs-syndrome,follow-up status,0.04651,finding
69,restless-legs-syndrome,gravidity,0.04651,finding
69,restless-legs-syndrome,limb structure,0.04651,body part, organ, or organ component
69,restless-legs-syndrome,multiple endocrine neoplasia,0.04651,antibiotic - neoplastic process - organic chemical
69,restless-legs-syndrome,creatinine clearance,0.03876,finding
69,restless-legs-syndrome,malaise,0.03876,finding - sign or symptom
69,restless-legs-syndrome,pregnancy test negative,0.03876,finding - laboratory or test result
69,restless-legs-syndrome,contraception barrier,0.03876,therapeutic or preventive procedure
69,restless-legs-syndrome,opioids,0.03876,hazardous or poisonous substance - organic chemical - pharmacologic substance
69,restless-legs-syndrome,benzodiazepines,0.03876,organic chemical - pharmacologic substance
69,restless-legs-syndrome,pharmacotherapy,0.03101,therapeutic or preventive procedure
69,restless-legs-syndrome,household composition,0.03101,finding
69,restless-legs-syndrome,oral contraception,0.03101,pharmacologic substance - therapeutic or preventive procedure
69,restless-legs-syndrome,active brand of pseudoephedrine-triprolidine,0.03101,organic chemical - pharmacologic substance
69,restless-legs-syndrome,weighing patient,0.03101,diagnostic procedure - finding
69,restless-legs-syndrome,aspartate transaminase,0.03101,enzyme
69,restless-legs-syndrome,asleep,0.02326,finding
69,restless-legs-syndrome,ethanol,0.02326,organic chemical - pharmacologic substance
69,restless-legs-syndrome,disease of diaphragm,0.02326,body part, organ, or organ component - disease or syndrome
69,restless-legs-syndrome,contraceptives oral,0.02326,pharmacologic substance - therapeutic or preventive procedure
69,restless-legs-syndrome,screening for cancer,0.02326,diagnostic procedure
69,restless-legs-syndrome,current therapy,0.02326,therapeutic or preventive procedure
69,restless-legs-syndrome,alanine transaminase,0.0155,congenital abnormality - disease or syndrome - enzyme
69,restless-legs-syndrome,neoplasm metastasis,0.0155,neoplastic process
69,restless-legs-syndrome,positive finding,0.0155,finding
69,restless-legs-syndrome,movement disorders,0.0155,disease or syndrome
69,restless-legs-syndrome,antipsychotic agents,0.0155,pharmacologic substance
69,restless-legs-syndrome,sleeplessness,0.0155,finding - sign or symptom
69,restless-legs-syndrome,operative surgical procedures,0.0155,diagnostic procedure - therapeutic or preventive procedure
69,restless-legs-syndrome,blood pressure finding,0.0155,finding
69,restless-legs-syndrome,congenital abnormality,0.0155,congenital abnormality - disease or syndrome
69,restless-legs-syndrome,exercise pain management,0.0155,therapeutic or preventive procedure
69,restless-legs-syndrome,smoking,0.0155,hazardous or poisonous substance - individual behavior
69,restless-legs-syndrome,antidepressive agents,0.0155,pharmacologic substance
69,restless-legs-syndrome,nervous system disorder,0.0155,disease or syndrome
69,restless-legs-syndrome,anti-anxiety agents,0.00775,pharmacologic substance
69,restless-legs-syndrome,nervousness,0.00775,sign or symptom
69,restless-legs-syndrome,diastolic blood pressure,0.00775,clinical attribute - diagnostic procedure - finding
69,restless-legs-syndrome,multiple sclerosis,0.00775,body part, organ, or organ component - disease or syndrome - finding
69,restless-legs-syndrome,magnetic resonance imaging,0.00775,diagnostic procedure
69,restless-legs-syndrome,relate - vinyl resin,0.00775,organic chemical
69,restless-legs-syndrome,infantile neuroaxonal dystrophy,0.00775,disease or syndrome
69,restless-legs-syndrome,caffeine,0.00775,organic chemical - pharmacologic substance - therapeutic or preventive procedure
69,restless-legs-syndrome,pharmaceutical preparations,0.00775,pharmacologic substance
69,restless-legs-syndrome,psychotropic drugs,0.00775,pharmacologic substance
69,restless-legs-syndrome,drugs non-prescription,0.00775,pharmacologic substance - therapeutic or preventive procedure
69,restless-legs-syndrome,systolic pressure,0.00775,clinical attribute - diagnostic procedure
69,restless-legs-syndrome,anticonvulsants,0.00775,pharmacologic substance
69,restless-legs-syndrome,substance abuse problem,0.00775,mental or behavioral dysfunction
69,restless-legs-syndrome,intravenous infusion procedures,0.00775,therapeutic or preventive procedure
69,restless-legs-syndrome,investigational new drugs,0.00775,pharmacologic substance - therapeutic or preventive procedure
69,restless-legs-syndrome,malignant neoplasms,0.00775,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
69,restless-legs-syndrome,schizophrenia,0.00775,mental or behavioral dysfunction
69,restless-legs-syndrome,neurological observations,0.00775,finding
69,restless-legs-syndrome,drug abuse,0.00775,mental or behavioral dysfunction
69,restless-legs-syndrome,diastole,0.00775,clinical attribute
69,restless-legs-syndrome,depressed mood,0.00775,finding - mental or behavioral dysfunction
69,restless-legs-syndrome,mental disorders,0.00775,mental or behavioral dysfunction
70,schizophrenia,schizophrenia,0.68892,mental or behavioral dysfunction
70,schizophrenia,intravenous infusion procedures,0.42928,therapeutic or preventive procedure
70,schizophrenia,antipsychotic agents,0.33086,pharmacologic substance
70,schizophrenia,schizoaffective disorder,0.30366,mental or behavioral dysfunction
70,schizophrenia,negative finding,0.14342,finding
70,schizophrenia,contraceptive methods,0.13501,therapeutic or preventive procedure
70,schizophrenia,psychotic disorders,0.12562,mental or behavioral dysfunction
70,schizophrenia,mental disorders,0.12413,mental or behavioral dysfunction
70,schizophrenia,positive finding,0.10237,finding
70,schizophrenia,pharmacologic substance,0.07814,pharmacologic substance - therapeutic or preventive procedure
70,schizophrenia,body mass index,0.07715,clinical attribute - diagnostic procedure
70,schizophrenia,physical assessment findings,0.07171,finding
70,schizophrenia,bipolar disorder,0.05935,mental or behavioral dysfunction
70,schizophrenia,moderate adverse event,0.05589,finding
70,schizophrenia,depressed mood,0.05242,finding - mental or behavioral dysfunction
70,schizophrenia,mass of body structure,0.05242,finding
70,schizophrenia,pregnancy tests,0.04946,diagnostic procedure
70,schizophrenia,atypia morphology,0.04748,finding
70,schizophrenia,multiple endocrine neoplasia,0.04649,antibiotic - neoplastic process - organic chemical
70,schizophrenia,psychotic symptoms,0.045,sign or symptom
70,schizophrenia,active brand of pseudoephedrine-triprolidine,0.04352,organic chemical - pharmacologic substance
70,schizophrenia,operative surgical procedures,0.04352,diagnostic procedure - therapeutic or preventive procedure
70,schizophrenia,severe combined immunodeficiency,0.04253,diagnostic procedure - disease or syndrome
70,schizophrenia,electrocardiogram,0.04154,diagnostic procedure - finding - organic chemical - pharmacologic substance
70,schizophrenia,medical history,0.03956,finding
70,schizophrenia,gravidity,0.03709,finding
70,schizophrenia,sterility,0.03462,pathologic function
70,schizophrenia,nitric oxide synthase,0.03165,enzyme
70,schizophrenia,treatment protocols,0.02967,therapeutic or preventive procedure
70,schizophrenia,allergy severity - severe,0.02918,finding
70,schizophrenia,serum,0.02918,biologically active substance - body substance - pharmacologic substance
70,schizophrenia,psychotropic drugs,0.0277,pharmacologic substance
70,schizophrenia,unipolar depression,0.02522,mental or behavioral dysfunction
70,schizophrenia,major depressive disorder,0.02473,mental or behavioral dysfunction
70,schizophrenia,pharmaceutical preparations,0.02374,pharmacologic substance
70,schizophrenia,sexually active,0.02374,finding
70,schizophrenia,mood disorders,0.01978,mental or behavioral dysfunction
70,schizophrenia,ethanol,0.01929,organic chemical - pharmacologic substance
70,schizophrenia,vital signs,0.01879,clinical attribute
70,schizophrenia,blood pressure finding,0.01731,finding
70,schizophrenia,antidepressive agents,0.01731,pharmacologic substance
70,schizophrenia,anxiety disorders,0.01682,finding - mental or behavioral dysfunction
70,schizophrenia,relate - vinyl resin,0.01632,organic chemical
70,schizophrenia,substance abuse problem,0.01533,mental or behavioral dysfunction
70,schizophrenia,stabilizer - function,0.01385,organ or tissue function
70,schizophrenia,marihuana,0.01335,mental or behavioral dysfunction - organic chemical - pharmacologic substance
70,schizophrenia,screening for cancer,0.01236,diagnostic procedure
70,schizophrenia,disability,0.01137,finding
70,schizophrenia,magnetic resonance imaging,0.01039,diagnostic procedure
70,schizophrenia,hypertensive disease,0.00989,biologically active substance - disease or syndrome - finding
70,schizophrenia,current therapy,0.00989,therapeutic or preventive procedure
70,schizophrenia,benzodiazepines,0.0094,organic chemical - pharmacologic substance
70,schizophrenia,congenital abnormality,0.00841,congenital abnormality - disease or syndrome
70,schizophrenia,suicidal,0.00643,finding
70,schizophrenia,nicotine,0.00544,hazardous or poisonous substance - organic chemical - pharmacologic substance
70,schizophrenia,substance dependence,0.00544,mental or behavioral dysfunction
70,schizophrenia,mental retardation,0.00544,mental or behavioral dysfunction
70,schizophrenia,dementia,0.00544,mental or behavioral dysfunction
70,schizophrenia,nervous system disorder,0.00544,disease or syndrome
70,schizophrenia,breast,0.00544,body part, organ, or organ component
70,schizophrenia,alcoholic intoxication chronic,0.00495,mental or behavioral dysfunction
70,schizophrenia,unstable status,0.00495,finding
70,schizophrenia,craniocerebral trauma,0.00396,injury or poisoning
70,schizophrenia,diabetes mellitus,0.00346,disease or syndrome - pharmacologic substance
70,schizophrenia,thyroid gland,0.00297,body part, organ, or organ component - disease or syndrome - pharmacologic substance
70,schizophrenia,alcohol abuse,0.00247,mental or behavioral dysfunction
70,schizophrenia,consciousness related finding,0.00247,finding
70,schizophrenia,injury wounds,0.00247,body substance - injury or poisoning
70,schizophrenia,caffeine,0.00198,organic chemical - pharmacologic substance - therapeutic or preventive procedure
70,schizophrenia,hiv,0.00198,disease or syndrome - pharmacologic substance - virus
70,schizophrenia,cardiovascular diseases,0.00198,disease or syndrome
70,schizophrenia,illicit drugs,0.00198,hazardous or poisonous substance - pharmacologic substance
70,schizophrenia,unconscious state,0.00198,disease or syndrome - finding
70,schizophrenia,cerebrovascular accident,0.00198,disease or syndrome - therapeutic or preventive procedure
70,schizophrenia,malignant neoplasms,0.00198,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
70,schizophrenia,hypersensitivity,0.00148,clinical attribute - finding - pathologic function
70,schizophrenia,benign rolandic epilepsy,0.00148,disease or syndrome - therapeutic or preventive procedure
70,schizophrenia,investigational new drugs,0.00148,pharmacologic substance - therapeutic or preventive procedure
70,schizophrenia,brain injuries,0.00148,injury or poisoning
70,schizophrenia,suicide attempt,0.00148,finding - mental or behavioral dysfunction
70,schizophrenia,drug abuse,0.00148,mental or behavioral dysfunction
70,schizophrenia,kidney diseases,0.00099,disease or syndrome
70,schizophrenia,congestive heart failure,0.00099,congenital abnormality - disease or syndrome
70,schizophrenia,nervousness,0.00099,sign or symptom
70,schizophrenia,myocardial infarction,0.00099,disease or syndrome - finding
70,schizophrenia,delirium,0.00099,mental or behavioral dysfunction
70,schizophrenia,heart diseases,0.00099,disease or syndrome
70,schizophrenia,cardiac arrhythmia,0.00099,finding - pathologic function
70,schizophrenia,neurological observations,0.00099,finding
70,schizophrenia,liver diseases,0.00099,disease or syndrome
71,schizophrenia-and-disorders-with-psychotic-features,schizophrenia,0.69491,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,intravenous infusion procedures,0.43217,therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,antipsychotic agents,0.33182,pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,schizoaffective disorder,0.30459,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,negative finding,0.14473,finding
71,schizophrenia-and-disorders-with-psychotic-features,contraceptive methods,0.13565,therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,psychotic disorders,0.12658,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,mental disorders,0.12305,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,positive finding,0.10388,finding
71,schizophrenia-and-disorders-with-psychotic-features,pharmacologic substance,0.07867,pharmacologic substance - therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,body mass index,0.07514,clinical attribute - diagnostic procedure
71,schizophrenia-and-disorders-with-psychotic-features,physical assessment findings,0.07161,finding
71,schizophrenia-and-disorders-with-psychotic-features,bipolar disorder,0.05698,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,moderate adverse event,0.05648,finding
71,schizophrenia-and-disorders-with-psychotic-features,mass of body structure,0.05144,finding
71,schizophrenia-and-disorders-with-psychotic-features,depressed mood,0.05093,finding - mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,pregnancy tests,0.04942,diagnostic procedure
71,schizophrenia-and-disorders-with-psychotic-features,atypia morphology,0.04841,finding
71,schizophrenia-and-disorders-with-psychotic-features,psychotic symptoms,0.04589,sign or symptom
71,schizophrenia-and-disorders-with-psychotic-features,multiple endocrine neoplasia,0.04539,antibiotic - neoplastic process - organic chemical
71,schizophrenia-and-disorders-with-psychotic-features,active brand of pseudoephedrine-triprolidine,0.04387,organic chemical - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,operative surgical procedures,0.04337,diagnostic procedure - therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,severe combined immunodeficiency,0.04236,diagnostic procedure - disease or syndrome
71,schizophrenia-and-disorders-with-psychotic-features,electrocardiogram,0.04135,diagnostic procedure - finding - organic chemical - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,medical history,0.03933,finding
71,schizophrenia-and-disorders-with-psychotic-features,gravidity,0.03681,finding
71,schizophrenia-and-disorders-with-psychotic-features,sterility,0.03429,pathologic function
71,schizophrenia-and-disorders-with-psychotic-features,nitric oxide synthase,0.03177,enzyme
71,schizophrenia-and-disorders-with-psychotic-features,treatment protocols,0.03026,therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,serum,0.02925,biologically active substance - body substance - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,psychotropic drugs,0.02824,pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,allergy severity - severe,0.02774,finding
71,schizophrenia-and-disorders-with-psychotic-features,unipolar depression,0.02421,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,major depressive disorder,0.02421,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,pharmaceutical preparations,0.0237,pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,sexually active,0.0237,finding
71,schizophrenia-and-disorders-with-psychotic-features,mood disorders,0.02017,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,ethanol,0.01916,organic chemical - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,vital signs,0.01866,clinical attribute
71,schizophrenia-and-disorders-with-psychotic-features,antidepressive agents,0.01765,pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,blood pressure finding,0.01715,finding
71,schizophrenia-and-disorders-with-psychotic-features,anxiety disorders,0.01664,finding - mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,relate - vinyl resin,0.01664,organic chemical
71,schizophrenia-and-disorders-with-psychotic-features,substance abuse problem,0.01513,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,stabilizer - function,0.01412,organ or tissue function
71,schizophrenia-and-disorders-with-psychotic-features,marihuana,0.01362,mental or behavioral dysfunction - organic chemical - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,screening for cancer,0.01261,diagnostic procedure
71,schizophrenia-and-disorders-with-psychotic-features,disability,0.01109,finding
71,schizophrenia-and-disorders-with-psychotic-features,magnetic resonance imaging,0.01009,diagnostic procedure
71,schizophrenia-and-disorders-with-psychotic-features,current therapy,0.01009,therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,benzodiazepines,0.00958,organic chemical - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,hypertensive disease,0.00958,biologically active substance - disease or syndrome - finding
71,schizophrenia-and-disorders-with-psychotic-features,congenital abnormality,0.00807,congenital abnormality - disease or syndrome
71,schizophrenia-and-disorders-with-psychotic-features,suicidal,0.00656,finding
71,schizophrenia-and-disorders-with-psychotic-features,nicotine,0.00555,hazardous or poisonous substance - organic chemical - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,mental retardation,0.00555,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,dementia,0.00555,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,nervous system disorder,0.00555,disease or syndrome
71,schizophrenia-and-disorders-with-psychotic-features,breast,0.00555,body part, organ, or organ component
71,schizophrenia-and-disorders-with-psychotic-features,alcoholic intoxication chronic,0.00504,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,substance dependence,0.00504,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,unstable status,0.00504,finding
71,schizophrenia-and-disorders-with-psychotic-features,cocaine,0.00454,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,craniocerebral trauma,0.00403,injury or poisoning
71,schizophrenia-and-disorders-with-psychotic-features,diabetes mellitus,0.00353,disease or syndrome - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,thyroid gland,0.00303,body part, organ, or organ component - disease or syndrome - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,alcohol abuse,0.00252,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,injury wounds,0.00252,body substance - injury or poisoning
71,schizophrenia-and-disorders-with-psychotic-features,consciousness related finding,0.00252,finding
71,schizophrenia-and-disorders-with-psychotic-features,hiv,0.00202,disease or syndrome - pharmacologic substance - virus
71,schizophrenia-and-disorders-with-psychotic-features,cardiovascular diseases,0.00202,disease or syndrome
71,schizophrenia-and-disorders-with-psychotic-features,illicit drugs,0.00202,hazardous or poisonous substance - pharmacologic substance
71,schizophrenia-and-disorders-with-psychotic-features,unconscious state,0.00202,disease or syndrome - finding
71,schizophrenia-and-disorders-with-psychotic-features,cerebrovascular accident,0.00202,disease or syndrome - therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,malignant neoplasms,0.00202,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,caffeine,0.00151,organic chemical - pharmacologic substance - therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,hypersensitivity,0.00151,clinical attribute - finding - pathologic function
71,schizophrenia-and-disorders-with-psychotic-features,benign rolandic epilepsy,0.00151,disease or syndrome - therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,investigational new drugs,0.00151,pharmacologic substance - therapeutic or preventive procedure
71,schizophrenia-and-disorders-with-psychotic-features,brain injuries,0.00151,injury or poisoning
71,schizophrenia-and-disorders-with-psychotic-features,suicide attempt,0.00151,finding - mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,drug abuse,0.00151,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,kidney diseases,0.00101,disease or syndrome
71,schizophrenia-and-disorders-with-psychotic-features,nervousness,0.00101,sign or symptom
71,schizophrenia-and-disorders-with-psychotic-features,delirium,0.00101,mental or behavioral dysfunction
71,schizophrenia-and-disorders-with-psychotic-features,neurological observations,0.00101,finding
71,schizophrenia-and-disorders-with-psychotic-features,liver diseases,0.00101,disease or syndrome
71,schizophrenia-and-disorders-with-psychotic-features,myocardial infarction,5e-04,disease or syndrome - finding
71,schizophrenia-and-disorders-with-psychotic-features,heart diseases,5e-04,disease or syndrome
71,schizophrenia-and-disorders-with-psychotic-features,cardiac arrhythmia,5e-04,finding - pathologic function
72,self-injurious-behavior,suicide attempt,0.25731,finding - mental or behavioral dysfunction
72,self-injurious-behavior,depressed mood,0.12281,finding - mental or behavioral dysfunction
72,self-injurious-behavior,intravenous infusion procedures,0.10526,therapeutic or preventive procedure
72,self-injurious-behavior,valproic acid,0.08187,body part, organ, or organ component - organic chemical - pharmacologic substance
72,self-injurious-behavior,active brand of pseudoephedrine-triprolidine,0.07602,organic chemical - pharmacologic substance
72,self-injurious-behavior,major depressive disorder,0.07018,mental or behavioral dysfunction
72,self-injurious-behavior,borderline personality disorder,0.05848,disease or syndrome - mental or behavioral dysfunction
72,self-injurious-behavior,contraceptive methods,0.05848,therapeutic or preventive procedure
72,self-injurious-behavior,negative finding,0.05848,finding
72,self-injurious-behavior,personality disorders,0.05263,mental or behavioral dysfunction
72,self-injurious-behavior,moderate adverse event,0.04094,finding
72,self-injurious-behavior,allergy severity - severe,0.04094,finding
72,self-injurious-behavior,mini-mental status exam,0.04094,diagnostic procedure
72,self-injurious-behavior,mood disorders,0.04094,mental or behavioral dysfunction
72,self-injurious-behavior,multiple endocrine neoplasia,0.04094,antibiotic - neoplastic process - organic chemical
72,self-injurious-behavior,severe combined immunodeficiency,0.03509,diagnostic procedure - disease or syndrome
72,self-injurious-behavior,physical assessment findings,0.03509,finding
72,self-injurious-behavior,suicidality,0.03509,clinical attribute
72,self-injurious-behavior,pharmacologic substance,0.03509,pharmacologic substance - therapeutic or preventive procedure
72,self-injurious-behavior,mental disorders,0.03509,mental or behavioral dysfunction
72,self-injurious-behavior,positive finding,0.03509,finding
72,self-injurious-behavior,relate - vinyl resin,0.02924,organic chemical
72,self-injurious-behavior,malignant neoplasms,0.02924,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
72,self-injurious-behavior,post-traumatic stress disorder,0.02924,mental or behavioral dysfunction
72,self-injurious-behavior,bipolar disorder,0.02339,mental or behavioral dysfunction
72,self-injurious-behavior,depressive episode unspecified,0.02339,mental or behavioral dysfunction
72,self-injurious-behavior,unipolar depression,0.02339,mental or behavioral dysfunction
72,self-injurious-behavior,psychotropic drugs,0.02339,pharmacologic substance
72,self-injurious-behavior,traumatic brain injury,0.02339,disease or syndrome - injury or poisoning
72,self-injurious-behavior,pharmacotherapy,0.01754,therapeutic or preventive procedure
72,self-injurious-behavior,schizophrenia,0.01754,mental or behavioral dysfunction
72,self-injurious-behavior,kidney,0.01754,body part, organ, or organ component
72,self-injurious-behavior,antidepressive agents,0.01754,pharmacologic substance
72,self-injurious-behavior,mild adverse event,0.01754,finding
72,self-injurious-behavior,pregnancy tests,0.01754,diagnostic procedure
72,self-injurious-behavior,electrocardiogram,0.01754,diagnostic procedure - finding - organic chemical - pharmacologic substance
72,self-injurious-behavior,anxiety disorders,0.01754,finding - mental or behavioral dysfunction
72,self-injurious-behavior,nitric oxide synthase,0.01754,enzyme
72,self-injurious-behavior,unstable status,0.0117,finding
72,self-injurious-behavior,eating disorders,0.0117,mental or behavioral dysfunction
72,self-injurious-behavior,fluoxetine,0.0117,organic chemical - pharmacologic substance
72,self-injurious-behavior,ethanol,0.0117,organic chemical - pharmacologic substance
72,self-injurious-behavior,psychotherapy,0.0117,therapeutic or preventive procedure
72,self-injurious-behavior,liver diseases,0.0117,disease or syndrome
72,self-injurious-behavior,neoplasm metastasis,0.0117,neoplastic process
72,self-injurious-behavior,mental retardation,0.0117,mental or behavioral dysfunction
72,self-injurious-behavior,hepatic,0.0117,body location or region
72,self-injurious-behavior,selective serotonin re-uptake inhibitor,0.0117,pharmacologic substance
72,self-injurious-behavior,psychotic disorders,0.0117,mental or behavioral dysfunction
72,self-injurious-behavior,manic,0.00585,finding - mental or behavioral dysfunction
72,self-injurious-behavior,substance abuse problem,0.00585,mental or behavioral dysfunction
72,self-injurious-behavior,substance dependence,0.00585,mental or behavioral dysfunction
72,self-injurious-behavior,antipsychotic agents,0.00585,pharmacologic substance
72,self-injurious-behavior,obsessive-compulsive disorder,0.00585,disease or syndrome - mental or behavioral dysfunction
72,self-injurious-behavior,pharmaceutical preparations,0.00585,pharmacologic substance
72,self-injurious-behavior,hypersensitivity,0.00585,clinical attribute - finding - pathologic function
72,self-injurious-behavior,screening for cancer,0.00585,diagnostic procedure
72,self-injurious-behavior,lithium,0.00585,congenital abnormality - disease or syndrome - pharmacologic substance
72,self-injurious-behavior,impaired cognition,0.00585,finding - mental or behavioral dysfunction
73,sleep-deprivation,body mass index,0.16,clinical attribute - diagnostic procedure
73,sleep-deprivation,depressed mood,0.12,finding - mental or behavioral dysfunction
73,sleep-deprivation,physical assessment findings,0.08,finding
73,sleep-deprivation,unipolar depression,0.06667,mental or behavioral dysfunction
73,sleep-deprivation,mini-mental status exam,0.06667,diagnostic procedure
73,sleep-deprivation,intravenous infusion procedures,0.06667,therapeutic or preventive procedure
73,sleep-deprivation,mass of body structure,0.06667,finding
73,sleep-deprivation,medical history,0.05333,finding
73,sleep-deprivation,electrocardiogram,0.05333,diagnostic procedure - finding - organic chemical - pharmacologic substance
73,sleep-deprivation,contraceptive methods,0.05333,therapeutic or preventive procedure
73,sleep-deprivation,personal satisfaction,0.05333,finding
73,sleep-deprivation,smoking,0.05333,hazardous or poisonous substance - individual behavior
73,sleep-deprivation,personality inventories,0.05333,diagnostic procedure
73,sleep-deprivation,multiple endocrine neoplasia,0.05333,antibiotic - neoplastic process - organic chemical
73,sleep-deprivation,sleeplessness,0.05333,finding - sign or symptom
73,sleep-deprivation,hypertensive disease,0.04,biologically active substance - disease or syndrome - finding
73,sleep-deprivation,gravidity,0.04,finding
73,sleep-deprivation,asleep,0.04,finding
73,sleep-deprivation,relate - vinyl resin,0.04,organic chemical
73,sleep-deprivation,exercise pain management,0.04,therapeutic or preventive procedure
73,sleep-deprivation,pharmaceutical preparations,0.04,pharmacologic substance
73,sleep-deprivation,active brand of pseudoephedrine-triprolidine,0.04,organic chemical - pharmacologic substance
73,sleep-deprivation,pharmacologic substance,0.04,pharmacologic substance - therapeutic or preventive procedure
73,sleep-deprivation,mental disorders,0.04,mental or behavioral dysfunction
73,sleep-deprivation,operative surgical procedures,0.04,diagnostic procedure - therapeutic or preventive procedure
73,sleep-deprivation,nicotine,0.02667,hazardous or poisonous substance - organic chemical - pharmacologic substance
73,sleep-deprivation,agitation,0.02667,finding - sign or symptom
73,sleep-deprivation,epilepsy,0.02667,disease or syndrome
73,sleep-deprivation,oral contraception,0.02667,pharmacologic substance - therapeutic or preventive procedure
73,sleep-deprivation,bipolar disorder,0.02667,mental or behavioral dysfunction
73,sleep-deprivation,caffeine,0.02667,organic chemical - pharmacologic substance - therapeutic or preventive procedure
73,sleep-deprivation,hypersensitivity,0.02667,clinical attribute - finding - pathologic function
73,sleep-deprivation,psychotropic drugs,0.02667,pharmacologic substance
73,sleep-deprivation,smoker,0.02667,finding
73,sleep-deprivation,moderate adverse event,0.02667,finding
73,sleep-deprivation,major depressive disorder,0.02667,mental or behavioral dysfunction
73,sleep-deprivation,blood pressure finding,0.01333,finding
73,sleep-deprivation,congenital abnormality,0.01333,congenital abnormality - disease or syndrome
73,sleep-deprivation,treatment protocols,0.01333,therapeutic or preventive procedure
73,sleep-deprivation,allergy severity - severe,0.01333,finding
73,sleep-deprivation,restless legs syndrome,0.01333,disease or syndrome
73,sleep-deprivation,drug abuse,0.01333,mental or behavioral dysfunction
73,sleep-deprivation,contraceptives oral,0.01333,pharmacologic substance - therapeutic or preventive procedure
73,sleep-deprivation,pregnancy tests,0.01333,diagnostic procedure
73,sleep-deprivation,claustrophobia,0.01333,mental or behavioral dysfunction
73,sleep-deprivation,anxiety disorders,0.01333,finding - mental or behavioral dysfunction
73,sleep-deprivation,diastole,0.01333,clinical attribute
73,sleep-deprivation,leg,0.01333,body location or region
73,sleep-deprivation,antidepressive agents,0.01333,pharmacologic substance
73,sleep-deprivation,injury wounds,0.01333,body substance - injury or poisoning
73,sleep-deprivation,hearing examination finding,0.01333,finding
73,sleep-deprivation,systolic pressure,0.01333,clinical attribute - diagnostic procedure
73,sleep-deprivation,diastolic blood pressure,0.01333,clinical attribute - diagnostic procedure - finding
74,sleep-disorders,sleeplessness,0.15309,finding - sign or symptom
74,sleep-disorders,body mass index,0.11727,clinical attribute - diagnostic procedure
74,sleep-disorders,intravenous infusion procedures,0.08292,therapeutic or preventive procedure
74,sleep-disorders,moderate adverse event,0.07409,finding
74,sleep-disorders,contraceptive methods,0.07262,therapeutic or preventive procedure
74,sleep-disorders,mass of body structure,0.06379,finding
74,sleep-disorders,restless legs syndrome,0.05299,disease or syndrome
74,sleep-disorders,physical assessment findings,0.05299,finding
74,sleep-disorders,allergy severity - severe,0.04661,finding
74,sleep-disorders,negative finding,0.04612,finding
74,sleep-disorders,hypertensive disease,0.04122,biologically active substance - disease or syndrome - finding
74,sleep-disorders,multiple endocrine neoplasia,0.04024,antibiotic - neoplastic process - organic chemical
74,sleep-disorders,malignant neoplasms,0.0368,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
74,sleep-disorders,pharmacologic substance,0.03631,pharmacologic substance - therapeutic or preventive procedure
74,sleep-disorders,pregnancy tests,0.03533,diagnostic procedure
74,sleep-disorders,mental disorders,0.03435,mental or behavioral dysfunction
74,sleep-disorders,operative surgical procedures,0.03386,diagnostic procedure - therapeutic or preventive procedure
74,sleep-disorders,positive finding,0.03288,finding
74,sleep-disorders,active brand of pseudoephedrine-triprolidine,0.03189,organic chemical - pharmacologic substance
74,sleep-disorders,leg,0.0314,body location or region
74,sleep-disorders,gravidity,0.0314,finding
74,sleep-disorders,depressed mood,0.0314,finding - mental or behavioral dysfunction
74,sleep-disorders,asleep,0.02944,finding
74,sleep-disorders,agitation,0.02944,finding - sign or symptom
74,sleep-disorders,treatment protocols,0.02895,therapeutic or preventive procedure
74,sleep-disorders,pharmacotherapy,0.02846,therapeutic or preventive procedure
74,sleep-disorders,mild adverse event,0.02797,finding
74,sleep-disorders,relate - vinyl resin,0.02552,organic chemical
74,sleep-disorders,electrocardiogram,0.02453,diagnostic procedure - finding - organic chemical - pharmacologic substance
74,sleep-disorders,pharmaceutical preparations,0.02159,pharmacologic substance
74,sleep-disorders,ethanol,0.0211,organic chemical - pharmacologic substance
74,sleep-disorders,obesity,0.02061,disease or syndrome - finding
74,sleep-disorders,medical history,0.02012,finding
74,sleep-disorders,post-traumatic stress disorder,0.01963,mental or behavioral dysfunction
74,sleep-disorders,major depressive disorder,0.01865,mental or behavioral dysfunction
74,sleep-disorders,serum,0.01766,biologically active substance - body substance - pharmacologic substance
74,sleep-disorders,cerebrovascular accident,0.0157,disease or syndrome - therapeutic or preventive procedure
74,sleep-disorders,chronic obstructive airway disease,0.01472,disease or syndrome
74,sleep-disorders,blood pressure finding,0.01472,finding
74,sleep-disorders,arteries,0.01374,body part, organ, or organ component
74,sleep-disorders,anxiety disorders,0.01325,finding - mental or behavioral dysfunction
74,sleep-disorders,psychotropic drugs,0.01325,pharmacologic substance
74,sleep-disorders,benzodiazepines,0.01276,organic chemical - pharmacologic substance
74,sleep-disorders,neoplasm metastasis,0.01276,neoplastic process
74,sleep-disorders,dementia,0.01129,mental or behavioral dysfunction
74,sleep-disorders,antidepressive agents,0.01129,pharmacologic substance
74,sleep-disorders,exercise pain management,0.00981,therapeutic or preventive procedure
74,sleep-disorders,limb structure,0.00932,body part, organ, or organ component
74,sleep-disorders,unipolar depression,0.00883,mental or behavioral dysfunction
74,sleep-disorders,screening for cancer,0.00883,diagnostic procedure
74,sleep-disorders,impaired cognition,0.00883,finding - mental or behavioral dysfunction
74,sleep-disorders,injury wounds,0.00834,body substance - injury or poisoning
74,sleep-disorders,heart ventricle,0.00785,body part, organ, or organ component
74,sleep-disorders,epilepsy,0.00736,disease or syndrome
74,sleep-disorders,congestive heart failure,0.00687,congenital abnormality - disease or syndrome
74,sleep-disorders,smoking,0.00687,hazardous or poisonous substance - individual behavior
74,sleep-disorders,opioids,0.00687,hazardous or poisonous substance - organic chemical - pharmacologic substance
74,sleep-disorders,household composition,0.00638,finding
74,sleep-disorders,movement disorders,0.00638,disease or syndrome
74,sleep-disorders,bipolar disorder,0.00638,mental or behavioral dysfunction
74,sleep-disorders,caffeine,0.00638,organic chemical - pharmacologic substance - therapeutic or preventive procedure
74,sleep-disorders,schizophrenia,0.00589,mental or behavioral dysfunction
74,sleep-disorders,consumption-archaic term for tb,0.00589,disease or syndrome
74,sleep-disorders,breast,0.0054,body part, organ, or organ component
74,sleep-disorders,antipsychotic agents,0.0054,pharmacologic substance
74,sleep-disorders,congenital abnormality,0.0054,congenital abnormality - disease or syndrome
74,sleep-disorders,stimulant,0.0054,pharmacologic substance
74,sleep-disorders,asthma,0.00491,disease or syndrome
74,sleep-disorders,substance abuse problem,0.00491,mental or behavioral dysfunction
74,sleep-disorders,alcoholic intoxication chronic,0.00491,mental or behavioral dysfunction
74,sleep-disorders,unstable status,0.00491,finding
74,sleep-disorders,psychotic disorders,0.00442,mental or behavioral dysfunction
74,sleep-disorders,diabetes mellitus,0.00442,disease or syndrome - pharmacologic substance
74,sleep-disorders,heart diseases,0.00442,disease or syndrome
74,sleep-disorders,hypersensitivity,0.00442,clinical attribute - finding - pathologic function
74,sleep-disorders,suicidal,0.00393,finding
74,sleep-disorders,cardiovascular diseases,0.00393,disease or syndrome
74,sleep-disorders,myocardial infarction,0.00393,disease or syndrome - finding
74,sleep-disorders,hepatic,0.00343,body location or region
74,sleep-disorders,narcotics,0.00294,biologically active substance - hazardous or poisonous substance - pharmacologic substance
74,sleep-disorders,nervousness,0.00294,sign or symptom
74,sleep-disorders,craniocerebral trauma,0.00294,injury or poisoning
74,sleep-disorders,angina pectoris,0.00294,sign or symptom
74,sleep-disorders,drug abuse,0.00294,mental or behavioral dysfunction
74,sleep-disorders,chronic disease,0.00294,disease or syndrome
74,sleep-disorders,anti-anxiety agents,0.00245,pharmacologic substance
74,sleep-disorders,drugs non-prescription,0.00245,pharmacologic substance - therapeutic or preventive procedure
74,sleep-disorders,counter brand of terbufos,0.00245,hazardous or poisonous substance
74,sleep-disorders,investigational new drugs,0.00245,pharmacologic substance - therapeutic or preventive procedure
74,sleep-disorders,neurological observations,0.00245,finding
74,sleep-disorders,kidney diseases,0.00196,disease or syndrome
74,sleep-disorders,nervous system disorder,0.00196,disease or syndrome
74,sleep-disorders,cardiac arrhythmia,0.00196,finding - pathologic function
74,sleep-disorders,alcohol abuse,0.00147,mental or behavioral dysfunction
74,sleep-disorders,angina unstable,0.00147,disease or syndrome
74,sleep-disorders,liver diseases,0.00049,disease or syndrome
75,sleep-initiation-and-maintenance-disorders,sleeplessness,0.75068,finding - sign or symptom
75,sleep-initiation-and-maintenance-disorders,intravenous infusion procedures,0.26849,therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,contraceptive methods,0.13699,therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,mental disorders,0.10959,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,body mass index,0.09863,clinical attribute - diagnostic procedure
75,sleep-initiation-and-maintenance-disorders,asleep,0.09041,finding
75,sleep-initiation-and-maintenance-disorders,mass of body structure,0.07671,finding
75,sleep-initiation-and-maintenance-disorders,depressed mood,0.06849,finding - mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,pharmacologic substance,0.06575,pharmacologic substance - therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,active brand of pseudoephedrine-triprolidine,0.06575,organic chemical - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,negative finding,0.06575,finding
75,sleep-initiation-and-maintenance-disorders,physical assessment findings,0.06301,finding
75,sleep-initiation-and-maintenance-disorders,gravidity,0.06027,finding
75,sleep-initiation-and-maintenance-disorders,major depressive disorder,0.05479,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,pregnancy tests,0.05205,diagnostic procedure
75,sleep-initiation-and-maintenance-disorders,malignant neoplasms,0.05205,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,pharmaceutical preparations,0.0411,pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,anxiety disorders,0.03836,finding - mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,ethanol,0.03836,organic chemical - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,operative surgical procedures,0.03836,diagnostic procedure - therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,sexually active,0.03836,finding
75,sleep-initiation-and-maintenance-disorders,treatment protocols,0.03288,therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,personal satisfaction,0.03288,finding
75,sleep-initiation-and-maintenance-disorders,psychotropic drugs,0.03288,pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,post-traumatic stress disorder,0.03288,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,serum,0.03288,biologically active substance - body substance - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,multiple endocrine neoplasia,0.03288,antibiotic - neoplastic process - organic chemical
75,sleep-initiation-and-maintenance-disorders,pharmacotherapy,0.03014,therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,neoplasm metastasis,0.03014,neoplastic process
75,sleep-initiation-and-maintenance-disorders,relate - vinyl resin,0.03014,organic chemical
75,sleep-initiation-and-maintenance-disorders,electrocardiogram,0.03014,diagnostic procedure - finding - organic chemical - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,antidepressive agents,0.03014,pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,benzodiazepines,0.0274,organic chemical - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,unmarried,0.0274,finding
75,sleep-initiation-and-maintenance-disorders,moderate adverse event,0.0274,finding
75,sleep-initiation-and-maintenance-disorders,medical history,0.0274,finding
75,sleep-initiation-and-maintenance-disorders,allergy severity - severe,0.02466,finding
75,sleep-initiation-and-maintenance-disorders,blind vision,0.02466,disease or syndrome
75,sleep-initiation-and-maintenance-disorders,unipolar depression,0.02192,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,anxiety generalized,0.02192,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,generalized anxiety disorder,0.02192,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,alcoholic intoxication chronic,0.02192,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,leg,0.01918,body location or region
75,sleep-initiation-and-maintenance-disorders,severe combined immunodeficiency,0.01644,diagnostic procedure - disease or syndrome
75,sleep-initiation-and-maintenance-disorders,screening for cancer,0.01644,diagnostic procedure
75,sleep-initiation-and-maintenance-disorders,impaired cognition,0.01644,finding - mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,stress disorders traumatic,0.01644,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,attention deficit hyperactivity disorder,0.01644,disease or syndrome - mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,restless legs syndrome,0.0137,disease or syndrome
75,sleep-initiation-and-maintenance-disorders,caffeine,0.0137,organic chemical - pharmacologic substance - therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,schizophrenia,0.0137,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,agitation,0.0137,finding - sign or symptom
75,sleep-initiation-and-maintenance-disorders,hypersensitivity,0.0137,clinical attribute - finding - pathologic function
75,sleep-initiation-and-maintenance-disorders,epilepsy,0.01096,disease or syndrome
75,sleep-initiation-and-maintenance-disorders,panic disorder,0.01096,disease or syndrome - mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,nicotine,0.01096,hazardous or poisonous substance - organic chemical - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,bipolar disorder,0.01096,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,antipsychotic agents,0.01096,pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,delirium,0.01096,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,congenital abnormality,0.01096,congenital abnormality - disease or syndrome
75,sleep-initiation-and-maintenance-disorders,limb structure,0.01096,body part, organ, or organ component
75,sleep-initiation-and-maintenance-disorders,unstable status,0.01096,finding
75,sleep-initiation-and-maintenance-disorders,dementia,0.01096,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,kidney,0.01096,body part, organ, or organ component
75,sleep-initiation-and-maintenance-disorders,mini-mental status exam,0.01096,diagnostic procedure
75,sleep-initiation-and-maintenance-disorders,cancer remission,0.01096,finding - neoplastic process
75,sleep-initiation-and-maintenance-disorders,psychotic disorders,0.00822,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,breast,0.00822,body part, organ, or organ component
75,sleep-initiation-and-maintenance-disorders,positive finding,0.00822,finding
75,sleep-initiation-and-maintenance-disorders,movement disorders,0.00822,disease or syndrome
75,sleep-initiation-and-maintenance-disorders,drug dependence,0.00822,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,injury wounds,0.00822,body substance - injury or poisoning
75,sleep-initiation-and-maintenance-disorders,illicit drugs,0.00822,hazardous or poisonous substance - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,opiates,0.00822,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,obsessive-compulsive disorder,0.00822,disease or syndrome - mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,substance abuse problem,0.00822,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,suicidal,0.00548,finding
75,sleep-initiation-and-maintenance-disorders,psychiatric problem,0.00548,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,household composition,0.00548,finding
75,sleep-initiation-and-maintenance-disorders,manic,0.00548,finding - mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,chronic obstructive airway disease,0.00548,disease or syndrome
75,sleep-initiation-and-maintenance-disorders,cognitive therapy,0.00548,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,hepatic,0.00548,body location or region
75,sleep-initiation-and-maintenance-disorders,investigational new drugs,0.00548,pharmacologic substance - therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,personality inventories,0.00548,diagnostic procedure
75,sleep-initiation-and-maintenance-disorders,blood pressure finding,0.00548,finding
75,sleep-initiation-and-maintenance-disorders,exercise pain management,0.00548,therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,smoking,0.00548,hazardous or poisonous substance - individual behavior
75,sleep-initiation-and-maintenance-disorders,consumption-archaic term for tb,0.00548,disease or syndrome
75,sleep-initiation-and-maintenance-disorders,substance dependence,0.00274,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,craniocerebral trauma,0.00274,injury or poisoning
75,sleep-initiation-and-maintenance-disorders,personality disorders,0.00274,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,nervousness,0.00274,sign or symptom
75,sleep-initiation-and-maintenance-disorders,hiv,0.00274,disease or syndrome - pharmacologic substance - virus
75,sleep-initiation-and-maintenance-disorders,tobacco,0.00274,hazardous or poisonous substance - organic chemical - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,unconscious state,0.00274,disease or syndrome - finding
75,sleep-initiation-and-maintenance-disorders,mental retardation,0.00274,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,stimulant,0.00274,pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,psychotherapy,0.00274,therapeutic or preventive procedure
75,sleep-initiation-and-maintenance-disorders,consciousness related finding,0.00274,finding
75,sleep-initiation-and-maintenance-disorders,neurological observations,0.00274,finding
75,sleep-initiation-and-maintenance-disorders,drug abuse,0.00274,mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,behavior disorders,0.00274,injury or poisoning - mental or behavioral dysfunction
75,sleep-initiation-and-maintenance-disorders,nervous system disorder,0.00274,disease or syndrome
75,sleep-initiation-and-maintenance-disorders,narcotics,0.00274,biologically active substance - hazardous or poisonous substance - pharmacologic substance
75,sleep-initiation-and-maintenance-disorders,alcohol consumption,0.00274,individual behavior
76,smoking,smoke,0.1479,hazardous or poisonous substance - individual behavior
76,smoking,contraceptive methods,0.08609,therapeutic or preventive procedure
76,smoking,intravenous infusion procedures,0.07947,therapeutic or preventive procedure
76,smoking,tobacco,0.06549,hazardous or poisonous substance - organic chemical - pharmacologic substance
76,smoking,gravidity,0.06475,finding
76,smoking,active brand of pseudoephedrine-triprolidine,0.05519,organic chemical - pharmacologic substance
76,smoking,negative finding,0.05004,finding
76,smoking,ethanol,0.05004,organic chemical - pharmacologic substance
76,smoking,malignant neoplasms,0.04857,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
76,smoking,nicotine dependence,0.04415,mental or behavioral dysfunction
76,smoking,physical assessment findings,0.04268,finding
76,smoking,schizophrenia,0.04121,mental or behavioral dysfunction
76,smoking,body mass index,0.04047,clinical attribute - diagnostic procedure
76,smoking,pregnancy tests,0.039,diagnostic procedure
76,smoking,follow-up status,0.039,finding
76,smoking,pharmacologic substance,0.03091,pharmacologic substance - therapeutic or preventive procedure
76,smoking,infantile neuroaxonal dystrophy,0.03017,disease or syndrome
76,smoking,multiple endocrine neoplasia,0.02943,antibiotic - neoplastic process - organic chemical
76,smoking,schizoaffective disorder,0.02649,mental or behavioral dysfunction
76,smoking,positive finding,0.02649,finding
76,smoking,operative surgical procedures,0.02502,diagnostic procedure - therapeutic or preventive procedure
76,smoking,medical history,0.02428,finding
76,smoking,marihuana,0.02355,mental or behavioral dysfunction - organic chemical - pharmacologic substance
76,smoking,chronic obstructive airway disease,0.02281,disease or syndrome
76,smoking,depressed mood,0.02281,finding - mental or behavioral dysfunction
76,smoking,antipsychotic agents,0.02134,pharmacologic substance
76,smoking,pharmaceutical preparations,0.0206,pharmacologic substance
76,smoking,pharmacotherapy,0.01987,therapeutic or preventive procedure
76,smoking,moderate adverse event,0.0184,finding
76,smoking,asthma,0.01545,disease or syndrome
76,smoking,unstable status,0.01545,finding
76,smoking,mass of body structure,0.01545,finding
76,smoking,blood pressure finding,0.01472,finding
76,smoking,hypertensive disease,0.01472,biologically active substance - disease or syndrome - finding
76,smoking,substance abuse problem,0.01398,mental or behavioral dysfunction
76,smoking,consumption-archaic term for tb,0.01325,disease or syndrome
76,smoking,mental disorders,0.01325,mental or behavioral dysfunction
76,smoking,psychotic disorders,0.01251,mental or behavioral dysfunction
76,smoking,alcoholic intoxication chronic,0.01251,mental or behavioral dysfunction
76,smoking,electrocardiogram,0.01251,diagnostic procedure - finding - organic chemical - pharmacologic substance
76,smoking,angina pectoris,0.01251,sign or symptom
76,smoking,screening for cancer,0.01251,diagnostic procedure
76,smoking,household composition,0.01177,finding
76,smoking,myocardial infarction,0.01177,disease or syndrome - finding
76,smoking,illicit drugs,0.01177,hazardous or poisonous substance - pharmacologic substance
76,smoking,arteries,0.01177,body part, organ, or organ component
76,smoking,blood vessel,0.01104,body part, organ, or organ component - finding
76,smoking,unipolar depression,0.01104,mental or behavioral dysfunction
76,smoking,breast,0.01104,body part, organ, or organ component
76,smoking,hiv,0.0103,disease or syndrome - pharmacologic substance - virus
76,smoking,bipolar disorder,0.0103,mental or behavioral dysfunction
76,smoking,hypersensitivity,0.0103,clinical attribute - finding - pathologic function
76,smoking,anxiety disorders,0.00957,finding - mental or behavioral dysfunction
76,smoking,antidepressive agents,0.00957,pharmacologic substance
76,smoking,hepatic,0.00883,body location or region
76,smoking,observation of attack,0.00883,finding
76,smoking,cardiac arrhythmia,0.00809,finding - pathologic function
76,smoking,angina unstable,0.00809,disease or syndrome
76,smoking,alcohol consumption,0.00809,individual behavior
76,smoking,cardiovascular diseases,0.00736,disease or syndrome
76,smoking,opiates,0.00736,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
76,smoking,diabetes,0.00736,disease or syndrome
76,smoking,heart diseases,0.00736,disease or syndrome
76,smoking,congestive heart failure,0.00662,congenital abnormality - disease or syndrome
76,smoking,investigational new drugs,0.00662,pharmacologic substance - therapeutic or preventive procedure
76,smoking,injury wounds,0.00589,body substance - injury or poisoning
76,smoking,major depressive disorder,0.00589,mental or behavioral dysfunction
76,smoking,alcohol abuse,0.00515,mental or behavioral dysfunction
76,smoking,diastole,0.00515,clinical attribute
76,smoking,cerebrovascular accident,0.00515,disease or syndrome - therapeutic or preventive procedure
76,smoking,suicidal,0.00442,finding
76,smoking,psychotropic drugs,0.00442,pharmacologic substance
76,smoking,congenital abnormality,0.00442,congenital abnormality - disease or syndrome
76,smoking,cocaine,0.00442,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
76,smoking,monoamine oxidase inhibitors,0.00368,organic chemical - pharmacologic substance
76,smoking,craniocerebral trauma,0.00368,injury or poisoning
76,smoking,allergy severity - severe,0.00368,finding
76,smoking,kidney diseases,0.00294,disease or syndrome
76,smoking,benzodiazepines,0.00294,organic chemical - pharmacologic substance
76,smoking,epilepsy,0.00221,disease or syndrome
76,smoking,drug abuse,0.00221,mental or behavioral dysfunction
76,smoking,liver diseases,0.00147,disease or syndrome
76,smoking,panic disorder,0.00074,disease or syndrome - mental or behavioral dysfunction
76,smoking,dementia,0.00074,mental or behavioral dysfunction
77,somatoform-disorders,intravenous infusion procedures,0.10241,therapeutic or preventive procedure
77,somatoform-disorders,limb structure,0.07229,body part, organ, or organ component
77,somatoform-disorders,negative finding,0.06627,finding
77,somatoform-disorders,anxiety disorders,0.06627,finding - mental or behavioral dysfunction
77,somatoform-disorders,physical assessment findings,0.06627,finding
77,somatoform-disorders,moderate adverse event,0.05422,finding
77,somatoform-disorders,contraceptive methods,0.04819,therapeutic or preventive procedure
77,somatoform-disorders,depressed mood,0.04819,finding - mental or behavioral dysfunction
77,somatoform-disorders,multiple endocrine neoplasia,0.04819,antibiotic - neoplastic process - organic chemical
77,somatoform-disorders,positive finding,0.04217,finding
77,somatoform-disorders,active brand of pseudoephedrine-triprolidine,0.04217,organic chemical - pharmacologic substance
77,somatoform-disorders,allergy severity - severe,0.04217,finding
77,somatoform-disorders,pregnancy tests,0.04217,diagnostic procedure
77,somatoform-disorders,pharmacologic substance,0.03614,pharmacologic substance - therapeutic or preventive procedure
77,somatoform-disorders,mental disorders,0.03614,mental or behavioral dysfunction
77,somatoform-disorders,psychotic disorders,0.03012,mental or behavioral dysfunction
77,somatoform-disorders,pharmaceutical preparations,0.0241,pharmacologic substance
77,somatoform-disorders,psychotropic drugs,0.0241,pharmacologic substance
77,somatoform-disorders,operative surgical procedures,0.0241,diagnostic procedure - therapeutic or preventive procedure
77,somatoform-disorders,opioids,0.0241,hazardous or poisonous substance - organic chemical - pharmacologic substance
77,somatoform-disorders,antidepressive agents,0.0241,pharmacologic substance
77,somatoform-disorders,psychiatric problem,0.01807,mental or behavioral dysfunction
77,somatoform-disorders,bipolar disorder,0.01807,mental or behavioral dysfunction
77,somatoform-disorders,anticonvulsants,0.01807,pharmacologic substance
77,somatoform-disorders,mood disorders,0.01807,mental or behavioral dysfunction
77,somatoform-disorders,psychotic symptoms,0.01807,sign or symptom
77,somatoform-disorders,pharmacotherapy,0.01205,therapeutic or preventive procedure
77,somatoform-disorders,body mass index,0.01205,clinical attribute - diagnostic procedure
77,somatoform-disorders,magnetic resonance imaging,0.01205,diagnostic procedure
77,somatoform-disorders,gravidity,0.01205,finding
77,somatoform-disorders,eating disorders,0.01205,mental or behavioral dysfunction
77,somatoform-disorders,stimulation procedure,0.01205,therapeutic or preventive procedure
77,somatoform-disorders,unstable status,0.00602,finding
77,somatoform-disorders,epilepsy,0.00602,disease or syndrome
77,somatoform-disorders,antipsychotic agents,0.00602,pharmacologic substance
77,somatoform-disorders,disability,0.00602,finding
77,somatoform-disorders,benzodiazepines,0.00602,organic chemical - pharmacologic substance
77,somatoform-disorders,breast,0.00602,body part, organ, or organ component
77,somatoform-disorders,schizophrenia,0.00602,mental or behavioral dysfunction
77,somatoform-disorders,ethanol,0.00602,organic chemical - pharmacologic substance
77,somatoform-disorders,personality disorders,0.00602,mental or behavioral dysfunction
77,somatoform-disorders,psychotherapy,0.00602,therapeutic or preventive procedure
77,somatoform-disorders,narcotics,0.00602,biologically active substance - hazardous or poisonous substance - pharmacologic substance
77,somatoform-disorders,cognitive therapy,0.00602,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
77,somatoform-disorders,malignant neoplasms,0.00602,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
77,somatoform-disorders,mass of body structure,0.00602,finding
78,substance-related-disorders,intravenous infusion procedures,0.22839,therapeutic or preventive procedure
78,substance-related-disorders,ethanol,0.20129,organic chemical - pharmacologic substance
78,substance-related-disorders,contraceptive methods,0.15419,therapeutic or preventive procedure
78,substance-related-disorders,pharmacologic substance,0.10935,pharmacologic substance - therapeutic or preventive procedure
78,substance-related-disorders,alcoholic intoxication chronic,0.09129,mental or behavioral dysfunction
78,substance-related-disorders,negative finding,0.08968,finding
78,substance-related-disorders,positive finding,0.0829,finding
78,substance-related-disorders,physical assessment findings,0.07871,finding
78,substance-related-disorders,opioids,0.07032,hazardous or poisonous substance - organic chemical - pharmacologic substance
78,substance-related-disorders,pregnancy tests,0.0671,diagnostic procedure
78,substance-related-disorders,gravidity,0.06613,finding
78,substance-related-disorders,smoker,0.06581,finding
78,substance-related-disorders,multiple endocrine neoplasia,0.06161,antibiotic - neoplastic process - organic chemical
78,substance-related-disorders,marihuana,0.06065,mental or behavioral dysfunction - organic chemical - pharmacologic substance
78,substance-related-disorders,opiate addiction,0.05935,mental or behavioral dysfunction
78,substance-related-disorders,alcohol consumption,0.05194,individual behavior
78,substance-related-disorders,pharmaceutical preparations,0.04774,pharmacologic substance
78,substance-related-disorders,opiates,0.0471,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
78,substance-related-disorders,medical history,0.04258,finding
78,substance-related-disorders,substance abuse problem,0.04194,mental or behavioral dysfunction
78,substance-related-disorders,smoke,0.04,hazardous or poisonous substance - individual behavior
78,substance-related-disorders,electrocardiogram,0.03839,diagnostic procedure - finding - organic chemical - pharmacologic substance
78,substance-related-disorders,active brand of pseudoephedrine-triprolidine,0.03806,organic chemical - pharmacologic substance
78,substance-related-disorders,screening for cancer,0.03774,diagnostic procedure
78,substance-related-disorders,follow-up status,0.0371,finding
78,substance-related-disorders,body mass index,0.03452,clinical attribute - diagnostic procedure
78,substance-related-disorders,personal satisfaction,0.03419,finding
78,substance-related-disorders,malignant neoplasms,0.03355,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
78,substance-related-disorders,operative surgical procedures,0.0329,diagnostic procedure - therapeutic or preventive procedure
78,substance-related-disorders,pregnancy test negative,0.0329,finding - laboratory or test result
78,substance-related-disorders,mental disorders,0.03161,mental or behavioral dysfunction
78,substance-related-disorders,pharmacotherapy,0.03129,therapeutic or preventive procedure
78,substance-related-disorders,nicotine dependence,0.03032,mental or behavioral dysfunction
78,substance-related-disorders,severe combined immunodeficiency,0.03032,diagnostic procedure - disease or syndrome
78,substance-related-disorders,consumption-archaic term for tb,0.02774,disease or syndrome
78,substance-related-disorders,treatment protocols,0.02645,therapeutic or preventive procedure
78,substance-related-disorders,moderate adverse event,0.02613,finding
78,substance-related-disorders,schizophrenia,0.02581,mental or behavioral dysfunction
78,substance-related-disorders,tobacco,0.02419,hazardous or poisonous substance - organic chemical - pharmacologic substance
78,substance-related-disorders,hiv,0.0229,disease or syndrome - pharmacologic substance - virus
78,substance-related-disorders,mass of body structure,0.02258,finding
78,substance-related-disorders,depressed mood,0.02194,finding - mental or behavioral dysfunction
78,substance-related-disorders,illicit drugs,0.02129,hazardous or poisonous substance - pharmacologic substance
78,substance-related-disorders,serum,0.02129,biologically active substance - body substance - pharmacologic substance
78,substance-related-disorders,allergy severity - severe,0.02097,finding
78,substance-related-disorders,alcohol abuse,0.02097,mental or behavioral dysfunction
78,substance-related-disorders,relate - vinyl resin,0.01968,organic chemical
78,substance-related-disorders,detoxification procedure,0.01968,therapeutic or preventive procedure
78,substance-related-disorders,infantile neuroaxonal dystrophy,0.01935,disease or syndrome
78,substance-related-disorders,alanine transaminase,0.01871,congenital abnormality - disease or syndrome - enzyme
78,substance-related-disorders,bilirubin,0.01839,biologically active substance - laboratory or test result - organic chemical
78,substance-related-disorders,post-traumatic stress disorder,0.0171,mental or behavioral dysfunction
78,substance-related-disorders,substance use disorders,0.01677,mental or behavioral dysfunction
78,substance-related-disorders,schizoaffective disorder,0.01613,mental or behavioral dysfunction
78,substance-related-disorders,aspartate transaminase,0.01613,enzyme
78,substance-related-disorders,antipsychotic agents,0.01548,pharmacologic substance
78,substance-related-disorders,hepatic,0.01419,body location or region
78,substance-related-disorders,anxiety disorders,0.01387,finding - mental or behavioral dysfunction
78,substance-related-disorders,psychotic disorders,0.0129,mental or behavioral dysfunction
78,substance-related-disorders,congenital abnormality,0.0129,congenital abnormality - disease or syndrome
78,substance-related-disorders,diabetes mellitus,0.01226,disease or syndrome - pharmacologic substance
78,substance-related-disorders,arteries,0.01161,body part, organ, or organ component
78,substance-related-disorders,substance dependence,0.01129,mental or behavioral dysfunction
78,substance-related-disorders,liver function,0.01129,organ or tissue function
78,substance-related-disorders,blood pressure finding,0.01097,finding
78,substance-related-disorders,psychotropic drugs,0.01032,pharmacologic substance
78,substance-related-disorders,unstable status,0.01032,finding
78,substance-related-disorders,benzodiazepines,0.00968,organic chemical - pharmacologic substance
78,substance-related-disorders,breast,0.00968,body part, organ, or organ component
78,substance-related-disorders,bipolar disorder,0.00968,mental or behavioral dysfunction
78,substance-related-disorders,stimulant,0.00968,pharmacologic substance
78,substance-related-disorders,diastole,0.00968,clinical attribute
78,substance-related-disorders,drug dependence,0.00935,mental or behavioral dysfunction
78,substance-related-disorders,hypersensitivity,0.00935,clinical attribute - finding - pathologic function
78,substance-related-disorders,major depressive disorder,0.00935,mental or behavioral dysfunction
78,substance-related-disorders,liver diseases,0.00871,disease or syndrome
78,substance-related-disorders,unipolar depression,0.00871,mental or behavioral dysfunction
78,substance-related-disorders,hypertensive disease,0.00839,biologically active substance - disease or syndrome - finding
78,substance-related-disorders,impaired cognition,0.00806,finding - mental or behavioral dysfunction
78,substance-related-disorders,drug abuse,0.00806,mental or behavioral dysfunction
78,substance-related-disorders,magnetic resonance imaging,0.00774,diagnostic procedure
78,substance-related-disorders,cardiac arrhythmia,0.00774,finding - pathologic function
78,substance-related-disorders,injury wounds,0.00742,body substance - injury or poisoning
78,substance-related-disorders,consciousness related finding,0.0071,finding
78,substance-related-disorders,mood disorders,0.00645,mental or behavioral dysfunction
78,substance-related-disorders,transaminases,0.00645,enzyme
78,substance-related-disorders,myocardial infarction,0.00613,disease or syndrome - finding
78,substance-related-disorders,caffeine,0.00581,organic chemical - pharmacologic substance - therapeutic or preventive procedure
78,substance-related-disorders,manic,0.00548,finding - mental or behavioral dysfunction
78,substance-related-disorders,blood vessel,0.00548,body part, organ, or organ component - finding
78,substance-related-disorders,lung,0.00516,body part, organ, or organ component - disease or syndrome
78,substance-related-disorders,antidepressive agents,0.00516,pharmacologic substance
78,substance-related-disorders,angina pectoris,0.00484,sign or symptom
78,substance-related-disorders,anticonvulsants,0.00419,pharmacologic substance
78,substance-related-disorders,epilepsy,0.00323,disease or syndrome
78,substance-related-disorders,monoamine oxidase inhibitors,0.00323,organic chemical - pharmacologic substance
78,substance-related-disorders,investigational new drugs,0.00323,pharmacologic substance - therapeutic or preventive procedure
78,substance-related-disorders,suicidal,0.0029,finding
78,substance-related-disorders,asthma,0.0029,disease or syndrome
78,substance-related-disorders,unconscious state,0.0029,disease or syndrome - finding
78,substance-related-disorders,dementia,0.0029,mental or behavioral dysfunction
78,substance-related-disorders,suicide attempt,0.0029,finding - mental or behavioral dysfunction
78,substance-related-disorders,cerebrovascular accident,0.0029,disease or syndrome - therapeutic or preventive procedure
78,substance-related-disorders,heart diseases,0.0029,disease or syndrome
78,substance-related-disorders,kidney diseases,0.00258,disease or syndrome
78,substance-related-disorders,craniocerebral trauma,0.00226,injury or poisoning
78,substance-related-disorders,nervous system disorder,0.00194,disease or syndrome
78,substance-related-disorders,cardiovascular diseases,0.00129,disease or syndrome
79,substance-withdrawal-syndrome,intravenous infusion procedures,0.26582,therapeutic or preventive procedure
79,substance-withdrawal-syndrome,contraceptive methods,0.25316,therapeutic or preventive procedure
79,substance-withdrawal-syndrome,opioids,0.22785,hazardous or poisonous substance - organic chemical - pharmacologic substance
79,substance-withdrawal-syndrome,ethanol,0.16456,organic chemical - pharmacologic substance
79,substance-withdrawal-syndrome,pharmacologic substance,0.12658,pharmacologic substance - therapeutic or preventive procedure
79,substance-withdrawal-syndrome,opiates,0.12658,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
79,substance-withdrawal-syndrome,physical assessment findings,0.12658,finding
79,substance-withdrawal-syndrome,spermatocidal agents,0.11392,pharmacologic substance
79,substance-withdrawal-syndrome,opiate addiction,0.11392,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,marihuana,0.11392,mental or behavioral dysfunction - organic chemical - pharmacologic substance
79,substance-withdrawal-syndrome,screening for cancer,0.11392,diagnostic procedure
79,substance-withdrawal-syndrome,negative finding,0.10127,finding
79,substance-withdrawal-syndrome,disease of diaphragm,0.10127,body part, organ, or organ component - disease or syndrome
79,substance-withdrawal-syndrome,positive finding,0.08861,finding
79,substance-withdrawal-syndrome,benzodiazepines,0.07595,organic chemical - pharmacologic substance
79,substance-withdrawal-syndrome,body mass index,0.07595,clinical attribute - diagnostic procedure
79,substance-withdrawal-syndrome,personal satisfaction,0.07595,finding
79,substance-withdrawal-syndrome,operative surgical procedures,0.07595,diagnostic procedure - therapeutic or preventive procedure
79,substance-withdrawal-syndrome,gravidity,0.07595,finding
79,substance-withdrawal-syndrome,smoker,0.07595,finding
79,substance-withdrawal-syndrome,pharmaceutical preparations,0.06329,pharmacologic substance
79,substance-withdrawal-syndrome,contraceptives oral,0.06329,pharmacologic substance - therapeutic or preventive procedure
79,substance-withdrawal-syndrome,mass of body structure,0.06329,finding
79,substance-withdrawal-syndrome,sterility,0.05063,pathologic function
79,substance-withdrawal-syndrome,nicotine dependence,0.05063,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,illicit drugs,0.05063,hazardous or poisonous substance - pharmacologic substance
79,substance-withdrawal-syndrome,blood pressure finding,0.05063,finding
79,substance-withdrawal-syndrome,medical history,0.05063,finding
79,substance-withdrawal-syndrome,implantation procedure,0.05063,therapeutic or preventive procedure
79,substance-withdrawal-syndrome,alcoholic intoxication chronic,0.05063,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,allergy severity - severe,0.03797,finding
79,substance-withdrawal-syndrome,oral contraception,0.03797,pharmacologic substance - therapeutic or preventive procedure
79,substance-withdrawal-syndrome,smoke,0.03797,hazardous or poisonous substance - individual behavior
79,substance-withdrawal-syndrome,pregnancy tests,0.03797,diagnostic procedure
79,substance-withdrawal-syndrome,contraception barrier,0.03797,therapeutic or preventive procedure
79,substance-withdrawal-syndrome,consumption-archaic term for tb,0.03797,disease or syndrome
79,substance-withdrawal-syndrome,mental disorders,0.03797,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,caffeine,0.02532,organic chemical - pharmacologic substance - therapeutic or preventive procedure
79,substance-withdrawal-syndrome,current therapy,0.02532,therapeutic or preventive procedure
79,substance-withdrawal-syndrome,breast,0.02532,body part, organ, or organ component
79,substance-withdrawal-syndrome,active brand of pseudoephedrine-triprolidine,0.02532,organic chemical - pharmacologic substance
79,substance-withdrawal-syndrome,liver function,0.02532,organ or tissue function
79,substance-withdrawal-syndrome,systolic pressure,0.02532,clinical attribute - diagnostic procedure
79,substance-withdrawal-syndrome,moderate adverse event,0.02532,finding
79,substance-withdrawal-syndrome,detoxification procedure,0.02532,therapeutic or preventive procedure
79,substance-withdrawal-syndrome,mercury,0.02532,hazardous or poisonous substance
79,substance-withdrawal-syndrome,serum,0.02532,biologically active substance - body substance - pharmacologic substance
79,substance-withdrawal-syndrome,alcohol consumption,0.02532,individual behavior
79,substance-withdrawal-syndrome,psychotic disorders,0.01266,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,anxiety disorders,0.01266,finding - mental or behavioral dysfunction
79,substance-withdrawal-syndrome,alanine transaminase,0.01266,congenital abnormality - disease or syndrome - enzyme
79,substance-withdrawal-syndrome,tobacco,0.01266,hazardous or poisonous substance - organic chemical - pharmacologic substance
79,substance-withdrawal-syndrome,stimulant,0.01266,pharmacologic substance
79,substance-withdrawal-syndrome,schizophrenia,0.01266,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,diastole,0.01266,clinical attribute
79,substance-withdrawal-syndrome,substance dependence,0.01266,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,antipsychotic agents,0.01266,pharmacologic substance
79,substance-withdrawal-syndrome,drug dependence,0.01266,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,psychotropic drugs,0.01266,pharmacologic substance
79,substance-withdrawal-syndrome,traumatic brain injury,0.01266,disease or syndrome - injury or poisoning
79,substance-withdrawal-syndrome,heart ventricle,0.01266,body part, organ, or organ component
79,substance-withdrawal-syndrome,substance abuse problem,0.01266,mental or behavioral dysfunction
79,substance-withdrawal-syndrome,congenital abnormality,0.01266,congenital abnormality - disease or syndrome
79,substance-withdrawal-syndrome,consciousness related finding,0.01266,finding
79,substance-withdrawal-syndrome,hypertensive disease,0.01266,biologically active substance - disease or syndrome - finding
79,substance-withdrawal-syndrome,gene therapy,0.01266,therapeutic or preventive procedure
79,substance-withdrawal-syndrome,heart rate,0.01266,clinical attribute
79,substance-withdrawal-syndrome,brain injuries,0.01266,injury or poisoning
79,substance-withdrawal-syndrome,transaminases,0.01266,enzyme
79,substance-withdrawal-syndrome,injury wounds,0.01266,body substance - injury or poisoning
79,substance-withdrawal-syndrome,liver diseases,0.01266,disease or syndrome
79,substance-withdrawal-syndrome,malignant neoplasms,0.01266,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
79,substance-withdrawal-syndrome,diagnosis psychiatric,0.01266,mental or behavioral dysfunction
80,suicidal-ideation,depressed mood,0.22,finding - mental or behavioral dysfunction
80,suicidal-ideation,suicide attempt,0.16,finding - mental or behavioral dysfunction
80,suicidal-ideation,major depressive disorder,0.16,mental or behavioral dysfunction
80,suicidal-ideation,intravenous infusion procedures,0.12,therapeutic or preventive procedure
80,suicidal-ideation,active brand of pseudoephedrine-triprolidine,0.12,organic chemical - pharmacologic substance
80,suicidal-ideation,mini-mental status exam,0.1,diagnostic procedure
80,suicidal-ideation,valproic acid,0.1,body part, organ, or organ component - organic chemical - pharmacologic substance
80,suicidal-ideation,suicidality,0.08,clinical attribute
80,suicidal-ideation,moderate adverse event,0.06,finding
80,suicidal-ideation,unipolar depression,0.06,mental or behavioral dysfunction
80,suicidal-ideation,depressive episode unspecified,0.06,mental or behavioral dysfunction
80,suicidal-ideation,antidepressive agents,0.06,pharmacologic substance
80,suicidal-ideation,contraceptive methods,0.06,therapeutic or preventive procedure
80,suicidal-ideation,pregnancy tests,0.06,diagnostic procedure
80,suicidal-ideation,mild adverse event,0.06,finding
80,suicidal-ideation,severe combined immunodeficiency,0.06,diagnostic procedure - disease or syndrome
80,suicidal-ideation,mood disorders,0.06,mental or behavioral dysfunction
80,suicidal-ideation,negative finding,0.06,finding
80,suicidal-ideation,mental disorders,0.06,mental or behavioral dysfunction
80,suicidal-ideation,treatment protocols,0.04,therapeutic or preventive procedure
80,suicidal-ideation,electrocardiogram,0.04,diagnostic procedure - finding - organic chemical - pharmacologic substance
80,suicidal-ideation,household composition,0.04,finding
80,suicidal-ideation,nitric oxide synthase,0.04,enzyme
80,suicidal-ideation,post-traumatic stress disorder,0.04,mental or behavioral dysfunction
80,suicidal-ideation,schizophrenia,0.02,mental or behavioral dysfunction
80,suicidal-ideation,psychotic disorders,0.02,mental or behavioral dysfunction
80,suicidal-ideation,allergy severity - severe,0.02,finding
80,suicidal-ideation,substance dependence,0.02,mental or behavioral dysfunction
80,suicidal-ideation,physical assessment findings,0.02,finding
80,suicidal-ideation,pharmaceutical preparations,0.02,pharmacologic substance
80,suicidal-ideation,anxiety disorders,0.02,finding - mental or behavioral dysfunction
80,suicidal-ideation,eating disorders,0.02,mental or behavioral dysfunction
80,suicidal-ideation,marihuana,0.02,mental or behavioral dysfunction - organic chemical - pharmacologic substance
80,suicidal-ideation,pharmacologic substance,0.02,pharmacologic substance - therapeutic or preventive procedure
80,suicidal-ideation,psychotropic drugs,0.02,pharmacologic substance
80,suicidal-ideation,ethanol,0.02,organic chemical - pharmacologic substance
80,suicidal-ideation,screening for cancer,0.02,diagnostic procedure
80,suicidal-ideation,unstable status,0.02,finding
80,suicidal-ideation,selective serotonin re-uptake inhibitor,0.02,pharmacologic substance
80,suicidal-ideation,substance abuse problem,0.02,mental or behavioral dysfunction
80,suicidal-ideation,positive finding,0.02,finding
81,suicide,suicide attempt,0.25989,finding - mental or behavioral dysfunction
81,suicide,depressed mood,0.14124,finding - mental or behavioral dysfunction
81,suicide,intravenous infusion procedures,0.10734,therapeutic or preventive procedure
81,suicide,valproic acid,0.08475,body part, organ, or organ component - organic chemical - pharmacologic substance
81,suicide,active brand of pseudoephedrine-triprolidine,0.0791,organic chemical - pharmacologic substance
81,suicide,major depressive disorder,0.07345,mental or behavioral dysfunction
81,suicide,depressive episode unspecified,0.0565,mental or behavioral dysfunction
81,suicide,borderline personality disorder,0.0452,disease or syndrome - mental or behavioral dysfunction
81,suicide,mood disorders,0.0452,mental or behavioral dysfunction
81,suicide,negative finding,0.0452,finding
81,suicide,mini-mental status exam,0.03955,diagnostic procedure
81,suicide,contraceptive methods,0.03955,therapeutic or preventive procedure
81,suicide,suicidality,0.03955,clinical attribute
81,suicide,pharmacologic substance,0.03955,pharmacologic substance - therapeutic or preventive procedure
81,suicide,malignant neoplasms,0.03955,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
81,suicide,positive finding,0.03955,finding
81,suicide,moderate adverse event,0.0339,finding
81,suicide,post-traumatic stress disorder,0.0339,mental or behavioral dysfunction
81,suicide,pharmacotherapy,0.0339,therapeutic or preventive procedure
81,suicide,relate - vinyl resin,0.0339,organic chemical
81,suicide,allergy severity - severe,0.0339,finding
81,suicide,bilirubin,0.0339,biologically active substance - laboratory or test result - organic chemical
81,suicide,bipolar disorder,0.0339,mental or behavioral dysfunction
81,suicide,personality disorders,0.0339,mental or behavioral dysfunction
81,suicide,life expectancy,0.0339,group attribute
81,suicide,physical assessment findings,0.0339,finding
81,suicide,mental disorders,0.0339,mental or behavioral dysfunction
81,suicide,unipolar depression,0.02825,mental or behavioral dysfunction
81,suicide,creatinine clearance,0.02825,finding
81,suicide,kidney,0.02825,body part, organ, or organ component
81,suicide,traumatic brain injury,0.02825,disease or syndrome - injury or poisoning
81,suicide,ethanol,0.02825,organic chemical - pharmacologic substance
81,suicide,multiple endocrine neoplasia,0.02825,antibiotic - neoplastic process - organic chemical
81,suicide,hepatic,0.02825,body location or region
81,suicide,antidepressive agents,0.0226,pharmacologic substance
81,suicide,anxiety disorders,0.0226,finding - mental or behavioral dysfunction
81,suicide,severe combined immunodeficiency,0.0226,diagnostic procedure - disease or syndrome
81,suicide,brain injuries,0.01695,injury or poisoning
81,suicide,electrocardiogram,0.01695,diagnostic procedure - finding - organic chemical - pharmacologic substance
81,suicide,psychotropic drugs,0.01695,pharmacologic substance
81,suicide,neoplasm metastasis,0.01695,neoplastic process
81,suicide,schizophrenia,0.01695,mental or behavioral dysfunction
81,suicide,pregnancy tests,0.01695,diagnostic procedure
81,suicide,mild adverse event,0.01695,finding
81,suicide,unstable status,0.0113,finding
81,suicide,psychotic disorders,0.0113,mental or behavioral dysfunction
81,suicide,treatment protocols,0.0113,therapeutic or preventive procedure
81,suicide,eating disorders,0.0113,mental or behavioral dysfunction
81,suicide,screening for cancer,0.0113,diagnostic procedure
81,suicide,liver diseases,0.0113,disease or syndrome
81,suicide,selective serotonin re-uptake inhibitor,0.0113,pharmacologic substance
81,suicide,substance abuse problem,0.00565,mental or behavioral dysfunction
81,suicide,dementia,0.00565,mental or behavioral dysfunction
81,suicide,alcoholic intoxication chronic,0.00565,mental or behavioral dysfunction
81,suicide,disability,0.00565,finding
81,suicide,substance dependence,0.00565,mental or behavioral dysfunction
81,suicide,antipsychotic agents,0.00565,pharmacologic substance
81,suicide,pharmaceutical preparations,0.00565,pharmacologic substance
81,suicide,manic,0.00565,finding - mental or behavioral dysfunction
81,suicide,mental retardation,0.00565,mental or behavioral dysfunction
81,suicide,medical contraindication,0.00565,finding
82,tic-disorders,tic disorder,0.61957,mental or behavioral dysfunction
82,tic-disorders,intravenous infusion procedures,0.3913,therapeutic or preventive procedure
82,tic-disorders,contraceptive methods,0.15217,therapeutic or preventive procedure
82,tic-disorders,physical assessment findings,0.15217,finding
82,tic-disorders,negative finding,0.11957,finding
82,tic-disorders,movement disorders,0.11957,disease or syndrome
82,tic-disorders,pregnancy tests,0.11957,diagnostic procedure
82,tic-disorders,ethanol,0.1087,organic chemical - pharmacologic substance
82,tic-disorders,osteochondritis dissecans,0.1087,disease or syndrome - mental or behavioral dysfunction
82,tic-disorders,gravidity,0.1087,finding
82,tic-disorders,attention deficit hyperactivity disorder,0.1087,disease or syndrome - mental or behavioral dysfunction
82,tic-disorders,mental disorders,0.1087,mental or behavioral dysfunction
82,tic-disorders,obsessive-compulsive disorder,0.09783,disease or syndrome - mental or behavioral dysfunction
82,tic-disorders,pharmacologic substance,0.08696,pharmacologic substance - therapeutic or preventive procedure
82,tic-disorders,antipsychotic agents,0.08696,pharmacologic substance
82,tic-disorders,moderate adverse event,0.08696,finding
82,tic-disorders,allergy severity - severe,0.08696,finding
82,tic-disorders,compulsive disorder,0.08696,finding
82,tic-disorders,hyperactive behavior,0.06522,finding
82,tic-disorders,treatment protocols,0.06522,therapeutic or preventive procedure
82,tic-disorders,anxiety disorders,0.05435,finding - mental or behavioral dysfunction
82,tic-disorders,relate - vinyl resin,0.05435,organic chemical
82,tic-disorders,congenital abnormality,0.05435,congenital abnormality - disease or syndrome
82,tic-disorders,current therapy,0.05435,therapeutic or preventive procedure
82,tic-disorders,depressed mood,0.05435,finding - mental or behavioral dysfunction
82,tic-disorders,epilepsy,0.04348,disease or syndrome
82,tic-disorders,nervousness,0.04348,sign or symptom
82,tic-disorders,integumentary scale,0.04348,body part, organ, or organ component
82,tic-disorders,fluoxetine,0.04348,organic chemical - pharmacologic substance
82,tic-disorders,personal satisfaction,0.04348,finding
82,tic-disorders,pregnancy test negative,0.04348,finding - laboratory or test result
82,tic-disorders,neurological observations,0.04348,finding
82,tic-disorders,chronic disease,0.04348,disease or syndrome
82,tic-disorders,psychotic disorders,0.03261,mental or behavioral dysfunction
82,tic-disorders,pervasive development disorder,0.03261,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
82,tic-disorders,malaise,0.03261,finding - sign or symptom
82,tic-disorders,hepatic,0.03261,body location or region
82,tic-disorders,pharmaceutical preparations,0.03261,pharmacologic substance
82,tic-disorders,active brand of pseudoephedrine-triprolidine,0.03261,organic chemical - pharmacologic substance
82,tic-disorders,psychotropic drugs,0.03261,pharmacologic substance
82,tic-disorders,anticonvulsants,0.03261,pharmacologic substance
82,tic-disorders,disease of diaphragm,0.03261,body part, organ, or organ component - disease or syndrome
82,tic-disorders,sexual intercourse - finding,0.03261,finding
82,tic-disorders,pharmacotherapy,0.03261,therapeutic or preventive procedure
82,tic-disorders,sterility,0.03261,pathologic function
82,tic-disorders,schizophrenia,0.03261,mental or behavioral dysfunction
82,tic-disorders,contraception barrier,0.03261,therapeutic or preventive procedure
82,tic-disorders,developmental disabilities,0.03261,mental or behavioral dysfunction
82,tic-disorders,disability,0.02174,finding
82,tic-disorders,stimulant,0.02174,pharmacologic substance
82,tic-disorders,magnetic resonance imaging,0.02174,diagnostic procedure
82,tic-disorders,bipolar disorder,0.02174,mental or behavioral dysfunction
82,tic-disorders,caffeine,0.02174,organic chemical - pharmacologic substance - therapeutic or preventive procedure
82,tic-disorders,traumatic brain injury,0.02174,disease or syndrome - injury or poisoning
82,tic-disorders,liver function,0.02174,organ or tissue function
82,tic-disorders,substance abuse problem,0.02174,mental or behavioral dysfunction
82,tic-disorders,operative surgical procedures,0.02174,diagnostic procedure - therapeutic or preventive procedure
82,tic-disorders,heart diseases,0.02174,disease or syndrome
82,tic-disorders,medical history,0.02174,finding
82,tic-disorders,unipolar depression,0.02174,mental or behavioral dysfunction
82,tic-disorders,electrocardiogram,0.02174,diagnostic procedure - finding - organic chemical - pharmacologic substance
82,tic-disorders,mild adverse event,0.02174,finding
82,tic-disorders,atypia morphology,0.02174,finding
82,tic-disorders,autistic disorder,0.02174,mental or behavioral dysfunction
82,tic-disorders,mood disorders,0.02174,mental or behavioral dysfunction
82,tic-disorders,screening for cancer,0.02174,diagnostic procedure
82,tic-disorders,treatment-psychosocial effects,0.02174,finding
82,tic-disorders,hypertensive disease,0.02174,biologically active substance - disease or syndrome - finding
82,tic-disorders,weighing patient,0.02174,diagnostic procedure - finding
82,tic-disorders,injury wounds,0.02174,body substance - injury or poisoning
82,tic-disorders,nervous system disorder,0.02174,disease or syndrome
82,tic-disorders,hypersensitivity,0.02174,clinical attribute - finding - pathologic function
82,tic-disorders,cognitive therapy,0.02174,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
82,tic-disorders,vital signs,0.02174,clinical attribute
82,tic-disorders,kidney diseases,0.01087,disease or syndrome
82,tic-disorders,psychiatric problem,0.01087,mental or behavioral dysfunction
82,tic-disorders,liver diseases,0.01087,disease or syndrome
82,tic-disorders,positive finding,0.01087,finding
82,tic-disorders,blood vessel,0.01087,body part, organ, or organ component - finding
82,tic-disorders,anxiety generalized,0.01087,mental or behavioral dysfunction
82,tic-disorders,generalized anxiety disorder,0.01087,mental or behavioral dysfunction
82,tic-disorders,craniocerebral trauma,0.01087,injury or poisoning
82,tic-disorders,post-traumatic stress disorder,0.01087,mental or behavioral dysfunction
82,tic-disorders,cocaine,0.01087,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
82,tic-disorders,unstable status,0.01087,finding
82,tic-disorders,stress disorders traumatic,0.01087,mental or behavioral dysfunction
82,tic-disorders,agitation,0.01087,finding - sign or symptom
82,tic-disorders,blind vision,0.01087,disease or syndrome
82,tic-disorders,brain injuries,0.01087,injury or poisoning
82,tic-disorders,dementia,0.01087,mental or behavioral dysfunction
82,tic-disorders,aggressive behavior,0.01087,mental or behavioral dysfunction
82,tic-disorders,infantile neuroaxonal dystrophy,0.01087,disease or syndrome
82,tic-disorders,sexually active,0.01087,finding
82,tic-disorders,stimulation procedure,0.01087,therapeutic or preventive procedure
82,tic-disorders,cerebrovascular accident,0.01087,disease or syndrome - therapeutic or preventive procedure
82,tic-disorders,therapeutic brand of coal tar,0.01087,organic chemical - pharmacologic substance - therapeutic or preventive procedure
82,tic-disorders,malignant neoplasms,0.01087,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
83,tobacco-use-disorder,smoke,0.16995,hazardous or poisonous substance - individual behavior
83,tobacco-use-disorder,contraceptive methods,0.13657,therapeutic or preventive procedure
83,tobacco-use-disorder,intravenous infusion procedures,0.12898,therapeutic or preventive procedure
83,tobacco-use-disorder,nicotine dependence,0.10926,mental or behavioral dysfunction
83,tobacco-use-disorder,physical assessment findings,0.08953,finding
83,tobacco-use-disorder,gravidity,0.08649,finding
83,tobacco-use-disorder,ethanol,0.07436,organic chemical - pharmacologic substance
83,tobacco-use-disorder,negative finding,0.06829,finding
83,tobacco-use-disorder,medical history,0.06829,finding
83,tobacco-use-disorder,pregnancy tests,0.06222,diagnostic procedure
83,tobacco-use-disorder,personal satisfaction,0.05918,finding
83,tobacco-use-disorder,active brand of pseudoephedrine-triprolidine,0.05615,organic chemical - pharmacologic substance
83,tobacco-use-disorder,schizophrenia,0.05311,mental or behavioral dysfunction
83,tobacco-use-disorder,body mass index,0.04856,clinical attribute - diagnostic procedure
83,tobacco-use-disorder,pharmacologic substance,0.04704,pharmacologic substance - therapeutic or preventive procedure
83,tobacco-use-disorder,malignant neoplasms,0.04704,biologically active substance - finding - neoplastic process - pharmacologic substance - therapeutic or preventive procedure
83,tobacco-use-disorder,infantile neuroaxonal dystrophy,0.03642,disease or syndrome
83,tobacco-use-disorder,multiple endocrine neoplasia,0.0349,antibiotic - neoplastic process - organic chemical
83,tobacco-use-disorder,schizoaffective disorder,0.03187,mental or behavioral dysfunction
83,tobacco-use-disorder,pharmaceutical preparations,0.03187,pharmacologic substance
83,tobacco-use-disorder,marihuana,0.03035,mental or behavioral dysfunction - organic chemical - pharmacologic substance
83,tobacco-use-disorder,unstable status,0.02883,finding
83,tobacco-use-disorder,follow-up status,0.02883,finding
83,tobacco-use-disorder,severe combined immunodeficiency,0.02731,diagnostic procedure - disease or syndrome
83,tobacco-use-disorder,antipsychotic agents,0.0258,pharmacologic substance
83,tobacco-use-disorder,mass of body structure,0.0258,finding
83,tobacco-use-disorder,moderate adverse event,0.02428,finding
83,tobacco-use-disorder,illicit drugs,0.02276,hazardous or poisonous substance - pharmacologic substance
83,tobacco-use-disorder,serum,0.02276,biologically active substance - body substance - pharmacologic substance
83,tobacco-use-disorder,depressed mood,0.02276,finding - mental or behavioral dysfunction
83,tobacco-use-disorder,mental disorders,0.02276,mental or behavioral dysfunction
83,tobacco-use-disorder,electrocardiogram,0.02124,diagnostic procedure - finding - organic chemical - pharmacologic substance
83,tobacco-use-disorder,breast,0.01973,body part, organ, or organ component
83,tobacco-use-disorder,substance abuse problem,0.01973,mental or behavioral dysfunction
83,tobacco-use-disorder,consumption-archaic term for tb,0.01973,disease or syndrome
83,tobacco-use-disorder,liver function,0.01821,organ or tissue function
83,tobacco-use-disorder,hypersensitivity,0.01821,clinical attribute - finding - pathologic function
83,tobacco-use-disorder,psychotic disorders,0.01669,mental or behavioral dysfunction
83,tobacco-use-disorder,asthma,0.01669,disease or syndrome
83,tobacco-use-disorder,contraception barrier,0.01669,therapeutic or preventive procedure
83,tobacco-use-disorder,opiates,0.01669,hazardous or poisonous substance - mental or behavioral dysfunction - pharmacologic substance
83,tobacco-use-disorder,screening for cancer,0.01669,diagnostic procedure
83,tobacco-use-disorder,relate - vinyl resin,0.01517,organic chemical
83,tobacco-use-disorder,hypertensive disease,0.01517,biologically active substance - disease or syndrome - finding
83,tobacco-use-disorder,pharmacotherapy,0.01366,therapeutic or preventive procedure
83,tobacco-use-disorder,myocardial infarction,0.01366,disease or syndrome - finding
83,tobacco-use-disorder,positive finding,0.01366,finding
83,tobacco-use-disorder,alcoholic intoxication chronic,0.01366,mental or behavioral dysfunction
83,tobacco-use-disorder,caffeine,0.01366,organic chemical - pharmacologic substance - therapeutic or preventive procedure
83,tobacco-use-disorder,operative surgical procedures,0.01366,diagnostic procedure - therapeutic or preventive procedure
83,tobacco-use-disorder,angina pectoris,0.01366,sign or symptom
83,tobacco-use-disorder,bipolar disorder,0.01214,mental or behavioral dysfunction
83,tobacco-use-disorder,arteries,0.01062,body part, organ, or organ component
83,tobacco-use-disorder,unipolar depression,0.01062,mental or behavioral dysfunction
83,tobacco-use-disorder,allergy severity - severe,0.01062,finding
83,tobacco-use-disorder,angina unstable,0.01062,disease or syndrome
83,tobacco-use-disorder,alcohol consumption,0.01062,individual behavior
83,tobacco-use-disorder,hepatic,0.0091,body location or region
83,tobacco-use-disorder,post-traumatic stress disorder,0.0091,mental or behavioral dysfunction
83,tobacco-use-disorder,observation of attack,0.0091,finding
83,tobacco-use-disorder,cardiac arrhythmia,0.0091,finding - pathologic function
83,tobacco-use-disorder,investigational new drugs,0.0091,pharmacologic substance - therapeutic or preventive procedure
83,tobacco-use-disorder,alcohol abuse,0.0091,mental or behavioral dysfunction
83,tobacco-use-disorder,hiv,0.00759,disease or syndrome - pharmacologic substance - virus
83,tobacco-use-disorder,chronic obstructive airway disease,0.00759,disease or syndrome
83,tobacco-use-disorder,magnetic resonance imaging,0.00759,diagnostic procedure
83,tobacco-use-disorder,blood vessel,0.00759,body part, organ, or organ component - finding
83,tobacco-use-disorder,cocaine,0.00759,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
83,tobacco-use-disorder,injury wounds,0.00759,body substance - injury or poisoning
83,tobacco-use-disorder,antidepressive agents,0.00759,pharmacologic substance
83,tobacco-use-disorder,major depressive disorder,0.00759,mental or behavioral dysfunction
83,tobacco-use-disorder,psychotropic drugs,0.00607,pharmacologic substance
83,tobacco-use-disorder,blood pressure finding,0.00607,finding
83,tobacco-use-disorder,congenital abnormality,0.00607,congenital abnormality - disease or syndrome
83,tobacco-use-disorder,counter brand of terbufos,0.00607,hazardous or poisonous substance
83,tobacco-use-disorder,impaired cognition,0.00607,finding - mental or behavioral dysfunction
83,tobacco-use-disorder,heart diseases,0.00607,disease or syndrome
83,tobacco-use-disorder,anxiety disorders,0.00455,finding - mental or behavioral dysfunction
83,tobacco-use-disorder,benzodiazepines,0.00455,organic chemical - pharmacologic substance
83,tobacco-use-disorder,claustrophobia,0.00455,mental or behavioral dysfunction
83,tobacco-use-disorder,drugs non-prescription,0.00455,pharmacologic substance - therapeutic or preventive procedure
83,tobacco-use-disorder,systolic pressure,0.00455,clinical attribute - diagnostic procedure
83,tobacco-use-disorder,craniocerebral trauma,0.00455,injury or poisoning
83,tobacco-use-disorder,mercury,0.00455,hazardous or poisonous substance
83,tobacco-use-disorder,attention deficit hyperactivity disorder,0.00455,disease or syndrome - mental or behavioral dysfunction
83,tobacco-use-disorder,drug abuse,0.00455,mental or behavioral dysfunction
83,tobacco-use-disorder,stimulant,0.00455,pharmacologic substance
83,tobacco-use-disorder,diabetes,0.00455,disease or syndrome
83,tobacco-use-disorder,kidney diseases,0.00303,disease or syndrome
83,tobacco-use-disorder,epilepsy,0.00303,disease or syndrome
83,tobacco-use-disorder,manic,0.00303,finding - mental or behavioral dysfunction
83,tobacco-use-disorder,monoamine oxidase inhibitors,0.00303,organic chemical - pharmacologic substance
83,tobacco-use-disorder,liver diseases,0.00303,disease or syndrome
83,tobacco-use-disorder,insulin,0.00303,pharmacologic substance
83,tobacco-use-disorder,suicide attempt,0.00303,finding - mental or behavioral dysfunction
83,tobacco-use-disorder,diastole,0.00303,clinical attribute
83,tobacco-use-disorder,suicidal,0.00152,finding
83,tobacco-use-disorder,anti-anxiety agents,0.00152,pharmacologic substance
83,tobacco-use-disorder,cardiovascular diseases,0.00152,disease or syndrome
83,tobacco-use-disorder,unconscious state,0.00152,disease or syndrome - finding
83,tobacco-use-disorder,consciousness related finding,0.00152,finding
83,tobacco-use-disorder,opioids,0.00152,hazardous or poisonous substance - organic chemical - pharmacologic substance
83,tobacco-use-disorder,dementia,0.00152,mental or behavioral dysfunction
83,tobacco-use-disorder,cerebrovascular accident,0.00152,disease or syndrome - therapeutic or preventive procedure
84,tourette-syndrome,tic disorder,0.6875,mental or behavioral dysfunction
84,tourette-syndrome,intravenous infusion procedures,0.4375,therapeutic or preventive procedure
84,tourette-syndrome,contraceptive methods,0.1625,therapeutic or preventive procedure
84,tourette-syndrome,negative finding,0.1375,finding
84,tourette-syndrome,pregnancy tests,0.1375,diagnostic procedure
84,tourette-syndrome,mental disorders,0.1375,mental or behavioral dysfunction
84,tourette-syndrome,movement disorders,0.125,disease or syndrome
84,tourette-syndrome,ethanol,0.125,organic chemical - pharmacologic substance
84,tourette-syndrome,attention deficit hyperactivity disorder,0.125,disease or syndrome - mental or behavioral dysfunction
84,tourette-syndrome,physical assessment findings,0.125,finding
84,tourette-syndrome,osteochondritis dissecans,0.1125,disease or syndrome - mental or behavioral dysfunction
84,tourette-syndrome,gravidity,0.1125,finding
84,tourette-syndrome,obsessive-compulsive disorder,0.1125,disease or syndrome - mental or behavioral dysfunction
84,tourette-syndrome,pharmacologic substance,0.1,pharmacologic substance - therapeutic or preventive procedure
84,tourette-syndrome,antipsychotic agents,0.1,pharmacologic substance
84,tourette-syndrome,moderate adverse event,0.1,finding
84,tourette-syndrome,allergy severity - severe,0.1,finding
84,tourette-syndrome,compulsive disorder,0.0875,finding
84,tourette-syndrome,serum,0.075,biologically active substance - body substance - pharmacologic substance
84,tourette-syndrome,treatment protocols,0.0625,therapeutic or preventive procedure
84,tourette-syndrome,relate - vinyl resin,0.0625,organic chemical
84,tourette-syndrome,current therapy,0.0625,therapeutic or preventive procedure
84,tourette-syndrome,hyperactive behavior,0.05,finding
84,tourette-syndrome,anxiety disorders,0.05,finding - mental or behavioral dysfunction
84,tourette-syndrome,integumentary scale,0.05,body part, organ, or organ component
84,tourette-syndrome,fluoxetine,0.05,organic chemical - pharmacologic substance
84,tourette-syndrome,psychotropic drugs,0.05,pharmacologic substance
84,tourette-syndrome,pregnancy test negative,0.05,finding - laboratory or test result
84,tourette-syndrome,depressed mood,0.05,finding - mental or behavioral dysfunction
84,tourette-syndrome,chronic disease,0.05,disease or syndrome
84,tourette-syndrome,epilepsy,0.0375,disease or syndrome
84,tourette-syndrome,psychotic disorders,0.0375,mental or behavioral dysfunction
84,tourette-syndrome,pervasive development disorder,0.0375,congenital abnormality - inorganic chemical - mental or behavioral dysfunction - pharmacologic substance
84,tourette-syndrome,nervousness,0.0375,sign or symptom
84,tourette-syndrome,malaise,0.0375,finding - sign or symptom
84,tourette-syndrome,hepatic,0.0375,body location or region
84,tourette-syndrome,pharmaceutical preparations,0.0375,pharmacologic substance
84,tourette-syndrome,personal satisfaction,0.0375,finding
84,tourette-syndrome,congenital abnormality,0.0375,congenital abnormality - disease or syndrome
84,tourette-syndrome,contraception barrier,0.0375,therapeutic or preventive procedure
84,tourette-syndrome,sterility,0.0375,pathologic function
84,tourette-syndrome,schizophrenia,0.0375,mental or behavioral dysfunction
84,tourette-syndrome,neurological observations,0.0375,finding
84,tourette-syndrome,developmental disabilities,0.0375,mental or behavioral dysfunction
84,tourette-syndrome,disability,0.025,finding
84,tourette-syndrome,stimulant,0.025,pharmacologic substance
84,tourette-syndrome,magnetic resonance imaging,0.025,diagnostic procedure
84,tourette-syndrome,bipolar disorder,0.025,mental or behavioral dysfunction
84,tourette-syndrome,caffeine,0.025,organic chemical - pharmacologic substance - therapeutic or preventive procedure
84,tourette-syndrome,active brand of pseudoephedrine-triprolidine,0.025,organic chemical - pharmacologic substance
84,tourette-syndrome,disease of diaphragm,0.025,body part, organ, or organ component - disease or syndrome
84,tourette-syndrome,substance abuse problem,0.025,mental or behavioral dysfunction
84,tourette-syndrome,heart diseases,0.025,disease or syndrome
84,tourette-syndrome,unipolar depression,0.025,mental or behavioral dysfunction
84,tourette-syndrome,electrocardiogram,0.025,diagnostic procedure - finding - organic chemical - pharmacologic substance
84,tourette-syndrome,mood disorders,0.025,mental or behavioral dysfunction
84,tourette-syndrome,screening for cancer,0.025,diagnostic procedure
84,tourette-syndrome,treatment-psychosocial effects,0.025,finding
84,tourette-syndrome,hypertensive disease,0.025,biologically active substance - disease or syndrome - finding
84,tourette-syndrome,weighing patient,0.025,diagnostic procedure - finding
84,tourette-syndrome,nervous system disorder,0.025,disease or syndrome
84,tourette-syndrome,cognitive therapy,0.025,diagnostic procedure - enzyme - hazardous or poisonous substance - therapeutic or preventive procedure
84,tourette-syndrome,kidney diseases,0.0125,disease or syndrome
84,tourette-syndrome,psychiatric problem,0.0125,mental or behavioral dysfunction
84,tourette-syndrome,liver diseases,0.0125,disease or syndrome
84,tourette-syndrome,anxiety generalized,0.0125,mental or behavioral dysfunction
84,tourette-syndrome,traumatic brain injury,0.0125,disease or syndrome - injury or poisoning
84,tourette-syndrome,generalized anxiety disorder,0.0125,mental or behavioral dysfunction
84,tourette-syndrome,operative surgical procedures,0.0125,diagnostic procedure - therapeutic or preventive procedure
84,tourette-syndrome,medical history,0.0125,finding
84,tourette-syndrome,post-traumatic stress disorder,0.0125,mental or behavioral dysfunction
84,tourette-syndrome,cocaine,0.0125,hazardous or poisonous substance - injury or poisoning - organic chemical - pharmacologic substance
84,tourette-syndrome,infantile neuroaxonal dystrophy,0.0125,disease or syndrome
84,tourette-syndrome,atypia morphology,0.0125,finding
84,tourette-syndrome,unstable status,0.0125,finding
84,tourette-syndrome,autistic disorder,0.0125,mental or behavioral dysfunction
84,tourette-syndrome,agitation,0.0125,finding - sign or symptom
84,tourette-syndrome,stress disorders traumatic,0.0125,mental or behavioral dysfunction
84,tourette-syndrome,blind vision,0.0125,disease or syndrome
84,tourette-syndrome,dementia,0.0125,mental or behavioral dysfunction
84,tourette-syndrome,aggressive behavior,0.0125,mental or behavioral dysfunction
84,tourette-syndrome,hypersensitivity,0.0125,clinical attribute - finding - pathologic function
84,tourette-syndrome,sexually active,0.0125,finding
84,tourette-syndrome,stimulation procedure,0.0125,therapeutic or preventive procedure
84,tourette-syndrome,vital signs,0.0125,clinical attribute
84,tourette-syndrome,cerebrovascular accident,0.0125,disease or syndrome - therapeutic or preventive procedure
84,tourette-syndrome,therapeutic brand of coal tar,0.0125,organic chemical - pharmacologic substance - therapeutic or preventive procedure
84,tourette-syndrome,brain injuries,0.0125,injury or poisoning
